adrenoceptor
wide
distribut
activ
either
norepinephrin
releas
sympathet
nerv
termin
epinephrin
releas
adren
medulla
receptor
activ
mediat
varieti
function
includ
contract
smooth
muscl
cardiac
stimul
cellular
prolifer
activ
hepat
gluconeogenesi
glycolysi
cn
activ
adrenoceptor
result
depolar
increas
neuron
fire
rate
popul
plasma
membran
rat
heart
ventricl
consist
subtyp
constant
concentr
radioligand
hprazosin
nm
incub
increas
concentr
nonlabel
test
drug
mm
presenc
plasma
membran
rat
heart
ventricl
test
drug
exhibit
affin
abl
compet
radioligand
receptor
bind
thu
lower
concentr
rang
test
drug
competit
reaction
occur
potent
test
drug
assay
use
evalu
concentrationbind
characterist
drug
atria
adrenoceptor
male
spraguedawley
rat
g
sacrif
decapit
dissect
heart
place
icecold
prepar
buffer
remov
atria
ventricl
approx
g
rat
minc
scalpel
mm
piec
ventricl
homogen
ultraturrax
g
ml
prepar
buffer
homogen
filter
gauz
centrifug
g
min
pellet
discard
supernat
collect
centrifug
g
min
result
pellet
resuspend
approx
ml
prepar
buffer
b
homogen
ultraturrax
centrifug
final
pellet
dissolv
ultraturrax
prepar
buffer
b
correspond
g
ventricl
wet
ml
buffer
membran
suspens
immedi
store
aliquot
ml
protein
content
membran
suspens
determin
accord
method
lowri
et
al
bovin
serum
albumin
standard
day
experi
requir
volum
membran
suspens
slowli
thaw
centrifug
g
min
pellet
resuspend
volum
icecold
rins
buffer
yield
membran
suspens
protein
content
mgml
homogen
ultraturrax
membran
suspens
stir
cool
min
start
experi
concentr
sampl
prepar
triplic
total
volum
incub
sampl
microtit
plate
bind
reaction
start
ad
membran
suspens
per
incub
sampl
mg
proteinml
sampl
incub
min
shake
bath
reaction
stop
withdraw
total
incub
volum
rapid
vacuum
filtrat
glass
fiber
filter
therebi
membranebound
radioact
separ
free
activ
filter
wash
immedi
approx
ml
icecold
rins
buffer
per
sampl
retain
membranebound
radioact
filter
measur
addit
ml
liquid
scintil
cocktail
per
sampl
liquid
scintil
counter
follow
paramet
calcul
total
bind
nonspecif
bind
specif
bind
total
bindingnonspecif
bind
dissoci
constant
k
test
drug
determin
competit
experi
hprazosin
versu
nonlabel
drug
computersupport
analysi
bind
data
ic
concentr
test
drug
compet
specif
bound
hprazosin
competit
experi
h
concentr
hprazosin
competit
experi
k
h
dissoci
constant
hprazosin
determin
satur
experi
k
valu
test
drug
concentr
receptor
occupi
test
drug
affin
constant
k
moll
record
serv
paramet
assess
efficaci
test
drug
bind
hwb
adrenerg
receptor
brain
use
test
hypotens
activ
possibl
side
effect
neurolept
drug
test
describ
chapter
neurolept
activ
couldwel
et
al
found
rat
prostat
gland
possess
typic
adrenoceptor
similar
found
va
deferen
sever
subtyp
adrenoceptor
identifi
pharmacolog
mean
adrenoceptor
endoh
et
al
et
al
ohmura
et
al
regan
cotecchia
satoh
et
al
schwinn
lomasney
veenstra
et
al
aboud
et
al
oshita
et
al
varga
et
al
ruffolo
et
al
minneman
esbenshad
alexand
et
al
recombin
technolog
adrenoceptor
correspond
pharmacolog
defin
adrenoceptor
nativ
tissu
bylund
et
al
bylund
et
al
hiebl
et
al
graham
et
al
hiebl
ruffolo
alexand
et
al
hawrylyshyn
et
al
waitl
bind
radioligand
h
prazosin
adrenoceptor
subtyp
measur
membran
prepar
male
wistar
rat
submaxillari
gland
michel
et
al
bind
radioligand
h
prazosin
adrenoceptor
subtyp
measur
membran
prepar
male
wistar
rat
liver
adolfo
et
al
accord
eltz
boer
adrenoceptor
agonist
sdz
nvi
discrimin
adrenoceptor
subtyp
va
deferen
kidney
aorta
rat
may
therefor
use
tool
either
detect
rat
va
deferen
kidney
exclud
rat
aorta
function
involv
smooth
muscl
contract
stam
et
al
found
cyclazosin
behav
select
highaffin
adrenoceptor
ligand
bind
experi
show
profil
adrenoceptor
antagonist
function
tissu
decreas
blood
pressur
respons
mice
defici
adrenerg
receptor
found
caval
et
al
kenni
et
al
use
contractil
respons
rat
aorta
adrenalin
applic
variou
adrenoceptor
antagonist
character
adrenoceptor
adrenoceptor
wide
distribut
activ
norepinephrin
releas
sympathet
nerv
termin
epinephrin
releas
adren
medulla
neuron
cn
extens
character
action
prejunct
mediat
inhibit
releas
neurotransmitt
mani
peripher
central
neuron
adrenoceptor
also
present
postjunct
site
mediat
action
smooth
muscl
contract
platelet
aggreg
inhibit
insulin
secret
activ
postsynapt
brainstem
result
inhibit
sympathet
outflow
peripheri
clonidin
centrallyact
antihypertens
agent
lower
blood
pressur
mostli
reduc
sympathet
tone
act
nucleu
tractu
solitariu
brain
stem
kobing
walland
clonidin
howev
act
peripher
central
receptor
peripher
administ
clonidin
caus
brief
increas
blood
pressur
follow
prolong
decreas
rand
wilson
function
studi
hne
releas
indic
presynapt
mechan
clonidin
langer
langer
stark
howev
lesion
studi
fail
confirm
presynapt
locat
clonidin
receptor
either
cn
peripheri
uprichard
et
al
bylund
martinez
uprichard
et
al
chang
clonidin
receptor
site
seen
lesion
cerebr
cortex
may
due
fact
receptor
preand
postsynapt
hiebl
et
al
alphaadrenerg
agonist
potent
displac
hclonidin
ergot
compound
dopamin
agonist
mianserin
also
fairli
potent
uprichard
et
al
survey
function
mediat
adrenerg
receptor
given
ruffolo
et
al
role
neurotransmitt
central
regul
cardiovascular
system
mccall
although
clonidin
reliev
autonom
symptom
morphin
withdraw
gold
et
al
evid
direct
opiatereceptor
interact
purpos
assay
assess
interact
hypotens
agent
central
receptor
determin
possibl
clonidinelik
mechan
action
clonidin
bind
may
also
relev
activ
class
drug
antidepress
interact
receptor
yield
tri
hcl
ph
contain
nacl
mm
kcl
mm
cacl
mm
mgcl
mm
h
clonidin
hydrochlorid
obtain
new
england
nuclear
ic
determin
hclonidin
made
concentr
nm
ad
tube
yield
final
concentr
nm
ml
volum
assay
stock
solut
mm
clonidin
made
determin
nonspecif
bind
yield
final
concentr
assay
ml
test
compound
assay
mm
stock
solut
made
suitabl
solvent
serial
dilut
final
concentr
assay
rang
seven
concentr
use
assay
higher
lower
concentr
use
depend
potenc
drug
male
wistar
rat
sacrif
decapit
cortic
tissu
rapidli
dissect
tissu
homogen
volum
tri
buffer
ph
buffer
brinkman
polytron
centrifug
g
min
supernat
discard
final
pellet
rehomogen
volum
buffer
tissu
suspens
store
ice
final
tissu
concentr
mgml
specif
bind
total
ad
ligand
total
bound
ligand
tissu
homogen
incub
min
nm
hclonidin
vari
drug
concentr
immedi
filter
reduc
pressur
whatman
gfb
filter
filter
wash
five
ml
volum
tri
buffer
ph
transfer
scintil
vial
specif
clonidin
bind
defin
differ
total
bound
radioact
bound
presenc
clonidin
ic
calcul
perform
use
logprobit
analysi
percent
inhibit
drug
concentr
mean
triplic
determin
perri
uprichard
describ
h
rauwolscin
specif
radioligand
brain
adrenerg
receptor
goldberg
robertson
review
yohimbin
pharmacolog
probe
studi
adrenoreceptor
pimoul
et
al
character
h
rx
specif
adrenoceptor
antagonist
radioligand
murphi
bylund
character
adrenerg
receptor
ok
cell
opossum
kidney
cell
line
bind
radioligand
h
rauwolscin
adrenoceptor
subtyp
measur
membran
prepar
rabbit
spleen
michel
et
al
bind
radioligand
h
yohimbin
adrenoceptor
subtyp
measur
membran
prepar
male
wistar
rat
kidney
cortic
connaughton
docherti
use
hrauwolscin
ligand
broadhurst
et
al
studi
exist
two
alpha
adrenoreceptor
subtyp
bylund
et
al
use
h
yohimbin
h
rauwolscin
studi
adrenerg
subtyp
tissu
cell
line
contain
one
subtyp
brown
et
al
found
h
yohimbin
label
adrenoceptor
wherea
h
idazoxan
label
adrenoceptor
addit
imidazolin
bind
site
sever
subtyp
adrenoceptor
identifi
pharmacolog
mean
adrenoceptor
ruffulo
wikberg
gleason
hiebl
satoh
takayanagi
takano
et
al
ruffolo
et
al
recombin
technolog
bylund
et
al
hiebl
et
al
hiebl
ruffolo
alexand
et
al
waitl
gleason
hiebl
report
human
retinoblastoma
cell
line
may
repres
addit
exampl
et
al
recommend
use
recombin
human
adrenoceptor
character
subtyp
select
antagonist
bind
three
adrenoceptor
type
serv
autoreceptor
postganglion
sympathet
neuron
trendelenburg
et
al
et
al
found
adrenerg
radioligand
h
select
among
human
adrenoceptor
et
al
test
bind
radioligand
h
human
guinea
pig
pig
adrenoceptor
compar
valu
rauwolscin
yohimbin
h
nonselect
adrenoceptor
subtyp
show
high
affin
three
exist
presynapt
receptor
regul
evok
releas
neurotransmitt
function
demonstr
peripher
central
nervou
system
langer
stark
raiteri
et
al
miller
presynapt
adrenerg
receptor
regul
evok
releas
norepinephrin
compris
short
neg
feedback
loop
agonist
clonidin
guanabenz
inhibit
evok
releas
antagonist
yohimbin
idazoxan
enhanc
evok
releas
assay
use
biochem
screen
agent
enhanc
inhibit
releas
h
norepinephrin
hne
particularli
use
test
receptor
function
adrenerg
agonist
antagonist
procedur
use
emphas
delic
care
slice
treat
slice
great
care
one
abl
incub
low
tracer
concentr
hne
nm
thu
minim
nonspecif
label
releas
pool
noradrenerg
nerv
termin
also
permit
use
low
physiolog
stimul
paramet
allow
neuron
recov
easili
stimul
flood
synapt
cleft
releas
ne
would
compet
appli
drug
thu
decreas
sensit
assay
base
method
describ
zahnis
et
al
made
individu
remov
razor
blade
twirl
artist
paint
brush
underneath
slice
care
taken
compress
slice
impal
bristl
slice
place
cold
oxygen
buffer
ml
incub
min
oxygen
incub
buffer
decant
leav
slice
behind
ml
cold
oxygen
buffer
ad
enough
h
ne
bring
final
concentr
nm
incub
shaken
min
oxygen
step
buffer
decant
load
slice
rapidli
place
nylon
mesh
stimul
chamber
use
cutoff
pipetman
tip
assay
establish
stabl
baselin
control
buffer
pump
chamber
h
flow
rate
mlmin
first
stimul
one
hour
allow
pass
second
stimul
drug
use
concentr
prepar
separ
flask
control
buffer
allow
equilibr
tissu
slice
min
second
stimul
experi
stop
min
second
stimul
stimul
paramet
set
hz
ms
durat
ms
delay
voltag
set
siu
experi
complet
chamber
wash
distil
water
least
min
ml
methanol
distil
water
distil
water
least
min
convers
dpm
percent
fraction
releas
calcul
fraction
use
spreadsheet
program
percent
fraction
releas
defin
amount
radiolabel
compound
releas
divid
amount
present
tissu
moment
time
spontan
releas
sp
valu
averag
two
fraction
preced
first
fraction
rang
stimul
period
stimul
sum
differ
percent
fraction
releas
stimul
appropri
sp
valu
effect
drug
report
ratio
normal
data
drug
effect
estim
first
calcul
valu
control
drugtreat
slice
express
valu
drugtreat
slice
percentag
valu
control
slice
experi
condit
test
slice
anim
langer
sz
imidazolin
receptor
constitut
famili
nonadrenerg
highaffin
bind
site
clonidin
idazoxan
alli
drug
drug
select
bind
imidazolin
receptor
expect
less
side
effect
clonidin
ernsberg
et
al
ernsberg
et
al
molder
et
al
limon
et
al
one
major
subclass
receptor
mainli
distribut
brain
brain
stem
partli
mediat
central
hypotens
action
clonidinelik
drug
receptor
subclass
mitochondri
g
protein
coupl
diversifi
function
may
involv
neuroprotect
cerebr
ischemia
two
bind
site
h
paminoclonidin
adrenoceptor
imidazolin
bind
site
could
separ
ernsberg
et
al
bricca
et
al
kamisaki
et
al
least
subtyp
imidazolineguanidiniumrecept
site
found
photoaffin
label
lanier
et
al
sever
endogen
ligand
imidazolin
receptor
collect
term
clonidin
displac
substanc
cdss
detect
tissu
serum
rei
et
al
chan
et
al
endogen
substanc
clonidinelik
properti
origin
isol
brain
bind
select
imidazolin
receptor
describ
atla
burstein
ernsberg
et
al
atla
meeley
et
al
dontenwil
et
al
ragunathan
rei
endogen
substanc
agmatin
decarboxyl
arginin
may
physiolog
agonist
imidazolin
receptor
act
neurotransmitt
gonzal
et
al
head
et
al
herman
rei
regunathan
candid
endogen
ligand
discuss
rei
ragunathan
critic
review
imidazolin
bind
site
given
eglen
et
al
whole
bovin
brain
adren
gland
obtain
local
slaughterhous
later
medulla
oblongata
isol
sagitt
section
later
margin
pyramid
bisect
ventral
half
defin
ventrolater
medulla
fresh
bovin
adren
gland
perfus
retrograd
adren
vein
twice
ml
icecold
krebshenseleit
bicarbon
buffer
gland
perfus
ml
icecold
krebshenseleit
buffer
contain
collagenas
type
sigma
chemic
incub
room
temperatur
h
perfus
ml
fresh
buffer
contain
collagenas
incub
min
digest
gland
split
medulla
remov
cortex
adren
medulla
minc
incub
stir
min
digest
filter
centrifug
g
min
cell
pellet
resuspend
ml
kreb
solut
without
collagenas
recentrifug
flashfrozen
store
fresh
bovin
ventrolater
medulla
collagenasedigest
rat
renal
medulla
homogen
polytron
tekmar
tissum
set
twice
vol
icechil
hepesbuff
isoton
sucros
ph
contain
proteas
inhibitor
phenylmethylsulfonyl
fluorid
bovin
adrenomedullari
chromaffin
cell
homogen
ml
hepesbuff
isoton
sucros
stroke
glassglass
handhold
homogen
homogen
centrifug
g
min
remov
nuclei
debri
pellet
resuspend
ml
homogen
buffer
centrifug
g
min
supernat
centrifug
g
min
result
pellet
resuspend
vol
mm
trishcl
buffer
ph
contain
mm
edta
recentrifug
g
min
result
membran
pellet
resuspend
trishcl
contain
mm
nacl
preincub
min
chill
ice
centrifug
resuspend
final
time
trishcl
alon
centrifug
flashfrozen
store
determin
specif
bind
imidazolin
site
adrenerg
receptor
radioligand
bind
assay
perform
h
clonidin
h
piodoclonidin
h
moxonidin
membran
slowli
thaw
resuspend
trishcl
trishep
buffer
ph
assay
conduct
total
volum
polypropylen
well
plate
beckman
macrowel
well
contain
membran
suspens
radioligand
drug
vehicl
incub
initi
addit
membran
suspens
carri
min
nonspecif
bind
defin
presenc
either
piperoxan
phentolamin
mm
imidazolineadrenerg
agent
specif
adrenerg
bind
defin
epinephrin
mm
experi
catecholamin
sampl
contain
ascorb
acid
final
concentr
incub
termin
vacuum
filtrat
reevesangel
whatman
gfc
fiberglass
filter
use
cell
harvest
brandel
filter
wash
four
time
ml
icecold
trishcl
place
scintil
vial
cover
ml
scintil
cocktail
count
effici
protein
assay
modifi
lowri
et
al
method
peterson
use
deoxycholatetrichloroacet
acid
protein
precipit
techniqu
provid
rapid
quantit
recoveri
solubl
membran
protein
interf
substanc
even
dilut
solut
sodium
dodecyl
sulfat
ad
allevi
possibl
nonion
cation
deterg
lipid
interfer
provid
mild
condit
rapid
denatur
membran
proteolipid
protein
data
obtain
disintegr
per
min
transfer
equilibrium
bind
data
analysi
program
mcpherson
sever
experi
analyz
simultan
ligand
program
nonlinear
curv
fit
munson
rodbard
ic
valu
estim
inhibit
curv
nonlinear
curv
fit
mutolski
ransna
protein
assay
data
also
analyz
nonlinear
curv
fit
mcpherson
tesson
et
al
defin
subcellular
local
imidazolineguanidiniumrecept
site
perform
bind
studi
radioligand
h
idazoxan
lanier
et
al
visual
multipl
imidazolineguanidiniumrecept
site
photoaffin
adduct
iodophenoxi
methyl
imidazolin
molder
et
al
character
imidazolin
receptor
involv
modul
noradrenalin
releas
rabbit
pulmonari
arteri
preincub
h
noradrenalin
molder
determin
electr
k
evok
tritium
overflow
superfus
rabbit
aortic
strip
preincub
h
noradrenalin
order
character
presynapt
imidazolin
receptor
mediat
noradrenalin
releas
compar
imidazolin
radioligand
bind
site
ernsberg
et
al
describ
optim
radioligand
bind
assay
imidazolin
site
munk
et
al
report
synthesi
pharmacolog
evalu
potent
receptor
specif
agent
piletz
et
al
compar
affin
sever
ligand
piodoclonidin
bind
human
platelet
imidazol
bind
site
sever
select
ligand
imidazolin
receptor
identifi
lsl
alemani
et
al
menargu
et
al
mackinnon
et
al
brown
et
al
analogu
jordan
et
al
lion
et
al
alemani
et
al
hosseini
et
al
wiest
steinberg
hudson
et
al
wide
distribut
found
central
peripher
site
activ
either
via
norepinephrin
releas
sympathet
nerv
termin
via
epinephrin
releas
adren
medulla
import
physiolog
consequ
activ
includ
stimul
cardiac
rate
forc
relax
vascular
urogenit
bronchial
smooth
muscl
stimul
renin
secret
juxtaglomerular
apparatu
stimul
insulin
glucagon
secret
endocrin
pancrea
stimul
glycogenolysi
liver
skelet
muscl
stimul
lipolysi
adipocyt
three
protein
clone
characterist
recombin
receptor
correspond
three
well
character
nativ
tissu
design
possibl
role
adrenoceptor
cardiovascular
system
discuss
gauthier
et
al
addit
modulatingcardiac
contractil
design
kaumann
et
al
initi
thought
cardiac
stimul
involv
primarili
adrenoceptor
appear
receptor
subtyp
may
involv
bronchodil
appear
mediat
adrenoceptor
adrenoceptor
respons
lipolysi
white
adipos
tissu
thermogenesi
brown
adipos
tissu
found
rodent
renin
releas
appear
mediat
adrenoceptor
waitl
popul
plasma
membran
bovin
heart
ventricl
consist
adrenoceptor
use
tissu
allow
parallel
investig
bind
characterist
drug
adrenoceptor
adrenoceptor
coexist
rat
ventricular
myocyt
stimul
receptor
subtyp
elicit
qualit
differ
cell
respons
level
ionic
channel
myofila
sarcoplasm
reticulum
xiao
lakatta
constant
concentr
radioligand
hdihydroalprenolol
hdha
nm
incub
increas
concentr
nonlabel
test
drug
mm
presenc
plasma
membran
bovin
heart
ventricl
test
drug
exhibit
affin
abl
compet
radioligand
receptor
bind
site
thu
lower
concentr
rang
test
drug
competit
reaction
occur
effect
test
drug
bind
reaction
start
ad
membran
suspens
per
incub
sampl
approx
mg
proteinml
sampl
incub
min
shake
water
bath
reaction
stop
rapid
vacuum
filtrat
total
incub
volum
glass
fiber
filter
therebi
membranebound
radioact
separ
free
activ
filter
wash
immedi
approx
ml
icecold
rins
buffer
per
sampl
retain
membranebound
radioact
filter
measur
addit
ml
liquid
scintil
cocktail
per
sampl
packard
liquid
scintil
counter
follow
paramet
calcul
total
bind
nonspecif
bind
specif
bind
total
bindingnonspecif
bind
dissoci
constant
k
test
drug
determin
competit
experi
hdha
versu
nonlabel
drug
computersup
uprichard
et
al
bylund
snyder
iodohydroxypindolol
weiland
et
al
dha
potent
mukherje
et
al
label
adrenerg
receptor
bind
characterist
ligand
brain
describ
bylund
snyder
show
antagonist
compet
potent
agonist
less
potent
although
stereospecif
maintain
pharmacolog
bind
consist
receptor
occup
lesion
studi
wolf
et
al
combin
nonlinear
regress
analysi
data
shown
rat
cerebellum
primarili
subtyp
occur
rat
cerebr
cortex
physiolog
signific
assay
use
evalu
direct
interact
drug
label
h
dihydroalprenolol
tri
buffer
ph
g
tri
hcl
qs
liter
tri
ph
g
tri
base
b
dilut
distil
water
tri
ph
h
dihydroalprenolol
hydrochlorid
cimmol
obtain
new
england
nuclear
ic
determin
stock
solut
nm
hdha
made
distil
h
ad
tube
yield
final
concentr
nm
ml
assay
propranolol
hcl
obtain
ayerst
mm
propranolol
stock
solut
made
distil
water
dilut
distil
water
give
propranolol
solut
twenti
dilut
stock
solut
ad
tube
determin
nonspecif
bind
yield
final
concentr
ml
assay
test
compound
assay
mm
stock
solut
made
suitabl
solvent
serial
dilut
final
concentr
assay
rang
seven
concentr
use
assay
higher
lower
concentr
may
use
depend
potenc
compound
male
rat
decapit
brain
rapidli
remov
cerebr
cortic
dissect
free
weigh
homogen
ml
icecold
tri
buffer
ph
homogen
centrifug
g
supernat
decant
pellet
resuspend
recentrifug
g
final
pellet
resuspend
initi
volum
fresh
tri
buffer
ph
tissu
suspens
store
ice
final
tissu
concentr
assay
mgml
specif
bind
total
ad
ligand
total
bound
ligand
assay
h
tri
buffer
ph
vehicl
total
bind
propranolol
nonspecif
bind
appropri
drug
concentr
hdha
stock
solut
tissu
suspens
tissu
homogen
incub
min
nm
hdha
vari
drug
concentr
bind
assay
triplic
sampl
incub
propranolol
ident
condit
determin
nonspecif
bind
assay
stop
vacuum
filtrat
whatman
gfb
filter
wash
time
ml
icecold
tri
buffer
ph
filter
count
ml
liquiscint
scintil
cocktail
percent
inhibit
drug
concentr
mean
triplic
determin
ic
valu
obtain
computerderiv
logprobit
analysi
dooley
et
al
recommend
cgp
use
tool
quantit
adrenoceptor
land
et
al
classifi
subtyp
accord
differ
action
variou
catecholamin
synthesi
select
help
confirm
exist
receptor
subtyp
base
catecholamin
pharmacolog
differ
tissu
distribut
suggest
receptor
serv
receptor
norepinephrin
act
neurotransmitt
receptor
serv
receptor
epinephrin
act
hormon
nahorski
arien
simoni
lefkowitz
et
al
minneman
sinc
h
dihydroalprenolol
nonspecif
ligand
necessari
select
tissu
enrich
receptor
order
convey
specif
assay
tissu
predominantli
includ
lung
uprichard
et
al
arien
simoni
lefkowitz
et
al
cerebellum
lefkowitz
et
al
minneman
et
al
rat
frog
erythrocyt
mukherje
et
al
lefkowitz
et
al
ciliari
process
nathanson
wherea
forebrain
heart
avian
erythrocyt
rel
enrich
subtyp
lefkowitz
et
al
due
poor
bind
characterist
cerebellum
rat
lung
chosen
tissu
adrenerg
receptor
compound
select
would
less
like
produc
cardiac
effect
like
produc
bronchiolar
constrict
test
use
determin
affin
compound
adrenerg
receptor
subtyp
measur
receptor
subtyp
select
determin
data
compar
obtain
adrenerg
assay
rat
cerebr
cortex
present
nomenclatur
receptor
review
alexand
et
al
tissu
homogen
incub
min
nm
hdha
vari
drug
concentr
bind
assay
triplic
sampl
incub
propranolol
ident
condit
determin
nonspecif
bind
assay
stop
vacuum
filtrat
whatman
gfb
filter
wash
time
ml
icecold
tri
buffer
ph
filter
count
ml
liquiscint
scintil
cocktail
percent
inhibit
drug
concentr
mean
triplic
determin
ic
valu
obtain
computerderiv
logprobit
analysi
dooley
et
al
recommend
cgp
use
tool
quantit
adrenoceptor
mccrea
hill
describ
salmeterol
longact
agonist
mediat
cyclic
amp
accumul
neuroblastoma
cell
line
sarsero
et
al
recommend
h
cgp
radioligand
put
adrenoceptor
mcconnel
et
al
mcconnel
et
al
owicki
parc
use
special
apparatu
cytosensor
microphysiomet
measur
rate
proton
excret
cultur
cell
chines
hamster
ovari
cell
transfect
human
adrenerg
receptor
adrenerg
receptor
activ
adenyl
cyclas
result
increas
cyclic
amp
concentr
within
cell
measur
acidif
addit
isoproterenol
cyclic
amp
forskolin
induc
revers
acidif
hoffmann
et
al
compar
human
receptor
subtyp
use
character
stabli
transfect
receptor
cho
cell
cdna
human
receptor
cdna
code
human
receptor
express
vector
verifi
sequenc
comparison
respect
genebank
entri
translat
amino
acid
sequenc
correspond
publish
sequenc
adrenerg
receptor
friell
et
al
adrenerg
receptor
schofield
et
al
adrenerg
receptor
emorin
et
al
respect
polymorph
receptor
use
studi
correspond
follow
variant
receptor
receptor
receptor
variant
correspond
sequenc
origin
term
wildtyp
chines
hamster
ovari
cell
cell
american
type
cultur
collect
rockvil
md
usa
transfect
plasmid
dna
stabl
express
use
calcium
phosphat
precipit
method
chen
okayama
describ
rat
adenosin
receptor
freund
et
al
posit
clone
select
neomycin
analog
singl
clonal
line
isol
limit
dilut
express
receptor
verifi
radioligand
bind
cell
cultur
membran
prepar
chines
hamster
ovari
cell
stabli
transfect
human
receptor
subtyp
grown
adher
maintain
dulbecco
modifi
eagl
medium
nutrient
mixtur
contain
fetal
calf
serum
penicillin
uml
streptomycin
lglutamin
mm
geneticin
mgml
co
air
cell
split
time
weekli
ratio
order
harvest
cell
cultur
medium
remov
cell
wash
twice
pb
membran
prepar
cell
frozen
dish
later
prepar
membran
crude
membran
fraction
prepar
fresh
measur
adenylyl
cyclas
frozen
cell
radioligand
bind
result
membran
pellet
resuspend
mm
trishcl
buffer
ph
give
final
protein
concentr
mgml
radioligand
bind
experi
perform
membran
prepar
describ
assay
done
volum
mm
trishcl
ph
assay
buffer
presenc
gtp
ensur
monophas
bind
curv
agonist
satur
bind
experi
human
pm
icyp
receptor
pm
icyp
use
nonspecif
bind
determin
presenc
alprenolol
competit
bind
pm
icyp
case
receptor
pm
icyp
receptor
use
competit
bind
experi
membran
intermedi
receptor
express
fmolmg
protein
fmolmg
protein
fmolmg
protein
use
select
compound
demonstr
higher
receptor
express
affect
k
valu
data
shown
membran
incub
min
filter
whatman
gfc
filter
wash
time
icecold
assay
buffer
sampl
count
counter
wallac
wizard
k
valu
icyp
calcul
nonlinear
curv
fit
program
sctfit
ligand
ic
valu
calcul
use
origin
originlab
corpor
northampton
mass
usa
transform
k
valu
accord
cheng
prusoff
adenylyl
cyclas
activ
cell
membran
determin
accord
jakob
et
al
membran
protein
ad
incub
mixtur
final
concentr
mm
trishcl
ph
camp
bsa
gtp
atp
mm
mgcl
ibmx
mm
phosphocreatin
uml
creatin
kinas
membran
incub
cpm
p
atp
min
incub
mixtur
describ
klotz
et
al
accumul
p
camp
linear
least
min
condit
reaction
stop
addit
mm
znacsolut
mm
na
co
sampl
centrifug
min
rpm
laboratori
microcentrifug
result
supernat
wase
final
appli
alumina
sigma
column
elut
twice
ml
mm
trishcl
ph
uprichard
dc
bylund
db
snyder
sh
hepinephrin
hdihydroalprenolol
bind
noradrenerg
receptor
brain
heart
lung
membran
j
biol
chem
adenosin
receptor
belong
class
purinoceptor
burnstock
burnstock
olsson
pearson
purinoceptor
divid
two
gener
type
basi
recogn
natur
ligand
p
receptor
recogn
adenosin
amp
p
receptor
recogn
atp
amp
fredholm
et
al
abbracchio
burnstock
jacobson
et
al
propos
nomenclatur
system
wide
accept
two
famili
purinoceptor
ionotrop
ligandg
ion
channel
receptor
north
metabotrop
gproteincoupl
receptor
costanzi
et
al
nomenclatur
seven
subtyp
receptor
six
subtyp
receptor
agre
nciuphar
subcommitte
burnstock
alexand
et
al
waitl
effect
adenosin
mediat
effect
camp
sattin
rall
vancalk
et
al
discov
adenosin
could
either
inhibit
stimul
format
camp
discoveri
dual
effect
adenyl
cyclas
led
propos
two
distinct
adenosin
receptor
refer
receptor
subtyp
adenosin
receptor
mediat
inhibit
adenyl
cyclas
wherea
subtyp
mediat
stimul
adenyl
cyclas
methylxanthin
rel
nonselect
inhibitor
adenosin
receptor
subtyp
pharmacolog
properti
thought
mostli
due
antagon
receptor
comparison
adenosin
receptor
gprotein
link
receptor
indic
compris
famili
g
protein
coupl
receptor
group
subtyp
speci
thu
addit
sever
author
describ
receptor
speci
depend
differ
jacobson
et
al
jacobson
et
al
zhou
et
al
linden
et
al
salvator
et
al
linden
et
al
fredholm
et
al
alexand
et
al
nomenclatur
classif
adenosin
receptor
publish
fredholm
et
al
waitl
klotz
review
adenosin
receptor
ligand
four
subtyp
adenosin
receptor
refer
member
superfamili
gproteincoupl
receptor
recent
discov
member
adenosin
receptor
famili
receptor
uniqu
pharmacolog
profil
salvator
et
al
avila
et
al
purpos
assay
measur
affin
test
compound
adenosin
receptor
evid
adenosin
receptor
guinea
pig
atrium
given
colli
adenosin
play
physiolog
role
mani
system
includ
platelet
aggreg
lipolysi
steroidogenesi
smooth
muscl
tone
dali
vasodilatori
cardiac
depress
effect
adenosin
well
known
addit
cardiovascular
effect
adenosin
mark
effect
cn
includ
depress
electrophysiolog
activ
siggin
schubert
anticonvuls
activ
analges
properti
ahlijanian
takemori
inhibit
neurotransmitt
releas
harm
et
al
agonist
h
cyclohexyladenosin
cha
affin
receptor
nanomolar
concentr
rang
proven
suitabl
ligand
receptor
assay
brun
et
al
brun
et
al
select
schingnitz
et
al
antagonist
shimada
et
al
jacobson
et
al
describ
adenosin
nucleotid
cardiovascular
predominantli
cerebr
activ
philli
wu
dali
fredholm
et
al
tri
buffer
ph
b
tri
buffer
ph
adenosin
deaminas
obtain
sigma
chemic
co
adenosin
deaminas
ad
trishcl
buffer
ph
final
resuspens
membran
pellet
concentr
assay
uml
tissu
cyclohexyladenosin
n
mm
stock
solut
made
deioniz
water
ad
tube
determin
nonspecif
bind
yield
mm
final
concentr
assay
assay
mm
stock
solut
prepar
dmso
serial
dilut
final
concentr
assay
rang
seven
concentr
use
assay
higher
lower
concentr
may
use
depend
potenc
drug
male
wistar
rat
sacrif
decapit
whole
brain
minu
cerebellum
remov
weigh
homogen
volum
icecold
tri
buffer
ph
homogen
centrifug
g
min
supernat
decant
pellet
resuspend
volum
buffer
centrifug
final
pellet
resuspend
tri
buffer
contain
uml
adenosin
deaminas
tube
incub
hour
assay
stop
vacuum
filtrat
whatman
gfb
filter
wash
time
ml
tri
buffer
filter
place
scintil
vial
ml
liquiscintil
cocktail
left
soak
overnight
count
specif
bind
defin
differ
total
bind
bind
presenc
mm
theophyllin
ic
valu
calcul
percent
specif
bind
drug
concentr
complex
interact
adenosin
ligand
receptor
brun
et
al
preclud
simpl
calcul
k
valu
chengprusoff
equat
stile
et
al
use
ilabel
n
ethyladenosin
select
ligand
probe
structur
receptor
lohs
et
al
describ
dpcpx
high
affin
antagonist
radioligand
adenosin
receptor
klotz
et
al
describ
h
cyclopentyladenosin
h
ccpa
high
affin
agonist
radioligand
adenosin
receptor
von
lubitz
et
al
studi
therapeut
implic
chronic
nmda
receptor
stimul
adenosin
receptor
partial
agon
adenosin
receptor
report
ijzerman
et
al
libert
et
al
report
clone
function
character
human
adenosin
receptor
adenosin
deaminas
ad
trishcl
buffer
ph
contain
mm
cacl
final
resuspens
membran
pellet
concentr
assay
uml
tissu
adenosin
specif
activ
mcimmol
obtain
amersham
ic
determin
hneca
made
concentr
nm
ad
tube
yield
final
concentr
nm
assay
cyclopentyladenosin
cpa
obtain
research
biochem
inc
mm
stock
solut
made
dmso
ad
tube
determin
nonspecif
bind
yield
final
concentr
assay
sinc
h
neca
specif
ligand
receptor
cpa
ad
tube
mask
receptor
final
concentr
nm
assay
mm
stock
solut
made
suitabl
solvent
serial
dilut
final
concentr
assay
rang
seven
concentr
use
assay
higher
lower
concentr
may
use
depend
potenc
drug
male
wistar
rat
sacrif
decapit
striata
remov
weigh
homogen
volum
icecold
tri
buffer
ph
homogen
centrifug
g
min
supernat
decant
pellet
resuspend
volum
buffer
centrifug
final
pellet
resuspend
volum
tri
buffer
contain
mm
cacl
uml
adenosin
deaminas
assay
tissu
suspens
cpa
vehicl
cpa
appropri
concentr
test
compound
hneca
tube
incub
hour
assay
stop
vacuum
filtrat
whatman
gfb
filter
wash
time
ml
tri
buffer
filter
place
scintil
vial
ml
liquiscint
scintil
cocktail
left
soak
overnight
count
specif
bind
defin
differ
total
bind
bind
presenc
cpa
ic
valu
calcul
percent
specif
bind
drug
concentr
complex
interact
adenosin
ligand
receptor
preclud
simpl
calcul
k
valu
chengprusoff
equat
jarvi
et
al
report
h
cg
select
adenosin
receptor
agonist
directli
label
receptor
rat
brain
h
cg
bind
greatest
striatal
membran
neglig
specif
bind
obtain
rat
cortic
membran
gurden
et
al
describ
function
character
three
adenosin
receptor
type
hutchinson
et
al
describ
arylalkylamino
uronamid
new
class
highli
select
adenosin
receptor
ligand
adenosin
receptor
rat
striatum
rat
pheochromocytoma
cell
character
radioligand
bind
activ
adenyl
cyclas
hide
et
al
nonaka
et
al
report
e
potent
select
adenosin
receptor
antagonist
vitro
pharmacolog
zm
potent
nonxanthin
select
adenosin
receptor
antagonist
report
poucher
et
al
monopoli
et
al
describ
pharmacolog
select
adenosin
receptor
agonist
nethylcarboxamidoadenosin
jacobson
et
al
describ
structureact
relationship
select
adenosin
antagonist
varani
et
al
report
pharmacolog
biochem
character
purifi
adenosin
receptor
human
platelet
membran
h
cg
bind
van
der
ploeg
et
al
character
adenosin
receptor
human
tcell
leukemia
jurkat
cell
rat
phaeochromocytoma
cell
use
adenosin
receptor
agonist
brun
rf
lu
gh
pugsley
ta
adenosin
receptor
clone
character
zhou
et
al
possibl
role
reproduct
discuss
role
central
adenosin
receptor
may
mediat
behavior
depress
effect
jacobson
et
al
design
select
ligand
adenosin
receptor
therapeut
concept
includ
effect
locomotor
activ
cardiovascular
effect
effect
cerebr
ischemia
von
lubitz
et
al
cardiac
precondit
antagonist
inflamm
asthma
discuss
jacobson
et
al
von
lubitz
et
al
notic
anticonvuls
activ
adenosin
receptor
select
agonist
ibmeca
n
nmethylcarboxamid
stimul
adenosin
receptor
facilit
releas
allerg
mediat
mast
cell
ramkumar
et
al
induc
hypotens
rat
hannon
et
al
bind
site
model
structureact
relationship
rat
adenosin
receptor
describ
van
galen
et
al
nmethylcarboxamidoadenosin
recommend
high
affin
radioligand
rat
adenosin
receptor
olah
et
al
molecular
clone
function
express
sheep
adenosin
receptor
report
linden
et
al
g
proteindepend
activ
phospholipas
c
adenosin
receptor
rat
brain
report
abbracchio
et
al
molecular
clone
character
human
adenosin
receptor
report
salvator
et
al
differenti
interact
rat
adenosin
receptor
multipl
gprotein
describ
palmer
et
al
baraldi
borea
describ
new
potent
select
human
adenosin
receptor
antagonist
use
radioligand
bind
studi
human
receptor
abbracchio
mp
brambilla
r
ceruti
kim
ho
von
lu
bitz
dkje
jacobson
ka
cattabeni
f
g
proteindepend
activ
phospholipas
c
adenosin
receptor
rat
brain
mol
pharmacol
baraldi
pg
borea
pa
new
potent
select
human
adenosin
receptor
antagonist
trend
pharmacol
sci
cheng
yc
prusoff
wh
relationship
inhibit
constant
k
concentr
inhibitor
caus
inhibit
ic
adenosin
regul
multipl
physiolog
function
anim
human
play
potent
neuromodulatori
role
mainli
inhibit
presynapt
transmitt
releas
e
g
glutam
aspart
releas
synapt
stimul
hypoxia
central
peripher
nervou
system
adenosin
play
neuroprotect
role
hypoxia
ischemia
sinc
reduc
excess
stimul
nmda
receptor
use
adenosin
uptak
inhibitor
propos
new
therapeut
strategi
hypoxicischem
diseas
due
vasodilatori
action
adenosin
play
key
role
regul
coronari
cerebr
blood
flow
rapid
cellular
uptak
adenosin
erythrocyt
reason
short
durat
action
adenosin
human
erythrocyt
use
cellular
model
detect
adenosin
uptak
inhibitor
erythrocyt
treat
test
compound
thereaft
incub
hadenosin
uptak
hadenosin
evalu
relat
untreat
control
group
dipyridamol
potent
inhibitor
adenosin
uptak
ic
bufferwash
fresh
human
erythrocyt
deplet
atp
incub
isoton
glycylglycin
buffer
aliquot
erythrocyt
suspens
incub
min
fresh
glycylglycin
buffer
solut
contain
addit
mm
glucos
testor
standard
compound
screen
assay
test
compound
ad
concentr
drug
show
effect
assay
test
concentr
rang
determin
ic
valu
triplic
sampl
concentr
suspens
incub
radioact
label
h
adenosin
adenosin
uptak
stop
ad
cold
buffer
contain
adenosin
glucos
dipyridamol
centrifug
tritium
radioact
determin
supernat
percent
chang
hadenosin
uptak
rel
vehicl
control
group
determin
hadenosin
uptak
control
group
taken
subsequ
result
express
percentag
ic
valu
determin
plot
percent
inhibit
test
compound
concentr
ic
defin
dose
drug
lead
inhibit
adenosin
uptak
statist
evalu
perform
mean
student
ttest
standard
data
ic
dipyridamol
marango
et
al
verma
marango
recommend
h
nitrobenzylthioinosin
bind
probe
studi
adenosin
uptak
site
brain
variou
speci
highest
densiti
bind
site
found
caudat
hypothalamu
human
rat
brain
bowmer
cj
yate
ms
therapeut
potenti
new
select
adenosin
receptor
ligand
metabol
inhibitor
trend
pharmacol
sci
geiger
jd
fyda
dm
adenosin
transport
nervou
system
tissu
stone
tw
ed
adenosin
nervou
system
academ
press
london
san
diego
new
york
pp
marango
pj
patel
j
clarkrosenberg
r
martino
h
nitrobenzylthioinosin
bind
probe
studi
adenosin
uptak
site
brain
j
neurochem
porsch
e
effect
methylxanthin
deriv
adenosin
uptak
human
erythrocyt
irc
med
sci
rudolphi
ka
schubert
p
parkinson
fe
fredholm
bb
adenosin
brain
ischemia
cerebrovasc
brain
metab
rev
verma
marango
pj
nitrobenzylthioinosin
bind
brain
interspeci
studi
life
sci
winn
hr
rubio
gr
bern
rm
role
adenosin
regul
cerebr
blood
flow
j
cerebr
blood
flow
metab
vasopeptidas
inhibitor
vpi
inhibit
angiotensin
convert
enzym
ace
neprilysin
nep
thu
reduc
activ
reninangiotensin
system
potenti
vasodilatori
natriuret
antiprolif
effect
bradykinin
natriuret
peptid
burnett
bralet
schwartz
combin
inhibit
neutral
endopeptidas
nep
ace
candid
therapi
hypertens
cardiac
failur
duncan
et
al
heath
et
al
describ
quantif
dual
aceiconvert
enzymeneutr
endopeptidas
inhibitor
activ
thiol
metabolit
dog
plasma
highperform
liquid
chromatographi
ultraviolet
absorpt
detect
dumoulin
et
al
studi
metabol
bradykinin
rat
coronari
vascular
bed
found
combin
treatment
ace
inhibitor
enalapril
nep
inhibitor
retrothiorphan
reduc
bradykinin
degrad
lower
valu
enalapril
alon
hubner
et
al
report
invitro
invivo
inhibit
rat
neutral
endopeptidas
ace
vasopeptidas
inhibitor
gemopatrilat
dumoulin
et
al
compar
effect
vasopeptidas
inhibitor
neutral
endopeptidas
ace
inhibitor
bradykinin
metabol
rat
coronari
bed
crackow
et
al
describ
ace
essenti
regul
heart
function
three
differ
rat
model
hypertens
messeng
rna
protein
express
markedli
reduc
target
disrupt
mice
result
sever
cardiac
contractil
defect
comparison
vasopeptidas
inhibitor
neutral
endopeptidas
angiotensinconvert
enzym
inhibitor
bradykinin
metabol
rat
coronari
bed
j
cardiovasc
pharmacol
duncan
jame
gm
anastasopoulo
f
kladi
brisco
ta
campbel
dj
interact
neutral
endopeptidas
angiotensin
convert
enzym
rat
myocardi
infarct
effect
cardiac
hypertrophi
angiotensin
bradykinin
peptid
level
j
pharmacol
exp
ther
heath
tg
massad
dd
carrol
ji
mathew
bs
chang
j
scott
kuo
bs
toren
pc
quantif
dual
angiotensin
iconvert
enzymeneutr
endopeptidas
inhibitor
activ
thiol
metabolit
dog
plasma
highperform
liquid
chromatographi
ultraviolet
absorpt
detect
j
chromatogr
hubner
ra
kubota
e
casley
dj
johnston
ci
burrel
lm
invitro
vivo
inhibit
rat
neutral
endopeptidas
angiotensin
convert
enzym
vasopeptidas
inhibitor
gemopatrilat
j
hyperten
vitro
system
use
screen
potenti
angiotensinconvert
enzym
inhibitor
fluoresc
gener
artifici
substrat
presenc
absenc
inhibitor
measur
detect
inhibitori
activ
mm
trishcl
buffer
ph
mm
nacl
mm
potassium
phosphat
buffer
ph
substrat
oaminobenzoylglycylpnitrolphenylalanyllprolin
molecular
weight
bachem
gentec
inc
torranc
california
usa
stock
solut
mg
substrat
ml
mm
trishcl
buffer
ph
mm
nacl
b
work
solut
ml
stock
solut
ad
ml
mm
trishcl
buffer
ph
mm
nacl
final
concentr
assay
compound
made
concentr
mm
mm
trishcl
buffer
ph
mm
nacl
methanol
trisnacl
insolubl
aqueou
buffer
alon
give
final
concentr
assay
mm
inhibit
seen
dilut
trisnacl
made
lung
tissu
rat
dice
homogen
blender
puls
homogen
centrifug
g
min
pellet
discard
supernat
dialyz
three
liter
chang
mm
potassium
phosphat
buffer
ph
overnight
cold
centrifug
g
min
pellet
discard
mg
nh
ad
ml
supernat
give
satur
solut
stir
ice
min
pellet
form
dissolv
ml
potassium
phosphat
buffer
ph
dialyz
buffer
overnight
cold
three
liter
chang
protein
precipit
dialysi
suspens
centrifug
g
min
supernat
discard
final
solubil
enzym
prepar
aliquot
store
least
month
enzym
inhibit
studi
enzym
activ
measur
perkin
elmer
fluoresc
spectrophotomet
equival
excit
wavelength
nm
emiss
wavelength
nm
enzym
assay
vehicl
inhibitor
solut
enzym
preincub
min
substrat
work
solut
ad
sampl
mix
draw
fluid
back
pipett
pipet
cuvett
initi
control
run
day
auto
zero
push
immedi
place
sampl
cuvett
individu
fluoresc
slope
measur
inhibit
calcul
follow
inhibit
inhibit
slope
presenc
inhibitor
control
slope
inhibitor
concentr
either
side
ic
test
gener
doserespons
curv
ic
calcul
use
litchfieldwilcoxon
logprobit
analysi
standard
data
ic
valu
inhibit
angiotensin
iconvert
enzym
compound
ic
captopril
assay
use
cleavag
hippur
acid
tripeptid
hipglygli
hiphisleu
wherebi
hippur
acid
either
tritium
label
determin
spectrophotometr
cushman
cheung
cheung
friedland
silverstein
santo
et
al
hecker
et
al
studi
bind
inhibit
kinet
ramipril
ramipril
hoe
diacid
highli
purifi
angiotensin
convert
enzym
use
furanacryloylpheglygli
substrat
import
tissu
convert
enzym
inhibit
addit
inhibit
plasma
verifi
sever
studi
unger
et
al
unger
et
al
linz
eriksson
et
al
oudit
et
al
danilczyk
et
al
danilczyk
et
al
discuss
role
homolog
angiotensinconvert
enzym
cardiovascular
physiolog
appear
neg
regul
reninangiotensin
system
cleav
ang
ang
ii
inact
ang
ang
differ
specif
physiolog
role
ace
neutral
endopeptidas
cleav
variou
peptid
enkephalin
kinin
chemotact
peptid
atrial
natriuret
factor
substanc
p
review
neutral
endopeptidas
enkephalinas
given
skidgel
roqu
et
al
structur
requir
investig
santo
et
al
sever
enzymat
assay
develop
measur
neutral
endopeptidas
nep
activ
radiolabel
method
vogel
altstein
lloren
et
al
colorimetr
assay
almenoff
et
al
almenoff
orlowski
fluorometr
assay
florentin
et
al
goudreau
et
al
burel
et
al
hubner
et
al
use
select
nep
inhibitor
radioligand
ilabel
cavalho
et
al
cavalho
et
al
describ
highli
select
assay
neutral
endopeptidas
base
cleavag
fluorogen
substrat
relat
leuenkephalin
recombin
solubl
form
nep
rnep
express
use
baculovirusinsectcel
system
purifi
immunoaffin
substrat
nmol
incub
rnep
ng
final
volum
mm
trishcl
buffer
ph
min
inhibit
assay
enzym
preincub
thiorphan
captopril
min
incub
substrat
reaction
stop
heat
min
centrifug
g
min
supernat
fraction
inject
hplc
column
elut
gradient
acetonitril
contain
trifluoroacet
acid
period
min
flow
rate
mlmin
substrat
product
detect
uv
absorb
nm
fluoresc
em
nm
ex
nm
detector
arrang
seri
collect
identifi
cleavag
site
amino
acid
analysi
kinet
paramet
nepcatalyz
hydrolysi
determin
doublereciproc
lineweaverburkq
plot
sulpizio
et
al
describ
determin
nep
activ
tissu
vivo
treatment
rat
ace
inhibitor
sacrific
anim
approxim
mg
kidney
tissu
homogen
volum
kh
po
ph
nacl
znso
use
teflonglass
motordriven
pestl
nep
activ
measur
ad
homogen
well
contain
buffer
phosphoramidon
next
mm
ndansyldalaglypnitrophegli
substrat
florentin
et
al
ad
sampl
yield
mm
final
concentr
incub
min
subsequ
tca
ad
plate
centrifug
pellet
precipit
protein
supernat
ad
ethanol
n
naoh
black
fluorometr
plate
min
plate
read
nm
emiss
nm
excit
fluoromet
describ
elisa
neuropeptid
endopeptidas
human
serum
leukocyt
gro
et
al
studi
protect
atrial
natriuret
factor
degrad
diuret
natriuret
respons
vivo
inhibit
enkephalinas
ec
acetorphan
increas
tissu
neutral
endopeptidas
activ
spontan
hypertens
hamster
report
vishwanata
et
al
graf
et
al
studi
regul
neutral
endopeptidas
human
vascular
smooth
muscl
cell
glucocorticoid
protein
kinas
c
pham
et
al
describ
effect
select
endopeptidas
inhibitor
renal
function
blood
pressur
consciou
normotens
wistar
hypertens
docasalt
rat
nep
involv
organ
system
cardiovascular
system
exampl
brain
lung
ratti
et
al
studi
correl
neutral
endopeptidas
nep
serum
degre
bronchial
hyperreact
shirotani
et
al
found
neprilysin
degrad
amyloid
peptid
rapidli
effici
newel
et
al
found
thiorphaninduc
neprilysin
inhibit
rais
amyloid
level
rabbit
cortex
cerebrospin
fluid
facchinetti
et
al
describ
ontogeni
region
cellular
distribut
metalloproteas
neprilysin
rat
comparison
neprilysin
endothelinconvert
cavalho
km
boileau
g
camargo
acm
juliano
l
highli
select
assay
neutral
endopeptidas
base
cleavag
fluorogen
substrat
relat
leuenkephalin
anal
biochem
eg
skidgel
ra
neutral
endopeptidas
enkephalinas
relat
regulatori
peptid
hormon
fasb
j
facchinetti
p
rose
c
schwartz
jc
ouimet
ontogeni
region
cellular
distribut
novel
metalloproteas
neprilysin
rat
comparison
neprilysin
endothelinconvert
neurosci
florentin
sassi
roqu
bp
highli
sensit
fluorometr
assay
enkephalinas
neutral
metalloendopeptidas
releas
tyrosineglycineglycin
enkephalin
anal
biochem
goudreau
n
gui
c
soleilhac
jm
roqu
bp
dnsgli
pno
specif
fluorogen
substrat
neutral
endopeptidas
anal
biochem
graf
k
c
fleck
e
kunkel
g
johnston
ci
burrel
lm
invitro
vivo
inhibit
rat
neutral
endopeptidas
angiotensin
convert
enzym
vasopetidas
inhibitor
gemopatrilat
j
hyperten
lloren
c
malfroy
b
schwartz
jc
gacel
g
roqu
bp
mor
gat
jl
javoyagid
f
agid
enkephalin
dipeptidyl
carboxypeptidas
enkephalinas
activ
select
radioimmunoassay
properti
region
distribut
human
brain
j
neurochem
newel
aj
sue
li
scott
rauschkolb
pk
walker
dg
potter
pe
beach
tg
thiorphaninduc
neprilysin
inhibit
rais
amyloid
level
rabbit
cortex
cerebrospin
fluid
neurosci
lett
pham
el
amrani
ai
fourniezaluski
mc
corvol
p
roqu
b
michel
jb
effect
select
endopeptidas
inhibitor
retrothiophan
renal
function
blood
pressur
consciou
normotens
wistar
hypertens
docasalt
rat
j
cardiovasc
pharmacol
ratti
h
zhang
kunkel
g
cardiac
angiotensin
convert
enzym
quantifi
tissu
rat
heart
chronic
infarct
left
coronari
ligat
computer
vitro
autoradiographi
kohzuki
et
al
procedur
myocardi
infarct
induc
wistar
rat
left
coronari
arteri
ligat
see
variou
time
interv
month
anim
decapit
heart
rapidli
remov
snapfrozen
isopentan
frozen
section
cut
cryostat
section
thawmount
onto
gelatinco
slide
dri
desicc
h
store
radioligand
tyrosyl
deriv
lisinopril
potent
competit
inhibitor
ace
iodin
chloramin
method
separ
free
sp
sephadex
column
chromatographi
bind
section
preincub
mmoll
sodium
phosphat
buffer
ph
contain
mmoll
nacl
bovin
serum
albumin
min
section
incub
kbqml
buffer
min
nonspecif
bind
determin
presenc
moll
lisinopril
bind
isotherm
determin
use
set
serial
section
incub
moll
lisinopril
min
incub
section
rapidli
dri
stream
cold
air
place
xray
cassett
expos
agfa
scopix
xray
film
h
room
temperatur
exposur
section
fix
formaldehyd
stain
haematoxylin
eosin
optic
densiti
xray
film
quantifi
use
imag
devic
control
person
comput
optic
densiti
autoradiograph
calibr
term
radioact
densiti
dpmmm
refer
standard
maintain
procedur
appar
bind
site
concentr
b
max
bind
affin
constant
k
area
exclud
coronari
arteri
right
ventricl
intraventricular
septum
infarct
area
left
ventricl
noninfarct
area
left
ventricl
estim
iter
nonlinear
modelfit
comput
program
ligand
munson
rodbard
kohzuki
johnston
ci
chai
sy
jackson
b
perich
r
paxton
mendelson
fao
measur
angiotensin
convert
enzym
induct
inhibit
use
quantit
vitro
autoradiographi
tissu
select
induct
chronic
lisinopril
treatment
j
hyperten
kohzuki
kanazawa
yoshida
k
kamimoto
wu
xm
jiang
zl
yasujima
abe
k
johnston
ci
sato
cardiac
angiotensin
convert
enzym
endothelin
receptor
rat
chronic
myocardi
infarct
jpn
circ
j
mendelsohn
fao
chai
dunbar
sy
et
al
vitro
autoradiograph
local
angiotensinconvert
enzym
rat
brain
use
ilabel
j
hyperten
suppl
munson
pj
rodbard
ligand
versatil
computer
approach
character
ligandbind
system
anal
biochem
reninangiotensinaldosteron
hormon
axi
major
longterm
control
regul
arteri
blood
pressur
sodium
balanc
support
normotens
hypertens
via
angiotensin
vasoconstrict
angiotensin
plu
aldosteroneinduc
renal
sodium
retent
laragh
unger
volp
et
al
wagner
et
al
show
regul
aldosteron
biosynthesi
adren
renin
mediat
receptor
renin
transgen
rat
easthop
jarvi
review
pharmacolog
pharmacokinet
clinic
data
angiotensin
ii
antagonist
candesartan
cilexetil
lee
trimarco
b
regul
aldosteron
biosynthesi
adren
renin
mediat
receptor
renin
transgen
rat
circ
re
wagner
j
thile
f
ganten
reninangiotensin
system
transgen
rat
pediatr
nephrol
angiotensin
ii
receptor
bind
angiotensin
ii
receptor
subtyp
identifi
structur
dissimilar
antagonist
differ
distribut
organ
variou
speci
specif
radioligand
chiu
et
al
chiu
et
al
chiu
et
al
chiu
et
al
chang
lotti
gibson
et
al
chansel
et
al
steckel
et
al
aiyar
et
al
barn
et
al
et
al
bottari
et
al
dzau
et
al
feuillan
et
al
van
meel
et
al
alexand
et
al
two
type
receptor
clone
sasaki
et
al
murphi
et
al
mukoyama
et
al
kambayashi
et
al
two
mammalian
receptor
name
describ
de
gasparo
et
al
function
correl
angiotensin
ii
receptor
discuss
timmerman
et
al
timmerman
et
al
bernstein
berk
effect
angiotensin
mediat
via
receptor
possibl
role
angiotensin
ii
subtyp
receptor
endotheli
cell
isol
ischem
rat
heart
suggest
wiemer
et
al
b
clearanc
studi
dog
indic
angiotensin
type
receptor
may
relat
water
handl
kidney
keiser
et
al
evid
receptor
subtyp
report
iwai
inagami
kakar
et
al
balmforth
et
al
matsubara
et
al
bauer
ream
de
gasparo
et
al
chai
et
al
describ
properti
angiotensin
ivat
receptor
assay
describ
use
determin
affin
test
compound
angiotensin
ii
receptor
measur
inhibitori
activ
bind
hangiotensin
ii
plasma
membran
prepar
rat
bovin
adren
cortex
fresh
bovin
adren
gland
obtain
local
slaughter
hous
rat
adren
gland
male
spraguedawley
rat
weigh
g
sacrif
adren
separ
fat
tissu
medulla
remov
cortic
minc
homogen
mm
tri
buffer
contain
mm
mgcl
mm
sucros
ph
use
chill
potter
homogen
homogen
centrifug
g
min
supernat
recentrifug
g
min
pellet
resuspend
mm
tri
buffer
contain
mm
mgcl
ph
recentrifug
twice
g
min
last
centrifug
pellet
suspend
mm
tri
buffer
contain
mm
mgcl
mm
sucros
ph
sampl
ml
frozen
liquid
nitrogen
store
competit
experi
hangiotensin
ii
one
constant
concentr
test
compound
concentr
membran
suspens
rat
bovin
adren
cortex
approx
mg
wet
weightml
per
sampl
incub
bath
shaker
min
incub
buffer
contain
mm
hepe
mm
edta
mm
nacl
mm
mgcl
bovin
serum
albumin
ph
satur
experi
perform
concentr
hangiotensin
ii
total
bind
determin
presenc
incub
buffer
nonspecif
bind
determin
presenc
nonlabel
angiotensin
ii
reaction
stop
rapid
vacuum
filtrat
glass
fiber
filter
therebi
membranebound
radioact
separ
free
one
retain
membranebound
radioact
filter
measur
addit
ml
liquid
scintil
cocktail
per
sampl
liquid
scintil
counter
follow
paramet
calcul
total
bind
hangiotensin
ii
nonspecif
bind
bind
presenc
mepyramin
doxepin
specif
bind
total
bindingnonspecif
bind
inhibit
hangiotensin
ii
bind
bind
percentag
control
valu
dissoci
constant
k
ic
valu
test
drug
determin
competit
experi
hangiotensin
ii
versu
nonlabel
drug
computersupport
analysi
bind
data
mcpherson
olin
et
al
perform
competit
studi
rat
uterin
smooth
muscl
membran
rat
adren
cortex
membran
use
label
angiotensin
ii
membran
cultur
rat
aortic
smooth
muscl
cell
human
myometrium
use
bind
studi
label
angiotensin
ii
criscon
et
al
wiener
et
al
use
membran
prepar
rat
lung
adren
medulla
bind
studi
label
angiotensin
ii
bradburi
et
al
use
guinea
pig
adren
membran
prepar
studi
nonpeptid
angiotensin
ii
receptor
antagonist
cazaubon
et
al
prepar
purifi
plasma
membran
rat
liver
aii
bind
assay
noda
et
al
describ
inhibit
rabbit
aorta
angiotensin
ii
aii
receptor
nonpeptid
aii
antagonist
kushida
et
al
test
ii
receptor
bind
particul
fraction
rat
mesenter
arteri
rat
adren
cortex
medulla
iat
ii
chang
et
al
use
rabbit
aorta
rat
adren
human
receptor
cho
cell
receptor
rat
adren
brain
character
nonpeptid
angiotensin
antagonist
aiyar
et
al
test
inhibit
angiotensin
ii
angiotensin
ii
sar
ile
bind
variou
membran
cell
prepar
rat
mesenter
arteri
rat
adren
cortex
rat
aortic
smooth
muscl
cell
human
liver
recombin
human
receptor
bovin
cerebellum
bovin
ovari
caussad
et
al
test
sar
ile
angiotensin
ii
bind
rat
adren
membran
rat
aortic
smooth
muscl
cell
use
sar
ile
angiotensin
ii
radioligand
de
gasparo
whitebread
compar
affin
constant
valsartan
losartan
liver
adren
rat
marmoset
human
adren
rat
aortic
smooth
muscl
cell
webb
et
al
transfect
vascular
angiotensin
ii
receptor
cdna
chines
hamster
ovari
cell
gener
stabl
cell
line
choat
recommend
cell
use
model
studi
receptor
domain
critic
signal
pathway
kiyama
et
al
use
co
cell
transfect
cdna
encod
human
angiotensin
ii
receptor
evalu
nonpeptid
angiotensin
ii
receptor
antagonist
mizuno
et
al
use
bovin
adren
cortic
membran
nozawa
et
al
membran
fraction
rat
aorta
bovin
cerebellum
human
myocardium
angiotensin
ii
radioligand
renzetti
et
al
b
use
membran
rat
adren
cortex
bovin
cerebellum
bind
assay
h
angiotensin
ii
radioligand
interspeci
differ
angiotensin
receptor
investig
kawano
et
al
angiotensin
ii
receptor
subtyp
high
affin
lorsatan
design
angiotensin
receptor
receptor
high
affin
acid
angiotensin
receptor
bumpu
et
al
nozawa
et
al
chang
et
al
order
determin
affin
angiotensin
subtyp
radioligand
bind
assay
isarcosin
isoleucin
angiotensin
ii
chang
lotti
chang
et
al
wong
et
al
incub
membran
tissu
receptor
presenc
occupi
bind
site
angiotensin
subtyp
presenc
lorsatan
occupi
bind
site
hilditch
et
al
use
membran
rat
liver
h
ii
determin
bind
affin
receptor
membran
bovin
cerebellum
tyr
ii
receptor
lu
et
al
studi
influenc
freez
bind
isarcosin
isoleucin
angiotensin
ii
angiotensin
ii
receptor
subtyp
rat
result
suggest
studi
aii
receptor
subtyp
involv
freez
tissu
underestim
densiti
affin
receptor
subtyp
addit
receptor
receptor
attract
increas
interest
gallinat
et
al
nouet
nahmia
steckel
et
al
review
knowledg
receptor
distribut
signal
function
emphasi
growthantigrowth
differenti
regener
neuron
tissu
wan
et
al
wan
et
al
describ
porcin
myometri
membran
receptor
assay
myometri
membran
prepar
porcin
uteri
nielsen
et
al
found
myometrium
nonpregn
sow
ang
ii
receptor
almost
exclus
receptor
presum
interfer
bind
receptor
block
addit
losartan
bind
ang
ii
membran
conduct
final
volum
ml
contain
mm
trishcl
ph
mm
nacl
mm
mgcl
mm
edta
bacitracin
bsa
homogen
correspond
mg
origin
tissu
weight
ang
ii
nm
variabl
concentr
test
substanc
sampl
incub
h
bind
termin
filtrat
whatman
gfb
glassfib
filter
sheet
presoak
overnight
polyethylamin
use
brandel
cell
harvest
filter
wash
ml
trishcl
ph
transfer
tube
radioact
measur
counter
determin
perform
triplic
characterist
angiibind
receptor
determin
use
six
differ
concentr
nmoll
label
ang
ii
nonspecif
bind
determin
presenc
ang
ii
specif
bind
determin
subtract
nonspecif
bind
total
bound
ang
ii
ic
determin
scatchard
analysi
data
obtain
ang
ii
use
grafit
erithacu
softwar
uk
whitebread
et
al
describ
radioligand
cgp
highaffin
highli
select
ligand
character
angiotensin
receptor
heemskerk
saavedra
perform
quantit
autoradiographi
ang
ii
receptor
cgp
heerd
et
al
perform
mutat
analysi
ang
ii
type
receptor
order
studi
contribut
conserv
extracellular
amino
acid
hoe
et
al
report
molecular
clone
character
distribut
gerbil
ang
ii
receptor
utsunomiya
et
al
describ
ang
ii
receptor
local
cardiovascular
tissu
antibodi
develop
genedelet
mice
gallinat
busch
raizada
mk
summer
c
angiotensin
ii
type
receptor
enigma
multipl
variat
j
physiol
heemskerk
fjm
saavedra
jm
isol
rabbit
aorta
use
evalu
angiotensin
ii
agonist
liu
angiotensin
ii
antagonist
chang
et
al
chang
et
al
noda
et
al
aiyar
et
al
cirillo
et
al
kushida
et
al
mochizuki
et
al
renzetti
et
al
wong
et
al
hong
et
al
kawano
et
al
new
zealand
white
male
rabbit
weigh
kg
sacrif
exsanguin
thorac
aorta
remov
clean
adher
fat
connect
tissu
vascular
endothelium
remov
gentli
rub
intim
surfac
vessel
spiral
aortic
strip
mm
wide
mm
long
prepar
mount
ml
organ
bath
contain
krebshenseleit
solut
mm
nacl
mm
kcl
mm
mgso
kh
po
cacl
mm
nahco
glucos
mm
ph
organ
bath
kept
gass
continu
co
strip
attach
isometr
transduc
connect
polygraph
rest
tension
g
appli
strip
chang
contract
analyz
digit
comput
aortic
strip
allow
equilibr
h
wash
everi
min
two
consecut
contractilerespons
curv
cumul
addit
atii
mm
construct
curv
strip
wash
time
allow
relax
baselin
tension
afterward
strip
incub
min
vehicl
singl
concentr
antagonist
mm
third
concentrationrespons
curv
angiotensin
ii
obtain
result
concentr
express
percentag
maximum
respons
aii
pa
pd
valu
calcul
van
rossum
isol
guinea
pig
aorta
use
mizuno
et
al
cirillo
et
al
evalu
antagon
aiiinduc
vasoconstrict
rat
isol
perfus
kidney
chang
et
al
chang
et
al
determin
aiiinduc
aldosteron
releas
rat
adren
cell
aiiinduc
h
inositol
phosphat
accumul
cultur
rat
aorta
smooth
muscl
cell
shibouta
et
al
describ
pharmacolog
profil
highli
potent
longact
ang
ii
receptor
antagonist
prodrug
ojima
et
al
studi
mechan
insurmount
antagon
candesartan
angiotensin
receptor
antagonist
angiiinduc
rabbit
aortic
contract
contract
bind
studi
effect
atii
antagonist
blood
pressur
measur
anesthet
olin
et
al
beauchamp
et
al
kawano
et
al
pith
caze
et
al
christoph
et
al
cirillo
et
al
deprez
et
al
et
al
consciou
junggren
et
al
nozawa
et
al
shibasaki
et
al
hashimoto
et
al
normotens
hypertens
rat
male
spraguedawley
rat
anesthet
mgkg
ip
inactin
place
servocontrol
heat
pad
maintain
bodi
temperatur
cathet
implant
femor
arteri
vein
measur
arteri
blood
pressur
administ
compound
respect
cathet
place
trachea
ensur
airway
patenc
arteri
pressur
measur
continu
connect
arteri
cathet
transduc
coupl
gould
pressur
transduc
output
record
polygraph
mean
arteri
pressur
deriv
electron
min
stabil
period
autonom
transmiss
block
treatment
mecamylamin
mgkg
iv
atropin
mgkg
iv
arteri
pressur
stabil
angiotensin
infus
iv
isoton
salin
syring
pump
pressur
respons
angiotensin
stabil
angiotensin
ii
antagonist
given
increas
dose
dose
given
intraven
cumul
fashion
e
next
highest
dose
given
time
maximum
respons
prior
dose
data
present
percent
inhibit
angiotensin
pressor
respons
dose
antagonist
plot
log
cumul
dose
antagonist
linear
regress
use
calcul
dose
respons
angiotensin
inhibit
id
rat
mean
calcul
olin
et
al
cirillo
et
al
determin
also
antihypertens
effect
consciou
spontan
hypertens
rat
consciou
sodiumdefici
dog
stasch
et
al
studi
longterm
blockad
angiotensin
ii
receptor
renin
trangen
rat
saltload
dahl
rat
strokepron
spontan
hypertens
rat
nishioka
et
al
richter
et
al
use
transgen
tg
rat
hypertens
model
depend
increas
express
renin
angiotensin
system
explor
role
angiotensin
receptor
control
cardiovascular
renal
excretori
function
simo
e
silva
et
al
evalu
effect
chronic
administr
angiotensin
antagonist
diuresi
natriuresi
normotens
spontan
hypertens
rat
kai
et
al
examin
effect
angiotensin
ii
type
antagonist
cardiac
hypertrophi
nephropathi
use
tsukuba
hypertens
mice
thm
carri
human
renin
angiotensinogen
gene
kivlighn
et
al
b
gabel
et
al
studi
angiotensin
ii
antagonist
consciou
rat
dog
rhesu
monkey
chimpance
keiser
et
al
studi
arteri
blood
pressur
consciou
renal
hypertens
rat
consciou
sodiumdeplet
dog
consciou
sodiumdeplet
monkey
consciou
renal
hypertens
monkey
kim
et
al
examin
effect
angiotensin
receptor
antagonist
volum
overloadinduc
cardiac
gene
express
rat
cardiac
volum
overload
prepar
abdomin
aortocav
shunt
cardiac
tissu
mrna
measur
northern
blot
analysi
specif
probe
yamamoto
et
al
ogilvi
et
al
studi
angiotensin
ii
receptor
antagonist
acut
heart
failur
induc
coronari
arteri
ligat
anesthet
dog
chronic
heart
failur
induc
left
ventricular
rapidpac
consciou
dog
massart
et
al
evalu
cumul
hypotens
effect
angiotensin
iiand
antagonist
model
renovascular
hypertens
dog
hayashi
et
al
examin
hemodynam
effect
angiotensin
ii
type
receptor
antagonist
rat
myocardi
infarct
induc
coronari
ligat
kivlighn
et
al
studi
effect
nonpeptid
mimic
biolog
action
angiotensin
ii
anesthet
rat
huckl
et
al
evalu
angiotensin
ii
receptor
antagonist
abil
inhibit
vascular
intim
thicken
porcin
coronari
arteri
model
vascular
injuri
beauchamp
ht
chang
rsl
siegl
pk
gibson
contrast
enzym
renin
show
rather
high
speci
specif
relev
human
human
renin
use
one
reason
human
renin
specif
human
angiotensinogen
lie
sequenc
human
angiotensinogen
inhibit
renin
measur
angiotensinogen
form
presenc
angiotensinas
inhibitor
follow
procedur
use
determin
effect
potenti
renin
inhibitor
purifi
human
kidney
renin
without
interfer
plasma
protein
lipid
synthet
substrat
repres
first
fourteen
amino
acid
nterminu
human
angiotensinogen
aspargvaltyrilehisprophehisleuvalilehisasn
assay
mixtur
compos
phosphat
buffer
ph
bovin
serum
albumin
mm
edta
mm
phenylmethylsulfonyl
fluorid
pmsf
genapol
pf
test
compound
dissolv
dmso
substrat
purifi
human
kidney
renin
calbiochem
gmbh
frankfurtm
germani
cat
mixtur
incub
two
hour
reaction
stop
transfer
preheat
eppendorf
tube
amount
angiotensin
liber
measur
ria
renin
maia
kit
serono
diagnostika
gmbh
freiburg
germani
human
angiotensinogen
may
use
substrat
instead
tetradekapeptid
ph
valu
incub
mixtur
may
lower
use
maleic
acid
buffer
result
higher
renin
activ
hepe
sulfon
acid
may
substitut
phosphat
ph
buffer
renin
activ
e
angiotensin
product
ngml
h
correct
angiotensin
ilik
immunoreact
measur
assay
sampl
even
absenc
ad
renin
ic
valu
determin
plot
renin
activ
per
cent
control
vs
molar
concentr
test
compound
wang
et
al
describ
continu
fluoresc
assay
renin
activ
employ
new
fluorigen
peptid
substrat
inhibit
plasma
renin
activ
blood
sampl
variou
speci
determin
order
evalu
speci
specif
renin
inhibitor
blood
sampl
obtain
dog
sheep
rhesu
monkey
venipunctur
wistar
rat
guinea
pig
anesthet
nembut
mgkg
intraperiton
blood
collect
punctur
abdomin
aorta
human
blood
collect
volunt
donafix
blood
collect
set
braun
melsungen
ag
melsungen
fr
germani
cool
bottl
blood
sampl
anticoagul
naedta
final
concentr
mm
renin
dissolv
dmso
stock
solut
dilut
experi
dmso
endogen
format
ang
plasma
incub
determin
measur
renin
activ
gener
quantit
ang
perform
use
commerci
radio
immunoassay
kit
reninmaia
serono
diagnostika
gmbh
freiburg
fr
germani
plasma
sampl
thaw
ice
centrifug
addit
pmsf
solut
kit
per
ml
assay
mixtur
contain
plasma
plu
vv
pmsf
solut
buffer
phosphat
buffer
ph
ramipril
renin
inhibitor
solut
dilut
dmso
requir
pure
dmso
control
assay
incub
appropri
time
hour
ang
measur
sampl
triplic
determin
basal
ang
immunoreact
plasma
determin
unincub
control
assay
preincub
valu
subtract
measur
renin
activ
presenc
renin
inhibitor
calcul
percent
activ
relat
control
sampl
contain
dmso
ic
valu
determin
semilogarithm
plot
percent
renin
activ
versu
concentr
renin
inhibitor
wood
et
al
determin
activ
synthet
renin
inhibitor
rat
mous
dog
guinea
pig
rabbit
cat
marmoset
human
renin
use
plasma
pool
speci
plasma
speci
collect
use
edta
anticoagul
sampl
plasma
incub
presenc
absenc
vari
concentr
test
compound
ang
form
measur
radioimmunoassay
shibasaki
et
al
use
squirrel
monkey
studi
vivo
activ
specif
renin
inhibitor
intraven
oral
applic
bohlend
et
al
reconstruct
human
reninangiotensin
system
transgen
rat
overexpress
human
angiotensin
gene
tgr
hogen
chronic
inject
human
recombin
renin
intraven
use
alzet
pump
salimbeni
et
al
test
vitro
inhibit
human
plasma
renin
activ
two
synthet
angiotensinogen
transit
state
analogu
wood
et
al
determin
inhibitori
potenc
oral
effect
renin
inhibitor
vitro
human
renin
human
recombin
renin
ngml
incub
synthet
tetradecapeptid
substrat
tdp
correspond
termin
amino
acid
human
angiotensinogen
te
buffer
ph
contain
human
serum
albumin
neomycin
sulphat
h
enzymat
reaction
stop
ad
ml
icecold
trisacet
buffer
ph
contain
hsa
angiotensin
gener
incub
measur
radioimmunoassay
oral
activ
confirm
hypertens
patient
gradman
et
al
r
benzylpropionyl
lhistidinyl
acet
show
pafdefici
mice
absenc
plateletactiv
factor
receptor
protect
mice
osteoporosi
follow
ovariectomi
model
postmenopaus
osteoporosi
paf
also
implic
estrogeninduc
angiogenesi
via
nuclear
activ
seo
et
al
delay
corneal
wound
heal
bazan
paf
receptor
belong
superfamili
g
proteincoupl
receptor
chao
olson
izumi
shimizu
clone
studi
indic
singl
human
paf
receptor
gene
contain
intron
flank
region
provid
altern
sequenc
ishi
shimizu
follow
procedur
use
detect
compound
inhibit
bind
hpaf
platelet
activ
factor
rabbit
platelet
paf
receptor
crude
rabbit
platelet
incub
plastic
tube
min
buffer
solut
gl
kh
po
gl
na
hpo
gl
nacl
gl
bsa
ph
nm
synthet
hlabel
paf
h
variou
concentr
test
compound
nonspecif
bind
determin
presenc
cv
bound
ligand
separ
incub
medium
rapid
filtrat
whatman
gfc
glass
fibr
filter
follow
rins
icecold
buffer
ml
filter
place
ml
scintil
cocktail
radioact
determin
follow
paramet
calcul
total
bind
hpaf
nonspecif
bind
presenc
cv
specif
bind
total
bindingnonspecif
bind
inhibit
bind
percentag
control
valu
compound
first
test
singl
high
concentr
nm
triplic
show
inhibit
displac
curv
construct
use
differ
concentr
test
compound
bind
potenc
compound
express
either
rel
bind
affin
rba
respect
standard
compound
cv
test
parallel
ic
rba
ic
standard
compound
ic
compound
standard
data
cv
ic
nm
n
sever
author
casalsstenzel
et
al
dent
et
al
b
ring
et
al
ukena
et
al
endothelin
endotheliumderiv
peptid
famili
consist
three
peptid
potent
longlast
vasoconstrict
activ
yanagisawa
et
al
b
king
et
al
yanagisawa
masaki
inou
et
al
shinmi
et
al
vanhoutt
et
al
davenport
masaki
process
prepro
big
convert
endothelinconvertingenzym
ece
subtyp
endothelin
receptor
describ
takayanagi
et
al
miyazaki
et
al
molecular
character
et
et
b
receptor
report
miyazaki
et
al
sakuarai
et
al
addit
exist
third
type
et
c
found
xenopu
laevi
karn
et
al
comparison
recombin
endothelin
receptor
show
differ
affin
rank
order
three
endothelin
masaki
et
al
grant
et
al
report
vitro
express
et
et
b
et
receptor
prostat
epithelium
stroma
et
peptid
elicit
potent
longlast
contract
isol
strip
variou
blood
vessel
vitro
also
increas
blood
pressur
vivo
suggest
peptid
famili
may
involv
pathogenesi
cardiovascular
diseas
simonson
dunn
masaki
doherti
goto
et
al
gray
webb
dougla
ohlstein
sarafotoxin
origin
isol
snake
venom
agonist
distinguish
endothelin
subtyp
william
et
al
endothelin
degradet
vascular
smooth
muscl
cell
bernmek
et
al
denud
confirm
absenc
relax
acetylcholin
ring
precontract
norepinephrin
rest
forc
adjust
optimum
rest
tension
g
pulmonari
arteri
ring
g
aortic
ring
maximum
contract
kcl
determin
subsequ
respons
endothelin
express
percentag
maximum
kcl
contract
determin
maximum
effect
percentag
maximum
endothelin
contract
determin
potenc
concentrationrespons
curv
compar
use
method
carpent
data
express
mean
sem
statist
comparison
perform
use
student
ttest
p
consid
signific
lembeck
et
al
studi
effect
endothelin
cardiovascular
system
smooth
muscl
prepar
differ
speci
reynold
mok
studi
role
thromboxan
prostaglandin
h
receptor
vasoconstrictor
respons
rat
aorta
endothelin
pang
et
al
studi
cellular
mechan
action
endothelin
isol
canin
coronari
arteri
et
al
use
perfus
pressur
mesenter
resist
arteri
rat
human
intern
mammari
arteri
studi
interact
endothelin
endotheliumderiv
relax
factor
michel
et
al
studi
endothelin
system
variou
anim
model
pulmonari
hypertens
adveni
et
al
studi
contractil
activ
three
endothelin
human
isol
bronchu
wallac
et
al
compar
effect
rat
stomach
aldosteron
secret
cultur
calf
zona
glomerulosa
cell
stimul
sarafotoxin
similar
degre
less
angiotensin
ii
gomezsanchez
brock
danthuluri
use
cultur
vascular
smooth
muscl
cell
studi
cellular
action
endothelin
pigment
dispers
cultur
dermal
melanophor
xenopu
laevi
use
indic
et
c
receptor
mediat
respons
karn
et
al
j
biol
chem
lembeck
f
decrini
pertl
c
amann
r
donner
j
effect
endothelin
cardiovascular
system
smooth
muscl
prepar
differ
speci
naunynschmiedeberg
arch
pharmacol
tf
boulang
c
yang
z
dohi
competit
endothelin
antagonist
therapeut
interest
ihara
et
al
fujimoto
et
al
fukuroda
et
al
urad
et
al
breu
et
al
mihara
fujimoto
sogab
et
al
warner
opgenorth
brunner
sensit
sandwichenzym
immunoassay
human
endothelin
establish
suzuki
et
al
ventricl
rat
heart
minc
scissor
homogen
vol
icecold
mm
nahco
contain
mm
pmsf
phenylmethylsulfonyl
fluorid
ph
polytron
homogen
brinkman
instrument
inc
westberg
ny
homogen
centrifug
g
min
pellet
discard
supernat
centrifug
g
min
pellet
wash
resuspend
tri
buffer
mm
ph
contain
mm
pmsf
store
use
bind
studi
gu
et
al
cardiac
membran
mgml
protein
incub
pm
new
england
nuclear
final
assay
volum
ml
borosil
glass
tube
contain
mm
trishcl
mm
pmsf
aprotinin
leupeptin
pepstatin
bacitracin
soybean
trypsin
inhibitor
ph
bind
perform
min
bind
reaction
termin
addit
ml
icecold
mm
trishcl
ph
follow
rapid
filtrat
whatman
gfc
glass
fibr
filter
presoak
polyethyleneimin
reduc
pressur
filter
quickli
wash
time
ml
buffer
radioact
retain
filter
count
nonspecif
bind
defin
presenc
specif
bind
differ
total
nonspecif
bind
k
valu
scatchard
plot
calcul
nomenclatur
endothelin
receptor
review
alexand
et
al
cain
et
al
describ
receptor
bind
assay
high
throughput
chemic
screen
use
clonal
cell
line
smooth
muscl
cell
deriv
embryon
rat
thorac
aorta
function
endothelinsarafotoxin
receptor
describ
rat
heart
myocyt
galron
et
al
rat
uteru
boussomittl
mihara
fujimoto
cultur
rat
aortic
smooth
muscl
cell
express
et
receptor
takuwa
et
al
human
girardi
heart
cell
express
et
b
receptor
mihara
fujimoto
receptor
specif
could
demonstr
mihara
et
al
character
nonpeptid
endothelin
receptor
antagonist
vitro
rat
aortic
smooth
muscl
cell
girardi
heart
cell
vivo
pith
rat
compar
anoth
endothelin
receptor
antagonist
discrep
vitro
vivo
data
explain
differ
plasma
bind
aramori
et
al
studi
receptorbind
properti
antagonist
activ
endothelin
antagonist
transfect
chines
ovari
hamster
cell
perman
express
two
et
receptor
subtyp
et
et
b
de
juan
et
al
character
endothelin
receptor
subtyp
b
retina
rat
clozel
et
al
perform
bind
assay
cell
membran
baculoviru
infect
insect
cell
express
recombin
et
et
b
receptor
cho
cell
express
recombin
et
et
b
receptor
cultur
human
vascular
smooth
muscl
cell
umbil
vein
rat
mesangi
cell
et
microsom
membran
human
placenta
porcin
cerebellum
et
porcin
trachea
et
use
sarafotoxin
ligand
william
et
al
use
cho
cell
express
clone
et
et
b
receptor
directli
bind
function
assay
without
prepar
membran
reynold
et
al
use
cell
express
recombin
human
et
b
receptor
ltk
cell
express
human
et
receptor
rabbit
renal
arteri
vascular
smooth
muscl
cell
express
rabbit
et
receptor
evalu
et
receptor
antagonist
rat
bovin
cerebella
use
differenti
receptor
subtyp
william
et
al
peter
davenport
propos
select
ligand
et
receptor
ihara
et
al
watakab
et
al
describ
radioligand
endothelin
et
b
receptor
vign
et
al
describ
properti
etalik
endothelin
receptor
brain
capillari
endotheli
cell
human
typeb
endothelin
receptor
clone
human
lung
poli
arna
express
cho
cell
chiou
et
al
dissoci
characterist
endothelin
receptor
agonist
antagonist
determin
stabl
et
al
describ
bioluminesc
assay
agonist
activ
gproteincoupl
receptor
endothelin
et
receptor
transient
express
apoaequorin
cho
cell
reconstitut
cofactor
coelenterazin
result
larg
concentr
depend
agonistmedi
luminesc
respons
follow
cotransfect
endothelin
et
angiotensin
ii
trh
neurokinin
nk
receptor
interact
predominantli
q
like
phosphoinositidaselink
gprotein
hickey
et
al
yanagisawa
et
al
yanagisawa
et
al
inou
et
al
kimura
et
al
ihara
et
al
fukuroda
et
al
sinc
smooth
musculatur
consid
contain
mainli
et
receptor
prepar
use
test
et
antagonist
left
anterior
descend
coronari
arteri
isol
fresh
porcin
heart
connect
tissu
adher
fat
remov
remov
vascular
endothelium
intim
surfac
spiral
strip
rub
gentli
filter
paper
endotheliumdenud
arteri
cut
spiral
strip
mm
long
mm
wide
strip
suspend
organ
bath
contain
krebshenseleit
solut
bubbl
co
equilibr
refer
contract
isometr
obtain
mm
kcl
concentrationrespons
curv
obtain
cumul
addit
antagonist
ad
min
cumul
addit
pa
valu
slope
obtain
analysi
schild
plot
opgenorth
et
al
character
oral
activ
highli
potent
et
select
receptor
antagonist
vitro
vivo
method
calo
et
al
investig
three
rabbit
vessel
carotid
pulmonari
arteri
jugular
vein
identifi
vascular
monoreceptor
system
either
et
et
b
structureact
studi
endothelin
antagonist
vedernikov
et
al
use
ring
left
circumflex
coronari
arteri
dog
denud
endothelium
expos
anox
period
august
et
al
urad
et
al
use
rat
aortic
smooth
muscl
denud
epithelium
sogab
et
al
spiral
cut
strip
rabbit
aorta
william
et
al
use
rat
aorta
rabbit
iliac
pulmonari
arteri
contractil
assay
anesthet
ferret
consciou
normotens
dog
vivo
model
character
nonpeptidyl
endothelin
antagonist
itoh
et
al
studi
prevent
effect
et
receptor
antagonist
experiment
cerebr
vasospasm
dog
use
twohemorrhag
model
subarachnoid
hemorrhag
clozel
et
al
perform
similar
experi
rat
vasodil
effect
isol
perfus
rat
mesenteri
found
infus
rat
endothelin
warner
et
al
select
et
b
receptor
agonist
sarafotoxin
william
et
al
antagon
endothelin
receptor
antagonist
clozel
et
al
ercan
et
al
found
increas
digoxininduc
ectop
ventricular
complex
endothelin
peptid
isol
guinea
pig
heart
could
antagon
endothelina
receptor
antagonist
endothelininduc
sustain
increas
blood
pressur
anesthet
rat
studi
yanagisawa
et
al
inou
et
al
ihara
et
al
intraven
bolu
inject
endothelin
caus
biphas
blood
pressur
respons
transient
decreas
probabl
mediat
releas
vasodil
mediat
prostacyclin
edrf
sustain
increas
rubanyi
bothelho
nishikib
et
al
examin
antihypertens
effect
endothelin
antagonist
genet
hypertens
model
strokepron
spontan
hypertens
rat
watanab
et
al
character
pharmacolog
profil
nonselect
endothelin
receptor
antagonist
studi
inhibit
myocardi
infarct
size
rat
contractil
activ
isol
guinea
pig
trachea
without
epithelium
guinea
pig
longitudin
muscl
use
urad
et
al
determin
et
b
receptor
mediat
respons
spinella
et
al
assess
bioactiv
specif
antagonist
isol
perfus
guinea
pig
lung
prepar
pulmonari
arteri
pressur
monitor
gosselin
et
al
demonstr
effect
select
et
receptor
antagonist
murin
model
allerg
asthma
tabrizchi
ford
studi
haemodynam
effect
endothelin
receptor
antagonist
tezosentan
anaesthet
rat
treat
tumor
necrosi
factoralpha
radioligand
iodin
iodin
use
iodogen
pierc
chemic
co
il
usa
bind
section
preincub
min
mmoll
hepe
buffer
ph
contain
mmoll
nacl
mmoll
cacl
bsa
bacitracin
section
incub
kbqml
buffer
min
nonspecif
bind
determin
presenc
moll
bind
isotherm
determin
use
set
serial
section
incub
moll
unlabel
min
incub
section
rapidli
dri
stream
cold
air
place
xray
cassett
expos
agfa
scopix
xray
film
h
room
temperatur
exposur
section
fix
formaldehyd
stain
hematoxylin
eosin
optic
densiti
xray
film
quantifi
use
imag
devic
control
person
comput
optic
densiti
autoradiograph
calibr
term
radioact
densiti
dpmmm
refer
standard
maintain
procedur
appar
bind
site
concentr
b
max
bind
affin
constant
k
area
exclud
coronari
arteri
right
ventricl
intraventricular
septum
infarct
area
left
ventricl
noninfarct
area
left
ventricl
estim
iter
nonlinear
modelfit
comput
program
ligand
munson
rodbard
endothelin
convert
enzym
inhibitor
suppress
biosynthesi
endothelin
therefor
potenti
antihypertens
drug
de
lombaert
et
al
trapani
et
al
morita
et
al
bihovski
et
al
cla
et
al
descomb
et
al
chackalamannil
et
al
jeng
jeng
de
lombaert
brunner
purif
rat
porcin
endothelin
convert
enzym
ece
report
ohmaka
et
al
takahashi
et
al
molecular
clone
character
enzym
perform
rat
shimada
et
al
bovin
ikura
et
al
schmidt
et
al
xu
et
al
human
tissu
schmidt
et
al
shimada
et
al
yorimitsu
et
al
second
enzym
term
clone
emoto
yanagisawa
walkden
turner
describ
express
endothelin
convert
enzym
relat
membran
peptidas
e
g
endopeptidas
human
endotheli
cell
line
rapid
select
vitro
assay
endothelinconvert
enzym
describ
fawzi
et
al
assay
base
quantit
determin
releas
iodotyrosyl
big
bind
membran
bound
endothelin
receptor
prepar
lung
membran
frozen
guinea
pig
lung
weigh
homogen
time
gram
tissu
weight
solut
mm
trishcl
ph
sucros
mm
edta
use
polytron
tissu
homogen
homogen
repeat
time
interv
homogen
homogen
spun
min
g
supernat
contain
membran
care
decant
save
pellet
rehomogen
solut
homogen
spun
g
min
supernat
remov
mix
supernat
first
spin
spun
g
min
pellet
contain
membran
suspend
solut
b
mm
trishcl
ph
sucros
use
dounc
homogen
sampl
divid
fraction
rapidli
frozen
dri
icemethanol
bath
store
rat
liver
membran
prepar
method
purifi
sucros
step
gradient
membran
suspend
solut
c
mm
trishcl
ph
contain
sucros
protein
concentr
mgml
sampl
ml
place
ultraclear
centrifug
tube
beckman
sw
rotor
overlaid
ml
solut
c
contain
sucros
spun
h
rpm
g
top
layer
contain
membran
collect
dilut
solut
c
obtain
sucros
concentr
sampl
spun
ti
rotor
g
h
supernat
discard
pellet
contain
membran
suspend
solut
b
divid
sampl
rapidli
frozen
dri
icemethanol
bath
store
endothelin
et
bind
assay
membran
prepar
incub
select
concentr
final
reaction
volum
solut
contain
mm
trishcl
ph
mm
nacl
mgml
bsa
min
reaction
termin
addit
ml
solut
e
contain
mm
trishcl
ph
mm
nacl
follow
rapid
filtrat
whatman
gfb
glass
microfib
filter
filter
presoak
h
solut
contain
mm
trishcl
ph
mgml
bsa
sodium
azid
test
tube
filter
wash
four
time
ml
solut
e
radioact
retain
filter
count
gamma
counter
nonspecif
bind
determin
presenc
unlabel
reaction
mixtur
endothelin
convert
enzym
assay
sampl
contain
protein
incub
solut
contain
mm
trishcl
ph
mm
nacl
mgml
bsa
final
volum
convers
reaction
initi
addit
big
obtain
final
concentr
pm
sampl
incub
h
measur
releas
big
convers
purifi
rat
liver
membran
sourc
et
receptor
ad
reaction
mixtur
reaction
volum
adjust
solut
composit
adjust
solut
endothelin
bind
assay
follow
incub
reach
equilibrium
bind
reaction
termin
addit
solut
e
follow
rapid
filtrat
whatman
gfb
glass
microfib
filter
nonspecif
bind
determin
presenc
unlabel
reaction
mixtur
specif
bind
use
index
endothelin
convert
enzym
activ
test
effect
endothelin
convert
enzym
inhibitor
endothelin
convert
enzym
assay
carri
presenc
desir
concentr
compound
endothelin
convert
enzym
activ
presenc
compound
express
percentag
control
endothelin
convert
enzym
activ
membran
prepar
determin
simultan
concentr
compound
produc
inhibit
endothelin
convert
enzym
activ
ic
valu
determin
plot
percentag
control
endothelin
convert
enzym
activ
versu
log
concentr
compound
male
spragu
dawley
rat
weigh
g
anesthet
ether
spinal
place
artifici
respir
vagu
nerv
cut
carotid
arteri
ligat
cathet
place
one
carotid
arteri
allow
measur
arteri
blood
pressur
second
cathet
place
penil
vein
allow
infus
inject
drug
stabil
anim
receiv
first
inject
either
big
norepinephrin
angiotensin
ii
pressor
respons
record
return
baselin
second
inject
agonist
given
either
presenc
absenc
inhibitor
data
calcul
mean
sem
student
ttest
pair
unpair
observ
use
analyz
result
littl
et
al
develop
twostep
protocol
highthroughput
assay
endothelin
convert
enzym
activ
human
umbil
vein
human
aorta
endotheli
cell
found
preferenti
convert
big
isopeptid
membranebound
thiorphaninsensit
phophoramidonsensit
zinc
metalloendopeptidas
endothelin
quantifi
separ
step
use
either
enzym
immunoassay
radioceptor
assay
format
method
use
either
character
ece
differ
tissu
screen
inhibitor
specif
ece
activ
mcmahon
et
al
test
effect
endothelin
convert
enzym
inhibitor
endothelin
receptor
subtyp
antagonist
blood
pressur
spontan
renal
hypertens
rat
chang
vascular
resist
isol
perfus
kidney
use
descomb
et
al
character
select
inhibitor
big
respons
studi
perform
kidney
taken
adult
male
wistar
rat
g
rat
anesthet
sodium
pentobarbit
mgkg
ip
left
kidney
prepar
infus
tyrod
solut
chang
renal
vascular
resist
record
chang
perfus
pressur
monitor
constant
flow
mlmin
stabil
bolu
inject
big
administ
result
pressur
respons
record
return
baselin
level
second
inject
endothelin
given
either
control
condit
presenc
put
enzym
inhibitor
increas
evid
implic
endothelin
play
role
pathophysiolog
cerebr
insult
kwan
et
al
studi
prevent
revers
cerebr
vasospasm
experiment
model
subarachnoid
hemorrhag
three
ml
arteri
blood
withdrawn
ear
arteri
rabbit
inject
cisterna
magna
anesthesia
drug
administ
either
h
procedur
fortyeight
hour
later
anim
anesthet
perfus
fixat
perform
hank
balanc
salt
solut
follow
mixtur
paraformaldehyd
glutaraldehyd
cross
section
basilar
arteri
analyz
computerassist
morphometri
review
knowledg
molecular
pharmacolog
endothelin
convert
enzym
given
turner
murphi
johnson
ahn
develop
intern
quench
fluoresc
substrat
select
endothelinconvert
luciani
et
al
describ
highli
sensit
select
fluoresc
assay
rapid
screen
endothelinconvert
enzym
inhibitor
endothelium
releas
labil
diffus
vasorelax
substanc
term
endotheliumderiv
relax
factor
edrf
endotheliumderiv
relax
factor
furchgott
zawadszki
nitric
oxid
releas
account
biolog
activ
endotheliumderiv
relax
factor
palmer
et
al
vanhoutt
nitric
oxid
play
role
wide
rang
physiolog
process
includ
regul
blood
flow
arteri
pressur
via
endotheliumdepend
relax
blood
vessel
ree
et
al
moncada
et
al
uman
levi
huraux
et
al
mcintyr
et
al
zanzing
hropot
et
al
ischemiareperfus
injuri
gao
et
al
schulz
et
al
peripher
nitregr
transmiss
smooth
muscl
rand
li
intracellular
commun
cn
activ
guanylyl
cyclas
target
neuron
southam
garthwait
experiment
stroke
willmot
et
al
learn
memori
susswein
et
al
neurogen
inflamm
kajekar
et
al
regul
leukocyt
recruit
hickey
macrophag
defens
mechan
follow
exposur
bacteri
product
et
al
kleinert
moncada
fiorucci
et
al
discuss
effect
nitric
oxidereleas
nsaid
nodonor
drug
sodium
nitrit
sodium
nitroprussid
snitrosonacetyld
lpenicillamin
snap
use
vasodil
et
al
megson
n
g
nitrolarginin
describ
antagonist
endotheliumdepend
dilat
respons
inhibit
endotheliumderiv
relax
factor
releas
moor
et
al
lamontagn
et
al
ribero
et
al
propos
inhibit
nitric
oxid
synthesi
longterm
treatment
rat
nitrolarginin
new
model
arteri
hypertens
excess
product
damag
dna
activ
poli
adpribos
polymeras
parp
pieper
et
al
case
massiv
product
neuron
enter
parpsuicid
pathway
damag
dna
via
major
pathway
first
involv
nitros
primari
secondari
amin
nucleic
acid
base
wherea
second
involv
combin
superoxid
peroxinitrit
et
al
et
al
like
reactiv
oxid
intermedi
respons
dna
breakag
peroxynitr
acid
rapidli
oxid
sulphydryl
group
also
nitrat
hydroxyl
aromat
compound
includ
tyrosin
tryptophan
guanosin
halliwel
downstream
dna
damag
follow
excess
product
result
signific
activ
poli
adpribos
polymeras
lead
rapid
energi
deplet
cell
death
feihl
et
al
davi
et
al
review
cyclicguanosinemonophosphatemedi
effect
includ
modif
protein
lipid
nucleic
acid
andreadi
et
al
describ
oxid
nitros
event
asthma
edrf
releas
arteri
endothelium
studi
sandwich
techniqu
use
donor
tissu
intact
endothelium
face
intim
side
intim
side
detector
tissu
rabbit
subject
variou
kind
treatment
e
g
atherogen
diet
drug
treatment
prevent
arteriosclerosi
aorta
segment
cm
length
prepar
cut
open
along
longitudin
axi
pin
tissu
suspend
without
damag
endothelium
segment
serv
donor
tissu
edrf
circumferenti
aorta
strip
abdomin
aorta
untreat
control
rabbit
deendotheli
gentli
blot
lumin
surfac
wet
filter
paper
denud
abdomin
aorta
strip
pin
opposit
donor
segment
intim
surfac
face
intim
surfac
function
detector
lumin
releas
edrf
sandwich
prepar
suspend
organ
bath
fill
oxygen
krebsring
buffer
contain
mm
indomethacin
connect
detector
strip
forc
transduc
angl
detector
strip
donor
segment
minim
distanc
donor
detector
tissu
standard
one
hour
stabil
strip
brought
optimum
lengthtens
relationship
repeat
exposur
mm
kcl
stabl
contractil
respons
establish
strip
precontract
phenylephrin
kclinduc
contract
stabil
plateau
phase
cumul
dose
acetylcholin
mm
ad
induc
edrf
releas
donor
tissu
relax
detector
strip
induc
edrf
releas
treat
donor
rabbit
aorta
compar
aorta
control
rabbit
bioassay
measur
function
cultur
endotheli
cell
use
comput
system
acquisit
analysi
vascular
contractil
publish
winn
et
al
endotheli
cell
abl
synthes
releas
potent
vasoconstrict
agent
endothelin
angiotensin
well
vasodil
agent
edrf
isol
arteri
segment
endotheli
surfac
function
destroy
allow
differenti
direct
action
drug
smooth
muscl
cell
indirect
effect
via
endothelium
isol
ring
rabbit
rat
aorta
use
model
studi
effect
endothelium
deriv
factor
edrf
endothelin
antagonist
linz
et
al
tracey
et
al
fujimoto
et
al
fukuroda
et
al
wiemer
et
al
survey
histori
techniqu
lead
discoveri
endotheliumdepend
relax
given
furchgott
descend
thorac
aorta
rabbit
either
sex
weigh
kg
excis
dissect
free
connect
tissu
care
taken
avoid
damag
endothelium
aorta
divid
mm
wide
ring
cut
small
strip
strip
endothelium
remov
gentli
rub
intim
surfac
finger
approxim
strip
suspend
ml
organ
bath
contain
krebsbicarbon
solut
gass
continu
co
contract
strip
record
isometr
load
g
tissu
equilibr
period
h
stabl
baselin
tone
reach
studi
vasodil
effect
compound
strip
contract
norepinephrin
angiotensin
ii
potassium
chlorid
mm
stabl
contract
plateau
reach
vasodil
agent
ad
variou
concentr
concentr
norepinephrin
angiotensin
ii
kcl
evok
respons
maxim
contract
intact
ring
rabbit
aorta
ring
without
endothelium
exhibit
respons
significantli
enhanc
comparison
respons
intact
prepar
norepinephrin
angiotensin
ii
precontract
indic
function
remov
endothelium
respons
prepar
test
known
endotheliumdepend
dilat
acetylcholin
endotheliumintact
ring
acetylcholin
relax
contract
induc
norepinephrin
angiotensin
ii
precontract
ring
devoid
endothelium
acetylcholin
show
relax
effect
caus
contract
higher
concentr
furchgott
zawadzki
exampl
atriopeptin
iii
caus
similar
concentrationdepend
relax
precontract
prepar
intact
function
destroy
endothelium
indic
direct
effect
smooth
muscl
cell
relax
accompani
increas
cgmp
statist
analys
perform
regress
analysi
dose
respons
curv
determin
ec
valu
data
given
mean
standard
deviat
isol
aortic
ring
rabbit
without
function
intact
endothelium
use
tool
differenti
direct
effect
arteri
smooth
musculatur
effect
mediat
endothelium
fujimoto
et
al
use
thorac
aorta
rat
studi
effect
endothelin
endothelin
receptor
antagonist
transvers
strip
ratthorac
aorta
mm
wide
mm
long
endothelium
remov
gentli
rub
interior
surfac
aorta
concentrationrespons
curv
contract
presenc
absenc
inhibitor
compar
pellisi
et
al
perfus
isol
mesenter
vascular
bed
rat
tyrod
solut
measur
perfus
pressur
inject
grade
dose
norepinephrin
dosedepend
relax
due
acetylcholin
vascular
bed
precontract
norepinephrin
infus
order
destroy
endotheli
layer
perfus
chang
hypoton
tyrod
solut
contain
constitu
present
normal
tyrod
solut
onetenth
concentr
result
disrupt
endotheli
cell
effect
norepinephrin
enhanc
wherea
effect
acetylcholin
abolish
legan
sisson
describ
method
denud
rat
aortic
endothelium
vitro
saponin
bohn
use
helic
strip
pulmonari
arteri
guinea
pig
endothelium
remov
biolog
detect
fukuroda
et
al
use
spiral
strip
porcin
coronari
arteri
vein
intrapulmonari
arteri
vein
remov
intim
surfac
lightli
rub
wet
filter
paper
concentrationcontract
curv
obtain
without
endothelin
antagonist
hayashi
et
al
describ
function
anatom
recoveri
endothelium
balloon
denud
left
circumflex
coronari
arteri
dog
endotheli
denud
left
circumflex
coronari
arteri
use
chu
cobb
studi
vasoact
effect
serotonin
proxim
coronari
arteri
awak
dog
experi
isol
ring
left
circumflex
left
anterior
descend
coronari
arteri
dog
without
endothelium
perform
desta
et
al
analyz
effect
antagonist
sumatriptan
induc
isometr
contract
endothelium
denud
segment
canin
coronari
arteri
ren
et
al
isol
coronari
arteri
japanes
monkey
macaca
fuscata
without
endothelium
studi
muscarin
receptor
subtyp
mediat
vasodilat
vasoconstrict
endotheli
cell
abl
synthes
releas
potent
vasoconstrictor
peptid
angiotensin
endothelin
also
potent
dilat
nitric
oxid
atp
substanc
p
bradykinin
noform
assess
determin
intracellular
cyclic
gmp
cultur
endotheli
cell
wherea
releas
cell
measur
stimulatori
effect
activ
solubl
guanylyl
cyclas
et
al
wiemer
et
al
linz
et
al
bogl
et
al
review
moncada
et
al
bovin
porcin
aorta
obtain
local
slaughter
hous
endotheli
cell
isol
digest
dispas
et
al
cell
seed
plate
e
g
nunc
interm
wiesbaden
germani
grown
confluenc
dulbecco
modifi
eaglesham
medium
contain
fetal
calf
serum
supplement
penicillin
uml
streptomycin
lglutam
mml
glutathion
mgml
l
ascorb
acid
mgml
biotect
protect
medium
primari
cultur
endotheli
cell
use
remov
cultur
medium
aspir
monolay
wash
twice
ml
hepestyrod
solut
thereaft
cell
preincub
min
ibmx
ml
time
drug
solvent
ad
predetermin
period
incub
medium
quickli
remov
cell
immedi
extract
ml
trichloroacet
acid
scrape
rubber
scraper
cell
suspens
sonic
centrifug
min
g
supernat
extract
four
volum
water
satur
diethyleth
sampl
frozen
analysi
protein
content
sampl
measur
accord
lowri
et
al
cyclic
gmp
determin
acetyl
sampl
variou
method
heath
et
al
e
g
use
commerci
avail
radioimmunoassay
new
england
nuclear
cyclic
gmp
content
express
picomol
gmp
per
milligram
protein
releas
endotheli
cell
assay
basi
stimulatori
effect
activ
solubl
guanylyl
cyclas
purifi
bovin
lung
gerzer
et
al
activ
enzym
determin
term
format
cyclic
p
gmp
p
gtp
reaction
carri
reaction
mixtur
contain
mm
triethanolaminehcl
ph
mm
reduc
glutathion
mm
mgcl
mm
cgmp
mgml
bovin
globulin
total
volum
ml
presenc
p
gtp
mm
solubl
guanylyl
cyclas
sampl
quickli
transfer
reaction
mixtur
enzymat
format
cgmp
allow
proceed
stop
addit
zinc
acet
mm
sodium
carbon
mm
complet
inhibit
cgmp
format
achiev
preincub
monolay
min
stereospecif
inhibitor
synthas
n
g
nitrolarginin
timerespons
curv
doserespons
curv
addit
variou
activ
inhibitor
synthas
establish
data
report
mean
valu
cgmp
pmolmg
protein
guanylyl
cyclas
activ
nmolmgmin
statist
evalu
perform
student
ttest
clinic
pharmacolog
larginin
review
isol
porcin
cerebr
capillari
endotheli
cell
describ
wiemer
et
al
feelisch
noack
nakazawa
et
al
use
chemiluminesc
techniqu
determin
method
onlin
detect
nitric
oxid
format
liquid
aqueou
phase
electron
paramagnet
reson
spectroscopi
describ
mordvintcev
et
al
similar
method
use
ichimori
et
al
lancest
et
al
steelgoodwin
et
al
hecker
et
al
use
cascad
superfus
bioassay
character
stabl
largininederiv
relax
factor
releas
cytokinestimul
vascular
smooth
muscl
cell
electrochem
microprob
direct
measur
tissu
develop
shibuki
ishida
et
al
smit
lefebvr
malinski
taha
linz
et
al
measur
nitric
oxid
releas
porphyrinicbas
microsensor
detect
limit
nmoll
amperometr
signal
constant
potenti
v
measur
voltametr
analyz
par
model
princeton
appli
research
interfac
ibm
comput
data
acquisit
softwar
gabriel
et
al
develop
method
detect
intracellular
nitric
oxid
gener
dissoci
cerebellar
granul
cell
use
dichlorofluorescin
diacet
flow
cytometri
sumpio
et
al
found
cyclic
mechan
stress
stimul
cultur
bovin
aortic
endotheli
cell
prolifer
use
method
rosal
et
al
found
exposur
endotheli
cell
cyclic
strain
induc
elev
cytosol
ca
concentr
mobil
intracellular
extracellular
pool
rh
sm
clinic
pharmacolog
larginin
annu
rev
pharmacol
toxicol
bogl
rg
coad
sb
moncada
pearson
jd
mann
ge
bradykinin
stimul
larginin
transport
nitric
oxid
releas
vascular
endotheli
cell
format
cytokinetr
rat
hepatocyt
blood
liver
sepsi
properti
variou
form
nitric
oxid
synthas
no
describ
mayer
et
al
leon
et
al
hevel
et
al
et
al
salter
et
al
pollock
et
al
schmidt
et
al
mungru
et
al
among
type
constitut
express
neuron
induc
type
ii
found
macrophag
hepatocyt
also
brain
moro
et
al
may
contribut
nomedi
neurotox
type
iii
constitut
express
endotheli
cell
knowl
moncada
no
inhibit
sever
rout
e
g
competit
larginin
nadph
flavin
tetrahydrobiopterin
interact
haem
group
no
interfer
ca
avail
calmodulin
bind
enzym
fukuto
chaudhuri
wide
use
inhibitor
lname
varga
et
al
select
inhibit
constitut
no
achiev
moor
et
al
induc
no
aminoguanidin
hydrochlorid
griffith
et
al
amt
nakan
et
al
linz
et
al
determin
no
left
cardiac
ventricl
hypertens
rat
tissu
ground
temperatur
liquid
nitrogen
use
microdismembran
braun
powder
extract
h
ice
mmoll
trishcl
ph
contain
sd
proteas
inhibitor
complet
boehring
mannheim
debri
remov
centrifug
g
total
protein
extract
subject
sdspage
electrophoresi
transfer
nitrocellulos
membran
hybond
amersham
eno
protein
detect
use
specif
antibodi
monoclon
antino
iii
transduct
laboratori
visual
enhanc
chemifluoresc
commerci
avail
kit
amersham
secondari
antibodi
antimous
igg
antibodi
coupl
alkalin
phosphatas
use
jackson
immunoresearch
laboratori
chemifluoresc
analyz
quantifi
scan
fluorimag
molecular
dynam
data
given
mean
sem
anova
use
follow
tuckey
test
postanova
multipl
pair
comparison
linz
et
al
measur
express
ecno
carotid
arteri
hypertens
rat
western
blot
analysi
frozen
vessel
thaw
extract
guanidium
isothiocyanatephenolchloroform
chomczynski
sacchi
crude
protein
fraction
obtain
alcohol
precipit
phenol
phase
total
protein
extract
subject
sdspage
transfer
nitrocellulos
membran
biorad
ponceau
stain
perform
verifi
qualiti
transfer
equipartit
protein
lane
ecno
protein
detect
specif
antibodi
mous
no
iii
transduct
laboratori
visual
enhanc
chemifluoresc
commerci
avail
kit
amersham
autoradiograph
analyz
scan
densitometri
mccall
et
al
identifi
niminoethyllornithin
irrevers
inhibitor
nitric
oxid
synthas
bauersach
et
al
bauersach
et
al
measur
vascular
reactiv
isol
rat
aortic
ring
mount
organ
bath
medic
instrument
seeheim
germani
isometr
forc
measur
determin
superoxid
anion
product
lucigeninenhanc
chemiluminesc
endotheli
nitric
oxid
synthas
solubl
guanylyl
cyclas
express
revers
transcriptionpolymeras
chain
reaction
von
der
leyen
et
al
report
gene
therapi
inhibit
neointim
vascular
lesion
rat
denud
endothelium
carotid
arteri
balloon
injuri
endotheli
cell
nitric
oxidas
express
vessel
wall
restor
use
sendai
virusliposom
vivo
gene
transfer
techniqu
lund
et
al
found
gene
transfer
endotheli
nitric
oxid
synthas
improv
relax
carotid
arteri
diabet
rabbit
mungru
et
al
discuss
lesson
murin
genet
model
role
no
heart
failur
rho
member
rasrel
famili
small
molecular
weight
gtpbind
protein
rho
work
molecular
switch
shuttl
gdpbound
inact
form
gtpbound
activ
form
rho
involv
cell
motil
cell
adhes
cytokinesi
rasinduc
transform
transcript
activ
cell
cycl
progress
action
rho
signal
mediat
downstream
rho
effector
rock
famili
rhoassoci
serinethreonin
protein
kinas
studi
rockspecif
inhibitor
indic
rock
pathway
work
contract
vascular
smooth
muscl
sever
studi
indic
rhokinas
may
novel
therapeut
target
treatment
cardiovascular
diseas
kobayashi
et
al
shimokawa
ito
et
al
ito
et
al
nakakuki
et
al
budzyn
et
al
winav
et
al
ishizaki
et
al
describ
pharmacolog
properti
specif
inhibitor
rhoassoci
kinas
recombin
rocki
rockii
pkn
citron
kinas
express
hela
cell
myctag
protein
transfect
use
lipofectamin
precipit
cell
lysat
use
monoclon
antimyc
antibodi
coupl
g
proteinsepharos
ishizaki
et
al
recov
immunocomplex
incub
variou
concentr
p
atp
histon
type
substrat
absenc
presenc
variou
concentr
test
compound
min
total
volum
kinas
buffer
contain
mm
hepesnaoh
ph
mm
mgcl
mm
mncl
briji
mm
dithiothreitol
incub
p
atp
histon
type
substrat
absenc
presenc
variou
concentr
test
compound
min
kinas
buffer
contain
mm
trishcl
ph
mm
cacl
mm
magnesium
acet
phosphatidyl
serin
ngml
leupeptin
total
volum
incub
termin
addit
laemmli
sampl
buffer
boil
min
mixtur
subject
sdspolyacrylamid
gel
electrophoresi
gel
gel
stain
coomassi
brilliant
blue
dri
band
correspond
histon
type
excis
radioact
measur
k
valu
either
determin
doubl
reciproc
plot
calcul
equat
k
ic
sk
k
concentr
atp
k
valu
atp
respect
studi
intestin
renal
brush
border
vesicl
plasma
membran
na
h
exchang
ubiquit
ph
regul
cellular
ion
transport
system
driven
na
gradient
extrud
proton
cytosol
exchang
extracellular
na
ion
aronson
frelin
et
al
fliegel
dyck
orlowski
grinstein
wakabayashi
et
al
dibrov
fliegel
six
mammalian
na
h
exchang
attaphitaya
et
al
szabo
et
al
describ
tse
et
al
orlowski
counillon
cardiac
tissu
exchang
major
role
control
intracellular
ph
onset
cardiac
ischemia
reperfus
na
h
exchang
excess
activ
low
intracellular
ph
sinc
deleteri
na
influx
condit
found
origin
mainli
na
h
exchang
frelin
et
al
et
al
exchang
seem
respons
increas
cytosol
sodium
ischem
cell
accumul
intracellular
na
caus
activ
na
k
atpas
frelin
et
al
rasmussen
et
al
turn
increas
atp
consumpt
ischemia
aerob
metabol
glucos
termin
lactic
acid
viciou
circl
lead
decreas
intracellular
ph
activ
na
h
exchang
result
energi
deplet
cellular
na
overload
final
due
coupl
na
ca
transport
via
na
ca
exchang
cellular
ca
overload
lazdunski
et
al
tani
neeli
scholz
albu
especi
ischem
cardiac
tissu
na
h
exchang
predomin
ph
regul
ion
transport
system
weissenberg
et
al
patholog
event
lead
increas
excit
precipit
cellular
death
therefor
desir
find
potent
well
toler
inhibitor
na
h
exchang
abl
interrupt
viciou
cycl
conserv
cellular
energi
store
diminish
cellular
excit
necrosi
cardiac
ischemia
effect
found
rel
weak
inhibitor
na
h
exchang
high
toxic
dose
amilorid
ethyl
isopropyl
amilorid
scholz
et
al
myocardi
na
h
exchang
regard
therapeut
target
prevent
myocardi
ischem
reperfus
injuri
attenu
postinfarct
heart
failur
karmazyn
et
al
potent
na
h
exchang
inhibitor
show
benefici
effect
ischemiareperfus
injuri
see
rat
aye
et
al
myer
et
al
aihara
et
al
dog
gumina
et
al
pig
portman
et
al
heart
hypertrophi
heart
failur
myocardi
infarct
reduc
yoshida
karmazyn
kusumoto
et
al
ischemiainduc
apoptosi
isol
rat
heart
attenu
sodiumhydrogen
exchang
inhibitor
chakrabarti
et
al
linz
busch
demonstr
effect
inhibit
protect
acut
ischemiareperfus
prevent
myocardi
remodel
inhibit
na
h
exchang
studi
platelet
measur
optic
densiti
osmot
cell
swell
rosskopf
et
al
ml
blood
withdrawn
venipunctur
human
donor
vena
jugulari
externa
beagl
dog
aorta
anesthet
wistar
rat
weigh
g
coagul
inhibit
ml
citrat
acid
dextros
mm
citric
acid
mm
glucos
mm
trisodium
citrat
plateletrich
plasma
prp
obtain
centrifug
whole
blood
g
min
room
temperatur
platelet
count
measur
e
g
casey
multichannelys
system
reutlingen
germani
experi
perform
prp
contain
platelet
volum
salin
activ
na
h
exchang
platelet
intracellular
acidif
propion
buffer
mm
napropion
mm
hcl
mm
cacl
mm
mgcl
mm
glucos
mm
hepe
ph
ad
prpnacl
solut
swell
platelet
result
decreas
optic
densiti
measur
aggregomet
e
g
turbitim
behringwerk
marburg
germani
system
activ
photometr
addit
propion
buffer
cuvett
experi
perform
without
addit
na
h
exchang
inhibitor
test
inhibitor
ad
concentr
moll
nethylnisopropyl
amilorid
eipa
use
standard
experi
solut
kept
temperatur
control
water
bath
result
given
mean
sd
student
ttest
employ
statist
evalu
ic
valu
calcul
doserespons
curv
rosskopf
morgenstern
e
scholz
w
osswald
u
siffert
w
rapid
determin
elev
na
k
exchang
platelet
patient
essenti
hypertens
use
optic
swell
assay
j
hyperten
inhibit
na
h
exchang
studi
cholesterol
activ
rabbit
erythrocyt
flame
photometri
sodium
scholz
et
al
scholz
et
al
white
rabbit
new
zealand
strain
ivanova
fed
rabbit
standard
chow
cholesterol
week
increas
na
h
exchang
scholz
et
al
make
erythrocyt
suitabl
measur
sodium
influx
via
na
h
exchang
flame
photometri
blood
drawn
ear
arteri
rabbit
coagul
prevent
iuml
potassium
heparin
hematocrit
sampl
determin
duplic
centrifug
aliquot
taken
measur
initi
sodium
content
erythrocyt
determin
amilorid
sensit
sodium
influx
erythrocyt
blood
sampl
ad
ml
buffer
made
hyperosmolar
sucros
mm
nacl
mm
kcl
mm
sucros
mm
ouabain
mm
trishydroxymethylaminomethan
ph
incub
min
subsequ
erythrocyt
wash
three
time
icecold
mgcl
ouabainsolut
mm
mgcl
mm
ouabain
determin
intracellular
sodium
content
cell
hemolyz
distil
water
cell
membran
centrifug
sodium
concentr
haemolys
measur
flame
photometri
net
influx
sodium
erythrocyt
calcul
differ
initi
sodium
content
sodium
content
incub
amiloridesensit
sodium
influx
calcul
differ
sodium
content
erythrocyt
incub
without
amilorid
experi
done
erythrocyt
differ
anim
case
comparison
na
content
base
erythrocyt
anim
dose
inhibitor
test
statist
analysi
data
obtain
perform
student
ttest
pair
group
ic
valu
calcul
doserespons
curv
inhibit
na
h
exchang
studi
cultur
cardiac
myocyt
scholz
et
al
rat
myocardi
cell
isol
heart
neonat
rat
trypsin
digest
cell
cultur
mm
dish
grown
confluenc
dulbecco
minimum
essenti
medium
dmem
gibco
atmospher
contain
co
confluenc
cell
use
measur
na
influx
cell
wash
twice
krebsringersolut
buffer
hepestri
krb
sodium
chlorid
replac
cholin
chlorid
cholin
chlorid
mm
cacl
mm
kcl
mm
mgcl
mm
hepe
mm
ph
tri
incub
min
buffer
ad
bovin
serum
albumin
bsa
mml
glucos
cultur
dish
incub
anoth
min
na
propion
cytosol
acidif
stimul
na
h
exchang
compound
dissolv
krb
sodium
chlorid
replac
cholin
chlorid
contain
addit
na
bicarbon
nethylnisopropyl
amilorid
eipa
stimul
period
sodium
influx
termin
wash
cell
twice
icecold
stop
solut
mm
mgcl
mm
tri
ph
subsequ
cell
lyze
trichloroacet
acid
scrape
dish
radioact
determin
packard
gamma
counter
dose
mml
standard
new
compound
test
six
dish
use
concentr
test
compound
mean
valu
sd
compar
student
ttest
ic
valu
calcul
doserespons
curv
inhibit
na
h
exchang
studi
endotheli
cell
scholz
et
al
chang
intracellular
ph
cultur
bovin
endotheli
cell
fluorometr
monitor
use
phdye
bi
carboxyethyl
carboxyfluorescein
bcecf
kitazano
et
al
method
use
studi
activ
inhibitor
na
h
exchang
prepar
isol
rat
ventricular
muscular
cell
yazawa
et
al
heart
male
wistar
rat
dissect
mount
langendorff
apparatu
perfus
first
min
tyrod
solut
adjust
ph
second
min
nomin
calcium
free
tyrod
solut
final
calcium
free
tyrod
solut
contain
mgml
collagenas
sigma
type
min
collagenas
treatment
heart
wash
storag
solut
composit
mmoll
koh
lglutam
acid
kcl
taurin
kh
po
mgcl
glucos
hepe
egta
ph
ventricl
cut
small
piec
myocyt
dispers
gentli
shake
final
filtrat
nylon
mesh
thereaft
cell
wash
twice
centrifug
rpm
min
kept
use
ph
recoveri
experi
cell
load
membran
permeabl
acetoxymethyl
ester
form
fluoresc
indic
bi
carboxyethyl
carboxyfluorescein
bcecf
bcecfam
dissolv
dmso
dilut
storag
solut
cardiomyocyt
load
solut
min
room
temperatur
centrifug
resuspend
storag
solut
measur
perform
bicarbonatefre
nacl
solut
nacl
kcl
cacl
mgcl
glucos
hepe
mml
ph
use
apparatu
accord
nitschk
et
al
phdepend
signal
bcecf
obtain
illumin
nm
divid
emit
light
signal
nm
background
signal
determin
close
shutter
subtract
total
signal
autofluoresc
determin
illumin
unload
cell
ignor
order
investig
function
na
h
exchang
system
intracellular
ph
ph
cell
decreas
nh
cl
prepuls
techniqu
rate
return
rest
ph
determin
test
compound
dissolv
incub
medium
test
concentr
recoveri
ph
first
record
control
nacl
solut
data
analyz
fit
straight
line
initi
min
data
point
ph
recoveri
curv
statist
present
slope
linear
curv
demonstr
report
data
present
mean
sem
statist
comparison
made
use
either
pair
unpair
ttest
phsensit
fluoresc
dye
carboxyseminaphthorhodafluor
use
yatsutak
et
al
shipolini
et
al
yokoyama
et
al
fischer
et
al
test
new
drug
na
h
exchang
chines
hamster
ovari
cell
enrich
isoform
na
h
antiport
na
h
exchang
stimul
nacl
rate
extracellular
acidif
quantifi
cytosensor
free
inhibit
na
depend
cl
hco
exchang
cell
aliquot
cell
cell
ph
recoveri
record
dualgrat
deltascan
singlephoton
count
fluoromet
photon
technolog
intern
south
brunswick
nj
usa
excit
wavelength
nm
nm
emiss
wavelength
nm
measur
time
vari
subtyp
inhibitor
first
dissolv
dmso
dilut
recoveri
medium
ad
volum
medium
clone
opossum
kidney
cell
line
helmlekolb
et
al
use
addit
cell
grown
monolay
growth
medium
mixtur
nutrient
mixtur
ham
dulbecco
modifi
medium
eagl
fetal
calf
serum
subcultiv
phrecoveri
experi
cell
detach
surfac
cultur
vessel
trypsinedta
solut
g
g
edta
per
liter
dulbecco
phosphatebuff
salin
suspend
growth
medium
measur
time
ph
recoveri
experi
porcin
renal
brushbord
membran
vesicl
bbmv
prepar
mg
precipit
techniqu
load
mmoll
nacl
mmoll
hepestri
ph
preincub
min
variou
concentr
nhe
inhibitor
intravesicular
acidif
na
h
exchang
start
dilut
bbmv
na
free
buffer
mmoll
tetramethylammonium
chlorid
mmol
hepestri
ph
contain
appropri
concentr
nhe
inhibitor
fluoresc
ph
indic
acridin
orang
fluoresc
chang
acridin
orang
record
continu
hitachi
spectrofluoromet
nm
excit
nm
emiss
wavelength
initi
acridin
orang
fluoresc
quench
control
inhibitor
set
valu
present
mean
sd
four
measur
per
concentr
ic
valu
hill
coeffici
calcul
use
sigma
plot
softwar
statist
signific
calcul
mean
distributionindepend
htest
nonparametr
utest
p
consid
signific
counillon
et
al
scholz
et
al
determin
nhe
subtyp
specif
na
h
antiport
abil
inhibit
initi
rate
amilorid
sensit
na
uptak
fibroblast
cell
line
separ
express
isoform
ko
et
al
determin
inhibitori
effect
flavonoid
phosphodiesteras
isozym
guinea
pig
structureact
relationship
counillon
lt
scholz
w
lang
hj
j
pharmacolog
character
stabli
transfect
na
h
antiport
isoform
use
amilorid
analog
new
inhibitor
exhibit
antiischem
properti
review
nomenclatur
structurefunct
relationship
cyclic
nucleotideregul
channel
mongillo
et
al
report
fluoresc
reson
energi
transferbas
analysi
camp
dynam
live
neonat
rat
cardiac
myocyt
reveal
distinct
function
compartment
phosphodiesteras
studi
realtim
monitor
activ
live
cell
nikolaev
et
al
found
hormonestimul
camp
hydrolysi
faster
hormonestimul
camp
synthesi
snyder
et
al
studi
role
cyclic
nucleotid
phosphodiesteras
regul
adipocyt
lipolysi
zhang
et
al
desrib
glutamin
switch
mechan
nucleotid
select
phosphodiesteras
male
spraguedawley
rat
g
decapit
heart
perfus
nacl
aorta
remov
blood
ventricl
minc
vol
mm
trishcl
buffer
contain
sucros
mm
edta
nm
dtt
mm
pmsf
ph
suspens
homogen
glassglass
potterelvejhem
homogen
centrifug
g
min
g
supernat
store
c
inject
hplc
column
cytosol
fraction
rat
ventricl
mg
protein
load
rate
mlmin
mono
q
hplc
column
previous
equilibr
buffer
mm
trishcl
mm
edta
mm
mm
pmsf
ph
condit
greater
pde
activ
bound
column
pde
activ
elut
flow
rate
mlmin
use
follow
step
step
linear
gradient
nacl
buffer
ml
nacl
ml
nacl
ml
nacl
ml
nacl
ml
nacl
separ
done
fraction
ml
collect
store
presenc
glycerol
fraction
test
pde
activ
peak
contain
differ
isoenzym
identifi
fraction
contain
preferenti
one
isoenzym
pool
pde
activ
assay
twostep
radioisotop
procedur
accord
thompson
et
al
boudreau
drummond
prigent
et
al
phosphodiesteras
activ
determin
use
plabel
gpt
reinsberg
reaction
perform
use
eppendorf
cup
mm
gtp
test
solut
p
gtp
reaction
start
mm
sodium
nitroprussid
solut
incub
period
min
reaction
stop
mm
sodium
carbon
zinc
acet
wherebi
zinc
carbon
substrat
gtp
almost
precipit
separ
cgmp
precipit
separ
centrifug
supernat
submit
chromatographi
aluminum
oxid
column
column
first
treat
tri
hcl
buffer
supernat
ml
appli
two
wash
period
cgmp
elut
five
fraction
fraction
measur
highest
activ
pool
pde
activ
calcul
differ
appli
p
gtp
minu
unalt
p
gtp
famili
compos
two
gene
mrna
enrich
blood
vessel
heart
megakaryocyt
oocyt
wherea
highest
adipocyt
hepatocyt
brain
renal
collect
duct
epithelium
develop
spermatocyt
reinhardt
et
al
inhibitor
extens
investig
develop
nonglycosid
nonsympathomimet
cardioton
agent
treatment
heart
failur
milrinon
studi
extens
use
inhibitor
use
acut
treatment
heart
failur
cruickshank
trequinsin
hl
inhibit
nanomolar
rang
ruppert
weithmann
also
inhibit
submicromolar
concentr
stoclet
et
al
boswellsmith
et
al
studi
pharmacolog
two
longact
trequinsinlik
phosphodiesteras
inhibitor
hambleton
et
al
studi
isoform
cyclic
nucleotid
phosphodiesteras
contribut
camp
hydrolyt
activ
subcellular
fraction
human
myocardium
masciarelli
et
al
describ
mice
defici
cyclic
nucleotid
phosphodiesteras
model
femal
infertil
adachi
et
al
report
effect
phosphodiesteras
inhibitor
olprinon
rhythmic
chang
tension
human
gastroepiplo
arteri
abbott
thompson
perform
analysi
activ
deriv
reveal
multipl
mechan
antiplatelet
activ
mainli
present
brain
houslay
et
al
inflammatori
cell
tenor
schudt
cardiovascular
tissu
stoclet
et
al
smooth
muscl
lack
platelet
four
gene
yield
larg
number
distinct
varaint
enzym
result
use
altern
promot
extens
splice
mrna
stratifi
long
short
form
conti
et
al
one
three
three
variant
express
rat
human
cardiac
tissu
houslay
adam
two
genederiv
variant
express
human
rat
aortic
mesenter
femor
contractilequiesc
syntheticactiv
vascular
smooth
muscl
cell
liu
et
al
role
campspecif
phosphodiesteras
cellular
signal
review
houslay
adam
conti
et
al
huai
et
al
studi
threedimension
structur
complex
rolipram
implic
inhibitor
select
bailli
et
al
found
camp
phosphodiesteras
recruit
regul
switch
g
g
antidepress
compound
rolipram
zk
select
inhibitor
schwabe
et
al
koma
et
al
odonnel
zhang
describ
antidepress
effect
inhibitor
camp
phosphodiesteras
mani
analog
studi
inhibitor
treatment
asthma
chronic
obstruct
pulmonari
diseas
copd
well
antiinflammatori
drug
howev
fail
due
emet
sideeffect
giembycz
select
inhibitor
cyclic
guanosin
monophosph
cgmp
phosphodiesteras
type
found
effect
treatment
erectil
dysfunct
men
jeremi
et
al
ballard
et
al
chuang
et
al
stief
et
al
corbin
franci
turko
et
al
walli
et
al
hosogai
et
al
rotella
saenz
de
tejada
et
al
ukita
et
al
famili
consist
singl
gene
encod
three
distinct
protein
loughney
et
al
wang
et
al
character
type
phosphodiesteras
corpu
cavernosum
sever
speci
qiu
et
al
demonstr
rabbit
corpu
cavernosum
smooth
muscl
show
differ
phosphodiesteras
profil
human
corpu
cavernosum
kim
et
al
compar
inhibit
cyclic
gmp
hydrolysi
human
corpu
cavernosum
smooth
muscl
cell
vardenafil
sildenafil
discoveri
novel
potent
select
inhibitor
report
bi
et
al
corbin
et
al
describ
structur
basi
higher
potenc
vardenafil
compar
sildenafil
inhibit
ccmpspecif
inhibitor
sildenafil
use
treatment
pulmonari
arteri
hypertens
et
al
cohen
et
al
found
inhibit
cgmpspecif
phosphodiesteras
select
vasodil
pulmonari
circul
rat
made
chronic
hypox
exposur
simul
high
altitud
chronic
hypoxia
augment
protein
kinas
gmediat
ca
desensit
pulmonari
vascular
smooth
muscl
inhibit
rhoarho
kinas
signal
jernigan
et
al
thompson
et
al
studi
effect
sildenafil
corpu
cavernos
smooth
muscl
relax
cgmp
format
diabet
rabbit
tantini
et
al
found
antiprolif
effect
sildenafil
human
pulmonari
arteri
smooth
muscl
cell
famili
identifi
result
bioinformaticsbas
genom
screen
soderl
beavo
search
inhibitor
begin
gillespi
beavo
discuss
inhibit
stimul
photoreceptor
phosphodiesteras
later
term
dipyridamol
b
darmour
et
al
investig
potenc
mechan
action
type
phosphodiesteras
isozymeselect
inhibitor
photoreceptor
phosphodiesteras
zhang
et
al
describ
efficaci
select
phosphodiesterasetarget
drug
inhibit
photoreceptor
phosphodiesteras
retin
photoreceptor
smith
et
al
report
discoveri
select
inhibitor
phosphodiesteras
discoveri
thiadiazol
novel
structur
class
potent
select
inhibitor
report
vergn
et
al
vergn
et
al
metzger
lindner
discov
posit
inotrop
vasodilatori
effect
forskolin
correl
stimul
adenyl
cyclas
campdepend
protein
kinas
subsequ
studi
seamon
demonstr
forskolin
unlik
hormon
guanin
nucleotid
fluorid
cholera
toxin
could
stimul
cyclas
activ
absenc
guanin
nucleotid
regulatori
protein
sinc
report
hundr
paper
publish
effect
forskolin
numer
mammalian
organ
cell
system
sever
comprehens
review
articl
also
publish
seamon
dali
dali
dali
forskolin
proven
invalu
research
tool
investig
adenyl
cyclas
system
salomon
et
al
seamon
et
al
seamon
et
al
report
effect
cardiovascular
lindner
et
al
pulmonari
chang
et
al
ocular
physiolog
caprioli
sear
caprioli
suggest
therapeut
potenti
seamon
well
describ
vitro
assay
use
compar
potenc
forskolin
forskolin
analog
direct
indirect
adenyl
cyclas
activ
stimul
adenyl
cyclas
heart
membran
purpos
assay
determin
compar
potenc
direct
indirect
activ
adenyl
cyclas
abil
stimul
heart
membran
adenyl
cyclas
vitro
heart
wistar
rat
hartley
guinea
pig
golden
syrian
hamster
cardiomyopath
hamster
use
sourc
adenyl
cyclas
assay
serial
dilut
made
final
concentr
assay
rang
concentr
vehicl
assay
one
entir
heart
rat
guinea
pig
hamster
dissect
weigh
homogen
volum
icecold
tri
buffer
ph
contain
mm
cacl
reagent
use
brinkman
polytron
set
homogen
centrifug
g
min
result
pellet
resuspend
volum
homogen
buffer
recentrifug
supernat
spin
discard
result
pellet
final
resuspend
volum
homogen
buffer
rat
hamster
volum
guinea
pig
tissu
final
prepar
filter
thin
layer
gauz
kept
ice
use
assay
protein
concentr
approxim
mgml
protein
concentr
aliquot
tissu
suspens
determin
day
experi
method
bradford
tube
incub
min
reaction
stop
place
tube
boil
water
bath
min
tube
centrifug
g
min
camp
level
determin
aliquot
supernat
use
radioimmunoassay
kit
code
obtain
amersham
accord
manufactur
protocol
test
principl
method
base
competit
unlabel
camp
fix
quantiti
hlabel
camp
bind
protein
high
specif
affin
cyclic
amp
amount
label
campprotein
complex
form
invers
relat
amount
unlabel
camp
present
assay
sampl
concentr
camp
unknown
determin
comparison
linear
standard
curv
data
express
pmol
campmg
proteinmin
doserespons
stimul
curv
subject
logic
analysi
determin
concentr
compound
exhibit
maxim
stimul
ed
activ
compound
determin
activ
counteract
isoproterenol
gtp
induc
stimul
rat
heart
membran
bound
adenyl
cyclas
greenslad
et
al
assay
use
identifi
compound
demonstr
high
affin
nm
associ
forskolin
bind
site
vitro
preliminari
screen
conjunct
stimul
adenyl
cyclas
determin
potenti
cardiac
chronotrop
inotrop
effect
forskolin
guinea
pig
heart
tissu
rat
brain
tissu
use
sourc
bind
assay
tube
incub
min
incub
dilut
ml
icecold
trishcl
buffer
ph
reagent
immedi
vacuum
filter
glass
fiber
filter
whatman
gfb
use
brandel
cell
harvest
filter
rapidli
wash
three
time
ml
aliquot
trishcl
buffer
reagent
ad
ml
scintil
cocktail
analyz
radioact
specif
bind
defin
differ
bind
hforskolin
absenc
presenc
forskolin
repres
total
bind
nm
hforskolin
result
doserespons
inhibit
curv
analyz
determin
concentr
compet
compound
inhibit
hforskolin
bind
site
ic
valu
determin
computerderiv
logprobit
analysi
activ
variou
forskolin
analog
base
ic
valu
categor
follow
compar
activ
variou
compound
experi
experi
inhibit
constant
k
determin
describ
cheng
prusoff
k
determin
equat
introduct
patch
clamp
techniqu
neher
sakmann
revolution
studi
cellular
physiolog
provid
highresolut
method
observ
function
individu
ionic
channel
varieti
normal
patholog
cell
type
use
variat
basic
record
methodolog
cellular
function
regul
studi
molecular
level
observ
current
individu
ionic
channel
liem
et
al
sakmann
neher
intrigu
method
call
oncel
cellattach
configur
ion
channel
record
intact
cell
jackson
mode
well
suit
investig
ion
channel
activ
hormon
stimul
trigger
intracellular
second
messeng
anoth
versatil
mode
cellexcis
configur
hamil
obtain
suddenli
remov
patch
pipett
cell
membran
patch
pull
cell
mode
easili
allow
investig
expos
channel
protein
drug
chang
bath
solut
singl
channel
current
record
videotap
analyz
offlin
comput
system
variou
paramet
evalu
singl
channel
conduct
open
close
time
channel
openst
probabl
percentag
time
channel
stay
open
state
addit
mode
enabl
record
singl
channel
current
also
possibl
measur
current
flow
entir
cell
wholecel
mode
obtain
ruptur
membran
patch
cellattach
mode
hamil
et
al
dietzel
et
al
achiev
appli
suction
interior
patch
pipett
wholecel
mode
allow
record
electr
current
also
measur
cell
potenti
moreov
cell
interior
dialyz
electrolyt
solut
contain
patch
pipett
fabric
patch
clamp
pipett
describ
sakmann
neher
et
al
variat
patch
clamp
techniqu
use
studi
neurotransmitt
transduct
mechan
smith
high
throughput
method
requir
develop
drug
work
ion
channel
function
math
bennett
guthri
patch
clamp
suffer
low
throughput
accept
drug
screen
fertig
et
al
brueggemann
et
al
brueggemann
et
al
present
nanopatch
clamp
technolog
base
planar
microstructur
glass
chip
enabl
automat
wholecel
patch
clamp
experi
planar
glass
substrat
contain
singl
microapertur
produc
ion
track
etch
use
record
current
ion
channel
live
mammalian
cell
falcon
et
al
report
high
throughput
screen
ion
channel
modul
set
beckmansagian
core
system
fulli
autom
function
fluorescencebas
assay
measur
ion
channel
function
voltagesensit
fluoresc
probe
appli
activ
channel
measur
use
aurora
voltageion
probe
reader
vipr
system
provid
platform
fulli
autom
high
throughput
screen
well
pharmacolog
character
ion
channel
modul
schroeder
et
al
describ
high
throughput
electrophysiolog
measur
platform
consist
computercontrol
fluid
handl
record
electron
process
tool
capabl
voltag
clamp
wholecel
record
thousand
individu
cell
per
day
system
use
planar
multiwel
substrat
patchplat
system
posit
one
cell
hole
separ
two
fluid
compart
well
substrat
voltag
control
current
record
cell
membran
made
subsequ
gain
access
cell
interior
appli
permeabil
agent
intracellular
side
willumsen
group
recommend
ion
channel
screen
qpatch
asmild
et
al
kutchiski
et
al
krzywkowski
et
al
system
claim
allow
fast
accur
electrophysiolog
character
ion
channel
e
g
determin
ic
valu
ion
channel
blocker
system
compris
parallel
patch
clamp
site
base
silicon
chip
microetch
patch
clamp
hole
intraand
extracellular
fluid
administ
laminar
flow
integr
miniatur
flow
channel
gener
action
potenti
heart
muscl
cell
depend
open
close
ionselect
channel
plasma
membran
patch
clamp
techniqu
enabl
investig
drug
interact
ionchannelform
protein
molecular
level
isol
cell
ventricular
muscl
rat
guinea
pig
prepar
describ
yazawa
et
al
hamil
et
al
isol
cell
place
thermostatcontrol
chamber
mount
stage
invert
microscop
equip
differenti
interfer
contrast
optic
optic
control
magnif
glass
micropipett
tip
open
place
onto
cell
patch
pipett
fabric
borosil
glass
tube
outer
diamet
mm
inner
diamet
mm
mean
electr
heat
puller
order
prevent
damag
cell
membran
tip
micropipett
fire
polish
move
heat
platinum
wire
close
tip
patch
pipett
fill
either
highnacl
kcl
solut
mount
micro
manipul
silver
chlorid
wire
connect
pipett
solut
head
stage
electron
amplifi
second
silver
chlorid
wire
insert
bath
serv
ground
electrod
establish
contact
cell
membran
slight
neg
pressur
appli
insid
patch
pipett
mean
syring
consequ
small
patch
membran
slightli
pull
open
micro
pipett
close
contact
glass
membran
form
lead
increas
electr
input
resist
gigaohm
rang
ohm
high
input
resist
enabl
record
small
electr
current
rang
picosiemen
flow
channelform
protein
situat
membran
patch
electr
current
driven
appli
electr
potenti
across
membran
patch
andor
establish
appropri
chemic
gradient
respect
ion
speci
patch
clamp
method
allow
one
investig
interact
drug
ion
channel
involv
function
heart
muscl
cell
k
na
ca
eventu
cl
channel
moreov
differ
type
k
channel
exist
cardiomyocyt
distinguish
differ
singlechannel
characterist
appropri
voltagepuls
protocol
wholecel
mode
concentrationrespons
curv
drug
inhibit
activ
ion
channel
record
either
singl
channel
level
measur
wholecel
current
ic
ec
valu
inhibit
activ
respect
obtain
method
patch
clamp
techniqu
use
evalu
antiarrhythm
agent
bennett
et
al
anno
hondeghem
gwilt
et
al
et
al
use
isol
ventricular
myocyt
guinea
pig
studi
cardioselect
inhibitor
atpsensit
potassium
channel
multipl
type
calcium
channel
identifi
patch
clamp
experi
tsien
et
al
effect
potassium
channel
open
measur
terzic
et
al
et
al
character
electropor
singl
cell
carbonfib
microelectrod
patch
clamp
record
fluoresc
microscopi
monyer
lambolez
review
molecular
biolog
physiolog
singl
cell
level
discuss
valu
polymeras
chain
reaction
singl
cell
level
use
patch
pipett
collect
content
singl
cell
revers
transcript
perform
patch
clamp
techniqu
found
versatil
investig
ion
channel
atrial
myocyt
especi
dog
human
cell
obtain
atria
either
sinu
rhythm
atrial
fibril
review
bosch
et
al
epitheli
na
channel
play
import
role
epitheli
na
absorpt
distal
colon
urinari
bladder
salivari
sweat
duct
respiratori
tract
importantli
distal
tubul
kidney
catteral
palmer
regul
epitheli
na
channel
major
impact
na
balanc
blood
volum
blood
pressur
inhibit
epitheli
na
channel
express
use
treatment
hypertens
endou
hosoyamada
busch
et
al
studi
blockad
epitheli
na
channel
triamteren
use
twomicroelectrod
voltag
clamp
experi
xenopu
oocyt
express
three
homolog
subunit
rat
epitheli
na
channel
renac
xenopu
laevi
oocyt
inject
appropri
crna
encod
subunit
canessa
et
al
rat
epitheli
na
channel
renac
crna
wildtyp
delet
mutant
alway
coinject
equal
amount
subunit
crna
ngoocyt
day
crna
inject
twomicroelectrod
voltag
clamp
method
use
record
current
xenopu
oocyt
record
perform
use
geneclamp
amplifi
axon
instrument
foster
citi
calif
usa
maclab
da
convert
softwar
data
acquisit
analysi
ad
instrument
castl
hill
australia
nd
solut
control
contain
mm
nacl
kcl
cacl
mgcl
experi
na
replac
nmethyldglucamin
nmdg
solut
microelectrod
fill
kcl
solut
resist
rang
chemic
e
g
triamteren
standard
ad
concentr
amplitud
induc
current
vari
consider
depend
day
channel
express
batch
oocyt
mutant
channel
induc
consider
smaller
current
wildtyp
channel
total
na
current
amplitud
determin
least
experiment
day
superfus
nmdg
solut
amilorid
solut
begin
end
set
experi
data
present
mean
sem
pair
student
ttest
use
level
statist
signific
set
p
nawada
et
al
studi
effect
sodium
calcium
potassium
antagonist
agent
sodium
current
whole
cell
voltag
clamp
techniqu
tip
resist
na
na
mmoll
guinea
pig
isol
ventricular
cell
sunami
hiraoka
studi
mechan
cardiac
na
channel
block
charg
class
antiarrhythm
agent
guinea
pig
ventricular
myocyt
use
patch
clamp
techniqu
wholecel
cellattach
insideout
configur
et
al
compar
effect
vinca
deriv
voltageg
na
channel
cultur
cell
rat
embryon
cerebr
cortex
effect
na
current
measur
appli
voltag
step
ms
durat
mv
hold
potenti
mv
everi
steadyst
inactiv
curv
obtain
clamp
membran
one
seri
prepuls
potenti
follow
ms
later
test
puls
mv
ragsdal
et
al
examin
action
na
channel
blocker
wholecel
voltag
clamp
record
chines
hamster
ovari
cell
transfect
cdna
encod
rat
brain
type
iia
na
channel
dissoci
rat
brain
neuron
taglialatela
et
al
studi
clone
voltagedepend
na
current
express
xenopu
oocyt
upon
inject
crna
encod
human
rat
brain
investig
pharmacolog
target
long
qt
mutant
sodium
channel
eller
et
al
measur
effect
calcium
antagonist
inward
na
current
na
wholecel
configur
patch
clamp
techniqu
na
record
depolar
hold
potenti
mv
test
potenti
mv
initi
tonic
block
rest
statedepend
block
defin
peak
na
inhibit
first
puls
min
drug
applic
compar
na
absenc
drug
use
frequenc
depend
block
na
measur
train
test
puls
hz
appli
mv
test
potenti
mv
equilibrium
period
drugcontain
solut
usedepend
block
express
percentag
decreas
peak
na
last
puls
train
compar
na
first
puls
khalifa
et
al
character
effect
antidepress
agent
fast
inward
current
na
isol
guinea
pig
ventricular
myocyt
current
record
wholecel
configur
patch
clamp
techniqu
presenc
ca
k
channel
blocker
haesel
et
al
measur
effect
preserv
ad
wide
varieti
drug
heterolog
express
wildtyp
paramyotonia
congenita
hyperkalem
period
paralysi
mutant
human
muscl
sodium
channel
use
wholecel
insideout
voltag
clamp
experi
song
et
al
studi
effect
nethylmaleimid
alkyl
agent
protein
sulfhydryl
group
tetrodotoxinsensit
ttx
tetrodotoxinresist
ttxr
sodium
channel
rat
dorsal
root
neuron
use
wholecel
configur
patch
clamp
techniqu
rat
age
day
anesthet
isofluran
spinal
cord
remov
cut
longitudin
dorsal
root
ganglia
pluck
area
vertebra
spinal
column
incub
phosphatebuff
salin
solut
contain
mgml
trypsin
min
enzym
treatment
ganglia
rins
dulbecco
modifi
eagl
medium
supplement
hors
serum
singl
cell
mechan
dissoci
tritur
firepolish
pasteur
pipett
plate
polyllysineco
glass
coverslip
cell
attach
coverslip
transfer
record
chamber
stage
invert
microscop
ionic
current
record
voltag
clamp
condit
wholecel
patch
clamp
techniqu
solut
pipett
contain
mm
cscl
naf
hepe
egta
ph
adjust
csoh
osmolar
mosmol
averag
extern
solut
contain
mm
nacl
cholin
chlorid
tetramethylammonium
chlorid
dglucos
hepe
mgcl
cacl
lanthanum
lacl
use
block
calcium
channel
current
solut
adjust
ph
tetramethylammonium
hydroxid
osmolar
mosmol
averag
agagcl
kclagar
bridg
use
refer
electrod
membran
current
record
use
amplifi
signal
digit
analogtodigit
interfac
filter
lowpass
bessel
filter
khz
sampl
khz
use
softwar
axon
instrument
ibmcompat
pc
seri
resist
compens
capacit
leakag
current
subtract
use
p
procedur
bezanilla
armstrong
liquid
junction
potenti
intern
extern
solut
averag
mv
ttx
nm
use
separ
ttxr
sodium
current
ttx
sodium
current
studi
ttx
sodium
channel
cell
express
ttx
sodium
channel
use
ttx
sodium
channel
complet
inactiv
within
ms
current
evok
depolar
step
mv
ttxr
sodium
channel
persist
ms
differ
kinet
use
identifi
type
sodium
current
abriel
et
al
describ
molecular
pharmacolog
sodium
channel
mutat
link
long
qt
syndrom
makielski
et
al
show
ubiquit
splice
variant
common
polymorph
affect
heterolog
express
recombin
human
heart
sodium
channel
viswanathan
et
al
studi
gate
mechan
flecainid
action
arrhythmia
syndrom
abriel
h
wehren
xht
benhorin
j
kerem
b
kass
rs
molecular
pharmacolog
sodium
channel
mutat
link
longqtsyndrom
potassium
channel
repres
larg
divers
collect
membran
protein
particip
import
cellular
function
regul
neuron
cardiac
electr
pattern
releas
neurotransmitt
muscl
contractil
hormon
secret
secret
fluid
modul
signal
transduct
pathway
main
categori
potassium
channel
gate
voltag
increas
intracellular
calcium
concentr
escand
henri
kaczorowski
garcia
alexand
et
al
atpsensit
potassium
channel
see
sect
delay
outward
potassium
current
heart
muscl
cell
sever
speci
made
rapidli
kr
slowli
ks
activ
compon
sanguinetti
jurkiewicz
wang
et
al
gintant
lei
brown
carmeliet
mubagawa
sever
potent
select
blocker
kr
channel
shown
prolong
effect
refractori
period
revers
ratedepend
activ
normal
elev
extracellular
potassium
concentr
colatski
et
al
inhibitor
slow
compon
ks
develop
order
circumv
neg
rate
depend
kr
channel
blocker
effect
refractori
period
busch
et
al
suessbrich
et
al
suessbrich
et
al
bosch
et
al
et
al
studi
effect
potent
inhibitor
ks
channel
xenopu
oocyt
guinea
pig
ventricular
myocyt
xenopu
oocyt
perform
twomicroelectrod
voltag
clamp
method
isol
oocyt
toad
anesthet
use
gl
solut
acid
ethyl
ester
place
ice
small
incis
made
retriev
sac
oocyt
subsequ
close
absorb
surgic
sutur
wake
toad
place
back
aquarium
ovari
cut
small
piec
oocyt
wash
ca
solut
mm
nacl
mm
kcl
mm
mgcl
mm
hepe
ph
subsequ
digest
contain
collagenas
mgml
worthington
type
ii
follicl
longer
detect
oocyt
surfac
oocyt
store
record
solut
nacl
mm
kcl
mm
cacl
mm
mgcl
mm
hepe
mm
ph
ad
sodium
pyruv
mgl
theophyllin
mgl
gentamicin
mgl
electrophysiolog
record
twomicroelectrod
voltag
clamp
configur
use
record
ion
current
xenopu
oocyt
inject
crna
perform
accord
methfessel
et
al
gold
oocyt
inject
individu
crna
encod
human
protein
mink
guinea
pig
human
herg
human
mous
human
case
mink
function
potassium
channel
heteromultim
compos
endogen
xenopu
inject
human
mink
heteromultimer
potassium
current
call
ks
barhanin
et
al
sanguinetti
et
al
electrophysiolog
record
perform
room
temperatur
use
geneclamp
amplifi
axon
instrument
maclab
da
convert
amplitud
record
current
measur
end
test
voltag
step
amplifi
inward
potassium
current
extern
potassium
concentr
rais
mm
kcl
nacl
concentr
lower
mm
microelectrod
fill
kcl
resist
record
oocyt
continu
perfus
case
test
compound
dissolv
dimethylsulfoxid
dmso
ad
buffer
current
amplitud
determin
min
washin
time
isol
ventricular
myocyt
guinea
pig
weight
g
spraguedawley
rat
either
sex
sacrif
cervic
disloc
heart
dissect
perfus
retrograd
via
aorta
first
nomin
ca
free
tyrod
solut
mmoll
nacl
kcl
mgcl
nah
po
glucos
hepe
ph
tyrod
solut
contain
mmoll
ca
mgml
collagenas
type
cl
ii
biochrom
berlin
germani
min
collagenas
treatment
ventricl
cut
small
piec
storag
solut
mmoll
lglutam
acid
monopotassium
salt
kcl
taurin
kh
po
mgcl
glucos
egta
ph
myocyt
dispers
gentl
shake
follow
filtrat
nylon
mesh
cell
final
wash
twice
centrifug
g
min
kept
storag
solut
room
temperatur
wholecel
current
record
tightseal
wholecel
mode
patch
clamp
techniqu
use
amplifi
heka
elektronik
lambrecht
germani
patch
pipett
pull
borosil
glass
capillari
wall
thick
mm
outer
diamet
mm
tip
firepolish
seri
resist
rang
compens
mean
epc
compens
circuit
ks
kr
current
guinea
pig
ventricular
myocyt
investig
voltag
puls
record
current
compon
follow
ks
current
hold
potenti
mv
mv
ms
mv
mv
mv
kr
current
hold
potenti
mv
mv
ms
mv
mv
mv
kr
evalu
tail
current
evok
voltag
puls
mv
mv
hold
potenti
mv
mv
ms
mv
order
suppress
ltype
ca
current
mmoll
nifedipin
ad
bath
solut
averag
data
present
mean
student
ttest
use
determin
signific
pair
observ
differ
consid
signific
p
use
wholecel
configur
patch
clamp
techniqu
grissmer
et
al
analyz
biophys
pharmacolog
properti
five
clone
voltageg
k
channel
stabli
express
mammalian
cell
line
sanchezchapula
studi
block
transient
outward
k
channel
disopyramid
isol
rat
ventricular
myocyt
use
wholecel
patch
clamp
techniqu
use
patch
clamp
techniqu
cao
et
al
investig
effect
central
act
muscl
relax
structur
relat
compound
recombin
smallconduct
ca
activ
k
channel
channel
hek
mammalian
cell
tagliatela
et
al
discuss
block
k
channel
encod
human
gene
herg
term
k
v
r
molecular
determin
rapid
compon
cardiac
repolar
current
k
vr
involv
cardiotox
potenti
cn
effect
firstgener
antihistamin
may
therapeut
target
antiarrhythm
agent
vandenberg
et
al
zhou
et
al
chabbert
et
al
investig
natur
electrophysiolog
properti
ca
independ
depolarizationactiv
potassium
current
acut
isol
mous
vestibular
neuron
use
wholecel
configur
patch
clamp
techniqu
three
type
current
identifi
furthermor
longobardo
et
al
studi
effect
quaternari
bupivacain
deriv
delay
rectifi
k
current
stabli
express
ltk
cell
use
wholecel
configur
patch
clamp
techniqu
moreno
et
al
studi
effect
select
angiotensin
ii
type
receptor
antagonist
clone
potassium
channel
involv
human
cardiac
repolar
sanchezchapula
et
al
investig
voltagedepend
block
wildtyp
mutant
herg
k
channel
antimalari
compound
chloroquin
anson
et
al
publish
molecular
function
character
common
polymorph
herg
potassium
channel
inform
evalu
herg
potassium
channel
safeti
pharmacolog
see
chap
id
brian
guth
treatment
atrial
fibrillationflutt
avail
potassium
channel
blocker
class
iii
antiarrhythm
agent
mainli
block
delay
rectifi
current
kr
associ
ventricular
proarrhythmia
prolong
ventricular
repolar
lead
earli
afterdepolar
torsad
de
point
evolv
therefor
blockad
cardiac
current
exclus
relev
atria
highli
desir
expect
devoid
ventricular
proarrhythm
effect
ultrarapid
delay
rectifi
potassium
current
kur
seem
ideal
atrial
antiarrhythm
target
sinc
found
contribut
action
potenti
atrium
ventricl
molecular
correl
human
cardiac
ultrarapid
delay
rectifi
potassium
current
potassium
channel
therefor
gain
much
interest
longobardo
et
al
perchenet
caballero
et
al
caballero
et
al
caballero
et
al
bachmann
et
al
kobayashi
et
al
matsuda
et
al
choi
et
al
moreno
et
al
choe
et
al
fedida
et
al
godreau
et
al
godreau
et
al
peukert
et
al
peukert
et
al
plane
et
al
vivo
studi
atrial
fibril
see
et
al
studi
effect
antiarrhythm
drug
cardiac
ion
channel
human
cdna
subclon
eukaryot
express
vector
invitrogen
groningen
netherland
cdna
encod
human
long
dilk
et
al
subclon
cdna
encod
human
short
decher
et
al
subclon
express
vector
chines
hamster
ovari
cho
cell
transfect
either
express
construct
transfect
carri
use
lipofectamin
life
technologiesgibco
brl
karlsruh
germani
accord
manufactur
instruct
boost
channel
express
cho
cell
consecut
transfect
express
construct
stabli
express
cho
cell
maintain
iscov
medium
biochrom
kg
berlin
germani
supplement
fetal
bovin
serum
mm
lglutamin
zeocin
invitrogen
paa
laboratori
herg
potassium
channel
underli
kr
current
human
heart
clone
transfect
cho
cell
describ
previous
ramp
et
al
cell
use
patch
clamp
seed
glass
plastic
coverslip
h
use
polyadenyl
rna
isol
pig
cardiac
tissu
oligotex
mrna
purif
kit
qiagen
per
tissu
resolv
denatur
formaldehyd
electrophoresi
blot
posit
charg
nylon
membran
membran
hybrid
diglabel
riboprob
dig
rna
label
kit
roch
encompass
entir
code
sequenc
human
expos
lumiimag
roch
pig
clone
rapid
amplif
rapid
amplif
cdna
end
race
reaction
adapt
ligat
doublestrand
cdna
librari
prepar
pig
heart
mrna
marathon
cdna
amplif
kit
clontech
race
race
reaction
perform
oligonucleotid
primer
deriv
partial
pig
nucleotid
sequenc
genbank
access
number
overlap
cdna
clone
obtain
repeat
reaction
dna
sequenc
determin
autom
dna
sequenc
strand
abi
perkin
elmer
fulllength
cdna
clone
establish
recombin
pcr
encod
open
read
frame
bp
protein
overal
sequenc
similar
human
protein
sequenc
pig
cdna
submit
genbank
access
number
xenopu
oocyt
express
cdna
encod
clone
oocyt
express
vector
psgem
villmann
et
al
cap
crna
synthes
use
mmessag
mmachin
kit
ambion
austin
tex
usa
handl
inject
xenopu
oocyt
perform
accord
bachmann
et
al
adult
femal
xenopu
laevi
frog
anesthet
acid
ethyl
ester
solut
gl
intact
ovari
lobe
remov
oocyt
defollicul
treatment
mg
collagenas
dissolv
ml
buffer
mm
nacl
kcl
mgcl
hepe
titrat
ph
naoh
min
oocyt
inject
nl
crna
use
microinjector
world
precis
instrument
sarasota
fla
usa
oocyt
store
gentl
shake
buffer
contain
mm
nacl
kcl
cacl
mgcl
hepe
napyruv
theophyllin
gentamicin
titrat
ph
naoh
use
experi
day
inject
twoelectrod
voltag
clamp
record
perform
room
temperatur
medium
contain
mm
nacl
kcl
cacl
mgcl
hepe
ph
naoh
microelectrod
pull
filament
borosil
glass
capillari
hilgenberg
malsfeld
germani
use
horizont
microelectrod
puller
zeitz
augsburg
germani
fill
kcl
pipett
resist
activ
channel
oocyt
clamp
hold
potenti
mv
mv
ms
data
record
turbo
tec
amplifi
npi
tamm
germani
use
interfac
instrutech
corpor
long
island
usa
puls
softwar
heka
elektronik
lambrecht
germani
cell
express
plu
assay
use
standard
wholecel
patch
clamp
techniqu
hamil
et
al
cell
mechan
remov
tissu
cultur
flask
place
perfus
chamber
solut
contain
mm
nacl
kcl
cacl
mgcl
hepe
ph
adjust
naoh
patch
pipett
pull
borosil
glass
capillari
heat
polish
fill
mm
nacl
kcl
egta
hepe
mgcl
ph
potassium
hydroxid
koh
pipett
resist
experi
carri
record
voltag
puls
ms
durat
appli
hold
potenti
mv
mv
frequenc
hz
record
hold
potenti
mv
test
puls
ms
durat
appli
mv
frequenc
hz
data
record
patch
clamp
amplifi
heka
elektronik
puls
softwar
heka
elektronik
store
pc
later
analysi
seri
resist
rang
compens
mean
compens
circuit
experi
perform
continu
superfus
cell
solut
heat
herg
channel
current
record
room
temperatur
use
wholecel
configur
patch
clamp
techniqu
axopatch
amplifi
axon
instrument
briefli
electrod
resist
fashion
glass
capillari
tube
world
precis
instrument
fill
pipett
solut
mm
potassium
aspart
kcl
na
atp
hepe
mgcl
ph
adjust
koh
herg
current
initi
posit
voltag
puls
mv
follow
neg
puls
mv
record
offlin
analys
herg
current
cell
perfus
control
extern
solut
mm
nacl
kcl
sodium
acet
mgcl
hepe
glucos
cacl
ph
adjust
naoh
stabil
cell
perfus
extern
solut
contain
compound
specif
concentr
percentag
inhibit
concentr
cell
peak
amplitud
steadyst
herg
tail
current
mv
measur
peak
amplitud
concentr
compar
control
solut
cell
express
percent
control
male
pig
weigh
kg
german
landrac
anesthet
pentobarbit
exactli
describ
previous
wirth
knobloch
left
thoracotomi
lung
retract
pericardium
incis
heart
quickli
remov
place
oxygen
nomin
ca
free
tyrod
solut
contain
mm
nacl
kcl
mgcl
nah
po
hepe
glucos
ph
adjust
naoh
heart
mount
langendorff
apparatu
perfus
via
left
circumflex
coronari
arteri
tyrod
solut
constant
pressur
cmh
coronari
vessel
descend
ventricular
wall
ligat
ensur
suffici
perfus
left
atrium
atrium
clear
blood
contract
ceas
min
perfus
continu
tyrod
solut
contain
mm
cacl
collagenas
type
cl
ii
biochrom
kg
berlin
germani
atrial
tissu
soften
min
thereaft
left
atrial
tissu
cut
small
piec
mechan
dissoci
tritur
cell
wash
storag
solut
contain
mm
lglutam
acid
kcl
taurin
kh
po
mgcl
glucos
hepe
egta
ph
koh
filter
nylon
mesh
isol
cell
kept
room
temperatur
storag
solut
ventricular
myocyt
isol
enzymat
digest
accord
et
al
dunkin
hardley
pirbright
white
guinea
pig
weight
g
sacrif
cervic
disloc
heart
dissect
perfus
retrograd
via
aorta
solut
use
isol
pig
atrial
myocyt
wholecel
current
record
patch
clamp
amplifi
heka
elektronik
describ
cho
cell
small
aliquot
cellcontain
solut
place
perfus
chamber
brief
period
allow
cell
adhes
chamber
cell
perfus
mm
nacl
kcl
cacl
mgcl
hepe
glucos
ph
adjust
naoh
patch
pipett
pull
borosil
glass
capillari
heat
polish
fill
mm
kcl
mgcl
hepe
egta
k
atp
gtp
phosphocreatin
ph
koh
pipett
resist
seri
resist
rang
compens
offset
voltag
gener
pipett
insert
nacl
solut
mv
zero
format
seal
effect
kach
record
pig
left
atrial
myocyt
appli
voltag
puls
ms
durat
hold
potenti
mv
mv
carbachol
ad
order
evok
kach
stabil
kach
min
ad
increas
concentr
continu
presenc
carbachol
current
measur
end
puls
min
incub
concentr
inhibit
carbacholactiv
current
calcul
experi
wash
applic
next
higher
concentr
also
ltype
ca
current
investig
pig
left
atrial
cell
experi
kcl
pipett
replac
cscl
voltag
puls
ms
durat
appli
potenti
mv
mv
possibl
effect
current
ks
kr
katp
investig
guinea
pig
ventricular
myocyt
current
record
voltag
step
mv
mv
last
ms
ks
kr
current
record
nisoldipin
ad
bath
block
ltype
ca
current
ks
assess
voltag
puls
mv
start
mv
kr
evalu
tail
current
evok
voltag
puls
mv
mv
katp
evok
ad
rilmakalim
kraus
et
al
bath
appli
voltag
ramp
mv
mv
ms
rilmakalimactiv
current
record
potenti
mv
patch
clamp
experi
perform
continu
superfus
cell
solut
heat
averag
data
present
mean
sem
student
ttest
use
determin
signific
pair
unpair
observ
differ
consid
signific
p
valu
halfmaxim
inhibit
ic
hill
coeffici
calcul
fit
data
point
concentrationrespons
curv
logist
function
repres
plateau
valu
low
drug
concentr
plateau
valu
high
drug
concentr
c
repres
ic
valu
n
hill
coeffici
curvefit
student
ttest
perform
comput
program
sigmaplot
calcium
influx
voltageg
ca
channel
mediat
rang
cytoplasmat
respons
includ
muscl
contract
releas
neurotransmitt
ca
depend
gene
transcript
regul
neuron
excit
review
sever
author
augustin
et
al
bean
miller
zamponi
snutch
et
al
addit
normal
physiolog
function
ca
channel
calcium
antagonist
also
implic
number
human
disord
see
also
use
patch
clamp
techniqu
structur
regul
voltageg
ca
channel
studi
mani
author
sculptoreanu
et
al
catteral
berjukow
et
al
analyz
role
inactiv
channel
conform
molecular
mechan
ca
channel
block
dihydropyridin
deriv
ltype
channel
construct
mutant
xenopu
oocyt
describ
electrophysiolog
evalu
inward
barium
current
ba
studi
two
microelectrod
voltageclamp
xenopu
oocyt
day
microinject
approxim
equimolar
crna
mixtur
construct
lchannel
mutant
experi
carri
room
temperatur
bath
solut
follow
composit
mm
ba
oh
mm
naoh
mm
hepe
mm
csoh
ph
adjust
methanesulfon
acid
voltag
record
current
inject
microelectrod
fill
cscl
csoh
mm
egta
mm
hepe
ph
resist
rest
channel
block
estim
peak
ba
inhibit
test
puls
mv
frequenc
hz
steadi
state
reach
dose
respons
curv
ba
inhibit
fit
use
hill
equat
ic
concentr
ba
inhibit
halfmaxim
c
appli
drug
concentr
fraction
ba
block
nh
hill
coeffici
recoveri
inactiv
studi
hold
potenti
mv
depolar
ca
channel
prepuls
mv
appli
test
puls
mv
variou
time
interv
condit
prepuls
peak
ba
valu
normal
peak
current
measur
prepuls
time
cours
ba
recoveri
inactiv
fit
monoor
biexponenti
function
voltag
depend
inactiv
quasisteadi
state
condit
measur
use
multi
step
protocol
account
rundown
less
control
test
puls
ms
mv
follow
step
mv
follow
condit
step
step
mv
subsequ
test
puls
mv
correspond
peak
potenti
iv
curv
inactiv
condit
puls
calcul
follow
puls
sequenc
appli
everi
min
hold
potenti
mv
inactiv
curv
drawn
accord
follow
boltzmann
equat
v
membran
potenti
v
midpoint
voltag
k
slope
factor
ss
fraction
non
inactiv
current
steadi
state
inactiv
mutat
channel
mv
estim
shift
membran
hold
potenti
mv
subsequ
monitor
correspond
chang
ba
amplitud
steadi
state
reveal
fraction
ca
channel
inactiv
state
mv
steadi
state
inactiv
differ
ltype
channel
construct
mv
estim
fit
time
cours
current
inactiv
biexponenti
function
ba
inactiv
time
constant
estim
fit
ba
decay
monoor
biexponenti
function
data
given
mean
se
statist
signific
calcul
accord
student
unpair
ttest
besid
xenopu
oocyt
waard
campel
here
et
al
krau
et
al
sever
cell
type
construct
cho
cell
sculptoreanu
et
al
stephen
et
al
human
embryon
kidney
cell
et
al
cell
subclon
mchugh
et
al
cardiac
myocyt
rat
scamp
et
al
tohs
et
al
gomez
et
al
rabbit
xu
et
al
isol
atrial
myocyt
fail
nonfail
human
heart
cheng
et
al
skelet
muscl
myotub
mice
rabbit
johnson
et
al
myocyt
guinea
pig
mesenteri
arteri
morita
et
al
dendrit
rat
pyramid
olfactori
bulb
neuron
markram
sakmann
stuart
spruston
koester
sakmann
margi
et
al
rat
amygdala
neuron
foehr
srcogg
young
et
al
use
studi
function
calcium
channel
use
wholecel
variat
patchclamp
techniqu
yang
et
al
studi
cellular
ttype
ltype
calcium
channel
current
mous
neuroblastoma
cell
cell
cultur
dulbecco
modifi
eagl
medium
contain
fetal
bovin
serum
humidifi
atmospher
co
air
medium
chang
everi
day
mechan
agit
cell
replant
tissu
cultur
dish
contain
ml
bath
solut
cell
attach
dish
mount
stage
invert
phasecontrast
microscop
ca
channel
current
record
cell
express
predominantli
channel
current
experi
l
channel
specif
sought
cell
grown
maintain
confluenc
week
cultur
condit
addit
dimethylsulfoxid
narahash
et
al
three
day
use
cell
replant
medium
cell
express
predominantli
l
channel
current
small
number
cell
also
express
channel
current
henc
cell
select
hold
potenti
mv
channel
compon
small
inward
current
measur
conduct
predominantli
l
channel
use
wholecel
perfor
patchclamp
techniqu
wu
et
al
show
mifrabidil
nondihydropyridin
compound
inhibitori
effect
tand
ltype
ca
current
pancreat
cl
channel
larg
ubiquit
highli
divers
group
ion
channel
involv
mani
physiolog
key
process
includ
regul
electr
excit
muscl
contract
secret
sensori
signal
transduct
cl
channel
belong
sever
distinct
famili
character
detail
voltageg
cl
channel
campregul
channel
cftr
cystic
fibrosi
transmembran
conduct
regul
ligandg
cl
channel
open
upon
bind
neurotransmitt
gaba
glycin
cl
channel
regul
cytosol
ca
concentr
jentsch
fring
et
al
cliff
frizel
studi
campand
ca
activ
secretori
cl
conduct
cl
secret
colon
tumor
epitheli
cell
line
use
wholecel
voltageclamp
techniqu
cell
use
day
plate
collagenco
coverslip
cell
maintain
temperatur
respons
cell
secretagogu
particularli
campdepend
agonist
improv
increas
cl
k
conduct
major
electr
event
stimul
cl
secret
accordingli
bathpipett
ion
gradient
chosen
transmembran
cl
k
current
monitor
independ
clamp
voltag
equal
revers
potenti
ion
pipett
solut
mm
kcl
mm
nmethyldglucamin
nmdg
glutam
mm
egta
mm
cacl
mm
mgcl
mm
na
atp
mm
na
gpt
mm
hepe
ph
bath
solut
mm
nacl
mm
nmdg
glutam
mm
potassium
glutam
mm
mgcl
mm
cacl
mm
hepe
ph
bath
na
cl
concentr
reduc
substitut
nmdg
chlorid
sodium
glutam
nacl
na
k
free
solut
use
na
k
replac
nmdg
cl
reduc
replac
cl
glutam
wholecel
record
membran
potenti
clamp
altern
three
differ
voltag
durat
computercontrol
voltageclamp
protocol
use
gener
currentvoltag
iv
relat
transmembran
current
rel
stabl
step
clamp
voltag
mv
mv
interv
test
drug
e
g
adenosin
cyclic
monophosph
forskolin
ionomycin
solubil
stock
solut
ethanol
dmso
dilut
instantan
relat
construct
current
record
msec
voltag
step
maerten
et
al
use
wholecel
patchclamp
techniqu
studi
effect
antimalari
drug
volumeregul
anion
channel
vrac
cultur
bovin
pulmonari
arteri
endotheli
cell
also
examin
effect
cl
channel
e
ca
activ
cl
channel
cystic
fibrosi
transmembran
conduct
regul
assess
specif
vrac
pusch
et
al
character
chlorid
channel
belong
clc
famili
chiral
clofibr
acid
deriv
test
human
channel
skelet
muscl
chlorid
channel
heterolog
express
xenopu
laevi
oocyt
mean
two
microelectrod
voltag
clamp
record
hyperpolarizationactiv
cation
current
term
f
h
q
play
key
role
initi
cardiac
neuron
pacemak
depolar
unlik
voltageg
channel
activ
hyperpolar
voltag
step
potenti
neg
mv
near
rest
potenti
cell
properti
earn
design
f
funni
q
queer
funni
current
pacemak
f
current
first
describ
cardiac
pacemak
cell
mammalian
sinoatri
node
current
slowli
activ
hyperpolar
voltag
diastol
voltag
rang
contribut
gener
cardiac
rhythmic
activ
control
sympathet
parasympathet
innerv
difrancesco
et
al
accili
et
al
accili
et
al
robinson
siegelbaum
baruscotti
et
al
sinoatri
cell
fchannel
modul
camp
independ
phosphoryl
mechan
involv
direct
interact
camp
intracellular
side
channel
difrancesco
tortora
boi
et
al
signific
advanc
studi
molecular
properti
pacemak
channel
achiev
new
famili
channel
clone
hcn
hyperpolarizationactiv
cyclic
nucleotid
gate
channel
ishii
et
al
kaupp
seifert
biel
et
al
macri
et
al
hcn
famili
relat
cyclic
nucleotideg
channel
eag
potassium
channel
famili
belong
superfamili
voltageg
cation
channel
hcn
channel
character
six
membranespan
segment
includ
voltagesens
pore
region
ctermin
region
contain
consensu
sequenc
bind
cyclic
nucleotid
heart
neurotransmitterinduc
control
cardiac
rhythm
mediat
f
secondmesseng
camp
whose
synthesi
stimul
inhibit
muscarin
agonist
respect
inhibit
f
channel
recommend
induct
bradycardia
treatment
coronari
diseas
thollon
et
al
thollon
et
al
simon
et
al
boi
et
al
deplon
et
al
acilli
et
al
rocchetti
et
al
monnet
et
al
monnet
et
al
bucchi
et
al
cerbai
et
al
rigg
et
al
vilain
et
al
albaladejo
et
al
colin
et
al
difrancesco
camm
moreno
et
al
mulder
et
al
vilain
chateli
et
al
leoni
et
al
romanelli
et
al
schipk
et
al
romanelli
et
al
report
design
synthesi
preliminari
biolog
evalu
zatebradin
analog
potenti
blocker
hyperpolarizationactiv
current
chateli
et
al
describ
calmodulin
antagonist
directli
inhibit
ftype
current
rabbit
sinoatri
cell
sinoatri
node
myocyt
rabbit
isol
difrancesco
et
al
cell
allow
settl
petri
dish
superfus
normal
tyrod
solut
contain
mm
nacl
kcl
cacl
mgcl
dglucos
hepesnaoh
ph
macropatch
experi
temperatur
kept
patch
pipett
solut
contain
mm
nacl
kcl
cacl
mgcl
bacl
mncl
hepeskoh
ph
control
solut
perfus
intracellular
side
membran
patch
contain
mm
potassium
aspart
nacl
cacl
egta
hepeskoh
ph
pca
experi
calcium
concentr
bath
solut
reduc
nm
accord
calcul
fabiato
fabiato
correct
tsien
rink
macropatch
contain
hundr
fchannel
form
use
largetip
pipett
difrancesco
tortora
test
compound
calmodulin
calbiochem
dissolv
either
distil
water
ethanol
distil
water
respect
divid
aliquot
store
use
ethanol
ad
control
solut
concentr
use
test
solut
lower
time
cours
macropatch
f
influenc
modifi
compound
record
appli
hyperpolar
step
durat
frequenc
hz
steadyst
voltag
depend
f
describ
equat
g
f
conduct
g
fmax
fulli
activ
conduct
e
steadyst
activ
paramet
e
f
revers
potenti
difrancesco
nobl
steadyst
currentvoltag
iv
curv
measur
appli
hyperpolar
voltag
ramp
rate
mvmin
hold
potenti
mv
conductancevoltag
g
f
e
relat
obtain
equat
ratio
steadyst
iv
curv
f
e
f
e
f
set
mv
difrancesco
mangoni
conduct
curv
fit
boltzmann
function
e
halfmaxim
voltag
activ
p
inverseslop
factor
allow
estim
shift
voltag
depend
conduct
e
activ
paramet
measur
chang
e
shift
f
activ
curv
caus
camp
also
determin
quicker
method
requir
measur
conductancevoltag
relat
accili
difrancesco
shift
obtain
appli
hyperpolar
step
mv
near
midpoint
f
activ
curv
adjust
hold
potenti
mv
control
solut
campinduc
chang
f
compens
control
f
magnitud
fulli
restor
sinc
compens
involv
chang
test
voltag
e
e
measur
displac
hold
potenti
mv
correct
introduc
obtain
shift
activ
curv
mv
accord
relat
compar
differ
set
data
statist
analysi
perform
either
student
ttest
analysi
varianc
anova
valu
p
consid
signific
statist
data
given
mean
sem
valu
intracellular
free
caconcentr
measur
cultur
endotheli
cell
fluorometr
method
tsien
et
al
grynkiewicz
et
al
et
al
buss
lamontagn
hock
et
al
cultur
endotheli
cell
pig
seed
quartz
coverslip
grown
confluenc
cell
load
fluoresc
probe
incub
pluron
nonion
deterg
thereaft
coverslip
wash
transfer
cuvett
fill
hepe
buffer
fluoresc
record
temperatur
control
spectrofluorophotomet
excit
wavelength
nm
emiss
wavelength
simultan
measur
nm
lee
et
al
measur
cytosol
calcium
transient
beat
rabbit
heart
use
indic
yangisawa
et
al
measur
intracellular
ca
concentr
coronari
arteri
smooth
muscl
dog
makujina
et
al
measur
intracellular
calcium
fluoresc
simultan
tension
evert
ring
porcin
coronari
arteri
denud
endothelium
hayashi
miyata
describ
properti
commonli
use
fluoresc
indic
intracellular
calcium
monteith
et
al
studi
ca
pumpmedi
efflux
vascular
spontan
hypertens
rat
buss
r
lamontagn
endotheliumderiv
bradykinin
respons
increas
calcium
produc
angiotensinconvert
enzym
inhibitor
human
endotheli
cell
eschenhagen
et
al
develop
method
cultur
embryon
cardiomyocyt
collagen
matrix
produc
coher
contract
model
heart
tissu
allow
direct
measur
isometr
contractil
forc
ventricl
day
incub
chicken
embryo
cavanaugh
minc
dulbecco
minim
essenti
medium
dmem
wash
edta
phosphat
buffer
salin
pb
ph
digest
fresh
trypsinedta
min
supernat
discard
pellet
subject
digest
collagenas
umg
pb
ph
min
supernat
discard
pellet
digest
sever
cycl
collagenas
min
pellet
complet
digest
dnase
mgml
pb
ad
cycl
depend
presenc
viscou
dna
isol
cell
kept
petri
dish
dmem
supplement
heatinactiv
fetal
calf
serum
co
incub
complet
digest
cell
incub
anoth
min
co
incub
preplat
cell
suspens
centrifug
rpm
g
pellet
resuspend
ml
cultur
medium
dmem
inactiv
hors
serum
chicken
embryo
extract
gibco
brl
mmoll
glutamin
streptomycin
uml
penicillin
g
recentrifug
rpm
final
resuspend
cultur
medium
cell
per
ml
cast
cardiomyocytepopul
collagen
gel
strip
velcro
glu
silicon
rubber
glass
tube
mm
length
mm
outer
diamet
mm
inner
diamet
pair
velcroco
tube
kept
fix
distanc
stainless
steel
wire
spacer
place
rectangular
well
mm
cut
layer
silicon
rubber
mm
polymethylenepenten
petri
dish
assembl
autoclav
use
gel
ml
icecold
collagencel
mixtur
pour
well
velcroco
glass
tube
mixtur
composit
cultur
medium
contain
addit
mg
neutral
collagen
rat
tail
upstat
biotechnolog
inc
cardiomyocyt
acet
acid
collagen
solut
naoh
neutral
mixtur
allow
gel
min
cultur
medium
ad
dish
medium
chang
perform
overnight
everi
day
day
cultur
gel
remov
cultur
dish
spacer
withdrawn
one
glass
tube
mount
fix
electrod
tube
connect
inelast
silk
string
isometr
forc
transduc
attach
wekagraph
thermal
array
record
instrument
heidelberg
germani
prepar
adjust
origin
spacer
length
immers
conventi
water
bath
fill
modifi
tyrod
solut
maintain
continu
gass
co
min
equilibr
period
without
pace
forc
frequenc
reach
stabl
valu
gel
electr
stimul
rectangular
puls
ms
v
standard
frequenc
hz
preload
stepwis
adjust
l
max
length
prepar
develop
maxim
forc
cumul
dose
inotrop
compound
e
g
isoprenalin
forskolin
ad
gel
expos
concentrationrespons
curv
calcium
mmoll
one
two
addit
inotrop
stimuli
valu
present
arithmet
mean
sem
student
ttest
pair
observ
use
compar
forc
contract
rest
tension
beat
frequenc
intervent
ferrara
et
al
studi
role
giprotein
agerel
declin
contract
guineapig
ventricular
myocyt
isol
myocyt
place
krebshenseleit
solut
perspex
chamber
stage
zeiss
im
invert
microscop
superfus
krebshenseleit
solut
contain
mmoll
ca
mlmin
cell
select
use
follow
criteria
rod
shape
without
sarcolemm
bleb
spontan
contract
stabl
baselin
contract
electr
stimul
hz
sarcomer
length
shorter
imag
cell
display
tv
monitor
length
chang
measur
video
motion
detector
contract
amplitud
veloc
express
chang
sarcomer
length
calcul
chang
length
myocyt
origin
sarcomer
length
use
adrenomedullin
acid
peptid
origin
discov
human
adren
pheochromocytoma
monitor
elev
activ
platelet
camp
kitamura
et
al
molecular
clone
rat
adrenomedullin
report
sakata
et
al
genom
structur
human
adrenomedullin
gene
report
ishimitsu
et
al
adrenomedullin
proadrenomedullin
ntermin
peptid
pamp
hypotens
bronchodil
deriv
preproadrenomedullin
kanazawa
et
al
iwasaki
et
al
shimosawa
fujita
hinson
et
al
samson
autelitano
tang
jimenez
et
al
lopez
et
al
tajima
et
al
adrenomedullin
found
ubiquit
tissu
organ
especi
cardiovascular
tissu
kidney
lung
brain
endocrin
gland
wimalawansa
van
rossum
et
al
eto
et
al
jougasaki
burnett
kitamuro
et
al
main
biolog
effect
vasodilat
ishiyama
et
al
nikitenko
et
al
hypotens
effect
found
rat
khan
rabbit
fukuhara
et
al
man
lainchburi
et
al
adrenomedullin
belong
calcitonin
generel
peptidecalcitonin
peptid
famili
share
approxim
homolog
calcitonin
generel
peptid
kitamura
et
al
sever
pharmacolog
studi
relat
vasodil
effect
adrenomedullin
e
g
mous
aorta
ashton
et
al
mesenter
vascular
bed
see
santiago
et
al
hind
limb
vascular
bed
see
santiago
et
al
pulmonari
vascular
bed
see
dewitt
et
al
lippton
et
al
heaton
et
al
nossaman
et
al
cerebr
blood
flow
dog
baskaya
et
al
cat
takao
et
al
renal
hemodynam
dog
see
yukawa
vasodil
perfus
rat
kidney
hayakawa
et
al
intraven
infus
adrenomedullin
exert
diuresi
natriuresi
without
major
chang
blood
pressur
produc
benefici
hemodynam
renal
vasodil
effect
rat
compens
heart
failur
vari
et
al
nagaya
et
al
isol
perfus
pace
rat
heart
prepar
adrenomedullin
show
dosedepend
inotrop
effect
szokodi
et
al
pulmonari
vasodil
respons
vasorelax
effect
isol
pulmonari
arteri
ring
found
gumusel
et
al
adrenomedullin
growthpromot
factor
cultur
vascular
smooth
muscl
cell
iwasaki
et
al
fibroblast
isumi
et
al
willenbrock
et
al
show
benefici
effect
adrenomedullin
renal
function
rat
aortocav
shunt
adrenomedullin
inhibit
gastric
secret
rat
chronic
gastric
fistula
see
rossowski
et
al
inhibit
reserpineinduc
gastric
lesion
rat
clementi
et
al
tsuchida
et
al
found
inhibit
cholecystokininstimul
amylas
secret
adrenomedullin
rat
pancreat
acini
rademak
et
al
discuss
role
adrenomedullin
pathophysiolog
heart
failur
lewi
et
al
describ
specif
sensit
radioimmunoassay
human
adrenomedullin
ohta
et
al
develop
onestep
direct
assay
adrenomedullin
monoclon
antibodi
ntermin
fragment
adrenomedullin
show
vasopressor
activ
watanab
et
al
adrenotensin
adrenomedullin
gene
product
contract
endotheliumdepend
manner
pulmonari
blood
vessel
gumusel
et
al
specif
adrenomedullin
bind
site
describ
human
brain
sone
et
al
rat
spinal
cord
owji
et
al
cultur
brain
cell
zimmermann
et
al
cultur
rat
mesangi
cell
osajima
et
al
human
brain
obtain
autopsi
prepar
membran
tissu
homogen
icecold
mm
hepe
buffer
ph
contain
sucros
soybean
trypsin
inhibitor
pepstatin
leupeptin
antipain
mgml
benzamidin
mgml
bacitracin
aprotinin
homogen
centrifug
g
min
pellet
resuspend
vol
buffer
without
sucros
centrifug
g
h
final
pellet
resuspend
concentr
mg
proteinml
aliquot
store
receptor
bind
assay
brain
membran
protein
incub
ml
bind
buffer
mm
hepe
buffer
ph
contain
mm
mgcl
mm
nacl
mm
kcl
mm
edta
bsa
contain
nm
ihuman
adrenomedullin
silicon
microcentrifug
tube
pellet
wash
ml
bind
buffer
count
counter
nonspecif
bind
determin
presenc
nm
unlabel
human
adrenomedullin
specif
bind
defin
total
bind
minu
nonspecif
bind
data
calcul
mean
sem
eguchi
et
al
studi
bind
human
adrenomedullin
analog
adenyl
cyclas
activ
cultur
rat
vascular
smooth
muscl
cell
zimmermann
et
al
show
adrenomedullin
calcitonin
generel
peptid
interact
receptor
cultur
human
neuroblastoma
sknmc
cell
moodi
et
al
investig
bind
affin
adrenomedullin
glioma
cell
find
belloni
et
al
suggest
exist
differ
receptor
subtyp
adrenomedullin
human
adren
cortex
mazzocchi
et
al
found
abund
adrenomedullin
bind
site
zona
glomerulosa
adren
medulla
rat
adren
gland
atria
mammalian
heart
synthes
secret
peptid
potent
natriuret
vasoact
properti
known
anf
atrial
natriuret
factor
de
bold
et
al
atrial
natriuret
peptid
hormon
system
consist
acid
prohormon
synthes
within
myocyt
heart
store
storag
granul
within
heart
releas
circul
kangawa
matsuo
oikawa
et
al
vese
hormon
system
contain
sever
peptid
acidprohormon
blood
pressur
lower
natriuret
diuret
andor
kaliuret
properti
martin
et
al
vese
et
al
thu
peptid
consist
amino
acid
lanp
longact
natriuret
peptid
vessel
dilat
kaliuret
peptid
anf
blood
pressur
lower
natriuret
diuret
andor
kaliuret
properti
human
anim
human
rat
atria
predominantli
secret
peptid
amino
acid
residu
anf
repres
cterminu
precursor
sequenc
amino
acid
residu
addit
vessel
dilat
lanp
circul
distinct
entiti
proteolyt
cleav
rest
amino
terminu
proteas
ackerman
et
al
plasma
immunoreact
anf
concentr
increas
normal
rat
volum
expans
infus
peptid
lower
blood
pressur
sever
anim
model
hypertens
intern
standard
atrial
natriuret
factor
establish
intern
collabor
studi
pool
et
al
human
anf
synthes
highli
purifi
distribut
sever
laboratori
perform
radioimmunoassay
radioreceptor
assay
vitro
assay
use
vasorelax
activ
precontract
rat
aortic
strip
ctype
natriuret
peptid
acid
peptid
initi
identifi
central
nervou
system
ogawa
et
al
barr
et
al
amin
et
al
distribut
ctype
natriuret
peptid
structur
homolog
atrial
brain
natriuret
peptid
also
similar
activ
wide
includ
endothelium
myocardium
gastrointestin
genitourinari
tract
brain
natriuret
peptid
describ
novel
cardiac
hormon
nakao
et
al
yasu
et
al
studi
local
mechan
secret
btype
natriuret
peptid
comparison
atyp
natriuret
peptid
normal
subject
patient
heart
failur
ntermin
probrain
natriuret
peptid
becam
diagnost
screen
tool
differenti
patient
normal
left
ventricular
systol
function
bay
et
al
gardner
et
al
jiao
baertschi
review
neural
control
endocrin
rat
heart
stimul
cardiac
sympathet
nerv
potent
stimul
anf
secret
anf
inhibit
prolifer
nonmyocardi
cell
antihypertroph
cardiomyocyt
silberbach
et
al
report
activ
extracellular
signalregul
protein
kinas
requir
antihypertroph
effect
atrial
natriuret
factor
neonat
rat
ventricular
myocyt
ackerman
bh
overton
rm
mccormick
mt
schocken
dd
vese
dl
disposit
vessel
dilat
longact
natriuret
peptid
healthi
human
onehour
infus
j
pharm
exp
ther
amin
j
carretero
oa
ito
mechan
action
atrial
natriuret
factor
ctype
natriuret
peptid
hypertens
barr
cs
rhode
p
struther
ad
matsui
et
al
describ
rapid
bioassay
quantif
atrial
natriuret
polypeptid
rat
continu
record
conduct
urin
urin
flow
blood
pressur
male
spragu
dawley
rat
weigh
g
anesthet
mgkg
ip
pentobarbit
sodium
anesthesia
maintain
inject
supplement
dose
pentobarbit
sodium
tracheotomi
cathet
place
left
jugular
vein
right
carotid
arteri
inject
sampl
infus
mannitol
salin
blood
pressur
record
small
suprapub
incis
bladder
cannul
collect
urin
cannula
connect
devic
continu
measur
urin
conduct
electrolyt
concentr
estim
urin
flow
rate
record
use
drop
counter
urin
sampl
collect
plastic
tube
complet
surgeri
ml
mannitol
salin
administ
jugular
vein
continu
infus
rate
mlh
syring
pump
follow
equilibr
min
bioassay
start
urin
flow
increas
test
sampl
volum
directli
inject
jugular
vein
follow
wash
inject
salin
mean
arteri
blood
pressur
urin
conduct
urin
flow
rate
simultan
record
doserespons
curv
serial
dilut
human
anf
test
substanc
prepar
vehicl
variou
dose
test
substanc
inject
random
sequenc
immedi
inject
urin
collect
min
urin
volum
determin
weigh
urinari
sodium
potassium
concentr
measur
flame
photometri
linearregress
analys
method
least
squar
use
evalu
doserespons
relationship
oneway
analysi
varianc
repeat
measur
newmankeul
test
use
detect
statist
differ
petersen
et
al
determin
atrial
content
plasma
level
atrial
natriuret
peptid
rat
chronic
renal
failur
natriuret
activ
bioassay
estim
increas
na
excret
urin
sampl
control
period
maxim
natriuret
respons
allen
gellai
measur
cardioinhibitori
effect
atrial
peptid
consciou
chronic
instrument
rat
hemodynam
renal
excretori
respons
measur
without
replac
urinari
fluid
loss
thibault
et
al
character
biolog
activ
atrial
natriuret
factorrel
peptid
vivo
natriuret
bioassay
vitro
relax
contract
intestin
smooth
muscl
chick
rectum
schiller
et
al
test
synthet
analog
atrial
natriuret
peptid
rabbit
aorta
assay
bioassay
monitor
suppress
aldosteron
secret
bovin
zona
glomerulosa
cell
dlouha
mcbroom
measur
diuret
natriuret
activ
atrial
extract
taurinetr
normal
cardiomyopath
hamster
urin
flow
na
excret
rat
bioassay
stloui
schiffrin
measur
vasorelax
effect
differ
atrial
natriuret
peptid
rat
aortic
mesenter
arteri
ring
compar
result
potenc
peptid
displac
ilabel
anp
membran
prepar
aorta
mesenter
vein
bed
kohs
et
al
describ
bioassay
quantit
determin
natriuret
peptid
human
biolog
sampl
use
bovin
aortic
bovin
kidney
epitheli
cultur
cell
amount
cyclic
amp
produc
cell
measur
radioimmunoassay
kecskemeti
et
al
studi
effect
atrial
natriuret
peptid
anp
action
potenti
characterist
variou
human
rabbit
guineapig
atrial
guinea
pig
ventricular
papillari
muscl
data
suggest
anp
inhibit
slow
inward
ca
channel
activ
facilit
k
channel
activ
saltsensit
hypertens
found
anp
knockout
mice
melo
et
al
allen
de
gellai
schiffrin
et
al
describ
receptor
atrial
natriuret
factor
rat
synthet
anf
iodin
modif
gutskowska
et
al
chloramin
method
greenwood
hunter
separ
radiolabel
anf
free
iodin
achiev
immunoaffin
chromatographi
follow
revers
phase
high
pressur
liquid
chromatographi
prepar
membran
spragu
dawley
rat
weigh
g
sacrif
decapit
atria
ventricl
renal
arteri
mesenteri
mesenteri
vascular
bed
adren
process
bind
studi
adren
capsul
separ
manual
compress
tissu
immers
sucros
solut
fine
minc
scissor
homogen
polytron
set
twice
homogen
centrifug
g
min
supernat
decant
recentrifug
final
supernat
filter
cheesecloth
centrifug
g
min
pellet
resuspend
trishcl
buffer
ph
contain
mm
nacl
mm
mgcl
mm
phenyl
methyl
sulfonyl
fluorid
bacitracin
aprotinin
protein
measur
coomassi
blue
method
spector
next
bovin
serum
ad
concentr
membran
dilut
protein
concentr
mgml
trisbuff
contain
albumin
iafn
bind
assay
use
pm
label
anf
unlabel
anf
competit
experi
satur
experi
increas
concentr
iafn
pm
use
nonspecif
bind
determin
incub
presenc
unlabel
anf
point
satur
curv
incub
done
receptor
protein
per
tube
min
assay
perform
duplic
separ
bound
free
radioact
achiev
rapid
filtrat
polyethyleniminetr
whatman
gfc
filter
soak
assay
buffer
filter
wash
twice
ml
nacl
allow
dri
count
gamma
counter
bind
data
analyz
comput
assist
nonlinear
regress
analysi
use
ligand
program
munson
rodbard
inhibit
constant
k
calcul
accord
cheng
prussoff
equat
misono
found
bind
atrial
natriuret
factor
receptor
depend
chlorid
concentr
product
atrial
natriuret
factor
brain
natriuret
peptid
measur
gene
express
use
total
rna
extract
northern
blot
analysi
quantit
competit
revers
transcript
polymeras
chain
reaction
hama
et
al
ogawa
et
al
ogawa
et
al
ogawa
et
al
ogawa
et
al
plasma
sampl
acidifi
ad
moll
hcl
pass
seppak
c
cartridg
millipor
prewet
ml
acetonitril
trifluoroacet
acid
tfa
ml
tfa
cartridg
absorb
peptid
wash
ml
tfa
elut
ml
acetonitril
tfa
tissu
sampl
homogen
vol
extract
mixtur
consist
n
hcl
moll
acet
acid
nacl
centrifug
g
min
supernat
extract
use
seppak
c
cartridg
elut
acetonitril
tfa
eluat
tissu
plasma
freezedri
process
ria
atrial
ventricular
tissu
sampl
individu
rat
extract
use
trizol
gibco
brl
total
rna
atrium
ventricl
electrophoret
separ
agaroseformaldehyd
gel
follow
blot
nylon
membran
hybond
n
amersham
overnight
membran
prehybrid
denhardt
solut
ssc
formamid
mmoll
kh
po
ph
sd
mgml
her
sssdna
h
cdna
probe
prehybrid
denhardt
solut
ssc
mmoll
nah
po
sd
mgml
her
sssdna
h
calcul
oligonucleotid
probe
hybrid
carri
h
temperatur
solut
prehybrid
condit
except
presenc
radiolabel
probe
five
cdna
probe
two
oligonucleotid
probe
use
cdna
probe
use
follow
ecorihindiii
fragment
contain
fulllength
rat
anf
cdna
sali
fragment
contain
fulllength
rat
bnp
cdna
ecorisali
fragment
mous
rrna
cdna
probe
bamhibglii
fragment
mous
pgk
gene
cdna
rat
iii
collagen
cdna
contain
bp
noncod
code
region
two
oligonucleotid
probe
base
fragment
specif
uniqu
region
untransl
region
rat
gene
gggatagcaacagcgaggctct
cdna
label
p
dctp
cimmol
amersham
use
megaprim
dna
label
system
amersham
oligonucleotid
label
p
atp
cimmol
amersham
use
endlabel
kit
amersham
end
hybrid
membran
wash
twice
ssc
sd
twice
ssc
sd
cdna
probe
wash
ssc
sd
twice
temperatur
hybrid
ssc
sd
oligonucleotid
probe
addit
probe
bound
count
complet
strip
membran
wash
twice
mmoll
sodium
citrat
ph
sd
min
autoradiograph
scan
ultrascan
xl
laser
densitomet
lkb
produckt
lkb
gelscan
xl
softwar
packag
scan
valu
anf
bnp
collageniii
mrna
normal
ribosom
rna
pgk
mrna
intern
control
correct
differ
amount
rna
appli
transfer
effici
plasma
cardiac
tissu
concentr
immunoreact
anf
bnp
determin
ria
antirat
anf
antirat
bnp
sera
respect
peninsula
laboratori
rna
sampl
revers
transcrib
super
script
ii
rnase
h
revers
transcriptas
oligo
dt
primer
use
revers
transcript
kit
gibco
brl
aliquot
cdna
product
use
pcr
amplif
anf
primer
dilut
seri
total
rna
mg
aliquot
prepar
sampl
dilut
spike
competitor
rna
pcr
aliquot
ml
pcr
product
electrophores
agaros
gel
visual
ethidium
bromid
stain
photograph
taken
polaroid
film
neg
scan
use
ultrascan
xl
laser
densitomet
gelscan
xl
softwar
packag
ratio
densiti
competitor
rna
target
rna
plot
amount
competitor
rna
ad
reaction
result
express
mean
sem
level
p
consid
signific
anova
perform
determin
statist
differ
among
multipl
group
signific
obtain
anova
fisher
least
squar
differ
post
hoc
analysi
use
determin
pairwis
differ
ramirez
et
al
report
nuclear
b
isoform
ca
calmodulindepend
protein
kinas
ii
regul
atrial
natriuret
gene
express
cultur
neonat
rat
ventricular
myocyt
thuerauf
et
al
found
mitogenactiv
protein
kinas
mediat
transcript
induct
atrial
natriuret
factor
gene
serum
respons
element
discuss
potenti
role
transcript
factor
kakita
et
al
studi
protein
coactiv
transcript
factor
transcript
cardiacrestrict
atrial
natriuret
factor
gene
bianciotti
de
bold
investig
effect
select
et
receptor
blockad
natriuret
peptid
gene
express
docasalt
hypertens
rat
gutkowska
et
al
develop
direct
radioimmunoassay
atrial
natriuret
factor
anf
method
use
synthet
fragment
anf
nativ
peptid
anf
small
molecul
necessari
coval
conjug
peptid
larger
protein
bovin
thyroglobulin
immun
mg
thyroglobulin
dissolv
ml
distil
water
ph
mg
cdi
carbodiimid
hcl
ad
ml
distil
water
ph
mg
anf
water
ad
dropwis
stir
solut
kept
overnight
anoth
mg
cdi
ad
mixtur
kept
h
room
temperatur
constant
stir
cloudi
mixtur
dialyz
h
salin
dialyz
materi
fraction
store
immun
anfthyroglobulin
complex
suspend
ml
salin
thoroughli
mix
ml
complet
freund
adjuv
inject
shave
back
new
zealand
white
rabbit
anim
receiv
also
ml
bordetella
pertussi
vaccin
subcutan
primari
immun
anim
reimmun
monthli
interv
antigen
incomplet
freund
adjuv
bled
ear
arteri
day
booster
inject
iodin
anf
ammonium
acet
ph
introduc
ml
eppendorf
vial
follow
addit
mci
na
volum
chloramin
ad
reaction
vial
later
sodium
metabisulfid
ad
addit
follow
mix
purif
iodin
tracer
achiev
hplc
c
column
elut
linear
gradient
acetonitril
trifluoroacet
acid
slope
min
flow
rate
ml
min
radioimmunoassay
procedur
perform
polystyren
tube
mix
standard
sampl
antiserum
dilut
ianf
buffer
contain
bsa
incub
h
free
antigenbound
ianf
separ
dextranco
charcoal
one
ml
dextrancharco
suspens
ad
tube
agit
tube
centrifug
rpm
min
supernat
decant
radioact
count
gamma
counter
doserespons
curv
prepar
scatchard
analysi
perform
radioimmunoassay
also
develop
longact
natriuret
peptid
vessel
dilat
vese
et
al
winter
et
al
urotensin
ii
cyclic
peptid
origin
isol
urophysi
hormon
storagesecret
organ
caudal
neurosecretori
system
teleost
fish
gillichthi
mirabili
pearson
et
al
maguir
davenport
sever
structur
form
urotensin
ii
report
differ
speci
peptid
show
smooth
muscl
contract
activ
itoh
et
al
report
contract
major
arteri
segment
rat
especi
thorac
aorta
urotensin
ii
human
urotensin
ii
peptid
retain
cyclic
portion
typic
fish
urotensin
ii
found
vascular
cardiac
tissu
potent
constrictor
certain
human
isol
arteri
vein
well
sever
vessel
speci
dougla
potenc
urotensin
ii
vasoconstrictor
order
magnitud
greater
make
human
urotensin
ii
potent
vasoconstrictor
identifi
far
human
urotensin
ii
also
potent
endotheliumdepend
relax
rat
precontract
arteri
katano
et
al
human
small
pulmonari
system
abdomin
resist
arteri
stirrat
et
al
bottril
et
al
found
human
urotensin
ii
contract
endotheliumintact
rat
isol
left
anterior
descend
coronari
arteri
contractil
respons
significantli
enhanc
remov
endothelium
howev
human
urotensin
ii
caus
concentrationdepend
relax
arteri
abolish
nnitrolarginin
methyl
ester
lname
remov
endothelium
use
merino
ewe
experiment
anim
watson
et
al
found
urotensin
ii
act
central
increas
epinephrin
adrenocorticotroph
hormon
acth
releas
caus
potent
inotrop
chronotrop
action
coy
et
al
investig
structur
requir
nterminu
urotensin
ii
octapeptid
carotenuto
et
al
investig
activ
conform
urotensin
ii
cd
spectroscopi
nmr
analysi
sd
micel
watson
may
studi
urotensin
analog
agonist
antagonist
use
isol
thorac
aorta
rat
pharmacolog
model
itoh
et
al
nothack
et
al
sauzeau
et
al
camarda
et
al
grieco
et
al
grieco
et
al
rossowski
et
al
sever
urotensin
ii
antagonist
test
model
behm
et
al
herold
et
al
patacchin
et
al
test
urantid
ultrapot
urotensin
ii
antagonist
peptid
rat
aorta
male
albino
rat
wistar
strain
g
decapit
ether
anesthesia
thorac
aorta
clear
surround
tissu
excis
aortic
arch
diaphragm
vessel
helic
cut
strip
prepar
cut
two
parallel
strip
endothelium
remov
gentli
rub
vessel
intim
surfac
cottontip
applic
effect
maneuv
assess
loss
relax
respons
acetylcholin
prepar
precontract
noradrenalin
prepar
place
organ
bath
fill
oxygen
normal
krebshenseleit
solut
motor
activ
strip
record
isoton
load
mn
cumul
concentrationrespons
curv
huii
construct
one
two
strip
serv
control
strip
receiv
antagonist
peptid
examin
incub
period
huii
administ
cumul
maxim
contractil
respons
prepar
huii
obtain
administr
kcl
mm
end
cumul
curv
antagonist
activ
express
term
pk
b
neg
logarithm
antagonist
dissoci
constant
assum
slope
estim
mean
individu
valu
obtain
equat
pk
b
log
dose
log
antagonist
concentr
kenakin
competit
antagon
check
schild
plot
method
plot
linear
regress
line
slope
significantli
differ
uniti
consid
proof
simpl
revers
competit
kenakin
gibson
et
al
studi
influenc
urotensin
ii
calcium
flux
rat
aorta
urotensin
ii
caus
increas
uptak
ca
segment
rat
aorta
increas
abolish
calcium
channel
block
drug
dougla
et
al
found
differenti
vasoconstrictor
activ
human
urotensin
ii
vascular
tissu
isol
rat
mous
dog
pig
marmoset
cynomolgu
monkey
depend
speci
anatom
local
camarda
et
al
studi
effect
human
urotensin
ii
isol
vessel
aorta
larg
arteri
vein
variou
speci
rat
guinea
pig
rabbit
pig
human
compar
vasoact
agent
noradrenalin
angiotensin
ii
endothelin
watanab
et
al
found
synergist
effect
urotensin
ii
serotonin
rabbit
vascular
smooth
muscl
cell
prolifer
tamura
et
al
examin
effect
urotensin
ii
activ
extracellular
signalregul
kinas
focal
adhes
kinas
cultur
vascular
smooth
muscl
cell
tzanidi
et
al
studi
direct
action
urotensin
ii
heart
rat
model
heart
failur
myocardi
infarct
implic
cardiac
fibrosi
hypertrophi
matsushita
et
al
show
urotensin
ii
autocrineparacrin
growth
factor
porcin
renal
epitheli
cell
line
behm
et
al
investig
role
urotensin
ii
etiolog
essenti
hypertens
intraven
inject
anesthet
cat
induc
increas
system
blood
pressur
peripher
vascular
resist
usa
expos
excit
nm
argon
laser
fluoresc
monitor
nm
emiss
well
simultan
data
read
everi
min
everi
thereaft
agonist
ad
concentrationrespons
curv
obtain
calcul
maxim
fluoresc
count
background
addit
concentr
agonist
antagonist
studi
bachem
king
prussia
pa
usa
ad
min
prior
addit
huii
california
peptid
research
napa
calif
usa
concentrationrespons
curv
analyz
nonlinear
regress
use
graphpad
prism
softwar
graphpad
san
diego
calif
usa
flohr
et
al
use
function
mammalian
cellbas
rsat
assay
acadia
pharmaceut
san
diego
calif
usa
identifi
nonpeptid
agonist
ii
receptor
highthroughput
screen
accord
shapiro
et
al
cell
grown
tissu
cultur
plate
confluenc
dulbecco
modifi
eagl
medium
supplement
calf
serum
penicillinstreptomycingln
cell
transfect
h
plasmid
dna
use
superfect
reagent
qiagen
valencia
calif
usa
accord
manufactur
protocol
rsat
perform
ngwell
receptor
ngwell
plasmid
dna
overnight
transfect
medium
replac
serumfre
dulbecco
modifi
eagl
medium
contain
kemp
biotechnolog
frederick
md
usa
penicillinstreptomycingln
vari
concentr
drug
cell
grown
humidifi
atmospher
ambient
co
day
medium
remov
plate
activ
measur
addit
onitrophenyl
phosphatebuff
salin
nonidet
deterg
result
colorimetr
reaction
measur
use
spectrophotometr
plate
reader
titertek
huntsvil
ala
usa
nm
ht
cell
transient
transfect
urotensin
ii
receptor
express
vector
plasmid
frozen
assay
thaw
plate
expos
drug
gproteincoupl
receptor
describ
marches
et
al
tal
et
al
liu
et
al
mori
et
al
identifi
urotensin
ii
endogen
ligand
orphan
gproteincoupl
receptor
renam
urotensin
ii
ut
receptor
uphar
dougla
human
rat
mous
monkey
receptor
clone
amino
acid
sequenc
ident
monkey
ut
receptor
ident
human
rat
sequenc
respect
mous
ut
receptor
ident
human
rat
sequenc
respect
brkovic
et
al
perform
function
bind
character
urotensiniirel
peptid
human
rat
urotensin
ii
receptor
assay
follow
fluorenylmethyloxycarbonylprotect
amino
acid
purchas
chemimpex
intern
wood
dale
ill
usa
ala
cy
trt
trt
phe
trp
ly
boc
tyr
tbu
asp
otbu
glu
otbu
pro
gln
trt
thr
tbu
arg
pbf
orn
boc
homoci
trt
cy
acm
dtrp
biograd
tfa
obtain
halocarbon
river
edg
nj
usa
diisopropylethylamin
aldrich
milwauke
wi
usa
wang
resin
dimethylamino
phosphonium
hexafluorophosph
purchas
albatross
montreal
qc
basal
iscov
medium
fetal
calf
serum
fc
biochrom
berlin
germani
gcmelt
pcr
kit
well
human
rat
genom
dna
purchas
clontech
palo
alto
calif
usa
mammalian
episom
express
vector
select
marker
puromycin
edg
biosystem
gaithersburg
md
usa
dulbecco
modifi
eagl
medium
dmem
lglutamin
hepe
lipofectamin
reagent
penicillinstreptomycin
invitrogen
carlsbad
calif
usa
mammalian
express
vector
invitrogen
calciumsensit
fluoresc
dye
pluron
obtain
molecular
probe
eugen
ore
usa
flashplat
plu
monoiodin
human
urotensin
ii
radioligand
bind
assay
perkin
elmer
life
scienc
boston
mass
usa
gentamicin
transfect
reagent
fugen
complet
proteas
inhibitor
purchas
roch
basel
switzerland
bacitracin
edtadisodium
salt
probenecid
mgcl
nacl
sucros
obtain
sigmaaldrich
st
loui
mo
usa
put
human
urotensin
ii
receptor
sequenc
intronless
protein
clone
human
genom
dna
via
pcr
pcr
condit
establish
amplifi
human
sequenc
min
follow
cycl
min
min
min
use
gcmelt
kit
primer
design
amplifi
code
sequenc
contain
bamhi
site
forward
xbai
site
revers
primer
respect
urotensin
receptor
code
region
flank
bamhixbai
site
clone
mammalian
express
vector
sequenc
direct
gener
stabl
cell
line
human
uii
receptor
code
sequenc
flank
ecori
site
ecorv
site
clone
mammalian
episom
express
vector
rat
uii
receptor
code
sequenc
flank
ecori
noti
site
amplifi
via
pcr
rat
kidney
cdna
clone
mammalian
express
vector
sequenc
urotensiniireceptorexpress
plasmid
verifi
dideoxi
sequenc
direct
cho
grown
basal
iscov
medium
supplement
fc
mm
lglutamin
penicillinstreptomycin
iuml
mgml
gentamicin
humidifi
co
incub
cell
transient
transfect
uii
receptor
cdna
use
lipofectamin
reagent
accord
manufactur
protocol
h
follow
transfect
cell
split
blackwal
plate
densiti
cellswel
cultur
addit
period
use
function
fluoresc
imag
plate
reader
flipr
assay
describ
detail
measur
intracellular
ca
releas
upon
receptor
activ
cell
load
plate
h
co
pb
without
ca
mg
nahco
contain
fluoresc
calcium
indic
pluron
dimethyl
sulfoxid
mm
probenecid
mm
egta
fc
cell
wash
three
time
pb
without
ca
mg
nahco
contain
mm
edta
mm
mgcl
mm
probenecid
final
wash
residu
volum
remain
cell
peptid
aliquot
solut
plate
transfer
instrument
ligand
plate
cell
plate
fluoresc
record
fluorometr
imag
plate
reader
flipr
molecular
devic
sunnyval
calif
usa
period
min
fluoresc
record
simultan
well
interv
first
minut
interv
last
min
fluoresc
data
gener
duplic
repeat
least
three
time
gener
stabl
cell
line
express
human
rat
urotensin
ii
receptor
cell
transfect
humanand
construct
use
fugen
transfect
reagent
accord
supplier
protocol
two
day
transfect
cell
select
dmem
supplement
fc
mm
hepe
penicillinstreptomycin
iuml
puromycin
period
week
co
rel
humid
function
activ
urotensiniireceptorexpress
cell
popul
verifi
flipr
assay
record
urotensiniimedi
intracellular
ca
releas
describ
cell
stabli
express
human
rat
urotensin
ii
receptor
cultur
confluenc
dmem
supplement
fc
mm
hepe
penicillinstreptomycin
iuml
puromycin
co
rel
humid
cell
wash
icecold
pb
second
time
pb
contain
proteas
inhibitor
cocktail
complet
cell
scrape
centrifug
gentli
pellet
resuspend
buffer
contain
mm
hepe
mm
edtadisodium
salt
cocktail
proteas
inhibitor
complet
incub
ice
min
cell
pellet
resuspend
homogen
unit
constant
cell
disrupt
system
honiley
warwickshir
uk
supernat
resuspend
pellet
combin
centrifug
g
beckman
avanti
cell
membran
pellet
resuspend
buffer
consist
mm
hepe
mm
edtadisodium
salt
mm
nacl
sucros
membran
aliquot
store
one
day
bind
assay
membran
thaw
pellet
resuspend
assay
buffer
consist
mm
hepe
mm
nacl
mm
edtadisodium
salt
bacitracin
complet
proteas
inhibitor
two
tablet
per
ml
membran
distribut
wheatgermagglutinin
flashplat
plu
incub
overnight
adsorpt
flashplat
plu
wash
twice
assay
buffer
equilibrium
bind
assay
nm
human
urotensin
ii
initi
specif
activ
ci
mmol
gbqmmol
incub
indic
amount
unlabel
competitor
h
radioact
count
microbeta
wallac
jet
wallac
turku
finland
data
flipr
assay
analyz
nonlinear
curv
fit
use
graphpad
prism
version
graphpad
softwar
san
diego
calif
usa
nonspecif
bind
determin
radioligand
bind
assay
presenc
human
uii
correspond
n
mean
sem
total
bind
membran
express
human
urotensin
ii
receptor
n
mean
sem
total
bind
membran
express
rat
urotensin
ii
receptor
data
analysi
perform
graphpad
prism
flohr
et
al
identifi
nonpeptid
urotensin
ii
receptor
antagonist
virtual
screen
phamacophor
model
deriv
structureact
relationship
nuclear
magnet
reson
studi
urotensin
ii
ut
receptor
express
vascular
tissu
ame
et
al
maguir
et
al
direct
link
uii
ut
receptor
vasoconstrict
assum
ame
et
al
dougla
ohlstein
behm
et
al
use
homolog
recombin
embryon
stem
es
cell
gener
mice
lack
ut
receptor
code
region
determin
effect
receptor
vascular
reactiv
vivo
vitro
verifi
uii
exert
effect
vascular
smooth
muscl
tone
via
interact
ut
gene
target
perform
murin
es
cell
replac
singl
code
exon
ut
receptor
locu
posit
select
cassett
contain
neomycin
phosphotransferas
gene
neo
driven
phosphoglycer
kinas
pgk
promot
homolog
arm
kb
clone
mous
genom
bacteri
artifici
chromosom
bac
librari
place
either
side
posit
select
cassett
homolog
recombin
neomycinresist
es
cell
confirm
southern
blot
bamhidigest
genom
dna
use
bamhi
smai
restrict
fragment
extern
probe
detect
band
wildtyp
target
locu
respect
approxim
clone
undergon
homolog
recombin
homolog
recombin
end
confirm
es
cell
clone
southern
blot
hindiiidigest
genom
dna
use
xmnihindiii
restrict
fragment
extern
probe
detect
band
wildtyp
target
locu
respect
three
target
clone
inject
blastocyst
male
chimera
cross
femal
give
offspr
subsequ
intercross
gener
offspr
addit
offspr
success
backcross
femal
gener
mice
intercross
creat
popul
studi
popul
genotyp
polymeras
chain
reaction
pcr
southern
blot
genom
dna
isol
heart
anim
use
studi
heart
wildtyp
ut
ut
receptor
knockout
ut
mice
cut
small
piec
mm
place
polypropylen
tube
extract
buffer
ml
mm
trishcl
ph
mm
nacl
mm
ethylenediaminetetraacet
acid
edta
sd
ml
rnase
ml
proteinas
k
ad
sampl
incub
h
complet
lyse
mixtur
extract
two
time
phenol
phenolchloroform
chloroform
maniati
et
al
genom
dna
precipit
ad
vol
cold
ethanol
wash
vv
ethanol
dissolv
mm
trishcl
mm
edta
te
ph
dissolv
puriti
concentr
dna
measur
spectrophotometri
absorb
nm
wavelength
pcr
amplif
perform
use
aliquot
mm
kcl
mm
trishcl
ph
mm
mgcl
nm
deoxynucleotid
dntp
vv
dimethylsulfoxid
taq
dna
polymeras
perkinelm
norwalk
conn
usa
use
ng
genom
dna
templat
pcr
primer
specif
neomycin
resist
gene
present
target
locu
tga
aca
aga
tgg
att
gca
cgc
agg
ttc
tcc
gcc
aag
ctc
ttc
agc
aat
atc
acg
ggt
yield
product
mous
ut
genespecif
primer
ctg
gct
gac
ctg
ctg
tat
ctg
cag
ggt
cac
aca
aag
cac
tct
yield
product
mous
dehydrogenas
gapdh
amplicon
use
intern
control
tgg
cca
agg
tca
tcc
atg
gtc
cac
cac
cct
gtt
gct
gta
yield
product
amplif
perform
cycl
anneal
extens
denatur
amplif
gapdh
doublet
alon
correspond
ut
genotyp
gapdh
doublet
alon
correspond
ut
genotyp
genom
dna
digest
bamhi
run
agaros
gel
agaros
gel
treat
denatur
solut
naoh
nacl
min
follow
neutral
trishcl
ph
nacl
min
dna
transfer
nylon
membran
genescreen
plu
nen
life
scienc
product
mass
usa
probe
cdna
correspond
fulllength
mous
ut
receptor
open
read
frame
orf
cdna
fragment
label
p
deoxycytidin
triphosph
dctp
use
standard
random
prime
method
quickprim
pharmacia
biotech
piscataway
nj
usa
membran
prehybrid
h
incub
overnight
cpm
denatur
radiolabel
probe
standard
buffer
deioniz
formamid
sodium
chlorid
sodium
citrat
ssc
denhardt
reagent
sodium
dodecyl
sulfat
sd
ml
denatur
fragment
salmon
sperm
dna
membran
wash
condit
low
stringenc
three
wash
ssc
sd
follow
high
stringenc
wash
sd
min
hybrid
signal
detect
convent
xray
autoradiographi
hyper
film
amersham
life
scienc
uk
phosphor
imag
storm
molecular
dynam
sunnyval
calif
usa
male
wildtyp
ut
homozyg
ut
receptor
knockout
ut
mice
anesthet
isofluran
underw
transthorac
echocardiograph
determin
left
ventricular
enddiastol
volum
edv
endsystol
volum
esv
stroke
volum
sv
cardiac
output
co
eject
fraction
ef
mice
reanesthet
follow
day
hemodynam
evalu
fluidfil
cathet
insert
left
carotid
arteri
measur
mean
arteri
blood
pressur
map
heart
rate
hr
cathet
advanc
left
ventricl
lv
obtain
measur
left
ventricular
endsystol
lvesp
enddiastol
pressur
lvedp
end
studi
select
organ
right
left
kidney
heart
right
left
ventricl
lung
isol
wet
weight
measur
male
month
g
wildtyp
ut
ut
receptor
knockout
ut
mice
anesthet
inhal
isofluran
kill
cervic
disloc
proxim
descend
thorac
aorta
isol
clean
adher
tissu
vessel
approxim
mm
length
suspend
organ
bath
contain
kreb
solut
follow
composit
mm
nacl
kcl
kh
po
mgso
cacl
nahco
dextros
kreb
solut
maintain
aerat
co
ph
contract
studi
vessel
denud
endothelium
rub
fine
forcep
indomethacin
mm
ad
buffer
chang
isometr
forc
measur
g
optim
rest
tension
use
forcedisplac
transduc
grass
instrument
quinci
mass
usa
coupl
model
polygraph
halpernmulvani
wire
myograph
model
danish
myo
technolog
denmark
use
measur
isometr
forc
develop
endotheliumintact
superior
mesenter
arteri
optim
rest
tension
g
data
record
use
grass
direct
thermal
record
follow
equilibr
period
vessel
treat
standard
concentr
kcl
mm
phenylephrin
mm
subsequ
agonistinduc
respons
normal
contractil
respons
phenylephrin
plateau
carbachol
ad
vessel
order
evalu
endotheli
integr
cumul
concentrationrespons
curv
phenylephrin
nm
angiotensin
ii
nm
nm
mm
huii
nm
obtain
vessel
ad
spasmogen
tissu
bath
halflog
increment
relax
studi
vessel
preconstrict
ec
concentr
phenylephrin
contractil
tone
revers
ad
cumul
amount
carbachol
nm
sodium
nitroprussid
nm
respons
allow
plateau
addit
subsequ
agonist
concentr
vessel
allow
recov
least
min
subsequ
agonistrespons
curv
expos
subsequ
agonist
treatment
either
huii
valu
express
mean
sem
n
repres
total
number
anim
vessel
isol
statist
comparison
made
use
unpair
twotail
ttest
fisher
exact
test
differ
consid
signific
p
concentrationrespons
curv
fit
logist
equat
previous
describ
dougla
et
al
coulouarn
et
al
report
clone
cdna
encod
urotensin
ii
precursor
preprouii
cdna
frog
human
intens
express
urotensin
gene
motoneuron
spinal
cord
found
indic
import
physiolog
function
urotensin
ii
elshourbagi
et
al
report
molecular
pharmacolog
character
gene
encod
urotensin
ii
peptid
cognat
gproteincoupl
receptor
mous
monkey
monkey
mous
preprouii
gene
identifi
encod
amino
acid
monkey
mous
ut
receptor
amino
acid
respect
express
mous
monkey
uiiut
receptor
mrna
found
also
extravascular
tissu
includ
lung
pancrea
skelet
muscl
kidney
liver
share
close
ident
angiotensin
receptor
rat
greatest
express
apj
mrna
detect
lung
suggest
apj
ligand
play
import
role
pulmonari
system
hosoya
et
al
clone
pharmacolog
character
brain
distribut
rat
apelin
receptor
report
de
mota
et
al
physiolog
role
apelin
receptor
rat
brain
reaux
et
al
hypothalam
hypophys
distribut
receptor
suggest
involv
apelin
control
neuroand
adenohypophys
hormon
releas
wherea
presenc
pineal
gland
discret
higher
brain
structur
point
possibl
role
regul
circadian
rhythm
water
food
intak
behavior
studi
distribut
apelinsynthes
neuron
adult
rat
brain
reaux
et
al
boucher
et
al
found
isol
mous
human
adipocyt
apelin
upregul
insulin
obes
ashley
et
al
found
apelin
improv
cardiac
contractil
reduc
cardiac
load
vivo
mice
male
mice
use
follow
studi
perform
magnet
reson
imag
heart
pressurevolum
hemodynam
effect
chronic
apelin
infus
assess
ventricular
hypertrophi
sacrific
express
apj
receptor
pressurevolum
hemodynam
assess
use
aria
system
millar
instrument
houston
tex
usa
measur
platform
specif
design
small
rodent
compris
ultraminiatur
f
mm
outer
diamet
cathet
incorpor
pressur
conduct
sensor
possess
hardwar
includ
analogdigit
convers
analysi
softwar
pressur
measur
directli
mmhg
conduct
blood
use
estim
volum
allow
construct
pressurevolum
relationship
real
time
male
mice
age
week
anesthet
isofluran
oxygen
intern
jugular
vein
cannul
pe
tube
albumin
solut
infus
follow
bolu
min
tracheostomi
cannula
insert
trachea
anim
ventil
tidal
volum
breath
per
minut
follow
incis
dorsal
xyphoid
cartilag
diaphragm
visual
diaphragmat
incis
left
ventricular
apex
visual
pressurevolum
cathet
insert
along
long
axi
left
ventricl
adjust
obtain
rectangularshap
pressurevolum
loop
baselin
loop
record
follow
volum
replac
point
inferior
vena
cava
visual
within
chest
occlus
paramet
record
manual
occlus
vessel
next
albumin
solut
replac
one
contain
nm
apelin
infus
min
follow
baselin
occlus
loop
record
signal
cathet
digit
use
powerlab
system
store
offlin
analysi
use
pvan
softwar
allow
analys
pressur
e
g
endsystol
pressur
enddiastol
pressur
deriv
pressuretim
volumetim
paramet
steadi
state
magnet
reson
imag
male
mice
age
week
scan
twice
subsequ
day
anim
underw
gener
anesthesia
breath
spontan
via
nose
cone
fit
care
minim
escap
anesthet
environ
two
percent
isofluran
administ
oxygen
flow
rate
lmin
platinum
needl
ecg
lead
insert
subcutan
respir
monitor
mean
pneumat
pillow
sensor
posit
abdomen
mous
bodi
temperatur
maintain
scan
flow
heat
air
thermostat
control
rectal
temperatur
probe
magnet
reson
imag
acquir
oxford
magnet
control
varian
inova
consol
varian
palo
alto
calif
usa
use
transmitrec
quadratur
volum
coil
inner
diamet
cm
imag
acquisit
gate
respir
ecg
r
wave
sa
instrument
stoni
brook
ny
usa
coron
sagitt
scout
imag
led
acquisit
multipl
contigu
short
axi
slice
orthogon
interventricular
septum
nine
cine
frame
taken
slice
level
follow
sequenc
paramet
te
ms
nex
fov
cm
matrix
flip
angl
cine
frame
space
ms
apart
acquir
slightli
one
cardiac
cycl
guarante
acquisit
systol
diastol
second
day
scan
mice
receiv
bodi
weight
apelin
intraperiton
inject
h
prior
scan
pilot
studi
previous
identifi
h
appropri
time
within
identifi
apelin
effect
result
periton
absorpt
planimetri
measur
enddiastol
endsystol
dimens
deriv
offlin
short
axi
view
left
ventricl
level
papillari
muscl
use
imagej
softwar
nation
institut
health
bethesda
md
usa
eject
fraction
calcul
lvedalvesa
lveda
lveda
left
ventricular
enddiastol
area
lvesa
left
ventricular
endsystol
area
data
analyz
use
student
statist
pair
repeat
measur
analysi
varianc
use
post
hoc
comparison
fisher
katugampola
et
al
katugampola
et
al
describ
pyr
apelin
radioligand
local
apj
orphan
receptor
human
rat
tissu
kasai
et
al
found
apelin
work
angiogen
factor
retin
endotheli
cell
line
transient
receptor
potenti
trp
ion
channel
name
role
channel
drosophila
phototransduct
montel
mammalian
gene
encod
least
channel
subunit
gene
clapham
moran
et
al
clapham
et
al
six
protein
famili
compris
mammalian
trp
superfamili
classic
trp
trpc
vanilloid
receptor
trp
trpv
melastatin
long
trp
trpm
mucolipin
trpml
polycystin
trpp
ankyrin
transmembran
protein
trp
channel
primari
structur
predict
six
transmembran
tm
domain
pore
domain
fifth
sixth
segment
c
n
termini
presum
locat
intracellularli
vannier
et
al
trp
superfamili
includ
relat
cation
channel
play
critic
role
process
rang
sensori
physiolog
vasorelax
male
fertil
defect
trp
channel
associ
chang
growth
control
one
trprelat
protein
may
tumor
suppressor
moreov
mutat
member
trp
superfamili
common
caus
polycyst
kidney
diseas
disrupt
anoth
respons
mucolipidosi
neurodegen
diseas
trp
protein
wide
express
nervou
system
nonexcit
cell
trprelat
channel
may
primari
mode
ca
entri
trp
protein
cation
channel
howev
vari
significantli
select
mode
activ
nevertheless
member
trp
superfamili
share
signific
sequenc
homolog
predict
structur
similar
base
primari
amino
acid
homolog
convent
trp
protein
classifi
three
subfamili
trpc
trpv
trpm
birnbaum
et
al
three
addit
distantli
relat
subfamili
recent
defin
ca
permeant
nonselect
cation
channel
mammalian
member
trpa
branch
trp
protein
activ
noxiou
cold
temperatur
pungent
mustard
oil
compound
may
addit
serv
mechanosensit
transduct
channel
auditori
hair
cell
well
ionotrop
cannabinoid
receptor
three
mucolipin
appear
ion
channel
intracellular
vesicl
mutat
caus
mucolipidosi
type
iv
neurodegen
lysosom
storag
disord
genet
defect
member
trpp
subfamili
frequent
encount
patient
suffer
autosom
domin
polycyst
kidney
diseas
albert
ap
larg
wa
trpc
famili
divid
three
subgroup
sequenc
homolog
well
function
similar
first
member
mammalian
trp
famili
purport
form
ion
channel
zitt
et
al
given
widespread
express
abil
coassembl
trpc
subunit
xu
et
al
lintsching
et
al
et
al
might
compon
differ
heteromer
trp
complex
subgroup
close
relat
compris
pdz
motifcontain
protein
form
homomer
cation
channel
activ
follow
stimul
g
q
coupl
receptor
okada
et
al
well
receptor
tyrosin
kinas
schaefer
et
al
xu
beech
found
membranespan
subunit
storeoper
ca
channel
nativ
vascular
smooth
muscl
cell
vandebrouck
et
al
describ
involv
trpc
abnorm
calcium
influx
observ
dystroph
mdx
mous
skelet
muscl
fiber
venkatachalam
et
al
discuss
regul
canon
transient
receptor
potenti
trpc
channel
function
diacylglycerol
protein
kinas
c
bergdahl
et
al
found
cholestrerol
deplet
impair
vascular
reactiv
reduc
storeoper
ca
entri
depend
amiri
et
al
publish
fretbas
analysi
trpc
subunit
stoichiometri
jho
et
al
report
oppos
vegfinduc
increas
endotheli
permeabl
inhibit
ca
influx
rao
kaminski
found
induct
intracellular
elev
tetrahydrocannabinol
cell
involv
channel
takai
et
al
distinguish
two
type
nonselect
cation
channel
muscarin
stimul
carbachol
bovin
muscl
cell
kumar
et
al
studi
upregul
channel
vascular
injuri
vivo
role
human
neointim
hyperplasia
less
inform
avail
share
approxim
sequenc
ident
subfamili
fulllength
mrna
sever
ntermin
splice
variant
found
mous
rat
tissu
seem
pseudogen
human
vannier
et
al
liman
protein
local
neuron
micovilli
rat
vomeronas
organ
liman
head
mous
sperm
jungnickel
et
al
ident
express
constitut
nonselect
cation
current
rectifi
inward
voltag
outward
voltag
direct
inwardli
outwardli
rectifi
rel
low
select
ca
na
activ
diacylglycerol
dag
hofmann
et
al
okada
et
al
putney
et
al
channel
seem
play
import
role
vascular
airway
smooth
muscl
trebak
et
al
yu
et
al
cortel
et
al
groschner
rosker
c
describ
versatil
transduc
molecul
serv
integr
diversif
cellular
signal
graziani
et
al
investig
potenti
role
membran
cholesterol
regul
cellular
conduct
smyth
et
al
found
dissoci
regul
traffick
channel
plasma
membran
activ
phospholipas
c
receptoroper
ca
nonselect
cation
channel
plant
schaefer
odel
et
al
found
epiderm
growth
factor
induc
tyrosin
phosphoryl
membran
insert
activ
transient
receptor
potenti
channel
saleh
et
al
describ
angiotensin
ii
activ
two
cation
channel
distinct
channel
properti
rabbit
mesenter
arteri
myocyt
shimizu
et
al
report
ca
myosin
light
chain
kinas
essenti
activ
channel
express
cell
shi
et
al
describ
multipl
regul
calcium
murin
homolog
transient
receptor
potenti
protein
express
cell
xu
et
al
identifi
activ
calcium
channel
control
vascular
smooth
muscl
activ
estacion
et
al
studi
activ
human
channel
receptor
stimul
basora
et
al
report
acid
activ
mous
channel
express
cell
maruyama
et
al
found
heteromultimer
channel
contribut
arginin
vasopressininduc
cation
current
vascular
smooth
muscl
cell
report
inhibit
channel
antifung
agent
clotrimazol
econazol
well
flufenam
acid
kraft
et
al
n
pamylcinnamoyl
anthranil
acid
identifi
first
sequenc
project
function
poorli
understood
gene
map
human
chromosom
encod
protein
similar
characterist
splice
variant
ca
activ
voltagemodul
monovalentselect
cation
channel
singlechannel
conduct
launay
et
al
hofmann
et
al
niliu
et
al
et
al
studi
ion
channel
tast
receptor
cell
compris
uniqu
subfamili
trp
protein
channel
kinas
activ
amino
acid
residu
identifi
yeast
twohybrid
screen
protein
interact
phospholipas
c
plc
runnel
et
al
schmitz
et
al
seem
ubiquit
express
takezawa
et
al
describ
receptormedi
regul
channel
endogen
protein
kinas
domain
protein
seem
contain
associ
enzymat
domain
nonselect
voltagemodul
conduct
colder
temperatur
presenc
menthol
current
activ
physiolog
rang
voltag
brauchi
et
al
voet
et
al
channel
express
smalldiamet
primari
sensori
neuron
presum
function
thermosensor
mckemi
et
al
peier
et
al
trpv
subfamili
name
first
mammalian
member
subfamili
vanilloid
receptor
caterina
et
al
benham
et
al
montel
et
al
clapham
mutai
heller
highli
ca
select
trp
channel
mediat
transepitheli
ca
transport
kidney
intestin
hoenderop
et
al
trpv
channel
subfamili
six
member
divid
two
group
vanilloid
receptor
best
understood
ion
channel
class
caterina
et
al
caterina
juliu
trpv
channel
temperatur
sensor
reviw
benham
et
al
express
capsaicin
receptor
heatprotonlipidvoltagemodul
ca
permeant
p
ca
p
na
ion
channel
voltaggatingcentr
explan
warmer
temperatur
presenc
capsaicin
current
activ
physiolog
rang
voltag
brauchi
et
al
desensit
intern
ca
activ
store
deplet
activ
synthet
compound
chung
et
al
hu
et
al
endogen
cannabinoid
receptor
ligand
anandamid
potenti
agonist
vanilloid
receptorlik
channel
ident
insensit
capsaicin
caterina
et
al
like
permeabl
ca
na
p
ca
p
na
propos
mediat
highthreshold
noxiou
heat
sensat
perhap
lightli
myelin
nociceptor
presenc
nonsensori
tissu
suggest
function
well
express
wide
strikingli
skin
increas
temperatur
mammalian
cell
transfect
elev
intracellular
calcium
activ
nonselect
cation
conduct
p
ca
p
na
peier
et
al
smith
et
al
xu
et
al
sensori
neuron
current
steepli
depend
temperatur
sensit
repeat
heat
display
strike
hysteresi
heat
cool
extent
express
sensori
neuron
controversi
base
properti
thermosensit
physiolog
rang
temperatur
may
play
role
pain
ident
liedtk
et
al
strotmann
et
al
express
mammalian
cell
compris
moder
select
cation
channel
p
ca
p
na
like
display
gentli
outwardli
rectifi
iv
relat
ident
liedtk
et
al
strotmann
et
al
express
mammalian
cell
compris
moder
select
cation
channel
p
ca
p
na
like
display
gentli
outwardli
rectifi
iv
relat
compris
separ
subfamili
trpv
ident
express
channel
strongli
inwardli
rectifi
ca
select
p
ca
p
na
niliu
et
al
venneken
et
al
yue
et
al
den
dekker
et
al
trp
channel
properti
consist
propos
mechan
ca
select
channel
neg
charg
glutam
aspart
acid
residu
provid
bind
site
dival
within
pore
intraand
extracellular
ca
yue
et
al
hirnet
et
al
flockerzi
calmodulin
lamber
et
al
regul
activ
local
proxim
small
intestin
collect
duct
kidney
along
mous
knockout
data
suggest
famili
import
calcium
uptak
via
epitheli
cell
hoenderop
et
al
lee
et
al
report
pip
activ
releas
inhibit
intracellular
mg
benham
cd
davi
jb
randal
ad
vanilloid
nonselect
cation
channel
predominantli
express
peripher
sensori
neuron
known
play
key
role
detect
noxiou
pain
stimuli
capsaicin
heat
smart
et
al
smart
et
al
found
endogen
lipid
anandamid
full
agonist
human
vanilloid
receptor
character
human
vanilloid
pharmacolog
use
flipr
method
gunthorp
et
al
identifi
character
potent
select
vanilloid
receptor
antagonist
human
cdna
identifi
use
publish
rat
sequenc
genbank
access
search
public
nucleotid
databas
express
sequenc
tag
identifi
sequenc
extend
rapid
amplif
cdna
end
use
cdna
templat
number
tissu
sourc
full
cdna
amplifi
brain
cdna
insert
express
vector
doublestrand
sequenc
stabli
express
cell
rat
cdna
amplifi
rat
drg
cdna
similarli
express
cell
cell
cultur
cell
grown
monolay
minimum
essenti
medium
mem
supplement
nonessenti
amino
acid
fetal
calf
serum
mm
lglutamin
maintain
co
cell
passag
everi
day
highest
passag
number
use
dissoci
rat
neonat
drg
cultur
prepar
describ
skaper
et
al
cell
plate
cultur
glass
coverslip
cell
cm
wholecel
voltag
clamp
record
perform
room
temperatur
use
standard
method
extracellular
solut
consist
mm
nacl
kcl
cacl
mgcl
glucos
hepesnaoh
ph
anandamid
applic
solut
supplement
lipidfre
bovin
serum
albumin
patch
pipett
resist
fabric
sutter
instrument
electrod
puller
fill
follow
solut
mm
cscl
mgcl
egta
hepescsoh
ph
record
made
singl
well
isol
phasebright
cell
current
record
hold
potenti
mv
use
axopatch
amplifi
data
acquisit
analysi
perform
use
softwar
suit
drug
applic
affect
autom
fastswitch
solut
exchang
devic
warner
instrument
time
solut
exchang
ms
cell
seed
blackwal
clearbas
plate
costar
uk
densiti
cell
per
well
mem
supplement
cultur
overnight
cell
incub
mem
contain
cytoplasm
calcium
indic
teflab
austin
tex
usa
min
cell
wash
four
time
final
cultur
tyrod
medium
contain
bsa
incub
min
either
buffer
alon
control
buffer
contain
variou
antagonist
plate
place
flipr
molecular
devic
uk
monitor
cell
fluoresc
ex
nm
em
nm
sullivan
et
al
addit
variou
agonist
respons
measur
peak
fluoresc
intens
fi
minu
basal
fi
appropri
express
percentag
maximum
capsaicininduc
respons
data
express
mean
sem
unless
otherwis
state
curvefit
paramet
estim
carri
use
graph
pad
prism
graphpad
softwar
calif
usa
pk
b
valu
gener
ic
curv
antagonist
vs
fix
ec
concentr
agonist
use
chengprusoff
equat
rao
kaminski
report
induct
intracellular
elev
tetrahydrocannabinol
cell
involv
channel
noradrenalin
sympathomimet
drug
increas
vascular
smooth
muscl
tone
stimul
receptor
contract
antagon
receptor
block
agent
phentolamin
drug
test
capac
reduc
vascular
smooth
muscl
contract
induc
adrenerg
receptoractiv
agent
noradrenalin
moreov
effect
peptid
bradykinin
test
strip
aorta
pulmonari
arteri
donor
anim
pirbright
white
guinea
pig
either
sex
weigh
g
chinchilla
rabbit
weigh
kg
spraguedawley
rat
weigh
g
use
vessel
test
thorac
aorta
arteria
pulmonali
anim
sacrif
stun
exsanguin
pulmonari
arteri
thorac
aorta
quickli
remov
cut
helic
strip
mm
width
mm
length
strip
mount
organ
bath
preload
g
krebshenseleit
buffer
solut
contain
glucos
maintain
oxygen
co
isoton
isometr
registr
perform
chang
length
record
isoton
use
lever
transduc
type
b
hugo
sach
elektronik
freiburg
isometr
forc
measur
forc
transduc
gouldstatham
oxnard
usa
follow
equilibr
period
min
contract
induc
repeat
administr
noradrenalin
hcl
concentr
test
contract
pulmonari
arteri
concentr
test
contract
aorta
obtain
stabl
plateau
ident
size
contract
cumul
dose
test
compound
ad
organ
bath
consecut
concentr
given
respons
previou
dose
reach
plateau
control
end
experi
compound
show
vasorelax
activ
dose
sensit
prepar
test
ad
phentolamin
compound
show
vasorelax
activ
revers
relax
test
increas
noradrenalin
concentr
contractil
forc
determin
drug
administr
percent
inhibit
spasmogeninduc
contract
test
drug
calcul
compar
maxim
contract
spasmogen
alon
ic
valu
determin
individu
doserespons
curv
ic
defin
dose
drug
lead
relax
noradrenalineinduc
contract
isol
vena
cava
rabbit
use
assay
activ
rabbit
sacrif
co
anesthesia
vena
cava
inferior
remov
cut
strip
percent
inhibit
epinephrin
norepinephrin
induc
contract
determin
effect
bradykinin
bradykinin
antagonist
test
isol
guinea
pig
arteri
isol
rabbit
aorta
contain
predominantli
bk
receptor
type
regoli
hock
et
al
wisskirchen
et
al
test
agonist
calcitonin
generel
peptid
homologu
antagonist
rat
isol
pulmonari
arteri
endotheliumintact
pulmonari
arteri
ring
contract
phenylephrin
cumul
doserespons
curv
relax
construct
furchgott
rf
semin
vesicl
guinea
pig
rat
tubular
organ
whose
longitudin
annular
muscl
innerv
sympathet
system
inhibit
contract
induc
norepinephrin
select
agonist
phenylephrin
indic
activ
sharif
gokhal
recommend
use
isol
rat
semin
vesicl
rather
sensit
specif
model
male
guinea
pig
weigh
g
sacrif
blow
neck
semin
vesicl
prepar
place
ringer
solut
organ
bath
maintain
oxygen
co
isoton
isometr
registr
perform
chang
length
record
isoton
use
lever
transduc
type
b
hugo
sach
elektronik
freiburg
isometr
forc
measur
forc
transduc
gouldstatham
oxnard
usa
follow
equilibr
period
min
contract
induc
repeat
administr
norepinephrin
hcl
concentr
phenylephrin
hcl
concentr
obtain
stabl
plateau
ident
contract
test
compound
ad
organ
bath
three
min
later
previou
concentr
norepinephrin
phenylephrin
ad
standard
phentolamin
use
concentr
contract
semin
vesicl
induc
agonist
addit
test
compound
compar
initi
valu
express
percentag
thereof
depth
analysi
full
doserespons
curv
agonist
record
addit
variou
dose
antagonist
parallel
shift
right
indic
competit
antagon
evalu
pa
x
valu
accord
schild
leitch
recommend
use
isol
semin
vesicl
rat
assay
sympatholyt
drug
va
deferen
guinea
pig
prefer
rat
use
quantit
evalu
adrenerg
antagonist
respons
organ
agonist
consist
strong
rapid
contract
follow
quick
relax
wash
agonist
tissu
male
wistar
rat
weigh
g
use
anim
sacrif
sharp
blow
neck
vasa
deferentia
dissect
free
extran
tissu
suspend
organ
bath
contain
tyrod
solut
oxygen
co
mixtur
isoton
registr
perform
preload
g
chang
length
record
isoton
use
lever
transduc
e
g
type
b
hugo
sach
elektronik
freiburg
frg
follow
equilibr
period
min
contract
induc
repeat
administr
norepinephrin
hcl
concentr
obtain
stabl
plateau
ident
contract
test
compound
ad
organ
bath
three
min
later
previou
concentr
norepinephrin
ad
standard
phentolamin
use
concentr
contract
va
deferen
induc
agonist
addit
test
compound
compar
initi
valu
express
percentag
thereof
depth
analysi
full
doserespons
curv
agonist
record
addit
variou
dose
antagonist
parallel
shift
right
indic
competit
antagon
evalu
pa
x
valu
accord
schild
electr
stimul
isol
ductu
deferen
result
releas
norepinephrin
stimul
induc
contract
organ
inhibit
clonidin
impair
adrenerg
neurotransmiss
activ
inhibitori
ductu
deferen
suspend
organ
bath
bubbl
carbogen
maintain
tension
adjust
mn
follow
min
equilibr
period
supramaxim
amplitud
stimul
hse
type
stimul
hugo
sach
elektronik
freiburg
appli
stabil
respons
clonidin
ad
organ
bath
accumul
dose
test
compound
ad
min
prior
clonidin
administr
percent
potenti
clonidin
induc
inhibit
contract
determin
taylor
et
al
use
rat
deferen
pharmacolog
character
purinerg
receptor
nervemuscl
prepar
va
deferen
review
holman
hugh
et
al
use
electr
stimul
mous
va
deferen
assess
agonist
antagonist
activ
narcot
analges
drug
ross
et
al
use
mous
va
deferen
studi
structureact
relationship
endogen
cannabinoid
anadamid
certain
analogu
vanilloid
receptor
oka
et
al
recommend
va
deferen
rabbit
specif
bioassay
opioid
agonist
mutafovayambolieva
radmirov
studi
effect
electricallyor
druginduc
contractil
respons
mediat
purinerg
adrenerg
receptor
isol
prostat
portion
rat
va
deferen
ward
et
al
use
isol
vasa
deferentia
prepar
rat
mous
studi
pharmacolog
profil
analges
pravadolin
hukov
describ
isol
ductu
deferen
prepar
togeth
sympathet
hypogastr
nerv
guinea
pig
cordellini
sannomiya
pretreat
guinea
pig
reserpin
isol
vasa
deferentia
concentrationeffect
curv
phenylephrin
establish
presenc
cocain
antagonist
effect
phenoxybenzamin
use
receptor
occup
studi
donoso
et
al
studi
neurotransmiss
epididym
prostat
segment
isol
superfus
rat
va
deferen
prepar
vaupel
su
use
va
deferen
prepar
guinea
pig
studi
sigma
phencyclidin
receptor
eltz
use
fieldstimul
maximum
voltag
hz
ms
portion
rabbit
va
deferen
studi
muscarin
receptor
dumont
et
al
use
isol
guinea
pig
heart
isol
rat
va
deferen
vitro
bioassay
calcitonin
generel
peptid
cgrp
agonist
antagonist
poyner
et
al
found
concentrationdepend
inhibit
electr
stimul
twitch
respons
guinea
pig
va
deferen
calcitonin
generel
peptid
amylin
adrenomedullin
couldwel
et
al
found
rat
prostat
gland
possess
typic
adrenoceptor
similar
found
va
deferen
wisskirchen
et
al
test
agonist
calcitonin
generel
peptid
homologu
antagonist
rat
isol
va
deferen
prostat
half
suspend
g
rest
tension
equilibr
kreb
solut
contractil
respons
prostat
va
induc
electr
field
stimul
hz
ms
v
parallel
platinum
electrod
either
side
tissu
agent
epinephrin
norepinephrin
electr
stimul
induc
contract
sympathet
innerv
organ
spleen
smooth
muscl
effect
antagon
drug
activ
phentolamin
male
spraguedawley
rat
weigh
g
use
anim
sacrif
co
anesthesia
spleen
remov
cut
longitudin
two
halv
part
place
organ
bath
contain
nutrit
solut
bath
solut
bubbl
carbogen
maintain
follow
min
incub
period
tension
g
contract
elicit
administr
epinephrin
gml
norepinephrin
gml
obtain
approxim
ident
spasm
test
compound
administ
follow
addit
spasmogen
min
later
contractil
respons
allow
plateau
record
standard
compound
phentolamin
contractil
forc
record
maxim
level
drug
administr
percent
inhibit
epinephrin
norepinephrin
induc
contract
determin
rat
anococcygeu
muscl
pharmacolog
tool
introduc
gillespi
gillespi
gibson
gillespi
smooth
muscl
dens
adrenerg
innerv
contract
noradrenalin
acetylcholin
histamin
moreov
muscl
contract
field
stimul
stimul
extrins
nerv
prepar
use
assess
preand
postsynapt
block
activ
drug
doggrel
doggrel
two
anococcygeu
muscl
aris
upper
coccyg
vertebra
close
one
anoth
midlin
pelvic
caviti
muscl
pass
caudal
lie
first
behind
one
side
colon
final
join
togeth
form
ventral
bar
front
colon
mm
anu
extrins
nerv
pass
branch
perin
nerv
either
side
enter
deep
surfac
muscl
format
ventral
bar
sacrific
abdomen
rat
open
midlin
pelvi
split
bladder
urethra
remov
care
requir
clear
lower
part
urethra
avoid
damag
ventral
bar
muscl
region
lie
ventral
colon
colon
cut
pelvic
brim
pelvic
portion
pull
forward
delic
connect
tissu
behind
clear
anococcygeu
muscl
come
view
muscl
isol
instanc
extrins
nerv
intact
extrins
nerv
either
side
run
posterior
scrotal
branch
perin
nerv
leav
enter
deep
surfac
anococcyg
muscl
lie
later
surfac
colon
ventral
bar
cut
muscl
mount
ml
bath
contain
kreb
solut
solut
gass
co
tension
measur
isometr
transduc
display
polygraph
field
stimul
intramur
nerv
appli
draw
muscl
pair
electrod
similar
describ
burn
rand
muscl
stimul
extrins
nerv
nerv
drawn
similar
electrod
stimul
either
intramur
extrins
nerv
ms
puls
hz
supramaxim
voltag
doserespons
curv
establish
dose
noradrenalin
acetylcholin
grade
frequenc
electr
stimul
effect
noradrenalin
abolish
antagonist
phentolamin
doserespons
curv
show
parallel
shift
characterist
competit
antagon
contract
anococcygeu
muscl
induc
agonist
addit
test
compound
compar
initi
valu
express
percentag
thereof
depth
analysi
full
doserespons
curv
agonist
record
addit
variou
dose
antagonist
parallel
shift
right
indic
competit
antagon
evalu
pa
x
valu
accord
schild
gibson
et
al
found
ln
g
nitroarginin
potent
inhibitor
nonadrenerg
noncholinerg
relax
rat
anococcygeu
muscl
oliveira
bendhack
found
dopamin
dual
effect
rat
anococcygeu
muscl
partial
effect
due
indirect
sympathomimet
action
partial
effect
due
interact
postjunct
receptor
brave
et
al
investig
interact
motor
sympathet
inhibitori
nonadrenerg
noncholinerg
nerv
rat
anococcygeu
muscl
use
ln
g
nitroarginin
inhibitor
larginin
synthas
cakici
et
al
describ
coaxial
bioassay
system
consist
guinea
pig
trachea
donor
organ
epitheli
derivedrelax
factor
phenylepinephrineprecontract
rat
anococcygeu
muscl
assay
tissu
iravani
zar
found
differenti
effect
nifedipin
nervemedi
noradrenalineevok
contract
rat
anococcygeu
muscl
rand
li
studi
modul
acetylcholineinduc
contract
rat
anococcygeu
muscl
activ
nitrerg
nerv
mudumbi
leighton
investig
mechan
action
relax
induc
bradykinin
electr
field
stimul
isol
rat
anococcygeu
muscl
contractil
tone
elev
clonidin
gwee
et
al
investig
prejunct
postjunct
inhibit
adrenerg
transmiss
rat
isol
anococcygeu
muscl
cimetidin
najbar
et
al
found
smooth
muscl
cell
rat
anococcygeu
muscl
endow
two
distinct
subserv
contract
de
godoy
et
al
evalu
inhibitori
effect
atropin
hexamethonium
angiotensiniiinduc
contract
rat
anococcygeu
muscl
pettibon
et
al
examin
inhibitori
potenc
select
oxytocin
antagonist
oxytocinstimul
contract
mous
anococcygeu
muscl
dehpour
et
al
radjae
et
al
use
isol
anococcygeu
muscl
rabbit
found
extrem
regular
activ
induc
methoxamin
clonidin
isoprenalin
isoproterenol
induc
increas
frequenc
forc
contract
spontan
beat
isol
right
atria
potenti
contract
electr
stimul
isol
left
atria
drug
activ
inhibit
isoprenalineinduc
effect
block
activ
drug
evalu
isol
right
left
b
guinea
pig
atria
sinc
heart
contain
predominantli
adrenoreceptor
block
activ
assess
test
pirbright
white
guinea
pig
either
sex
weigh
g
use
anim
sacrif
stun
exsanguin
heart
remov
right
left
atrium
cut
mount
ml
organ
bath
preload
mg
krebshenseleit
solut
maintain
aerat
co
contract
record
isoton
use
lever
transduc
type
b
hugo
sach
elektronik
freiburg
equilibr
period
min
isoprenalin
administ
organ
bath
potenti
inotropi
frequenc
isol
right
atrium
cumul
dose
isoprenalin
ad
start
concentr
consecut
dose
administ
min
interv
stabl
maximum
plateau
effect
achiev
organ
bath
thoroughli
flush
min
flush
repeat
twice
min
later
whole
procedur
repeat
isoprenalin
concentr
control
baselin
valu
test
compound
ad
organ
bath
min
later
isoprenalin
given
cumul
dose
test
compound
block
activ
higher
isoprenalin
concentr
necessari
induc
potenti
inotropi
frequenc
isoprenalin
concentr
ad
increas
inotropi
frequenc
reduc
end
experi
cycl
without
test
drug
perform
left
atrium
stimul
squar
wave
stimul
impulsess
voltag
v
impuls
durat
ms
equilibr
period
min
isoprenalin
ad
concentr
mgml
organ
bath
thoroughli
flush
min
flush
repeat
twice
min
later
whole
procedur
repeat
cumul
isoprenalin
concentr
control
baselin
valu
flush
procedur
stabl
plateau
contract
achiev
test
compound
ad
organ
bath
min
later
isoprenalin
ad
cumul
concentr
test
compound
block
activ
isoprenalineinduc
effect
inhibit
addit
refractori
period
determin
drug
administr
evalu
percent
inhibit
isoprenalineinduc
b
electricallyinduc
isoprenalinepotenti
increas
inotropi
frequenc
test
drug
calcul
compar
predrug
activ
b
percent
chang
refractori
period
calcul
ic
valu
determin
individu
doserespons
curv
statist
evalu
perform
mean
pair
ttest
standard
compound
propranolol
hcl
amrinon
nifedipin
milrinon
detail
descript
use
isol
atrial
prepar
given
levi
instead
right
atrium
doggrel
hugh
use
isol
right
ventricl
rat
assess
block
activ
propranolol
investig
competit
natur
isoproterenol
antagon
variou
dose
schildplot
analysi
doggrel
use
isol
left
atria
rat
simultan
assess
membranestabil
block
activ
berthold
et
al
describ
method
test
cardioton
sodium
channel
activ
isol
electr
stimul
left
guinea
pig
atria
potassium
depolar
olson
et
al
studi
function
isol
rat
left
atria
papillari
muscl
quantifi
voltagerespons
relationship
punctat
field
electr
stimul
pretreat
reserpin
male
pirbright
white
guinea
pig
weigh
g
use
anim
sacrif
stun
exsanguin
trachea
remov
cut
individu
ring
six
ring
connect
seri
mean
short
loop
silk
thread
tracheal
chain
mount
ml
organ
bath
preload
g
isoton
registr
nutrit
solut
tyrod
contain
ascorb
acid
gl
glucos
block
agent
phentolamin
spasmogen
carbachol
ngml
ad
solut
maintain
aerat
co
equilibr
period
min
cumul
dose
spasmolyt
agent
isoprenalin
ad
maxim
relax
obtain
organ
bath
flush
procedur
repeat
two
control
relax
isoprenalin
tissu
rins
thoroughli
first
dose
test
compound
administ
three
min
later
cumul
dose
isoprenalin
administ
follow
min
washout
recoveri
period
next
dose
test
compound
given
drug
concentr
test
one
organ
standard
compound
propranolol
practolol
evalu
percent
inhibit
isoprenalineinduc
relax
drug
treatment
calcul
compar
maxim
relax
induc
isoprenalin
alon
control
competit
antagon
test
compound
evalu
quantit
doserespons
curv
odonnel
wanstal
use
guinea
pig
tracheal
prepar
k
depolar
achiev
replac
na
kreb
solut
equival
amount
k
caus
sustain
contract
prepar
dosedepend
relax
effect
isoprenalin
could
obtain
provid
prepar
repolar
wash
normal
kreb
solut
curv
pa
valu
good
agreement
valu
obtain
type
tracheal
prepar
guinea
pig
superfus
trachea
dispers
tracheal
cell
use
buckner
et
al
compar
effect
isoproterenol
forskolin
immunolog
nonimmunolog
histamin
releas
lundblad
persson
found
epitheli
remov
littl
consequ
pharmacolog
guinea
pig
tracheal
open
ring
prepar
vitro
rat
portal
vein
recommend
model
assess
adrenoceptor
block
activ
drug
doggrel
angiotensinconvert
enzym
ace
respons
format
activ
angiotensin
ii
inact
angiotensin
enzym
respons
degrad
activ
peptid
bradykinin
inact
product
ace
activ
therefor
measur
two
way
activ
newli
form
angiotensin
ii
inhibit
activ
bradykinin
ace
inhibit
result
decreas
activ
precursor
angiotensin
potenti
bradykinin
effect
guinea
pig
ileum
contract
respons
peptid
angiotensin
ii
bradykinin
use
quantit
determin
ace
inhibit
activ
guinea
pig
either
sex
weigh
g
use
sacrif
stun
exsanguin
abdomen
open
scissor
distal
pyloru
cord
tie
around
intestin
sever
cord
intestin
gradual
remov
mesenteri
cut
away
necessari
colon
reach
intestin
cut
free
cord
intestin
cut
halfway
glass
tube
insert
tyrod
solut
pass
tube
intestin
effluent
clear
mesenteri
cut
away
intestin
join
colon
piec
cm
length
cut
prefer
distal
piec
use
sensit
one
piec
fix
tissu
clamp
brought
organ
bath
tyrod
solut
oxygen
end
fix
isometr
forc
transduc
uc
gouldstatham
oxnard
usa
respons
record
polygraph
equilibrium
time
min
angiotensin
ad
concentr
ngml
bath
solut
forc
contract
record
angiotensin
dosag
repeat
twice
respons
ident
potenti
ace
inhibitor
ad
min
incub
time
angiotensin
ad
contract
diminish
depend
activ
ace
inhibitor
piec
guinea
pig
ileum
prepar
describ
equilibrium
time
min
bradykinin
ad
concentr
ngml
bath
solut
forc
contract
record
bradykinin
addit
repeat
twice
respons
ident
potenti
ace
inhibitor
ad
min
incub
time
bradykinin
ad
contract
potenti
depend
activ
ace
inhibitor
contract
addit
ace
inhibitor
express
percentag
contract
without
ace
inhibitor
use
variou
dose
ace
inhibitor
ic
valu
concentr
induc
inhibit
calcul
standard
ramipril
enalapril
captopril
use
increas
contract
addit
ace
inhibitor
express
percentag
contract
without
ace
inhibitor
standard
ramipril
use
classic
method
isol
guinea
pig
ileum
proven
reliabl
method
screen
potenti
ace
inhibitor
contractil
process
within
vascular
smooth
muscl
result
increas
concentr
intracellular
ca
inhibit
vasoconstrict
occur
addit
calcium
antagonist
remov
extracellular
calcium
vasorelax
effect
compound
test
isol
rodent
arteri
pulmonari
arteri
thorac
aorta
arteri
ring
strip
without
endotheli
line
contract
differ
agent
e
g
extracellular
k
ca
agonist
phenylephrin
noradrenalin
ca
ionophor
thromboxan
receptor
agonist
compound
vasodil
activ
antagon
induc
contract
potassium
channel
open
cromakalin
nicorandil
pinacidil
hoe
induc
relax
contract
smooth
musculatur
bolton
et
al
effect
explain
data
patch
clamp
techniqu
ion
flux
experi
well
antagon
potassium
channel
blocker
indic
potenti
use
antihypertens
antiasthmat
drug
hamilton
weston
weston
weston
edward
studi
complic
high
divers
potassium
channel
includ
atpsensit
voltagesensit
ca
activ
channel
mourr
et
al
blatz
maglebi
ashcroft
ashcroft
jan
jab
pong
wann
sinc
function
channel
appear
consist
four
differ
subunit
possibl
exist
may
hundr
differ
voltagesensit
k
channel
depend
subunit
composit
ashcroft
gribbl
discuss
new
window
mechan
action
k
atp
channel
open
glibenclamid
antagonist
atpmodul
k
channel
allow
local
bind
site
eltz
french
et
al
mourr
et
al
miller
et
al
anim
sacrif
stun
exsanguin
least
isol
organ
test
per
drug
heart
pulmonari
arteri
quickli
remov
immers
pss
room
temperatur
arteri
dissect
ring
endotheli
cell
remov
gentli
rub
intim
surfac
spiral
cut
strip
mm
length
mm
width
suspend
rest
forc
mg
organ
bath
contain
ml
oxygen
co
pss
chang
length
record
isoton
use
lever
transduc
type
b
hugo
sach
elektron
freiburg
test
effect
compound
vessel
intact
endotheli
line
thorac
aorta
rat
isol
dissect
free
surround
tissu
ring
mm
width
cut
suspend
organ
bath
contain
pss
isometr
forc
measur
forc
transduc
gouldstatham
oxnard
usa
rest
tension
mg
function
integr
endothelium
test
drug
administr
one
acetylcholin
organ
bath
result
transient
relax
equilibr
period
h
contract
vessel
strip
ring
induc
addit
one
contract
agent
organ
bath
induc
contract
potassiumdepolar
vessel
three
differ
pss
solut
use
pss
min
pss
ii
min
pss
iii
contract
induc
presenc
pss
iii
ad
mm
ca
organ
bath
stabl
plateau
contract
achiev
cumul
concentr
test
compound
ad
organ
bath
obtain
drugrespons
curv
consecut
concentr
ad
either
hinterv
respons
previou
dose
reach
steadi
state
level
order
studi
time
cours
relax
durat
action
one
concentr
test
test
whether
mechan
action
vasorelax
agent
relat
liber
nitric
oxid
methylen
blue
oxyhemoglobin
ad
organ
bath
min
prior
cumul
administr
test
compound
methylen
blue
oxyhemoglobin
block
select
induc
relax
mean
valu
relax
sem
calcul
height
contract
first
drug
administr
taken
ic
valu
determin
individu
doserespons
curv
ic
defin
dose
drug
lead
relax
contract
induc
kcl
agonist
statist
evalu
perform
mean
ttest
calderon
et
al
compar
four
rat
aortic
prepar
singl
ring
spiral
strip
zigzag
strip
multipl
ring
basi
respons
noradrenalin
acetylcholin
recommend
multipl
ring
prepar
suitabl
four
studi
vasoact
drug
reproduc
contractur
relax
respons
kent
et
al
use
rat
aortic
strip
contract
stabl
tension
either
phenylephrin
barium
chlorid
comparison
vasodil
wilson
et
al
studi
isol
ring
rat
aorta
precontract
noradrenalin
antagon
glibenclamid
vasorelax
induc
cromakalin
et
al
cannul
cerebr
arteri
mice
glass
cannula
side
allow
applic
hydrostat
pressur
vessel
diamet
measur
use
videomicroscop
system
nikon
diaphot
germani
connect
person
comput
appropri
softwar
detect
chang
vessel
diamet
tse
bad
homburg
germani
nishimura
test
contractil
respons
basilar
arteri
superior
mesenter
arteri
thorac
aorta
strokepron
spontan
hypertens
rat
comparison
normal
wistarkyoto
rat
found
hyperrespons
mediat
differ
receptor
subtyp
fouda
et
al
use
isol
tail
arteri
rat
differ
vasoconstrictor
respons
potassium
norepinephrin
tail
arteri
spontan
hypertens
renovascular
hypertens
variou
strain
normotens
rat
found
hamilton
et
al
dacquet
et
al
studi
effect
calcium
entri
blocker
rat
portal
vein
hell
studi
inhibit
vascular
smooth
muscl
vasoact
intestin
peptid
vip
isol
rat
portal
vein
shetti
weiss
studi
inhibit
spontan
rhythmic
movement
norepinephrineinduc
tension
respons
rat
portal
vein
edward
et
al
compar
effect
sever
potassiumchannel
open
rat
bladder
rat
portal
vein
vitro
smith
et
al
test
abil
ctermin
truncat
fragment
human
generel
peptid
relax
mesenter
arteri
precontract
norepinephrin
studi
contractil
effect
noradrenalin
neuropeptid
given
alon
combin
isol
rat
mesenter
resist
vessel
gurden
et
al
use
guinea
pig
aorta
relax
function
character
adenosin
receptor
type
eltz
studi
antagon
glibenclamid
potassium
channel
open
isol
guinea
pig
pulmonari
arteri
et
al
use
circular
segment
proxim
part
main
pulmonari
arteri
guinea
pig
studi
contractil
relax
effect
adenosin
receptor
pikker
hugh
examin
effect
hydrochlorothiazid
intracellular
calcium
concentr
ca
tone
guinea
pig
mesenter
arteri
vessel
mount
microvascular
myograph
load
ca
sensit
fluoresc
dye
nishimura
et
al
use
isol
aorta
ring
syrian
hamster
contractil
respons
record
isometr
transduc
tse
bad
homburg
germani
store
tse
data
acquisit
softwar
meisheri
et
al
recommend
use
isol
rabbit
mesenteri
arteri
sensit
vitro
function
assay
detect
k
channeldepend
vasodil
mironneau
gargouil
studi
influenc
electrophysiolog
mechan
paramet
longitudin
smooth
muscl
strip
isol
rabbit
portal
vein
mean
doubl
sucros
gap
method
associ
photoelectr
devic
record
contract
lauth
et
al
perform
superfus
assay
rabbit
jugular
vein
four
venou
ring
segment
mm
long
test
simultan
mount
forc
transduc
rigid
support
measur
isometr
forc
increas
dose
bradykinin
appli
bolu
inject
ensu
constrictor
respons
monitor
aid
pcoper
analysi
system
biosi
tse
bad
homburg
germani
mcbean
et
al
mcbean
et
al
use
isol
segment
arteria
basilari
pig
detect
compound
antivasoconstrict
properti
contract
elicit
pgf
serotonin
norepinephrin
specimen
obtain
adult
pig
strain
deutsch
landrass
within
min
slaughter
local
slaughter
hous
store
nutrit
solut
vessel
trim
length
mm
segment
suspend
lshape
metal
hook
bath
contain
ml
modifi
kreb
henseleit
solut
nacl
mm
kcl
mm
cacl
mm
nahco
mm
glucos
mm
bath
solut
maintain
continu
gass
carbogen
produc
result
ph
prepar
incub
tension
mn
optim
passiv
load
produc
largest
contractil
respons
pgf
follow
minut
stabil
period
vessel
sensit
mm
kcl
min
vessel
wash
minut
allow
recov
min
addit
minut
wash
min
thereaft
contract
vessel
induc
ad
pgf
contractil
respons
allow
plateau
test
compound
administ
cumul
dose
test
compound
doserespons
curv
record
ec
obtain
graphic
mean
hill
plot
ec
defin
dose
drug
produc
half
maxim
respons
werner
et
al
studi
vascular
select
calcium
antagonist
use
porcin
isol
ventricular
trabecula
right
coronari
arteri
merkel
et
al
use
isol
porcin
coronari
arteri
ring
precontract
prostaglandin
f
demonstr
vasorelax
activ
adenosin
agonist
miwa
et
al
compar
effect
k
channel
open
cromakalim
nitroglycerin
nifedipin
contract
porcin
coronari
arteri
satoh
et
al
investig
isol
porcin
larg
coronari
arteri
whether
vasorelax
action
nicorandil
cromakalim
would
select
use
seven
differ
vasoconstrictor
agonist
yokoyama
et
al
studi
vasodil
mechan
sever
pyridinecarboximidamid
deriv
isol
porcin
coronari
arteri
makujina
et
al
describ
procedur
facilit
evers
vascular
smooth
muscl
vascular
segment
porcin
coronari
arteri
approxim
cm
length
sutur
portion
polyethylen
tube
insert
lumen
vessel
secur
stabil
tube
vessel
evert
immers
physiolog
buffer
intracellular
calcium
concentr
measur
fluorometri
tension
regist
simultan
evert
ring
denud
endothelium
izumi
et
al
test
k
channel
open
relat
compound
isol
porcin
coronari
arteri
contract
mm
kcl
et
al
describ
imped
planimetri
new
catheterbas
techniqu
measur
porcin
coronari
arteri
pharmacodynam
compar
result
commonli
use
wiremount
isometr
tension
techniqu
vitro
applic
nifedipin
variou
concentr
fourelectrod
imped
measur
system
locat
insid
long
balloon
introduc
cm
long
segment
left
anterior
descend
coronari
arteri
obtain
danish
landraceyorkshir
pig
hamel
et
al
dissect
segment
mm
long
tempor
ramif
middl
cerebr
arteri
bovin
brain
mount
two
lshape
metal
prong
tissu
bath
contain
krebsring
solut
chang
muscl
tension
measur
forc
displac
transduc
record
polygraph
sever
receptor
agonist
test
abil
induc
vasoconstrict
potenc
compar
author
conclud
bovin
pial
arteri
appear
best
avail
model
human
cerebrovascular
receptor
de
la
land
et
al
use
isol
segment
proxim
mm
id
distal
mm
id
bovin
coronari
arteri
found
heterogen
respons
glyceryl
trinitr
isol
human
coronari
arteri
use
studi
vasoconstrict
acut
act
antimigrain
drug
saxena
et
al
saxena
et
al
b
isol
guinea
pig
uret
show
phasicrhythm
contract
addit
kcl
organ
bath
inhibit
effect
explain
modul
potassium
channel
male
unfast
guinea
pig
weigh
g
sacrif
uret
remov
immedi
without
part
directli
connect
pelvi
order
exclud
pacemak
region
respons
spontan
activ
segment
cm
length
place
petri
dish
contain
tyrod
solut
freed
surround
connect
tissu
suspend
baselin
tension
p
ml
organ
bath
contain
tyrod
solut
aerat
co
ph
contract
measur
isometr
use
gouldstatham
uc
transduc
min
equilibr
period
kcl
ad
bath
final
concentr
moll
left
bath
min
kcl
induc
constant
seri
phasicrhythm
contract
without
rise
baselin
tone
subsequ
wash
caus
immedi
disappear
rhythmic
contract
addit
kcl
repeat
valu
two
experi
use
initi
valu
antagonist
activ
studi
addit
test
drug
one
min
prior
kcl
challeng
percentag
follow
paramet
determin
mean
height
contract
frequenc
contract
product
mean
height
frequenc
contract
interact
studi
potassium
channel
blocker
glibenclamid
moll
ad
min
prior
test
drug
arithmet
mean
standard
deviat
data
calcul
compar
initi
valu
use
student
ttest
isol
guinea
pig
uret
stimul
kcl
use
studi
modul
potassium
channel
yoshida
kuga
record
electr
activ
prepar
consist
pelvic
region
upper
uret
guinea
pig
train
field
stimul
pelvic
region
evok
train
nerv
action
potenti
follow
multiphas
smooth
muscl
action
potenti
latenc
smooth
muscl
respons
abolish
tetrodotoxin
dibucain
also
cholinerg
block
agent
effect
veratridin
yohimbin
efflux
norepinephrin
electr
stimul
guinea
pig
uret
studi
kalsner
maggi
giuliani
studi
excit
refractori
period
guinea
pig
uret
electr
field
stimul
roza
laird
laird
cervero
studi
pressor
respons
distens
uret
anesthet
rat
model
acut
viscer
pain
simpl
method
measur
ureter
peristalt
function
vivo
anesthet
rat
publish
kontani
et
al
isol
corpu
cavernosum
rabbit
gain
interest
pharmacolog
model
sinc
select
inhibitor
cyclic
guanosin
monophosph
cgmp
phosphodiesteras
type
found
effect
treatment
erectil
dysfunct
man
ballard
et
al
jeremi
et
al
chuang
et
al
liu
et
al
turko
et
al
walli
walli
et
al
stief
aydin
et
al
thompson
et
al
lin
et
al
male
new
zealand
white
rabbit
weigh
kg
sedat
intramuscular
inject
mgkg
mgkg
xylazin
anesthesia
maintain
intraven
inject
mgkg
nembut
peni
remov
level
attach
corpor
bodi
ischium
corpu
cavernosum
total
length
mm
sharpli
dissect
tunica
albuginea
two
longitudin
strip
unstretch
length
mm
made
proxim
muscular
portion
corpor
strip
place
organ
bath
contain
ml
tyrod
buffer
nacl
mmoll
kcl
mmoll
mgcl
mmoll
nah
po
h
mmoll
cacl
mmoll
glucos
tissu
equilibr
mixtur
co
ph
one
end
strip
connect
forc
displac
transduc
chang
muscl
tension
measur
record
polygraph
zero
balanc
transduc
strip
chart
g
tension
place
strip
strip
allow
equilibr
min
strip
prestimul
phenylephrin
relax
electr
field
stimul
squar
wave
puls
v
ms
durat
hz
frequenc
sodium
nitroprussid
ad
ad
donor
final
standard
sildenafil
nm
test
compound
ad
dosedepend
increas
relax
test
compound
standard
measur
doserespons
curv
activ
ratio
calcul
walli
et
al
studi
inhibit
human
phosphodiesteras
sildenafil
variou
tissu
cardiac
ventricl
corpu
cavernosum
skelet
muscl
retina
park
et
al
report
function
character
angiotensin
ii
receptor
rabbit
corpu
cavernosum
yildirim
et
al
investig
effect
castrat
testosteron
constrict
effect
phenylephrin
endotheliumdepend
andindepend
relax
effect
differ
agonist
corpu
cavernosum
male
rabbit
liu
et
al
analyz
pharmacolog
effect
vitro
ischemia
rabbit
corpu
cavernosum
found
activ
g
icoupl
postsynapt
adrenoceptor
caus
contract
smooth
muscl
corpu
cavernosum
rabbit
teixeira
et
al
use
bioassay
cascad
studi
effect
tityu
serrulatu
scorpion
venom
rabbit
isol
corpu
cavernosum
cellec
moncada
use
clitor
corpu
cavernosum
femal
rabbit
studi
role
nitrerg
neurotransmiss
nonadrenerg
noncholinerg
relax
respons
isol
corpu
cavernosum
rat
use
tong
cheng
gemalmaz
et
al
wingard
et
al
mice
gocmen
et
al
mizusawa
et
al
dog
hayashida
et
al
comit
et
al
monkey
okamura
et
al
hors
recio
et
al
studi
isol
human
corpu
cavernosum
perform
holmquist
et
al
bush
et
al
rajfer
et
al
cellek
moncada
ballard
et
al
omot
walli
et
al
lin
et
al
stief
et
al
vivostudi
measur
intracavern
pressur
rat
perform
ari
et
al
chan
et
al
vivo
studi
penil
erect
perform
cat
intracavern
pressur
measur
vivo
anesthet
dog
ayajiki
et
al
sarikaya
et
al
carter
et
al
noto
et
al
bischoff
schneider
decrib
simpl
quantit
model
studi
agent
influenc
penil
erect
consciou
rabbit
erect
assess
measur
length
uncov
mucosa
intraven
administr
agent
anmal
requir
anesthesia
cours
studi
test
use
detect
effect
compound
blood
pressur
heart
rate
anesthet
rat
check
possibl
interfer
adrenerg
receptor
antihypertens
agent
differ
mechan
action
detect
test
male
spraguedawley
rat
weigh
g
use
least
anim
necessari
screen
one
compound
rat
anesthet
intraperiton
inject
mlkg
solut
urethan
chloralos
trachea
cannul
facilit
spontan
respir
bodi
temperatur
maintain
place
anim
heat
pad
left
femor
vein
cannul
drug
administr
standard
inject
g
bodi
weight
period
min
measur
hemodynam
paramet
intraarteri
administr
test
compound
cannula
insert
retrograd
right
carotid
arteri
tip
cathet
posit
close
origin
subclavian
arteri
allow
inject
substanc
reach
cn
via
vertebr
arteri
go
gener
circul
continu
monitor
blood
pressur
systol
diastol
pressur
heart
rate
cathet
connect
pressur
transduc
statham
db
stabl
hemodynam
condit
achiev
least
min
control
valu
test
boli
adrenalin
mgkg
isoprenalin
mgkg
administ
baselin
valu
establish
increas
dose
test
substanc
mgkg
given
intraarteri
case
effect
interv
success
dose
min
otherwis
min
check
activ
adrenalin
isoprenalin
administr
repeat
inject
highest
dose
test
compound
test
compound
show
effect
standard
antihypertens
compound
administ
control
purpos
hemodynam
paramet
record
continu
whole
experi
chang
blood
pressur
heart
rate
drug
administr
compar
control
valu
obtain
min
predrug
period
maxim
chang
bp
hr
durat
effect
report
result
score
rel
efficaci
standard
compound
degre
effect
durat
effect
statist
signific
test
small
number
anim
use
n
sometim
larger
number
anim
use
quantit
evalu
due
administr
test
compound
via
right
common
carotid
arteri
peripher
act
vasodil
neuron
blocker
also
compound
affect
blood
pressur
regul
mechan
cn
detect
bolu
inject
adrenalin
isoprenalin
reveal
possibl
effect
standard
data
follow
compound
dose
indic
lead
strong
decreas
blood
pressur
clonidin
mgkg
dihydralazin
mgkg
phentolamin
mgkg
prazosin
mgkg
propranolol
mgkg
urapidil
mgkg
verapamil
mgkg
sever
author
mervaala
et
al
wallerath
et
al
rothermund
et
al
baltatu
et
al
monitor
arteri
pressur
heart
rate
use
pressur
transduc
system
continu
record
computerbas
registr
system
tse
bad
homburg
germani
procedur
differenti
intraarteri
pressur
record
differ
arteri
rat
describ
pang
chan
dewildt
sangster
describ
evalu
deriv
aortic
flow
paramet
measur
mean
electromagnet
flowmetri
indic
myocardi
contractil
anesthet
rat
use
special
millar
ultraminiatur
cathet
pressur
transduc
thermodilut
microprob
zimmer
et
al
zimmer
et
al
measur
right
ventricular
function
paramet
anesthet
closedchest
rat
veelken
et
al
publish
improv
method
baroreceptor
investig
chronic
instrument
rat
salgado
krieger
de
abreu
salgado
da
silva
et
al
studi
function
thebaroreceptor
reflex
thiopent
anesthet
rat
left
aortic
nerv
isol
support
bipolar
stainless
steel
electrod
care
insul
silicon
rubber
carotid
pressur
record
simultan
aortic
nerv
discharg
oscilloscop
monitor
loudspeak
king
et
al
develop
cross
circul
techniqu
rat
distinguish
central
peripher
cardiovascular
action
drug
right
common
carotid
arteri
ligat
left
common
carotid
arteri
left
right
extern
jugular
vein
two
phenobarbitalanesthet
rat
connect
polyethylen
tube
peripher
blood
one
rat
suppli
head
anoth
rat
b
return
bodi
vice
versa
peripher
blood
rat
b
rat
artifici
ventil
chest
open
subclavian
arteri
ligat
prior
ligat
subclavian
arteri
blood
flow
rat
suppli
brain
brain
hemispher
brain
stem
rat
b
follow
subclavian
arteri
ligat
blood
flow
rat
suppli
brain
suppli
hemispher
brain
stem
rat
b
head
rat
therefor
render
depend
carotid
arteri
blood
suppli
anoth
rat
rat
crosscircul
prepar
use
separ
central
peripher
cardiovascular
action
drug
zavisca
et
al
studi
hypertens
respons
defin
electr
mechan
stimuli
anesthet
rat
rat
given
etomid
mgkgh
intraven
follow
carotid
arteri
jugular
vein
cannul
min
begin
infus
type
noxiou
stimuli
administ
sequenti
interv
type
squar
electr
wave
cp
ms
durat
vari
current
type
singl
electr
stimulu
train
durat
type
tail
clamp
type
skin
incis
stimulu
maximum
chang
systol
blood
pressur
measur
grade
electr
stimul
allow
best
quantit
evalu
hypertens
respons
noxiou
stimuli
hyman
et
al
describ
novel
catheter
techniqu
vivo
measur
pulmonari
vascular
respons
rat
male
charl
river
rat
weigh
g
anesthet
strap
supin
posit
fluoroscop
tabl
breath
air
enrich
oxygen
endotrach
tube
insert
tracheostomi
cathet
insert
femor
blood
vessel
venou
cathet
pass
right
atrium
fluoroscopi
thermistor
cathet
pass
left
carotid
arteri
ascend
aorta
fluoroscopi
plastic
cathet
special
construct
curv
tip
pass
fluoroscop
left
jugular
vein
main
pulmonari
arteri
plastic
radiopaqu
cathet
mm
length
curv
tip
pass
mm
softtip
coronari
guid
cathet
right
jugular
vein
right
atrium
inferior
vena
cava
coronari
softtip
guid
withdrawn
special
curv
transsept
needl
mm
diamet
pass
though
cathet
needl
cathet
withdrawn
superior
portion
right
atrium
fluoroscop
guidanc
needl
cathet
rotat
freeli
rat
slight
left
anterior
obliqu
posit
cathet
needl
care
rotat
anteriorli
intraatri
septum
gentl
pressur
cathet
needl
felt
seen
fluoroscop
pass
atrial
septum
needl
withdrawn
curv
cathet
permit
passag
tip
vein
drain
either
left
right
lower
lobe
cathet
care
posit
near
pulmonari
venoatri
junction
fix
place
mean
pressur
femor
arteri
pulmonari
arteri
pulmonari
vein
venoatri
junction
measur
pressur
transduc
record
polygraph
cardiac
output
obtain
triplic
deliv
ml
normal
salin
room
temperatur
femor
venou
cathet
right
venoatri
junction
determin
thermodilut
cardiac
output
thermistor
cathet
ascend
aorta
hay
describ
techniqu
determin
contractil
intraventricular
pressur
heart
rate
anesthet
guinea
pig
insert
needl
attach
pressur
transduc
chest
wall
left
ventricl
william
et
al
use
castrat
male
ferret
anesthet
intramuscular
inject
mixtur
mgkg
ketamin
mgkg
xylazin
measur
effect
nonpeptidyl
endothelin
antagonist
endothelininduc
pressor
respons
pith
rat
propos
assess
pressor
substanc
shipley
tilden
prepar
frequent
use
evalu
drug
action
cardiovascular
system
sinc
prepar
devoid
neurogen
reflex
control
may
otherwis
modul
primari
drug
effect
male
rat
weigh
g
prepar
pith
halothan
anesthesia
left
carotid
arteri
cannul
blood
pressur
monitor
blood
sampl
furthermor
trachea
right
jugular
vein
cannul
rat
pith
insert
steel
rod
mm
diamet
cm
length
orbit
foramen
magnum
whole
length
spinal
canal
via
tracheotomi
tube
anim
ventil
small
anim
ventil
pump
inspir
air
oxygenenrich
provid
flow
oxygen
across
tpiec
attach
air
intak
ventil
pump
harvard
apparatu
model
rat
ventil
frequenc
cyclesmin
tidal
volum
bodi
weight
thirti
min
pith
ml
blood
sampl
withdrawn
carotid
cannula
immedi
analyz
po
pco
ph
deriv
bicarbon
concentr
use
automat
blood
ga
analyz
alter
respiratori
stroke
volum
pump
valu
adjust
pco
mm
hg
ph
po
mm
hg
continu
registr
blood
pressur
cardiac
frequenc
hellig
devic
statham
p
db
transduc
perform
via
left
carotid
arteri
order
measur
antagon
first
doserespons
curv
regist
use
dose
iv
phenylephrin
select
agonist
iv
bht
select
agonist
test
drug
administ
intraven
agonist
doserespons
curv
repeat
min
later
curv
blood
pressur
respons
agonist
shift
doserespons
curv
plot
logarithm
probit
scale
potenc
ratio
calcul
gillespi
muir
describ
method
stimul
complet
sympathet
outflow
spinal
cord
blood
vessel
pith
rat
coat
part
pith
rod
lay
sacral
cervic
region
spinal
cord
highresist
varnish
restrict
stimul
thoracolumbar
region
steel
rod
insul
adhes
throughout
length
except
cm
section
provid
suffici
stimul
area
lower
thoracolumbar
nerv
stimul
nerv
fiber
suppli
exclus
heart
pith
rod
use
insul
throughout
length
except
cm
section
cm
proxim
tip
spinal
cord
stimul
electr
use
pith
rod
cathod
hypoderm
needl
insert
skin
near
right
hindlimb
anod
vari
intens
andor
durat
stimul
doserespons
curv
regist
alter
treatment
drug
curti
et
al
describ
improv
pith
rat
method
mount
prepar
vertic
head
point
downward
result
consider
higher
blood
pressur
heart
rate
maclean
hiley
studi
effect
artifici
respiratori
volum
cardiovascular
respons
adrenoceptor
agonist
airventil
pith
rat
use
microspher
techniqu
analysi
arteri
blood
gase
ph
trolin
use
decerebr
rat
studi
clonidineinduc
circulatori
chang
balt
et
al
compar
angiotensin
ii
type
receptor
blocker
losartan
irbesartan
telmirsatan
ace
inhibitor
captopril
inhibit
angiotensiniiinduc
facilit
sympathet
neurotransmiss
pith
rat
method
use
demonstr
direct
vasodil
activ
potenti
antihypertens
agent
experiment
model
anesthet
ganglionblock
rat
whose
blood
pressur
maintain
intraven
infus
angiotensin
ii
test
allow
differenti
central
act
antihypertens
peripher
vasodil
male
wistar
rat
weigh
g
anesthet
combin
urethan
mgkg
chloralos
mgkg
administ
intraperiton
volum
mlkg
follow
induct
anesthesia
chlorisondamin
mgkg
inject
periton
caviti
abolish
sympathet
parasympathet
nerv
activ
right
femor
arteri
cannul
monitor
blood
pressur
statham
pressur
transduc
heart
rate
femor
vein
cannul
administ
drug
infus
angiotensin
ii
trachea
intub
anim
allow
breath
spontan
follow
stabil
interv
min
angiotensin
ii
infus
rate
volum
equival
mlmin
harvard
infus
pump
increas
blood
pressur
new
elev
steadyst
pressur
establish
within
min
drug
subsequ
inject
intraven
interv
min
volum
mlkg
mean
arteri
pressur
record
polygraph
min
initi
drug
administr
seven
anim
use
drug
dose
level
studi
blockad
determin
ganglionblock
rat
pressor
respons
grade
dose
phenylephrin
inject
intraven
obtain
min
administr
test
compound
suffici
concentr
phenylephrin
given
ensur
rise
mean
arteri
blood
pressur
mm
hg
data
obtain
anim
averag
result
doserespons
curv
plot
dose
phenylephrin
requir
elicit
mm
hg
increas
mean
arteri
blood
pressur
interpol
dose
respons
curv
standard
data
follow
compound
use
standard
dose
indic
lower
mean
arteri
blood
pressur
mm
hg
mean
valu
sem
given
mean
arteri
blood
pressur
heart
rate
chang
paramet
drug
administr
compar
control
valu
obtain
immedi
applic
test
compound
statist
signific
assess
mean
pair
ttest
hypotens
respons
model
appear
correl
close
antihypertens
activ
docasalt
hypertens
rat
vasodil
respons
perfus
hind
limb
anesthet
dog
allow
distinct
central
antihypertens
vasodil
santajuliana
et
al
develop
standard
ganglion
blockad
protocol
assess
neurogen
pressor
activ
consciou
rat
rat
instrument
arteri
venou
cathet
measur
arteri
pressur
heart
rate
administr
three
differ
ganglion
blocker
trimethaphan
hexamethonium
chlorisondamin
rat
spontan
experiment
induc
hypertens
wide
use
screen
potenti
antihypertens
compound
indirect
tail
cuff
method
allow
determin
systol
blood
pressur
accord
follow
principl
cuff
quickli
inflat
well
suspect
systol
blood
pressur
puls
obliter
thereaft
pressur
cuff
slowli
releas
pressur
fall
systol
blood
pressur
puls
reappear
method
analog
sphygmomanometri
human
appli
tail
awak
rat
also
dog
small
primat
indirect
tail
cuff
method
wide
use
evalu
influenc
antihypertens
drug
spontan
experiment
hypertens
rat
male
spontan
hypertens
rat
charl
river
weigh
g
rat
experiment
induc
hypertens
use
male
spraguedawley
rat
weigh
g
anesthet
intraperiton
inject
ml
chloralhydr
solut
kidney
expos
retroperiton
induc
renal
hypertens
silver
clip
mm
diamet
mm
length
place
onto
renal
arteri
kidney
repos
wound
close
sutur
within
week
oper
anim
attain
renal
hypertens
systol
blood
pressur
bp
mm
hg
mean
normal
physiolog
bp
rat
mm
hg
anim
bp
mm
hg
use
test
procedur
spontan
experiment
hypertens
rat
group
anim
use
per
dose
control
group
receiv
salin
reduc
spontan
variat
blood
pressur
anim
adjust
experiment
cage
bring
restrain
cage
enclos
measur
chamber
time
start
experi
period
min
measur
blood
pressur
tubular
inflat
cuff
place
around
base
tail
piezoelectr
puls
detector
posit
distal
cuff
cuff
inflat
approxim
mm
hg
pressur
cuff
slowli
releas
systol
pressur
detect
subsequ
record
polygraph
test
substanc
administ
intraperiton
gavag
per
day
period
day
usual
screen
dose
new
compound
mgkg
blood
pressur
heart
rate
measur
taken
follow
time
day
predos
h
postdrug
day
predos
h
postdrug
day
predos
h
postdrug
h
postdrug
measur
anim
return
home
cage
standard
compound
endralazin
score
decreas
systol
blood
pressur
durat
effect
allot
indirect
tailcuff
method
use
mani
laboratori
mani
modif
devic
pfeffer
et
al
found
good
correl
valu
obtain
indirect
tailcuff
method
valu
measur
directli
indwel
carotid
arteri
cannula
wherea
et
al
report
lack
correl
direct
indirect
measur
arteri
pressur
unanesthet
rat
patten
engen
found
difficulti
measur
accur
systol
valu
higher
blood
pressur
good
correl
direct
blood
pressur
data
carotid
arteri
rat
read
tail
cuff
method
found
matsuda
et
al
develop
sixchannel
automat
blood
pressur
measur
apparatu
highli
sensit
photoelectr
sensor
detect
tail
arteri
blood
flow
microcomput
system
automat
measur
systol
blood
pressur
heart
rate
data
acquisit
process
detail
tailcuff
method
rat
discuss
stanton
special
equip
measur
blood
pressur
rat
commerci
avail
e
g
tse
gmbh
bad
homburg
germani
widdop
li
describ
simpl
versatil
method
measur
tail
cuff
systol
blood
pressur
consciou
rat
tail
cuff
consist
metal
tpiec
tube
latex
rubber
insid
tube
place
around
tail
proxim
end
piezoelectr
transduc
model
strap
ventral
surfac
tail
record
puls
signal
caudal
arteri
connect
directli
maclab
dataacquisit
system
adinstru
pti
ltd
tailcuff
method
measur
blood
pressur
adapt
dog
monkey
wiester
ilti
cat
mahoney
brodi
blood
pressur
measur
hind
leg
rat
use
leg
cuff
photoelectr
cell
situat
dorsal
surfac
foot
kersten
et
al
leg
occlud
foot
swell
amount
light
strike
photocel
reduc
pressur
cuff
releas
arteri
blood
flow
restor
increas
foot
volum
decreas
amount
light
transvers
paw
increas
method
first
describ
week
allow
direct
measur
arteri
pressur
consciou
rat
elimin
influenc
anesthesia
cardiovascular
regul
order
prepar
cannula
cm
cm
long
piec
cut
pe
pe
tube
respect
stylet
wire
insert
pe
tube
pe
tube
also
slip
stylet
wire
end
tube
heat
current
hot
air
fuse
togeth
ridg
made
anchor
cannula
anim
tissu
order
make
ridg
stylet
wire
left
insid
cannula
cannula
heat
fine
jet
hot
air
polyethylen
point
heat
becom
soft
cannula
press
slightli
thu
ridg
form
one
ridg
form
pe
tube
cm
away
junction
pe
tube
ridg
form
pe
tube
distanc
cm
first
one
situat
cm
away
free
end
pe
tube
stylet
wire
remov
cannula
pe
portion
cannula
near
junction
pe
tube
wound
around
glass
rod
diamet
mm
two
round
made
dip
boil
water
bath
taken
bath
cannula
retain
circl
form
springlik
structur
male
spraguedawley
rat
weigh
g
use
rat
anesthet
mgkg
pentobarbit
ip
area
neck
abdomen
shave
clean
alcohol
viscera
expos
midlin
abdomin
incis
segment
abdomin
aorta
expos
bifurc
trocar
pass
psoa
muscl
adjac
segment
aorta
muscl
back
skin
emerg
skin
neck
cannula
insert
trocar
trocar
withdrawn
bodi
end
cannula
thu
come
neck
anchor
silk
sutur
neck
skin
psoa
muscl
cannula
fill
heparin
solut
end
project
neck
skin
block
tight
fit
stainless
steel
needl
end
cannula
implant
aorta
aorta
wipe
cottontip
applic
stick
bifurc
occlud
segment
punctur
bent
gaug
hypoderm
needl
tip
pe
cathet
insert
needl
advanc
aorta
intestin
replac
wound
sutur
rat
allow
recov
one
week
occlud
stainless
steel
needl
remov
cannula
flush
dilut
heparin
solut
rat
place
small
cage
restrict
movement
even
free
move
cannula
connect
statham
p
db
pressur
transduc
blood
pressur
record
polygraph
test
drug
standard
administ
either
subcutan
oral
record
taken
administr
drug
period
h
chang
blood
pressur
measur
degre
durat
five
rat
use
dose
compound
maxim
chang
group
averag
compar
standard
direct
measur
arteri
blood
pressur
unanesthet
rat
origin
introduc
week
becom
valuabl
wide
use
tool
cardiovascular
research
detail
descript
slightli
modifi
week
method
given
stanton
improv
method
continu
direct
record
arteri
blood
pressur
heart
rate
rat
describ
et
al
laffan
et
al
buckingham
garthoff
towart
garthoff
detail
descript
perman
cannul
iliolumbar
arteri
given
remi
et
al
wixson
et
al
describ
techniqu
chronic
catheter
carotid
arteri
rat
prepar
cannula
commerci
avail
irc
life
scienc
woodland
hill
ca
newer
modif
use
access
aorta
via
common
carotid
arteri
linz
et
al
rat
prepar
thiopent
anesthesia
arteri
line
intramed
clay
adam
usa
line
introduc
ascend
aorta
via
right
carotid
arteri
direct
measur
arteri
blood
pressur
jugular
vein
iv
applic
test
compound
line
fill
salin
contain
heparin
surfac
neck
anim
allow
recov
least
day
blood
pressur
monitor
statham
r
db
transduc
connect
record
devic
measur
line
kept
open
counter
current
salin
infus
rate
mlh
bao
et
al
place
one
cathet
via
right
femor
arteri
abdomin
aorta
rat
record
mean
arteri
pressur
two
addit
cathet
via
left
carotid
arteri
descend
aorta
applic
bradykinin
bradykinin
antagonist
arteri
pressur
record
unanesthet
rat
induct
sever
hypertens
complet
ligat
aorta
origin
renal
arteri
sweet
columbo
hilditch
et
al
describ
devic
direct
record
blood
pressur
consciou
dog
akrawi
wiedlund
describ
method
chronic
portal
vein
infus
unrestrain
rat
hepat
drug
metabol
studi
infus
portal
vein
blood
collect
femor
vein
robineau
describ
method
record
electrocardiogram
consciou
unrestrain
rat
electrod
implant
subcutan
socket
connector
sutur
head
anim
flexibl
cord
lead
swivel
collector
link
ecg
amplifi
kurowski
et
al
report
improv
method
implant
maintain
protect
arteri
venou
cathet
consciou
rat
extend
period
time
schenk
et
al
measur
cardiac
left
ventricular
pressur
consciou
rat
use
fluidfil
cathet
tsui
et
al
recommend
reliabl
techniqu
chronic
carotid
arteri
catheter
rat
et
al
describ
tailarteri
cannul
method
studi
blood
paramet
freeli
move
rat
liebmann
et
al
describ
vivo
longterm
perfus
system
base
autom
computercontrol
highfrequ
heparin
uml
flush
cannula
insert
tail
arteri
freeli
move
rat
santajuliana
et
al
use
consciou
rat
instrument
arteri
venou
cathet
assess
neurogen
pressor
activ
administr
ganglion
blocker
rezek
havlicek
describ
simpl
cannula
system
infus
experiment
substanc
chronic
unrestrain
anim
cannula
remov
cap
use
infus
variou
part
digest
tract
intraven
infus
perform
close
system
cannula
avoid
possibl
introduct
air
circul
kimura
et
al
describ
method
chronic
portal
venou
aortic
gastric
cannul
determin
portal
venou
aortic
glucos
lactat
level
consciou
rat
perman
cannul
jugular
vein
rat
combin
head
attach
apparatu
allow
easi
connect
cannula
first
introduc
steffen
modif
describ
brown
hege
nicolaidi
et
al
don
havlik
detail
descript
given
remi
et
al
rat
anesthet
n
halothan
shaven
neck
anim
right
side
disinfect
chlorhexidin
solut
incis
made
right
clavicl
connect
adipos
tissu
push
asid
blunt
forcep
jugular
vein
expos
extern
jugular
vein
follow
divis
maxillari
vein
facial
linguofaci
vein
identifi
largest
vein
chosen
mobil
distanc
mm
small
arteri
forcep
use
clamp
vessel
vein
ligat
rostral
clamp
silk
second
ligatur
put
loos
around
vessel
tighten
use
iridectomi
scissor
vshape
hole
cut
vein
mm
rostral
bifurc
prior
insert
vessel
steril
cannula
connect
ml
syring
fill
heparin
salin
solut
vessel
dilat
mean
sharp
point
jewel
forcep
cannula
slit
leg
forcep
gentli
push
vessel
tip
level
right
atrium
forcep
remov
caudal
ligatur
gentli
tie
rostral
ligatur
use
anchor
cannula
vessel
cannula
tunnel
emerg
top
head
skin
neck
held
firmli
arteri
forcep
insert
subcutan
caudal
direct
distanc
cm
turn
anticlockwis
direct
incis
neck
cannula
grasp
forcep
forcep
pull
back
cannula
emerg
crown
head
close
small
microvascular
clamp
cannula
slid
short
end
stainless
steel
needl
bent
cathet
flush
salin
fill
polyethyleneheparin
solut
long
end
lshape
stainless
steel
adapt
close
piec
heatseal
petub
wound
close
sutur
hutchaleelaha
et
al
describ
simpl
apparatu
serial
blood
sampl
extern
jugular
vein
permit
simultan
measur
locomotor
activ
freeli
move
rat
brown
mr
hedg
ga
thyroid
secret
unanesthet
stressfre
rat
suppress
pentobarbit
detail
descript
perman
cannul
renal
vein
rat
given
remi
et
al
rat
anesthet
n
halothan
open
abdomin
wall
intestin
lift
laid
next
anim
right
side
view
surgeon
gauz
moisten
warm
salin
solut
provid
excel
view
vena
cava
confluenc
vena
cava
right
renal
vein
strip
adipos
tissu
peritoneum
open
use
small
anatom
forcep
peritoneum
detach
vena
cava
make
small
spread
movement
forcep
beneath
peritoneum
subsequ
vena
cava
renal
vein
mobil
approxim
cm
allow
clamp
vessel
four
five
finestitch
pursestr
place
vessel
confluenc
vena
cava
right
renal
vein
use
barraqu
needl
holder
cottonwool
stick
silk
sutur
arm
needl
guid
vessel
stitch
bleed
immedi
arrest
appli
light
pressur
use
cottonwool
stick
complet
sutur
singl
knot
made
drawstr
three
microvascular
clip
place
vena
cava
renal
vein
first
proxim
clip
vena
cava
follow
clip
renal
vein
final
distal
vena
cava
clip
small
apertur
cut
immedi
insid
pursestr
sutur
use
iridectomi
scissor
jewel
forcep
cannula
fill
heparin
salin
solut
push
open
far
possibl
subsequ
pursestr
sutur
pull
taut
clip
renal
vein
remov
push
cannula
proxim
clip
vena
cava
remov
quickli
possibl
patenc
cannula
check
drawstr
pursestr
sutur
use
anchor
cannula
cannula
laid
kinkfre
abdomin
caviti
sutur
intern
abdomin
caviti
near
xiphoid
cartilag
abdomen
close
two
layer
cannula
tunnel
top
head
cannula
togeth
lshape
adapt
fix
skull
remi
et
al
addit
applic
platinum
electrod
around
portal
vein
close
proxim
cathet
tip
model
also
use
studi
presynapt
regul
neurotransmitt
releas
nonadrenerg
nerv
termin
remi
zaagsma
remi
et
al
remi
et
al
rat
anesthet
n
halothan
open
abdomin
wall
intestin
lift
laid
next
anim
right
side
view
surgeon
gauz
moisten
warm
salin
solut
use
micro
needl
holder
cottonwool
stick
four
five
fine
stitch
pursestr
sutur
silk
sutur
arm
needl
place
wall
portal
vein
side
opposit
gastroduoden
vein
diamet
pursestr
mm
sutur
complet
singl
knot
made
drawstr
portal
vein
clamp
small
curv
hemostat
bulldog
clamp
use
iridectomi
scissor
pair
jewel
forcep
center
pursestr
cut
cannula
fill
heparin
salin
insert
vessel
push
upward
pursestr
gentli
tighten
take
care
obstruct
cannula
drawstr
sutur
use
anchor
cannula
cannula
laid
kinkfre
abdomin
caviti
sutur
intern
abdomin
caviti
near
xiphoid
cartilag
abdomen
close
two
layer
cannula
tunnel
top
head
cannula
togeth
lshape
adapt
fix
skull
collect
lymph
rather
difficult
perform
mainli
dog
biedl
offer
gryaznova
gryaznova
vogel
techniqu
describ
rat
bollman
et
al
girardet
remi
et
al
obstruct
duct
place
pursestr
sutur
wall
duct
cannula
secur
anim
lymph
collect
experi
refil
cannula
lymph
flow
remain
undisturb
rat
anesthet
n
halothan
open
abdomin
caviti
intestin
place
gauz
moisten
warm
salin
laid
left
anim
supraren
abdomin
arteri
locat
mobil
gentli
tear
connect
tissu
use
blunt
dissect
techniqu
thorac
duct
mobil
along
dorsolater
surfac
aorta
small
three
four
fine
stitch
pursestr
sutur
place
wall
duct
use
ethilon
sutur
hole
cut
insid
pursestr
fine
pair
scissor
hold
wall
angl
jewel
forcep
cannula
fill
heparin
salin
solut
insert
duct
use
anatom
forcep
tip
cannula
insert
thorac
duct
curv
forcep
remov
total
tip
push
duct
ligatur
close
lymph
flow
cannula
cannula
secur
within
abdomin
caviti
attach
abdomin
muscl
near
xiphoid
cartilag
silk
sutur
follow
closur
abdomin
wall
tunnel
cannula
crown
head
lshape
adapt
place
cannula
fill
pvpsolut
close
heatseal
polyethylen
cap
russian
surgeon
eck
report
achiev
success
portacav
shunt
dog
lee
fischer
funov
et
al
de
boer
et
al
describ
portacav
shunt
rat
detail
descript
surgeri
portacav
anastomosi
rat
given
van
dongen
et
al
rat
anesthet
n
combin
either
enfluran
methoxyfluran
isofluran
open
abdomin
wall
intestin
place
left
anim
gauz
moisten
warm
salin
solut
proxim
distal
anim
right
renal
vein
vena
cava
strip
adipos
connect
tissu
retroperiton
caviti
open
use
anatom
forcep
peritoneum
dissect
vena
cava
make
small
spread
movement
forcep
vena
cava
portal
vein
pull
slightli
left
use
straight
anatom
forcep
freed
hepat
arteri
gastroduoden
arteri
curv
anatom
forcep
rostral
celiac
arteri
abdomin
arteri
cover
peritoneum
freed
later
muscl
bed
length
approxim
mm
provid
enough
space
place
small
bulldog
clamp
later
stage
oper
without
occlus
six
finestitch
pursestr
place
wall
vena
cava
close
confluenc
right
renal
vein
use
barraqu
needl
holder
cotton
wool
stick
silk
sutur
arm
needl
guid
vessel
stitch
bleed
arrest
immedi
appli
light
pressur
area
use
cotton
wool
stick
sutur
complet
singl
knot
made
drawstr
drawstr
come
togeth
rostral
part
pursestr
bulldog
clamp
modifi
resembl
satinski
vascular
clamp
place
vena
cava
clamp
abdomin
aorta
rostral
celiac
arteri
small
bulldog
clamp
ligatur
silk
place
around
portal
vein
close
possibl
hilu
liver
subsequ
clamp
place
aorta
ligatur
tighten
heifetz
clip
place
transvers
onto
portal
vein
confluenc
gastroduoden
vein
portal
vein
cut
distal
ligatur
prepar
button
slip
lefthand
straight
small
anatom
forcep
righthand
forcep
use
pass
portal
vein
lefthand
anatom
forcep
vein
grasp
pull
button
subsequ
button
push
close
possibl
heifetz
clip
clamp
clip
use
pill
bulldog
clamp
use
small
straight
curv
anatom
forcep
portal
vein
revers
around
button
fix
previous
prepar
silk
sutur
pill
bulldog
clamp
remov
replac
end
satinski
clamp
reason
stabil
vena
cava
somewhat
elev
bring
closer
contact
portal
vein
button
longitudin
cut
made
pursestr
sutur
use
iridectomi
scissor
jewel
forcep
one
drawstr
sutur
clamp
small
hemostat
put
slight
tension
rostral
direct
button
manipul
grip
push
vena
cava
pursestr
tighten
left
hand
whilst
right
hand
still
hold
button
posit
button
releas
two
addit
knot
tie
satinski
clamp
remov
first
follow
heifetz
clamp
bulldog
clamp
aorta
replac
intestin
abdomin
wall
close
two
layer
fulli
util
potenti
mous
model
specif
gene
mutat
necessari
studi
function
consequ
genet
manipul
fulli
intact
mice
lorenz
robbin
develop
valid
methodolog
studi
cardiovascular
paramet
closedchest
mice
adult
mice
either
sex
weigh
g
anesthet
intraperiton
inject
mgkg
ketamin
mgkg
thiobutabarbit
mice
place
thermal
control
surgic
tabl
bodi
temperatur
continu
monitor
via
rectal
probe
tracheotomi
perform
short
length
cm
tube
right
femor
arteri
cannul
polyethylen
tube
pull
flame
small
diamet
mm
od
cathet
advanc
cm
near
level
aorta
connect
directli
lowcompli
cobe
cdxiii
fixeddom
pressur
transduc
measur
arteri
blood
pressur
right
femor
vein
cannul
type
smalldiamet
tube
connect
microinject
pump
infus
experiment
drug
assess
myocardi
perform
right
carotid
arteri
cannul
millar
mikrotip
transduc
model
millar
instrument
houston
tx
highfidel
transduc
tip
diamet
mm
report
frequenc
respons
flat
hz
therefor
use
accur
monitor
high
frequenc
mous
ventricular
puls
pressur
continu
monitor
blood
pressur
wave
ascertain
anatom
posit
cathet
tip
transduc
care
advanc
ascend
aorta
left
ventricl
stabl
waveform
ventricular
pressur
profil
achiev
transduc
anchor
place
silk
sutur
complet
surgeri
wound
close
cyanoacryl
minim
evapor
loss
fluid
anim
allow
stabil
min
blood
pressur
signal
cobe
transduc
millar
transduc
amplifi
output
record
analyz
maclab
data
acquisit
system
connect
macintosh
comput
allow
calcul
follow
paramet
dpdt
first
deriv
ventricular
pressur
wave
map
mean
arteri
pressur
hr
heart
rate
lvp
systol
diastol
left
ventricular
pressur
lvedp
left
ventricular
enddiastol
pressur
indic
ventricular
perform
calcul
dpdt
champion
et
al
describ
rightheart
catheter
techniqu
vivo
measur
vascular
respons
lung
intact
mice
mice
weigh
g
anesthet
thiopentobarbit
mgkg
ip
ketamin
mgkg
ip
strap
supin
posit
thermoregul
fluoroscop
tabl
trachea
cannul
anim
breath
room
air
enrich
co
femor
arteri
cannul
measur
system
arteri
pressur
heart
rate
electron
monitor
systol
pressur
puls
tachomet
grass
model
left
jugular
vein
cannul
administr
agonist
antagonist
measur
pulmonari
arteri
pressur
special
singl
lumen
cathet
construct
cathet
mm
length
mm
outer
diamet
special
curv
tip
facilit
passag
right
heart
main
pulmonari
arteri
left
right
pulmonari
arteri
cathet
introduc
cathet
curv
initi
straighten
straight
angioplast
guid
wire
facilit
passag
right
jugular
vein
right
atrium
tricuspid
valv
fluoroscop
guidanc
straight
wire
remov
natur
curv
facilit
entri
cathet
right
ventricl
softtip
coronari
arteri
guid
wire
insert
cathet
pass
guid
wire
main
pulmonari
arteri
fluoroscop
guidanc
pressur
main
pulmonari
arteri
measur
pressur
transduc
mean
pulmonari
arteri
pressur
deriv
electron
record
continu
cardiac
output
measur
thermodilut
techniqu
known
volum
plu
cathet
dead
space
nacl
solut
inject
right
atrium
chang
blood
temperatur
measur
root
aorta
cardiac
output
comput
equip
smallanim
interfac
use
thermistor
microprob
insert
right
carotid
arteri
advanc
aortic
arch
chang
aortic
blood
temperatur
measur
cathet
place
right
jugular
vein
advanc
right
atrium
main
pulmonari
arteri
rapid
bolu
inject
salin
salin
solut
inject
constantr
syring
ensur
rapid
repeat
inject
salin
indic
solut
thermodilut
curv
record
chart
record
pulmonari
system
blood
pressur
monitor
continu
cathet
placement
verifi
postmortem
examin
least
min
allow
challeng
dose
permit
measur
paramet
return
baselin
test
drug
inject
variou
dose
follow
inject
challeng
drug
doserespons
curv
challeng
drug
establish
inject
test
drug
blood
pressur
experi
anesthet
cat
valuabl
screen
techniqu
cardiovascular
agent
moreov
potenti
norepinephrin
respons
use
screen
procedur
antidepress
norepinephrin
uptak
inhibit
activ
sander
investig
vasoconstrictor
vasodil
effect
procain
spinal
cat
anim
anesthet
ether
ventil
posit
pressur
pump
via
tracheal
cannula
spinal
cord
cut
second
third
vertebra
ether
administr
stop
remain
portion
spinal
cord
transect
destroy
pass
curett
spinal
canal
yardley
et
al
studi
cardiovascular
paramet
spinal
cat
anim
anesthet
mgkg
intraven
administ
spinal
cord
transect
crush
first
cervic
segment
tetracain
hydrochlorid
mg
ml
inject
region
cord
system
blood
pressur
support
level
suffici
maintain
constrict
pupil
mean
valu
mm
hg
volum
expans
blood
donor
ml
infus
dextran
sympathomimet
cholinomimet
compound
well
angiotensin
ii
carotid
occlus
exert
characterist
respons
blood
pressur
anesthet
dog
antagon
potenti
respons
allow
character
cardiovascular
activ
new
compound
adult
beagl
dog
either
sex
weigh
kg
anesthet
mgkg
sodium
thiopent
mgkg
sodium
barbit
mgkg
sodium
pentobarbit
addit
dose
sodium
pentobarbit
given
need
dog
intub
cuf
endotrach
tube
place
harvard
respir
mlkg
cyclesmin
femor
vein
arteri
cannul
use
polyethylen
tube
drug
administr
determin
arteri
blood
pressur
respect
anim
bilater
vagotom
arteri
cannula
connect
statham
model
transduc
record
made
polygraph
heart
rate
determin
beckman
cardiotach
connect
voltagepressurepuls
coupler
drug
challeng
one
follow
combin
drug
administ
iv
dog
challeng
given
fix
order
least
twice
prior
test
drug
administr
insur
consist
respons
start
min
post
test
drug
epinephrin
norepinephrin
isoproterenol
carbachol
tyramin
use
bilater
carotid
occlus
phenylephrin
isoproterenol
angiotensin
ii
carbachol
cardiovascular
drug
least
min
allow
challeng
dose
permit
measur
paramet
return
baselin
challeng
drug
dose
sometim
vari
keep
mean
arteri
pressur
within
follow
limit
epinephrin
mm
hg
norepinephrin
mm
hg
tyramin
mm
hg
isoproterenol
mm
hg
carbachol
mm
hg
phenylephrin
mm
hg
angiotensin
ii
mm
hg
bilater
carotid
occlus
mm
hg
record
studi
detect
chang
arteri
pressur
respons
challeng
drug
testdrug
administr
observ
chang
blood
pressur
heart
rate
result
express
percentag
chang
predrug
respons
hemodynam
effect
compound
suppos
affect
cardiovascular
system
evalu
measur
preload
afterload
heart
contractil
heart
rate
cardiac
output
peripher
coronari
flow
measur
cardiovascular
paramet
accur
use
larger
anim
dog
pig
necessari
experiment
model
allow
classif
test
drug
accord
action
posit
inotrop
effect
neg
inotrop
effect
ca
antagonist
antiarrhythm
hypertens
effect
hypotens
effect
coronarydil
effect
effect
effect
antiangin
effect
peripheralvasodil
effect
procedur
male
femal
inbr
beagl
labradorharri
dog
weigh
kg
use
anesthet
bolu
inject
mgkg
pentobarbit
continu
infus
mgkgh
cathet
place
cephal
vein
intraven
inject
anoth
cathet
place
duodenum
enter
administr
respir
maintain
room
air
tracheal
tube
use
posit
pressur
respir
e
g
blood
ga
analys
perform
regular
time
interv
oxygen
suppli
via
respir
need
blood
pressur
record
cannula
insert
left
femor
arteri
connect
statham
pressur
transduc
statham
p
db
determin
lvp
millar
microtip
cathet
type
pc
insert
via
left
common
carotid
arteri
left
ventricl
lvedp
measur
highsensit
scale
pressur
curv
dpdt
max
differenti
heart
rate
count
lvpsignal
also
trigger
cardiotachomet
cardiac
output
pulmonari
arteri
pressur
pap
stroke
volum
measur
thermodilut
techniqu
use
cardiac
output
comput
gouldstatham
sp
balloontip
tripl
lumen
cathet
gould
sp
thermistor
posit
pulmonari
arteri
via
jugular
vein
myocardi
oxygen
consumpt
mvo
calcul
pressureworkindex
accord
rook
feigl
femor
blood
flow
coronari
flow
measur
electromagnet
flow
probe
attach
femor
arteri
circumflex
branch
left
coronari
arteri
lcx
respect
stabl
hemodynam
condit
blood
ga
valu
po
mm
hg
pco
mm
hg
achiev
least
min
control
valu
test
substanc
administ
cathet
insert
cephal
vein
dose
mgkg
duodenum
dose
mgkg
paramet
record
continu
whole
experi
result
present
mean
sem
n
statist
signific
assess
mean
pair
ttest
effect
drug
carotid
arteri
occlus
effect
studi
anesthet
dog
occlus
right
left
common
carotid
arteri
perform
squeez
polyethylen
tube
twine
pass
insid
tube
around
carotid
arteri
occlus
carotid
arteri
caus
increas
systol
blood
pressur
mm
hg
inhibit
effect
drug
test
studi
anesthet
dog
use
determin
influenc
cardioton
drug
propranolol
induc
cardiac
insuffici
rajagopalan
et
al
instead
dog
pig
german
landrac
weigh
kg
use
pretreat
ketamin
ml
im
methomid
hydrochlorid
ml
ip
xylazin
ml
im
anaesthet
mgkg
pentobarbit
sodium
follow
continu
infus
mgkgh
paramet
evalu
similarli
experi
dog
measur
cardiac
output
thermodilut
method
rat
describ
richardson
et
al
mannesmann
thermodilut
method
use
rosa
et
al
anesthet
rat
carbonel
et
al
salyer
et
al
consciou
rat
determin
hemodynam
paramet
oxygen
pressur
carbon
dioxid
pressur
ph
coronari
venou
common
carotid
arteri
blood
anesthet
dog
measur
use
blood
ga
analyz
aisaka
et
al
acut
ischem
left
ventricular
failur
induc
anesthet
dog
repeat
inject
plastic
microspher
left
coronari
arteri
smiseth
sweet
et
al
et
al
coronari
cathet
introduc
right
femor
arteri
advanc
fluoroscopi
left
coronari
ostium
guid
inject
small
amount
contrast
medium
reach
baselin
valu
acut
left
ventricular
failur
induc
subsequ
intracoronari
inject
plastic
microspher
nonradioact
tracer
microspher
microspher
suspend
salin
drop
tween
sonifi
use
mg
ml
salin
correspond
approxim
microspher
inject
microspher
mgkg
microspher
inject
everi
min
min
microspher
inject
effect
immedi
stepwis
increas
lvedp
procedur
lvedp
increas
desir
level
control
manner
min
follow
embol
lvedp
continu
increas
approxim
mm
hg
anim
arrhythmia
exclud
studi
thirti
min
end
embol
hemodynam
paramet
stabil
drug
administr
start
valdescruz
et
al
develop
openchest
prepar
dog
valid
accuraci
twodimension
doppler
echocardiograph
method
estim
pressur
drop
across
discret
stenot
obstruct
order
assess
potenti
singl
breath
techniqu
use
effect
way
estim
cardiac
output
noninvas
frank
et
al
measur
simultan
singl
breath
techniqu
aortic
flow
use
electromagnet
flowmet
anesthet
dog
potenc
cardiovascular
drug
depend
direct
effect
cellular
level
respons
cardiovascular
control
mechan
latter
often
markedli
influenc
anesthesia
chronic
instrument
consciou
dog
renal
hypertens
therefor
realist
test
model
evalu
effect
antihypertens
antiangin
cardioton
compound
test
use
evalu
hemodynam
drug
effect
consciou
dog
experiment
model
chronic
arteri
ventricular
catheter
renal
arteri
constrict
male
femal
labradorharri
dog
weigh
kg
use
anaesthet
mgkg
xylazin
im
follow
mgkg
xylazin
iv
mgkg
pentobarbit
sodium
iv
chronic
instrument
induct
renal
hypertens
fluidfil
cathet
implant
abdomin
aorta
left
ventricl
cathet
tunnel
subcutan
exterior
nape
neck
dorsal
renal
hypertens
induc
place
silast
constrictor
around
renal
arteri
hemodynam
measur
perform
twoweek
recoveri
period
later
familiar
dog
test
surround
brought
laboratori
time
start
studi
thu
drug
test
possibl
without
sedat
experi
anim
rest
quietli
laboratori
tabl
hemodynam
measur
perform
connect
two
implant
cathet
statham
pressur
transduc
pressur
signal
electron
differenti
lvp
dpdt
max
heart
rate
record
polygraph
reach
stabl
hemodynam
condit
least
min
control
baselin
valu
test
compound
administ
either
oral
gelatin
capsul
intraven
inject
cephal
vein
hemodynam
paramet
record
continu
start
min
min
drug
administr
thereaft
h
interv
h
dosag
follow
paramet
monitor
mann
et
al
describ
simpl
procedur
direct
blood
pressur
measur
consciou
dog
use
consist
mm
reservoir
bodi
affix
silicon
rubber
cathet
describ
method
assess
vasoconstrictor
agent
record
venou
complianc
consciou
dog
chang
diamet
canin
saphen
vein
produc
inflat
mm
hg
sphygmomanomet
cuff
place
upper
hind
leg
record
hintz
vatner
compar
effect
nifedipin
nitroglycerin
consciou
dog
instrument
instantan
continu
measur
coronari
arteri
left
ventricular
diamet
ultrason
dimens
gaug
arteri
left
ventricular
pressur
implant
miniatur
gaug
coronari
blood
flow
electromagnet
flowmet
doppler
ultrason
flowmet
shimshak
et
al
studi
recoveri
region
myocardi
contractil
function
min
coronari
arteri
occlus
chronic
instrument
consciou
dog
wright
et
al
describ
minim
invas
techniqu
allow
assess
histamin
h
antagonist
activ
consciou
dog
base
inhibit
tachycardia
caus
intraven
administr
h
receptor
agonist
hashimoto
et
al
studi
coronari
effect
nicorandil
comparison
nitroglycerin
chronic
consciou
dog
instrument
ultrason
crystal
electromagnet
flowmet
circumflex
coronari
arteri
hartman
warltier
describ
model
multivessel
coronari
arteri
diseas
use
consciou
chronic
instrument
dog
hydraul
occlud
ameroid
constrictor
implant
around
left
anterior
descend
left
circumflex
coronari
arteri
pair
piezoelectr
crystal
implant
within
subendocardium
left
anterior
descend
left
circumflex
coronari
arteri
perfus
territori
measur
region
contractil
function
cathet
place
left
atrial
appendag
inject
radioact
microspher
measur
region
myocardi
perfus
hof
et
al
use
doppler
method
measur
cardiac
output
consciou
rabbit
groh
et
al
simultan
assess
cardiac
output
puls
doppler
electromagnet
flowmet
cardiac
stimul
prior
studi
human
be
studi
cardiovascular
effect
new
drug
monkey
necessari
instanc
rhesu
monkey
either
sex
weigh
kg
anesthet
mgkg
ketamin
hydrochlorid
follow
mgkg
pentobarbitalna
given
slowli
iv
small
sidebranch
femor
radial
arteri
surgic
expos
cannul
blood
pressur
record
use
blood
pressur
transduc
id
heart
rate
determin
convent
ecg
lead
biotachomet
compound
administ
either
intraven
via
gastric
fibroscop
e
g
olympu
xp
duodenum
visual
control
cardiovascular
paramet
regist
pretest
period
min
min
intraven
administr
h
intragastr
administr
test
drug
three
anim
use
evalu
mean
valu
sd
calcul
pretest
period
cardiovascular
effect
everi
min
min
iv
administr
everi
min
intragastr
administr
valu
regist
everi
min
min
everi
min
valu
administr
test
compound
compar
statist
pretest
valu
use
student
ttest
lacour
et
al
studi
cardiovascular
paramet
consciou
cynomolgu
monkey
macaca
fasciculari
silicon
cathet
intern
extern
diamet
mm
respect
implant
asept
condit
thorac
aorta
via
carotid
arteri
monkey
anesthet
mgkg
ketamin
mgkg
acepromazin
intramuscularli
vascular
cathet
fill
aqueou
solut
polyvinylpyrolidon
heparin
insert
carotid
arteri
patch
silicon
sewn
around
arteri
maintain
cathet
posit
latter
rout
subcutan
exterior
top
head
stainless
steel
connector
connector
fix
skull
screw
dental
cement
seal
plug
protect
cathet
damag
monkey
permit
minimum
recoveri
period
experi
perform
monkey
place
primaterestrain
chair
sever
occas
gradual
increas
durat
experi
acclimat
pulsatil
arteri
pressur
record
connect
arteri
cathet
polygraph
via
statham
pressur
transduc
mean
arteri
pressur
heart
rate
deriv
puls
pressur
signal
record
cathet
insert
acut
saphen
vein
administr
compound
lacour
c
roccon
cazaubon
c
segondi
nisato
pharmacolog
studi
sr
nonpeptid
angiotensin
ii
receptor
antagonist
consciou
monkey
j
hyperten
linz
w
klau
e
albu
u
becker
r
mania
englert
hc
ba
cardiovascular
effect
novel
potassium
channel
open
hemihydr
arzneimforschdrug
re
microspher
techniqu
allow
measur
cardiac
output
region
blood
flow
use
differ
radionuclid
repeat
determin
possibl
method
applic
dog
cat
minipig
hof
et
al
also
rat
mcdevitt
nie
bonnacrossi
et
al
ishis
et
al
stanek
et
al
use
microspher
appropri
size
male
spraguedawley
rat
weigh
g
anesthet
mgkg
ip
pentobarbit
right
carotid
right
femor
arteri
cannul
use
pressur
monitor
carotid
cannula
manipul
left
ventricl
carbon
microspher
diamet
label
sr
drawn
glass
inject
chamber
suspend
ml
dextran
chamber
contain
microspher
radioact
chamber
determin
gamma
scintil
count
microspher
inject
differ
amount
radioact
inject
microspher
inject
left
ventricl
total
volum
ml
dextran
simultan
arteri
blood
femor
arteri
withdrawn
mlmin
syring
withdraw
pump
refer
blood
sampl
use
calcul
cardiac
output
formula
cardiac
output
count
inject
refer
sampl
withdraw
rate
refer
sampl
count
obtain
refer
sampl
anim
sacrif
pentobarbit
organ
dissect
place
count
vial
count
min
region
distribut
cardiac
output
calcul
compar
radioact
organ
total
inject
radioact
organ
flow
determin
multipli
cardiac
output
fraction
distribut
cardiac
output
organ
problem
associ
microspher
techniqu
rat
hemodynam
effect
solut
use
inject
microspher
effect
blood
withdraw
repeat
determin
stanek
et
al
repeat
determin
nuclid
use
sc
cr
ce
hof
et
al
et
al
use
radiolabel
microspher
co
sn
sr
nb
sc
measur
region
cerebr
blood
flow
cat
faraci
heistad
measur
blood
flow
radioact
microspher
diamet
label
sc
nb
gd
sr
ce
anesthet
rabbit
grover
et
al
gross
et
al
measur
myocardi
blood
flow
dog
radioact
microspher
techniqu
kowallik
et
al
measur
region
myocardi
blood
flow
multipl
color
microspher
method
yield
valu
similar
obtain
radioact
microspher
skin
ventral
side
neck
care
shave
disinfect
cours
carotid
arteri
outlin
palpat
along
tracheal
border
cm
skin
taken
side
mark
width
flap
medial
incis
made
slightli
thyroid
cartilag
extend
caudal
point
cm
later
cm
manubrium
sterni
later
incis
lie
cm
line
carotid
arteri
parallel
later
incis
half
long
medial
one
incis
made
subcutan
tissu
platysma
muscl
skin
muscl
flap
undermin
bleed
point
care
clamp
tie
subcutan
tissu
platysma
myoid
muscl
anterior
fascia
neck
incis
cours
midlin
incis
plane
cleavag
sternohyoid
sternomastoid
muscl
blunt
dissect
muscl
separ
disclos
depth
neurovascular
bundl
lie
intern
jugular
vein
floor
space
isol
form
longu
capiti
muscl
care
dissect
muscl
separ
least
cm
limit
incis
skin
superior
thyroid
arteri
mark
uppermost
portion
carotid
arteri
suitabl
exterior
plane
cleavag
follow
caudal
origin
sternocleidomastoid
muscl
manubrium
sterni
throughout
limit
incis
arteri
dissect
free
intern
jugular
vein
vagu
nerv
first
step
exterior
arteri
reapproxim
muscl
border
beneath
vessel
mattress
sutur
order
prevent
tension
complet
loop
due
contract
sternomastoid
sternohyoid
muscl
import
reapproxim
muscl
throughout
cours
sutur
place
edg
skin
tubular
flap
skin
approxim
loos
around
carotid
arteri
essenti
skin
flap
fit
loos
around
arteri
continu
sutur
fine
silk
start
place
vessel
emerg
muscl
border
sutur
place
includ
arteri
sling
skin
isol
vessel
line
sutur
undersid
complet
loop
final
proxim
distal
quarter
flap
close
sutur
skin
tube
close
continu
sutur
antibiot
given
local
system
one
thick
gauz
place
beneath
loop
along
border
strip
gauz
order
reliev
loop
pressur
caus
remind
dress
around
neck
wrap
gauz
bandag
sever
turn
pass
behind
forelimb
order
prevent
dress
ride
upward
anim
neck
place
plaster
roll
protect
loop
anim
effort
scratch
dress
chang
fifth
seventh
day
sutur
remov
blood
pressur
measur
made
accord
rivarocci
principl
place
inflat
cuff
around
loop
carotid
arteri
loop
method
need
surgic
experi
meticul
caretak
anim
ultrason
transduc
construct
implant
describ
stinson
et
al
measur
left
ventricular
extern
diamet
lved
two
ultrason
transduc
fix
left
ventricular
wall
one
crystal
sutur
posterior
wall
within
rectangular
area
form
left
circumflex
coronari
arteri
left
posterior
descend
arteri
one
place
near
first
diagon
branch
left
anterior
descend
coronari
arteri
exact
posit
assur
oscilloscop
measur
left
ventricular
intern
diamet
lvid
transduc
place
anatom
area
epicardi
crystal
howev
push
wall
left
ventricl
stab
wound
incis
crystal
posit
across
greatest
transvers
diamet
left
ventricl
one
anterior
posterior
endocardi
wall
bleed
implant
procedur
control
umbil
tape
around
cranial
caudal
vein
purs
string
sutur
implant
site
pericardi
incis
chest
close
sutur
transduc
wire
connect
record
equip
dog
either
lved
lvid
measur
togeth
hemodynam
paramet
blood
pressur
record
cannul
femor
arteri
pressur
transduc
statham
p
db
determin
lvp
millar
microtip
cathet
type
pc
insert
via
left
caroti
communi
lvedp
measur
highsensit
scale
pressur
curv
dpdtmax
differenti
heart
rate
calcul
hemodynam
paramet
record
continu
whole
experi
stabl
hemodynam
condit
achiev
least
min
control
valu
test
substanc
administ
intraven
intraduoden
inject
read
taken
time
drug
administr
left
ventricular
dimens
measur
end
diastol
systol
characterist
blood
pressur
systol
blood
pressur
diastol
blood
pressur
left
ventricular
pressur
lvp
left
ventricular
enddiastol
pressur
left
ventricular
contractil
dpdt
heart
rate
hr
left
ventricular
extern
diamet
lved
left
ventricular
intern
diamet
lvid
chang
paramet
drug
administr
compar
control
valu
obtain
min
predrug
period
statist
signific
assess
mean
pair
ttest
sinc
chang
diamet
left
ventricl
reason
accur
index
left
ventricular
volum
reduct
lved
lvid
chang
dpdt
hr
consid
strong
indic
venou
pool
thu
antiangin
activ
compound
score
allot
rel
efficaci
standard
compound
assess
intens
well
durat
effect
standard
data
radiotelemetri
allow
record
cardiovascular
paramet
consciou
freemov
anim
sever
author
brockway
et
al
matt
lemmer
guiol
et
al
morimoto
et
al
basil
et
al
brockway
hassler
lemmer
et
al
lemmer
et
al
lemmer
et
al
calhoun
et
al
diamant
et
al
kramer
et
al
kramer
et
al
griffin
et
al
kuwahara
et
al
sato
et
al
van
den
buus
et
al
kinter
becker
et
al
witt
et
al
use
commerci
avail
system
modif
studi
circadian
rhythm
blood
pressur
influenc
drug
heart
rate
blood
pressur
motil
rat
telemetri
data
acquisit
system
e
g
data
scienc
intern
inc
st
paul
mn
consist
four
part
implant
transmitt
measur
pressur
devic
contain
highli
stabl
ionimpl
semiconductor
straingaug
sensor
batterypow
electron
process
inform
pressur
sensor
telemet
within
anim
arteri
pressur
transmit
sensor
via
diamet
fluidfil
cathet
receiv
detect
signal
implant
transmitt
convert
form
readabl
comput
pressur
refer
modul
measur
atmospher
pressur
allow
telemet
absolut
pressur
convert
gaug
pressur
data
acquisit
softwar
accept
data
refer
modul
receiv
filter
corrupt
sampl
incom
data
stream
convert
telemet
pressur
millimet
mercuri
subtract
atmospher
pressur
telemet
pressur
store
data
retriev
plot
analysi
pentobarbit
anesthesia
telemetri
transmitt
implant
rat
descend
aorta
expos
renal
arteri
vascular
clamp
made
put
two
surgic
thread
proxim
distal
part
arteri
cathet
tip
insert
incis
vessel
drop
cyanoacryl
glue
appli
dri
entri
point
transmitt
sutur
abdomin
musculatur
data
individu
anim
record
long
period
time
allow
investig
follow
circadian
rhythm
sever
experiment
condit
hess
et
al
monitor
pulmonari
arteri
pressur
freeli
move
rat
insert
sens
cathet
telemetr
system
small
hole
push
pulmonari
arteri
cardiovascular
studi
rat
use
telemetr
system
report
sgoifo
et
al
webb
et
al
kramer
et
al
use
telemetri
record
electrocardiogram
heart
rate
freeli
move
mice
carlson
wyss
use
small
telemetri
probe
long
term
record
arteri
pressur
heart
rate
mice
implant
carotid
arteri
abdomin
aorta
depasqual
et
al
use
radiotelemetri
monitor
cardiovascular
function
consciou
guinea
pig
telemetr
ecg
record
cardiomyopath
hamster
report
desjardin
et
al
van
den
buus
malpa
studi
cardiovascular
paramet
rabbit
radiotelemetri
astley
et
al
smith
et
al
use
telemetr
system
monitor
cardiovascular
respons
baboon
schnell
wood
measur
blood
pressur
heart
rate
telemetri
consciou
unrestrain
marmoset
ultrason
blood
flowmet
telemetri
system
cat
rabbit
describ
yonezawa
et
al
yonezawa
et
al
telemetri
use
symon
et
al
monitor
sever
event
repres
myocardi
dysfunct
miniswin
savori
kostal
appli
telemetr
system
chronic
measur
cardiovascular
paramet
chicken
radiotelemetri
also
use
pharmacolog
experi
field
potenti
analysi
radioelectroencephalographi
see
sect
step
passiv
avoid
see
sect
shockprod
buri
test
rat
see
sect
measur
bodi
temperatur
see
sect
motil
rat
mice
clement
et
al
guillet
et
al
diamant
et
al
van
den
buus
sever
drug
like
adrenerg
agonist
act
primarili
central
site
effect
clearli
demonstr
inject
cerebroventricular
system
first
experi
perform
cat
method
adapt
rat
rat
either
sex
weigh
g
anesthet
mgkg
hexobarbit
ip
scalp
cut
sagitt
line
dental
drill
hole
mm
diamet
drill
cranial
bone
mm
later
mm
caudal
bregma
pvccathet
introduc
perpendicular
bone
depth
mm
order
reach
later
cerebr
ventricl
cathet
fix
dental
cement
wound
close
test
substanc
administ
cathet
measur
blood
pressur
one
cathet
place
one
carotid
arteri
connect
statham
transduc
blood
pressur
heart
rate
record
polygraph
period
least
min
long
act
drug
registr
period
h
necessari
experi
anim
sacrif
brain
remov
confirm
site
inject
systol
diastol
blood
pressur
well
heart
rate
intracerebroventricular
inject
express
percentag
pretreat
valu
respons
compar
standard
clonidin
effect
dose
orthostat
hypotens
dizzi
unconsci
syndrom
occur
mani
human
individu
moreov
sever
drug
known
caus
orthostat
hypotens
sever
anim
speci
rabbit
cat
dog
syndrom
evok
chang
usual
horizont
posit
vertic
posit
head
upward
use
tilt
tabl
cat
either
sex
weigh
kg
temporarili
anesthet
ether
anesthesia
maintain
intraven
inject
mgkg
chloralos
anim
fix
leg
heat
oper
tabl
tilt
degre
carotid
arteri
cannul
measur
blood
pressur
statham
p
db
transduc
channel
hellig
record
femor
vein
cannul
inject
test
compound
blood
pressur
stabil
min
anim
quickli
tilt
vertic
posit
minut
due
chang
posit
gravit
forc
rapid
fall
blood
pressur
recov
soon
anim
restor
origin
posit
take
control
read
test
compound
administ
intraven
procedur
repeat
fall
blood
pressur
record
signific
increas
postur
hypotens
respect
control
would
indic
test
compound
may
produc
orthostat
hypotens
human
moreov
compound
like
sympathomimet
reduc
prevent
postur
hypotens
sponer
et
al
humphrey
mccall
describ
model
predict
orthostat
hypotens
acut
chronic
antihypertens
drug
therapi
rat
anesthet
chloralos
urethan
pentobarbit
use
heat
tilt
tabl
lee
et
al
evalu
postur
hypotens
induc
drug
consciou
restrain
normotens
rat
blood
pressur
record
cannul
femor
arteri
light
ether
anesthesia
special
tilt
tabl
build
simultan
studi
four
rat
martel
et
al
martel
et
al
studi
phenomenon
cardiovascular
decondit
observ
crew
member
space
flight
rat
tail
suspens
socci
et
al
studi
cardiovascular
respons
simul
micrograv
spraguedawley
rat
micrograv
known
induc
orthostat
intoler
baroreflex
impair
astronaut
author
use
tilt
wholebodi
suspens
tail
suspens
mimic
micrograv
find
treatment
amelior
symptom
baum
et
al
studi
antihypertens
orthostat
respons
drug
consciou
dog
cathet
place
subclavian
arteri
measur
blood
pressur
exterior
back
neck
day
prior
experi
anim
place
sling
tilt
posit
period
everi
hour
lift
forelimb
blood
pressur
respons
treatment
test
drug
measur
none
human
primat
model
evalu
potenti
antihypertens
drug
caus
orthostat
hypotens
describ
pal
orley
polyvinyl
cathet
implant
abdomin
aorta
vena
cava
via
extern
iliac
arteri
vein
cynomolgu
monkey
ketamin
anesthesia
cathet
rout
subcutan
groin
area
top
head
exterior
recoveri
anim
place
restrain
chair
allow
chang
vertic
horizont
posit
circulatori
collaps
intraven
inject
veratrin
first
describ
cat
known
bezoldjarischreflex
bezold
hirt
jarisch
richter
b
jarisch
aviado
guaveraaviado
fleckenstein
et
al
recommend
suitabl
anim
model
shock
origin
observ
triphas
blood
pressur
respons
cat
dog
character
short
last
fall
blood
pressur
accompani
bradycardia
follow
short
last
increas
longlast
decreas
blood
pressur
intraven
inject
veratridin
veratrum
alkaloid
kalkman
et
al
show
three
distinct
subtyp
serotonerg
receptor
mediat
triphas
blood
pressur
respons
serotonin
observ
bezoldjarisch
reflex
bezoldjarisch
reflex
studi
sever
speci
cat
takei
et
al
vayssettescouchay
et
al
dog
zucker
cornish
barron
bishop
harron
kobing
gile
sander
baugh
et
al
watson
et
al
ferret
andrew
bhandari
rabbit
chen
guinea
pig
rat
fozard
gyli
et
al
cohen
et
al
blower
miyata
et
al
turconi
et
al
matsumoto
et
al
meller
et
al
robertson
et
al
kishibayashi
et
al
geissler
et
al
haga
et
al
hegd
et
al
eglen
et
al
et
al
delagrang
et
al
de
vri
malinowska
et
al
godlewski
et
al
mice
eglen
et
al
middlefel
et
al
wherebi
speci
differ
observ
yamono
et
al
cat
dog
bezoldjarisch
reflex
elicit
veratrin
veratridin
also
capsaicin
receptor
agonist
phenylbiguanid
chlorophenylbiguanid
serotonin
rat
mostli
use
stimuli
character
receptor
antagonist
male
spragu
dawley
rat
weigh
g
given
food
water
ad
libitum
except
use
intraduoden
drug
administr
rat
depriv
food
overnight
anim
anesthet
intraperiton
inject
gkg
urethan
bodi
temperatur
maintain
place
anim
heat
pad
left
jugular
vein
duodenum
trachea
left
femor
vein
cannul
drug
administr
iv
id
facilit
respir
inject
respect
heart
rate
deriv
limb
lead
ii
ecg
monitor
via
subderm
platinum
electrod
record
amplifi
polygraph
doserespons
curv
iv
construct
rat
establish
submaxim
dose
usual
iv
elicit
reproduc
bradycard
respons
rat
receiv
singl
dose
test
drug
standard
challeng
min
post
dose
separ
group
rat
receiv
vehicl
salin
iv
deioniz
water
id
similarli
test
studi
durat
action
compound
assess
determin
period
time
inhibitori
effect
remain
significantli
differ
vehicl
control
statist
analysi
data
perform
repeat
measur
analysi
varianc
anova
follow
pairwis
comparison
control
time
period
use
fisher
multipl
comparison
test
harron
kobing
use
capsaicin
elicit
bezoldjarisch
reflex
anesthet
artifici
respir
dog
pretreat
betaadrenoceptor
antagonist
evalu
activ
clonidinelik
drug
central
alpha
adrenoceptor
intracistern
administr
bezooldjarisch
reflex
rat
use
evalu
receptor
agonist
rault
et
al
et
al
rocha
et
al
found
enhanc
bezoldjarisch
reflex
acut
phase
myocardi
infarct
anesthet
rabbit
andrew
plr
bhandari
p
resinferatoxin
ultrapot
capsaicin
analogu
antiemet
properti
ferret
mani
bacteri
infect
well
allerg
reaction
known
induc
pathophysiolog
event
may
lead
shock
man
experiment
anim
inject
endotoxin
galactosamin
shock
death
occur
untreat
anim
h
inject
endotoxin
induc
shock
mark
pulmonari
embol
bronchospasm
renal
failur
bacteri
liposaccharid
endotoxin
play
import
role
pathogen
gramneg
infect
reactiv
anim
endotoxin
may
enhanc
simultan
administr
galactosamin
galactosamin
specif
hepatotox
agent
lead
earli
metabol
alter
consequ
cellular
liver
damag
follow
procedur
use
detect
compound
prevent
occurr
endotoxininduc
shock
cardiovascular
paramet
endotoxin
induc
shock
greatli
influenc
variou
anesthet
reason
model
propos
brackett
et
al
schaefer
et
al
studi
circulatori
shock
pattern
endotoxemia
consciou
unrestrain
rat
male
spraguedawley
rat
weigh
g
anesthet
enfluran
tracheal
cannula
connect
rodent
respir
deliv
enfluran
via
right
jugular
vein
tip
one
cathet
place
adjac
right
atrium
inject
endotoxin
monitor
central
venou
pressur
rapid
inject
roomtemperatur
salin
produc
thermodilut
curv
calcul
cardiac
output
right
carotid
arteri
cannul
thermistorcathet
combin
measur
thermodilut
cardiac
output
curv
aortic
blood
pressur
thermistor
tip
place
aortic
arch
distal
aortic
valv
cathet
guid
skin
exit
back
neck
base
skull
anim
allow
regain
conscious
place
cage
allow
unrestrain
movement
cage
time
throughout
studi
handl
experiment
anim
receiv
infus
mgkg
endotoxin
e
coli
difco
pair
sham
anim
ident
cathet
receiv
equal
volum
salin
test
compound
inject
intraven
min
prior
endotoxin
inject
cardiac
output
measur
use
thermodilut
techniqu
rapidli
inject
volum
calcul
deliv
room
temperatur
salin
circulatori
system
central
venou
aortic
blood
pressur
heart
rate
continu
monitor
follow
h
cardiac
output
measur
made
min
endotoxin
end
studi
anim
sacrif
cathet
check
visual
ensur
proper
placement
central
venou
pressur
arteri
pressur
cardiac
output
drug
treat
anim
receiv
endotoxin
compar
anim
receiv
endotoxin
salin
sham
treat
anim
furthermor
cardiac
index
total
peripher
resist
stroke
volum
calcul
small
intestin
rat
examin
sever
hemorrhag
use
five
point
scale
repeatedmeasur
analysi
varianc
use
analyz
data
lindenbaum
et
al
studi
effect
e
coli
endotoxin
cardiovascular
paramet
anesthet
dog
inhibit
detori
metabol
function
improv
cardiovascular
paramet
found
cocarboxylas
treatment
endotoxin
induc
shock
test
mice
galano
et
al
group
male
mice
weigh
g
inject
intraven
mixtur
salmonella
abortu
equi
lipopolysaccharid
mg
galactosamin
ml
phosphat
buffer
salin
test
compound
administ
either
intraven
time
oral
min
prior
challeng
twentyfour
hour
later
number
surviv
mice
determin
metz
sheagren
male
cd
mice
g
treat
intraperiton
zymosan
mgkg
suspend
salin
solut
zymosan
drug
rosiglitazon
mgkg
intraperiton
h
zymosan
eighteen
hour
administr
zymosan
anim
assess
nonsept
shock
clinic
sever
system
toxic
score
whole
experiment
period
day
mice
zymosan
salin
inject
subject
scale
rang
absenc
mild
moder
seriou
rang
scale
use
toxic
sign
conjunct
ruffl
fur
diarrhea
lethargi
observ
anim
final
score
sum
singl
evalu
maximum
valu
overbergh
et
al
studi
acut
shock
induc
antigen
nod
mice
nod
balbc
mice
immun
inject
antigen
hen
egg
white
lysozym
hel
srlskvapvikarmmeygtt
bovin
insulin
b
insb
chain
heat
shock
protein
hsp
plp
peptid
amino
acid
ovalbumin
keyhol
limpet
hemocyanin
klh
tetanu
toxin
emulsifi
concentr
complet
freund
adjuv
cfa
incomplet
freund
adjuv
difco
laboratori
detroit
mich
usa
hind
footpad
nodscid
mice
inject
hel
antigen
suspend
cfa
mice
reinject
antigen
week
later
similar
manner
clinic
evolut
surviv
rate
sensit
variou
peptid
monitor
differ
mous
strain
shock
character
piloerect
prostrat
erythema
tail
ear
footpad
dyspnea
shallow
breath
serum
antibodi
measur
spleen
quantif
mrna
level
collect
immun
booster
administr
baldwin
et
al
test
effect
polymyxin
b
experiment
shock
meningococc
lipooligosaccharid
escherichia
coli
lipopolysaccharid
endotoxin
anesthet
rabbit
muacev
heuer
test
effect
plateletactiv
factor
antagonist
anesthet
rat
otterbein
et
al
test
effect
peptid
surviv
mice
inject
mgkg
lipopolysaccharid
endotoxin
mice
surviv
rat
fecal
periton
mountz
et
al
report
increas
suscept
fa
mutant
mrlipripr
mice
staphylococc
enterotoxin
binduc
septic
shock
hemorrhag
shock
one
sever
consequ
accid
sever
anim
model
variou
speci
develop
resembl
condit
man
test
therapeut
prophylact
measur
lamson
de
turk
selkurt
roth
mill
method
hemorrhag
shock
anesthet
well
unanesthet
rat
describ
van
der
meer
et
al
experiment
hemorrhag
shock
defin
situat
cardiovascular
system
period
hypovolemia
follow
complet
reinfus
shed
blood
gradual
detori
end
death
anim
femal
rat
weigh
g
anesthet
ip
inject
sodium
pentobarbit
mkg
follow
min
mgkg
kept
chamber
rel
humid
left
femor
vein
cannul
applic
test
drug
right
common
iliac
arteri
cannul
cannula
polyvinyl
chlorid
cm
long
inner
diamet
mm
fill
heparin
exterior
neck
intraarteri
inject
ml
heparin
iuml
cannula
connect
silicon
calibr
glass
reservoir
inner
diamet
mm
height
chang
adjust
surfac
shed
blood
fix
level
test
drug
inject
iv
min
prior
bleed
bleed
perform
heart
level
mm
hg
h
mm
hg
h
mm
hg
h
mm
hg
h
final
mm
hg
h
shed
blood
partial
taken
spontan
h
reinfus
start
increas
pressur
mm
hg
min
mm
hg
min
necessari
mm
hg
hypovolem
phase
respir
becom
gradual
slower
respir
arrest
immin
ml
glucos
inject
intraarteri
thu
avoid
death
period
hypovolemia
practic
rat
die
averag
h
complet
reinfus
surviv
time
taken
time
complet
reinfus
death
averag
surviv
time
treat
anim
compar
control
furthermor
autopsi
number
gastrointestin
lesion
subendocardi
hemorrhag
kidney
tubular
necrosi
liver
cell
necrosi
regist
histolog
examin
spite
fact
hemorrhag
shock
reflect
situat
traumat
shock
man
everi
aspect
condit
close
enough
use
model
test
compound
potenti
inhibit
amelior
shock
man
method
studi
hemorrhag
shock
dog
describ
detail
mill
larg
dog
weigh
kg
anesthet
iv
inject
mgkg
sodium
pentobarbit
anim
respir
mean
harvard
respir
set
stroke
volum
ml
rate
respirationmin
blood
ph
regul
vari
ga
flow
mixtur
co
central
arteri
blood
pressur
record
insert
cathet
one
femor
arteri
aortic
arch
pulmonari
arteri
pressur
measur
insert
pe
cathet
small
neck
vein
reach
right
ventricl
allow
float
pulmonari
arteri
right
atrial
cathet
also
insert
small
neck
vein
chest
open
left
atrial
cathet
tie
place
small
open
left
atrial
appendag
blood
flow
measur
ascend
aorta
cardiac
output
carotid
superior
mesenter
renal
femor
arteri
use
electromagnet
flowmet
furthermor
puls
rate
monitor
electrocardiogram
test
drug
inject
iv
min
prior
bleed
blood
remov
either
specif
volum
select
reduct
blood
pressur
occur
cardiovascular
paramet
treat
anim
compar
control
shock
associ
hemoconcentr
produc
dog
davi
bleed
carotid
arteri
inject
sodium
chlorid
solut
subcutan
dose
ml
effect
insulin
glucos
uptak
soleu
muscl
rat
hemorrhag
shock
studi
chaudri
et
al
bauer
et
al
use
hemorrhag
shock
rat
evalu
influenc
leukocyteendotheli
cell
interact
microcircul
liver
mean
intravit
microscopi
applic
receptor
antagonist
kitajima
et
al
studi
gastric
mucos
injuri
induc
hemorrhag
shock
rat
compress
extrem
man
heavi
object
period
sever
hour
result
socal
crush
syndrom
rescu
individu
show
immedi
favor
respons
therapi
within
hour
symptom
shock
develop
follow
sign
progress
renal
damag
lead
death
duncan
blalock
moreov
arteri
bleed
accid
need
applic
tourniquet
surgic
procedur
extrem
tourniquet
may
necessari
wilgi
time
limit
order
avoid
fatal
consequ
pathophysiolog
mechan
tourniquet
induc
shock
remain
still
elucid
nevertheless
anim
model
rat
chandra
dave
rabbit
littl
dog
goto
et
al
develop
evalu
drug
capabl
inhibit
fatal
consequ
crush
tourniquet
shock
wistar
rat
either
sex
weigh
g
anesthet
phenobarbit
tourniquet
consist
rubber
tube
intern
diamet
mm
extern
diamet
mm
tight
fasten
rubber
tube
pressur
monitor
miniatur
pressur
sensor
amplifi
e
g
kyowa
electron
instrument
co
tokyo
adjust
kgcm
rubber
tube
knot
sensor
remov
h
anim
treat
test
compound
control
solut
tourniquet
left
place
h
anim
remain
pentobarbit
anesthesia
rubber
tube
remov
rat
return
cage
within
min
reperfus
hind
limb
pale
blue
turn
pink
anim
allow
free
access
food
water
blood
withdrawn
differ
interv
tourniquet
afterward
measur
hematocrit
transaminas
urea
nitrogen
total
protein
time
death
regist
statist
evalu
surviv
interv
perform
log
rank
test
accord
peto
et
al
blood
chemic
data
analyz
use
kruskalw
rank
sum
test
multipl
comparison
correct
bonferroni
method
method
valuabl
find
drug
effect
lifethreaten
situat
ghussen
et
al
studi
effect
methylprednisolon
experiment
tourniquet
shock
dog
haugan
kirkebo
use
model
anesthet
rat
tourniquet
shock
bilater
hindlimb
occlus
h
burn
shock
scald
hind
bodi
surfac
water
horl
horl
investig
effect
tourniquet
ischemia
carbohydr
metabol
dog
skelet
muscl
et
al
follow
time
cours
appear
lactic
dehydrogenas
enzym
serum
rat
differ
period
ischemia
bilater
applic
rubber
band
tourniquet
hind
leg
et
al
studi
effect
allopurinol
biochem
chang
gastrocnemiu
muscl
rat
subject
tourniquet
shock
follow
reperfus
littl
ra
heat
stroke
medic
emerg
quick
diagnosi
treatment
victim
essenti
posit
prognosi
sever
anim
model
establish
investig
heat
relat
studi
rat
francesconi
mager
hubbard
et
al
hubbard
et
al
kielblock
et
al
rabbit
shih
et
al
dog
bynum
et
al
sheep
tayeb
marzouki
consid
suitabl
model
similar
man
respons
high
temperatur
male
spragu
dawley
rat
weigh
g
fast
h
experi
prevent
studi
anim
treat
subcutan
h
either
restrain
appropri
wire
cage
place
environment
chamber
set
ambient
temperatur
exercis
motordriven
treadmil
core
temperatur
rectal
probe
insert
cm
measur
use
copperconstantan
thermocoupl
conjunct
thermocoupl
refer
oven
data
acquisit
system
teletyp
printout
reach
exhaust
predetermin
core
temperatur
rat
monitor
ambient
temperatur
rest
plastic
cage
line
wood
shave
recoveri
anim
return
cage
allow
water
food
h
ld
valu
determin
treat
control
anim
kielblock
et
al
analyz
cardiovascular
function
direct
record
arteri
blood
pressur
ecganalysi
francesconi
mager
studi
pathochem
indic
serum
lactat
concentr
potassium
level
plasma
creatin
phosphokinas
kregel
et
al
investig
peripher
vascular
respons
hyperthermia
rat
implant
doppler
flow
probe
superior
mesenter
left
iliac
left
renal
extern
caudal
arteri
conclud
select
loss
compensatori
vasoconstrict
trigger
cascad
event
character
heat
stroke
shido
nagasaka
studi
thermoregulatori
respons
acut
bodi
heat
rat
acclim
continu
heat
exposur
indirect
extern
warm
perform
rais
jacket
water
temperatur
surround
calorimet
intraperiton
heat
made
electr
heater
implant
chronic
periton
caviti
chiu
et
al
report
increas
surviv
rat
heatstrok
reduc
hypothalam
serotonin
releas
administr
receptor
antagonist
simpl
method
test
mydriat
substanc
test
mous
pupil
describ
pulewka
diamet
pupil
narrow
intens
light
illumin
dosedepend
increas
pupil
diamet
achiev
intraperiton
applic
atropin
synthet
mydriat
ing
et
al
burn
et
al
mydriat
effect
hexamethonium
analogu
measur
blackman
et
al
mydriasi
induc
norepinephrin
epinephrin
isoproterenol
antagon
freundt
male
mice
weigh
g
use
kept
least
min
separ
beaker
bright
illumin
pupil
diamet
measur
dissect
microscop
contain
arbitrari
scale
eyepiec
make
illumin
uniform
possibl
beaker
contain
mice
place
beneath
long
lowpow
fluoresc
tube
top
glossi
white
paper
pupil
diamet
measur
mm
variou
time
interv
treatment
group
mice
use
dose
compound
vehicl
control
test
sympatholyt
activ
variou
dose
inject
subcutan
min
prior
intraven
inject
mgkg
norepinephrin
mgkg
epinephrin
mgkg
isoproterenol
effect
norepinephrin
block
effect
epinephrin
effect
isoproterenol
mean
valu
diamet
group
treat
compar
anim
treat
norepinephrin
epinephrin
isoproterenol
edg
use
mydriasi
mous
quantit
method
estim
parasympathet
ganglion
block
et
al
use
isol
iri
sphincter
pigment
rabbit
test
multipl
tachykinin
pool
sensori
nerv
fibr
eye
taken
within
min
sacrific
open
incis
mm
posterior
limbu
follow
excis
iri
ciliari
margin
iri
sphincter
muscl
open
cut
half
mount
vertic
perspex
holder
ml
tissu
bath
maintain
c
mechan
activ
electr
stimul
record
isometr
use
forc
displac
transduc
polygraph
kern
use
isol
sphincter
dilat
muscl
human
eye
obtain
autopsi
studi
sympathomimet
adrenerg
block
agent
cholinotrop
receptor
identifi
respons
bradykinin
capsaicin
isol
iri
sphincter
consid
mediat
substanc
p
releas
trigemin
nerv
ueda
et
al
pupillari
dilat
use
index
central
nervou
system
adrenoreceptor
activ
koss
clonidin
induc
mydriasi
mediat
adrenoreceptor
locat
brain
berridg
et
al
hey
et
al
blockad
presynapt
locat
adrenoreceptor
consid
possibl
mechan
antidepress
drug
mianserin
abl
antagon
clonidineinduc
mydriasi
rat
gower
al
studi
larg
number
psychotrop
drug
model
aim
reveal
vivo
adrenoreceptor
block
effect
new
compound
male
wistar
rat
weigh
g
anesthet
pentobarbit
mgkg
ip
polyethylen
cathet
insert
femor
vein
drug
administr
rat
head
rest
base
platform
binocular
olympu
microscop
posit
pupil
diamet
right
eye
could
measur
mean
micromet
insert
one
eyepiec
microscop
constant
light
intens
maintain
throughout
experi
rat
first
inject
salin
min
anesthesia
induct
pupil
diamet
measur
min
inject
five
min
measur
mydriasi
induc
clonidin
mgkg
iv
diamet
measur
min
inject
follow
test
compound
inject
min
interv
increas
dose
pupil
measur
min
inject
dose
inhibit
clonidineinduc
mydriasi
id
determin
per
rat
cumul
doserespons
curv
savontau
et
al
studi
effect
imidazolin
deriv
detomidineinduc
mydriasi
anesthet
rat
young
chick
clonidin
caus
loss
right
reflex
antagon
mianserin
pommier
et
al
phenomenon
use
measur
blockad
vivo
gower
et
al
male
white
leghorn
chick
use
either
hour
hatch
day
later
clonidineinduc
loss
right
reflex
sleep
determin
anim
time
two
anim
treat
placebo
dose
level
test
compound
test
group
anim
continu
anim
test
per
dose
level
placebo
treatment
chick
mark
ink
inject
intraperiton
placebo
test
compound
ten
min
later
mgkg
clonidin
inject
leg
muscl
anim
place
individu
small
macrolon
cage
begin
sleep
time
defin
moment
anim
place
back
remain
posit
sleep
time
record
return
feet
spontan
anoth
attempt
put
back
fail
sleep
time
record
maximum
period
min
statist
evalu
differ
median
sleep
time
done
mannwhitney
utest
doserespons
relat
variou
drug
calcul
compound
known
adrenoceptor
block
activ
antagon
clonidineinduc
sleep
chick
dosedepend
yohimbin
one
activ
compound
howev
also
central
activ
compound
main
effect
blockad
reduc
clonidineinduc
sleep
time
one
potent
apomorphin
act
dopamin
therefor
clonidineinduc
sleep
test
chick
regard
highli
specif
adrenoceptor
rel
potenc
catecholamin
stimul
mediat
respons
vari
differ
tissu
indic
exist
two
subtyp
land
et
al
heart
classifi
subtyp
uteru
diaphragm
bronchiol
small
intestin
classifi
subtyp
sinc
tissu
epinephrin
potent
norepinephrin
observ
led
develop
select
agonist
antagonist
isol
organ
see
predominantli
one
receptor
subtyp
isol
heart
isol
atrium
isol
uteru
isol
tracheal
chain
use
test
compound
select
activ
assess
activ
anim
vivo
result
advantag
pharmacokinet
metabol
influenc
drug
test
paramet
femal
spraguedawley
rat
g
anesthet
mgkg
pentobarbit
ip
prior
pith
gillespi
muir
anim
artifici
respir
room
air
use
harvard
small
anim
ventil
strokesmin
pressur
cm
h
bodi
temperatur
maintain
place
anim
heat
oper
tabl
left
carotid
arteri
cannul
continu
monitor
blood
pressur
via
statham
pressur
transduc
blood
pressur
signal
use
trigger
instantan
rate
meter
continu
monitor
heart
rate
femor
vein
cannul
intraven
administr
drug
midlin
incis
made
expos
one
horn
uteru
ovarian
arteri
cut
tie
one
horn
dissect
free
ovari
leav
myometri
blood
suppli
intact
cotton
thread
attach
free
end
uterin
horn
pass
glassjacket
organ
bath
connect
isometr
pioden
transduc
measur
spontan
contract
cannula
insert
periton
caviti
administr
drug
ip
rout
organ
bath
posit
surround
uterin
horn
without
touch
tissu
perifus
krebshenseleit
solut
gass
co
maintain
rest
tension
g
appli
tissu
allow
stabil
spontan
contract
constant
period
min
record
made
polygraph
doserespons
curv
iv
inject
establish
isoprenalin
nonselect
adrenoreceptor
salbutamol
select
noradrenalin
select
increas
heart
rate
beatsmin
decreas
height
uterin
contract
calcul
percentag
origin
amplitud
anim
given
noradrenalin
pretreat
phenoxybenzamin
mmolkg
iv
order
antagon
irrevers
agonist
doserespons
curv
n
heart
rate
uterin
relax
carri
assess
activ
least
dose
agonist
new
synthet
compound
test
intraperiton
administr
addit
abil
nonselect
propranolol
mmolkg
iv
select
atenolol
select
inhibit
respons
isoprenalin
heart
rate
uterin
relax
assess
compar
log
linear
portion
doserespons
curv
isoprenalin
absenc
presenc
antagonist
anim
dose
ratio
antagonist
calcul
method
describ
pierci
advantag
measur
agonist
antagonist
activ
differenti
effect
compar
test
isol
organ
vivo
activ
determin
intraperiton
intraduoden
administr
et
al
studi
influenc
variou
agent
contract
electr
stimul
isol
uteri
rabbit
guinea
pig
nathason
evalu
activ
betablock
inhibit
cardioacceleratori
effect
system
administ
isoproterenol
unanesthet
restrain
albino
rabbit
togeth
effect
membran
bound
adenyl
cyclas
homogen
ciliari
process
villi
order
find
compound
select
lower
intraocular
pressur
gillespi
js
muir
tc
intraven
administr
isoprenalin
isoproterenol
stimul
receptor
heart
detect
increas
contractil
dpdt
max
intraarteri
inject
isoprenalin
stimul
peripher
blood
vessel
lead
increas
peripher
blood
flow
therefor
activ
compound
reveal
inhibit
effect
isoprenalin
follow
test
use
evalu
activ
drug
screen
done
anesthet
dog
addit
test
allow
differenti
receptor
activ
determin
ed
valu
b
male
femal
beagl
dog
weigh
kg
use
anim
premed
g
inactin
iv
anesthet
intraven
administr
mgkg
chloralos
mgkg
urethan
addit
receiv
subcutan
inject
mgkg
morphin
h
start
anesthesia
anim
heparin
respir
maintain
tracheal
tube
use
posit
pressur
respir
endexpiratori
co
content
measur
continu
respiratori
rate
depth
respir
adjust
vol
endexpiratori
co
administr
isoprenalin
peripher
vein
cannul
record
peripher
systol
diastol
blood
pressur
cannula
insert
femor
arteri
connect
pressur
transduc
statham
p
db
determin
lvp
millar
microtip
cathet
pc
insert
via
left
arteria
caroti
communi
lvedp
measur
highsensit
scale
pressur
curv
dpdt
max
differenti
heart
rate
count
peripher
blood
flow
femor
arteri
measur
electromagnet
flow
probe
follow
steadyst
period
min
isoprenalin
administ
intraven
time
anesthet
anim
hemodynam
paramet
record
control
valu
test
substanc
inject
intraven
cumul
dose
final
concentr
mgkg
dose
min
drug
effect
monitor
measur
hemodynam
paramet
effect
isoprenalin
test
time
experi
singl
dose
drug
administ
determin
durat
action
test
compound
show
inhibitori
influenc
isoprenalin
effect
second
test
compound
administ
hemodynam
paramet
regist
continu
whole
experi
follow
steadyst
period
min
isoprenalin
administ
iv
administr
test
twice
dose
gkg
intraarteri
administr
test
twice
dose
hemodynam
paramet
record
control
valu
test
substanc
inject
intraven
cumul
dose
consecut
increas
dose
given
interv
dose
min
drug
effect
monitor
measur
hemodynam
paramet
thereaft
isoprenalin
given
intraven
min
later
intraarteri
hemodynam
paramet
regist
continu
whole
experi
receptor
antagon
measur
decreas
contractil
dpdt
max
inhibit
isoprenalineinduc
elev
heart
rate
consid
indic
nonselect
cardioselect
blocker
increas
dpdt
max
inhibit
lower
dose
test
drug
rise
heart
rate
receptor
blockad
test
drug
measur
inhibit
isoprenalineinduc
increas
peripher
blood
flow
differ
hemodynam
paramet
determin
percent
inhibit
isoprenalineinduc
effect
test
compound
calcul
compar
isoprenalin
effect
drug
administr
ed
valu
antagon
calcul
logprobit
analys
ed
defin
dose
drug
lead
inhibit
isoprenalin
effect
ed
ed
ratio
indic
agent
predominantli
influenc
receptor
cardioselect
read
turner
ra
block
agent
turner
ra
hebborn
p
ed
screen
method
pharmacolog
vol
ii
pp
academ
press
new
york
london
agent
classifi
agent
intrins
sympathomimet
activ
isa
agent
membran
stabil
activ
msa
agent
organ
select
high
affin
heart
receptor
follow
procedur
reserpinepretr
dog
agent
intrins
sympathomimet
activ
identifi
reserpin
administr
h
start
experi
lead
deplet
catecholamin
depot
thu
possibl
differenti
indirectli
act
sympathomimet
tyramin
directli
act
one
noradrenalin
test
use
identifi
drug
intrins
sympathomimet
activ
male
femal
beagl
dog
weigh
kg
use
twentyfour
h
test
dog
receiv
intramuscular
inject
mgkg
reserpin
day
experi
anim
anesthet
intraven
administr
mgkg
pentobarbit
sodium
respir
tracheal
tube
use
posit
pressur
respir
control
measur
endexpiratori
co
concentr
vol
record
peripher
systol
diastol
blood
pressur
femor
arteri
cannul
connect
pressur
transduc
statham
p
db
determin
lvp
millar
microtip
cathet
pc
insert
left
ventricl
via
left
common
carotid
arteri
lvedp
measur
highsensit
scale
pressur
curv
dpdt
max
differenti
heart
rate
count
test
substanc
administ
continu
intraven
infus
mgkg
mlmin
cumul
dose
mgkg
achiev
within
approxim
min
thereaft
veloc
infus
doubl
mgkg
mlmin
test
finish
cumul
dose
mgkg
achiev
total
time
approxim
min
hemodynam
paramet
regist
continu
entir
experi
characterist
blood
pressur
systol
blood
pressur
diastol
blood
pressur
left
ventricular
pressur
lvp
left
ventricular
enddiastol
pressur
lved
dpdt
max
heart
rate
hr
differ
hemodynam
paramet
determin
measur
intrins
sympathomimet
activ
isa
increas
dpdt
max
heart
rate
evalu
absolut
rel
differ
paramet
drugtreat
anim
compar
vehicl
control
valu
statist
evalu
perform
mean
student
ttest
n
score
allot
rel
efficaci
standard
compound
intens
well
durat
effect
dipalma
nicotin
acetylcholin
receptor
involv
ganglion
neurotransmiss
variou
subtyp
describ
nicotin
acetylcholin
receptor
sargent
mcgehe
role
karlin
akaba
alexand
et
al
nictit
membran
cat
use
extens
pharmacolog
studi
evalu
ganglion
block
activ
eas
movement
record
simplic
innerv
pure
adrenerg
fibr
cell
bodi
easili
access
superior
cervic
ganglion
site
blood
suppli
via
extern
carotid
arteri
access
intraarteri
inject
preganglion
postganglion
stimul
allow
interpret
mode
action
vasoact
drug
anim
anesthet
mgkg
pentobarbitalsodium
ip
tracheostomi
perform
tracheal
cannula
insert
one
side
sympathet
nerv
expos
separ
vagu
nerv
prepar
order
place
electrod
preganglion
postganglion
stimul
prefer
vagu
nerv
site
sever
central
end
head
anim
fix
head
holder
prevent
head
movement
linear
transduc
fix
mid
border
nictit
membran
allow
registr
contract
polygraph
preganglion
postganglion
stimuli
exert
squar
wave
stimul
puls
width
ms
amplitud
v
frequenc
amplitud
puls
width
vari
anim
anim
sympathet
nerv
stimul
administr
compound
chang
contract
nictit
membran
note
furthermor
respons
nictit
membran
exogen
adrenalin
regist
decreas
respons
drug
applic
express
percentag
control
drug
ganglion
blocker
decreas
respons
preganglion
stimul
influenc
postganglion
stimul
exogen
adrenalin
neuron
blocker
decreas
respons
preganglion
postganglion
stimul
affect
respons
exogen
adrenalin
may
even
enhanc
blocker
decreas
respons
preganglion
postganglion
stimul
well
decreas
effect
exogen
adrenalin
catecholamin
uptak
inhibitor
increas
respons
preganglion
postganglion
stimul
well
enhanc
respons
exogen
adrenalin
nictit
membran
prepar
wide
use
differenti
cardiovascular
effect
sinc
use
higher
anim
cat
limit
great
extent
model
use
except
altern
contract
inferior
eyelid
anesthet
rat
preganglion
electr
stimul
superior
cervic
ganglion
recommend
gertner
steinbrech
schmidwand
modif
use
steinbrech
schmidwand
method
suitabl
test
compound
potenti
adrenerg
antiadrenerg
activ
test
ganglion
block
activ
male
spragu
dawley
rat
anesthet
mgkg
thiobutabarbit
ip
kept
heat
oper
tabl
rectal
temperatur
one
femor
vein
cannul
fill
heparin
solut
one
femor
arteri
cannul
registr
blood
pressur
tracheotomi
perform
polyethylen
cathet
cm
length
insert
head
anim
fix
care
vibrissa
lower
eyelid
right
side
cut
thread
attach
margin
eyelid
attach
straingaug
immobil
musculatur
face
mouth
anim
sutur
head
support
attach
right
sympathet
nerv
expos
separ
vagu
nerv
prepar
order
place
electrod
preganglion
stimul
calibr
stimul
perform
twice
interv
contract
back
baselin
furthermor
dose
mgkg
adrenalin
given
bolu
inject
eyelid
contract
blood
pressur
increas
record
put
adrenerg
blocker
standard
mgmg
phentolamin
inject
intraven
eyelid
contract
electr
stimul
adrenalin
reduc
dosedepend
quilliam
shand
assess
select
drug
compar
effect
ganglion
transmiss
preand
postganglion
nerv
isol
superior
cervic
ganglion
prepar
rat
langer
trendelenburg
perform
experi
normal
nictit
membran
pith
cat
well
isol
normal
nictit
membran
koss
hey
use
frequencydepend
nictit
membran
respons
sympathet
nerv
stimul
anesthet
cat
determin
potenti
role
prejunct
histamin
h
receptor
gurtu
et
al
use
contract
cat
nictit
membran
explor
effect
calcium
channel
blocker
neurotransmiss
vivo
compar
effect
verapamil
nifedipin
contract
nictit
membran
follow
either
electr
stimul
superior
cervic
ganglion
intraven
inject
phenylephrin
koss
compar
peripher
central
nervou
system
sympatholyt
action
prazosin
use
cat
nictit
membran
submaxim
contract
nictit
membran
evok
electr
stimul
preganglion
cervic
sympathet
nerv
trunk
stimul
posterior
hypothalamu
anesthet
cat
badio
et
al
evalu
spiropyrrolizidin
new
structur
class
blocker
nicotin
receptor
channel
select
ganglion
type
receptor
rat
pheochromocytoma
cell
nicotin
receptor
human
medulloblastoma
cell
receptor
use
bovin
retractor
peni
muscl
assess
ganglionblock
activ
neuromuscular
block
drug
recommend
alaranta
et
al
kling
et
al
kling
perform
extens
studi
physiolog
pharmacolog
retractor
peni
bull
also
discuss
variou
hypothes
inhibitori
excitatori
innerv
muscl
present
mani
vertebr
hors
cat
dog
rat
men
rabbit
also
found
effect
isol
retractor
peni
muscl
penil
arteri
rather
similar
excitatori
innerv
found
predominantli
kling
et
al
kling
wherea
transmitt
histamin
bradykinin
effect
speci
relax
isol
retractor
peni
muscl
could
elicit
nicotin
nicotin
agonist
kling
et
al
studi
ganglionblock
activ
strip
retractor
peni
muscl
precontract
relax
induc
nicotin
antagon
ganglionblock
retractor
peni
muscl
obtain
bull
differ
breed
weigh
kg
sampl
dissect
cm
distal
point
pair
muscl
bundl
pass
anal
orific
immedi
slaughter
sampl
freed
fat
surround
tissu
place
tyrod
solut
strip
mm
length
mm
wide
prepar
mount
organ
bath
contain
tyrod
solut
aerat
co
equilibrium
time
h
allow
equilibrium
period
wash
perform
interv
chang
tension
record
mean
grass
ft
forc
displac
transduc
coupl
polygraph
highenough
tone
studi
nicotineinduc
relax
usual
g
gener
ad
concentr
organ
bath
wash
perform
min
applic
nicotin
min
later
tone
rais
applic
nicotin
repeat
effect
neuromuscular
block
drug
studi
relax
caus
nicotin
two
consecut
control
equal
size
block
activ
certain
concentr
drug
express
reduct
relax
muscl
strip
accord
follow
equat
size
control
relax
millimet
b
size
relax
block
drug
order
construct
regress
line
activ
four
five
dose
level
assum
linear
part
concentrationeffect
curv
studi
activ
dose
level
studi
least
strip
obtain
differ
anim
ic
valu
calcul
regress
line
parallel
regress
line
test
covari
analysi
molar
potenc
ratio
known
ganglionblock
agent
obtain
method
compar
result
method
inhibit
contract
cat
nictit
membran
evok
preganglion
sympathet
stimul
bowman
webb
see
inhibit
nicotineinduc
contract
isol
guinea
pig
ileum
feldberg
inhibit
contract
guinea
pig
va
deferen
evok
preganglion
stimul
hypogastr
nerv
vitro
birmingham
hussain
depress
postganglion
action
potenti
evok
preganglion
stimul
superior
cervic
ganglion
rat
vitro
quilliam
shand
induct
mydriasi
mous
block
ciliari
ganglion
edg
fair
complet
agreement
result
obtain
variou
method
found
gillespi
sheng
studi
effect
pyrogallol
hydroquinon
respons
nonadrenerg
noncholinerg
nerv
stimul
rat
anococcygeu
bovin
retractor
peni
muscl
parkkisenniemi
kling
use
sampl
retractor
peni
muscl
penil
arteri
bull
function
character
endothelin
receptor
la
et
al
studi
inhibit
nitrerg
nerveinduc
relax
rat
anococcygeu
bovin
retractor
peni
muscl
hydroxycobalamin
blood
pressur
reach
constant
valu
dose
test
compound
inject
via
jugular
vein
blood
pressur
record
min
interv
dose
angiotensin
ii
inject
establish
doserespons
curv
min
continu
infus
start
potenti
angiotensin
ii
blocker
dosag
mlmin
ten
min
begin
infus
dose
angiotensin
ii
inject
setup
angiotensin
ii
administ
continu
infus
dosag
mlmin
blood
pressur
reach
elev
steadi
state
level
mgkg
angiotensin
ii
antagonist
administ
intens
durat
fall
blood
pressur
record
increas
blood
pressur
indic
intrins
agonist
activ
increas
blood
pressur
graduat
dose
angiotensin
ii
infus
express
percentag
increas
infus
result
compar
known
angiotensin
ii
antagonist
test
potenc
durat
activ
also
intrins
agonist
activ
angiotensin
ii
antagonist
test
variou
pharmacolog
model
use
test
angiotensin
ii
antagonist
blood
pressur
consciou
unrestrain
rat
chronic
implant
cathet
normal
blood
pressur
spontan
hypertens
chronic
renal
hypertens
vogel
et
al
chiu
et
al
brook
et
al
aiyar
et
al
deprez
et
al
gabel
et
al
hilditch
et
al
keiser
et
al
nagura
et
al
nozawa
et
al
renzetti
et
al
wong
junggren
et
al
blood
pressur
consciou
spontan
hypertens
anesthet
ganglionblock
rat
olin
et
al
blood
pressur
pith
consciou
renovascular
hypertens
rat
criscon
et
al
wienen
et
al
deprez
et
al
kivlighn
et
al
kushida
et
al
blood
pressur
rat
intracerebroventricularli
inject
angiotensin
ii
vogel
et
al
batt
et
al
blood
pressur
consciou
angiotensin
iinfus
renindepend
hypertens
dog
brook
et
al
cazaubon
et
al
aiyar
et
al
deprez
et
al
gabel
et
al
keiser
et
al
wong
et
al
blood
pressur
heart
rate
consciou
sodiumdeplet
sodiumreplet
cynomolgu
monkey
lacour
et
al
cazaubon
et
al
keiser
et
al
angiotensin
ii
induc
pressor
respons
marmoset
nagura
et
al
blood
pressur
heart
rate
consciou
rhesu
monkey
anesthet
chimpanze
gabel
et
al
kivlighn
et
al
kivlighn
et
al
inhibit
angiotensin
iiinduc
contract
isol
aorta
ring
strip
rabbit
chui
et
al
chui
et
al
criscion
et
al
cazaubon
et
al
olin
et
al
wienen
et
al
aiyar
et
al
caussad
et
al
hilditch
et
al
keiser
et
al
kushida
et
al
nagura
et
al
renzetti
et
al
wong
et
al
rat
nozawa
et
al
neonat
rat
keiser
et
al
guinea
pig
mizuno
et
al
inhibit
angiotensin
iiinduc
contract
isol
rat
pulmonari
arteri
chang
et
al
antagon
angiotensin
ii
isol
strip
rabbit
aorta
rabbit
jugular
vein
rabbit
pulmonari
arteri
rat
portal
vein
rat
stomach
rat
urinari
bladder
human
urinari
bladder
human
colon
human
ileum
rhaleb
et
al
contract
guinea
pig
ileum
situ
khairallah
page
antagon
angiotensin
ii
isol
rat
uteru
wahhab
et
al
contractil
forc
prostaglandin
e
synthesi
electr
stimul
rabbit
isol
va
deferen
tracht
et
al
antagon
angiotensin
iiinduc
aldosteron
releas
bovin
adren
glomerulosa
cell
criscion
et
al
rat
dispers
adren
capsular
cell
chang
et
al
antagon
angiotensin
iiinduc
inhibit
guanyl
cyclas
activ
rat
pheochromocytoma
cell
line
brechler
et
al
brook
et
al
compar
cardiovascular
renal
effect
angiotensin
ii
receptor
antagonist
captopril
rat
chronic
renal
failur
induc
nephrectomi
sodium
pentobarbit
anesthesia
right
kidney
remov
approxim
two
third
left
kidney
infarct
ligat
two
three
branch
left
renal
arteri
kim
et
al
studi
effect
angiotensin
receptor
antagonist
volum
overloadinduc
cardiac
gene
express
rat
abdomin
aortacav
shunt
prepar
old
male
wistar
rat
sodium
pentobarbit
anesthesia
vena
cava
abdomin
aorta
expos
open
abdomin
caviti
via
midlin
incis
aorta
punctur
union
segment
two
third
caudal
renal
arteri
one
third
cephal
aortic
bifurc
dispos
needl
needl
advanc
aorta
perfor
adjac
wall
penetr
vena
cava
aorta
clamp
needl
withdrawn
drop
cyanoacryl
glue
use
seal
aortic
punctur
point
patenc
shunt
verifi
visual
swell
vena
cava
mix
arteri
venou
blood
rat
treat
either
vehicl
angiotensin
antagonist
four
day
prepar
ac
shunt
hurin
volum
electrolyt
aldosteron
measur
six
day
ac
shunt
blood
collect
punctur
tail
vein
plasma
renin
activ
aldosteron
measur
seven
day
ac
shunt
hemodynam
studi
perform
pentobarbit
anesthesia
afterward
heart
rapidli
excis
left
right
atria
ventricl
separ
frozen
liquid
nitrogen
extract
measur
cardiac
tissu
rna
shibasaki
et
al
test
effect
reninangiotensinaldosteron
system
consciou
rat
cannul
abdomin
aorta
anesthesia
day
experi
oral
dose
angiotensin
ii
receptor
antagonist
blood
sampl
withdrawn
plasma
renin
aldosteron
determin
radioimmunoassay
similar
effect
ace
inhibitor
lifespan
hypertens
rat
could
doubl
longterm
treatment
angiotensin
ii
type
receptor
blocker
linz
et
al
ledingham
laverti
treat
genet
hypertens
new
zealand
rat
specif
receptor
antagonist
via
osmot
minipump
sever
week
measur
effect
blood
pressur
cardiac
hypertrophi
structur
resist
arteri
transgen
anim
recommend
studi
influenc
human
reninangiotensin
system
et
al
wagner
et
al
bohlend
et
al
angiotensinconvert
enzym
ace
respons
cleavag
almost
inact
angiotensin
activ
angiotensin
ii
enzym
kininas
ii
respons
degrad
activ
peptid
bradykinin
inact
product
ace
activ
therefor
measur
two
way
activ
newli
form
angiotensin
ii
diminut
activ
bradykinin
ace
inhibit
result
decreas
activ
precursor
angiotensin
potenti
bradykinin
effect
cardiovascular
system
sensit
peptid
react
increas
blood
pressur
angiotensin
ii
decreas
bradykinin
reaction
use
quantit
determin
ace
inhibit
activ
male
spraguedawley
rat
weigh
g
use
anim
anesthet
ip
inject
mghg
pentobarbit
intub
trachea
artifici
respir
strokesmin
stroke
volum
ml
right
carotid
arteri
cannul
blood
pressur
regist
stathamel
p
db
polygraph
one
jugular
vein
cannul
iv
inject
laparotomi
cathet
insert
duodenum
enter
administr
wound
close
blood
pressur
stabil
normal
level
im
inject
mgkg
pentolinium
order
prevent
excess
mucu
product
bronchial
system
atropin
sulfat
inject
intramuscularli
stabil
blood
pressur
ngkg
angiotensin
inject
intraven
ml
salin
inject
repeat
interv
ident
pressur
reaction
occur
test
compound
administ
dose
mgkg
intraven
mgkg
intraduoden
min
iv
inject
min
id
administr
ngkg
angiotensin
inject
standard
ramipril
enalapril
captopril
low
dose
bradykinin
chosen
order
visual
bradykinin
potenti
one
eventu
bradykinin
inject
intraven
min
interv
stabl
reaction
achiev
three
min
iv
inject
min
intraduoden
administr
test
substanc
bradykinin
inject
repeat
diminut
pressur
reaction
angiotensin
administr
potenti
ace
inhibitor
paramet
activ
new
compound
inhibit
calcul
percent
control
use
variou
dose
ace
inhibitor
doserespons
curv
establish
id
valu
calcul
potenti
bradykinin
induc
vasodepress
express
percentag
control
use
variou
dose
test
compound
standard
doserespons
curv
establish
potenc
ratio
calcul
paramet
inhibit
angiotensin
respons
potenti
bradykinininduc
vasodepress
proven
reliabl
paramet
evalu
ace
inhibitor
natoff
et
al
use
ratio
respons
angiotensin
angiotensin
ii
spontan
hypertens
rat
either
pith
anesthet
urethan
determin
degre
durat
effect
captopril
blood
level
angiotensin
ii
also
measur
radioimmunoassay
sever
studi
rat
show
benefici
effect
prolong
treatment
ace
inhibitor
postop
mortal
rat
left
ventricular
hypertrophi
myocardi
infarct
decreas
ace
inhibit
inhibit
angiotensin
iinduc
pressur
respons
administr
aceinhibitor
measur
anesthet
rat
also
anesthet
dog
consciou
rat
consciou
dog
becker
et
al
lifelong
ace
inhibit
doubl
lifespan
hypertens
rat
treatment
start
age
one
month
linz
et
al
ramipril
also
increas
surviv
old
spontan
hypertens
rat
treatment
start
age
month
linz
et
al
panzenbeck
et
al
report
captoprilinduc
hypotens
inhibit
bradykinin
blocker
hoe
na
deplet
marmoset
becker
rha
ba
metzger
schulz
kj
pharmacolog
highli
specif
inhibitor
enzym
renin
consid
potenti
antihypertens
agent
agent
caus
fall
blood
pressur
sodiumdefici
dog
decreas
plasma
renin
activ
well
angiotensin
ii
level
adult
mongrel
dog
kg
either
sex
given
water
ad
libitum
maintain
low
sodium
diet
week
experi
singl
intramuscular
inject
mgkg
furosemid
given
h
experi
day
experi
dog
anesthet
sodium
pentobarbit
mgkg
iv
cuf
endotrach
tube
posit
allow
artifici
respir
measur
arteri
blood
pressur
femor
arteri
catheter
polyethylen
tube
right
left
femor
vein
catheter
drug
administr
deliveri
mainten
infus
sodium
pentobarbit
mgkgh
blood
pressur
measur
directli
cathet
connect
gouldstatham
pressur
transduc
blood
sampl
collect
arteri
cathet
increas
dose
potenti
renin
inhibitor
infus
min
follow
min
recoveri
period
immedi
last
recoveri
period
dog
given
iv
infus
angiotensin
receptor
antagonist
saralasin
min
measur
plasma
renin
activ
angiotensin
ii
level
dog
infus
period
min
test
compound
blood
withdrawn
min
start
infus
final
blood
draw
saralasin
infus
min
antibodytrap
method
prefer
measur
plasma
renin
activ
pra
procedur
pra
determin
ph
ria
quantif
angiotensin
ang
gener
trap
excess
antiang
antibodi
poulsen
jorgensen
nussberg
et
al
tube
coat
rabbit
antiang
antibodi
gamma
coat
plasma
renin
activ
ria
kit
baxter
travenol
diagnost
incub
icewat
bath
plasma
mix
tri
base
buffer
ph
contain
mm
edta
tri
base
ph
contain
gl
human
serum
albumin
fraction
v
sigma
tube
vortex
incub
min
incub
termin
place
tube
icewat
bath
next
tri
albumin
buffer
ad
follow
ml
phosphat
ria
buffer
gamma
coat
contain
cpm
ang
standard
ang
ngml
also
incub
min
trisalbumin
buffer
icewat
bath
low
renin
plasma
ad
standard
addit
ml
tracer
solut
sampl
standard
incub
h
tube
aspir
count
gamma
counter
level
immunoreact
angiotensin
ii
irang
ii
measur
use
procedur
describ
nussberg
et
al
twothre
ml
whole
blood
collect
prechil
glass
tube
contain
follow
inhibitor
solut
ethanol
mm
phenanthrolin
mm
edta
mm
pepstatin
mm
captopril
gl
neomycin
sulfat
mm
renin
inhibitor
cgp
tube
centrifug
plasma
quickli
frozen
liquid
nitrogen
store
extract
angiotensin
peptid
bondelut
cartridg
bondelutph
contain
mg
phenylsilica
use
along
vac
elut
vacuum
manifold
analytichem
harbor
citi
ca
cartridg
precondit
ml
methanol
hplc
grade
follow
ml
water
hplc
grade
vacuum
pressur
mm
hg
one
ml
thaw
sampl
appli
cartridg
wash
ml
hplc
grade
water
angiotensin
peptid
retain
column
elut
ml
methanol
hplc
grade
vacuum
pressur
less
mm
hg
polypropylen
tube
coat
buffer
contain
tri
nan
mgml
fatti
acidfre
bovin
serum
albumin
ph
glacial
acet
acid
methanol
evapor
irang
ii
measur
use
antibodi
igg
corp
nashvil
tn
greater
select
ang
ii
data
express
mean
sem
hypotens
respons
variou
dose
renin
antagonist
compar
inhibit
plasma
renin
activ
decreas
immunoreact
angiotensin
ii
antibodytrap
method
report
give
better
correl
blood
pressur
lower
effect
dog
convent
method
base
ria
gener
ang
palmer
et
al
pal
et
al
describ
rat
model
evalu
inhibitor
human
renin
use
anesthet
nephrectom
ganglionblock
rat
blood
pressur
rise
induc
sustain
infus
renin
dosedepend
decreas
renin
inhibitor
reninangiotensinsystem
main
regul
blood
pressur
influenc
sever
way
one
approach
involv
inhibit
renin
renin
aspartyl
proteas
hydrolyz
angiotensinogen
releas
dekapeptid
angiotensin
subsequ
convert
angiotensin
ii
angiotensinconvertingenzym
sequenc
renin
angiotensinogen
variou
speci
reveal
mark
speci
differ
enzym
substrat
inhibitor
develop
human
renin
show
high
specif
primat
renin
show
weak
inhibit
renin
subprim
speci
mean
common
laboratori
anim
rat
dog
suitabl
vivo
evalu
renin
inhibitor
marmoset
chosen
wood
et
al
wood
et
al
primat
model
marmoset
callithrix
jacchu
sex
weigh
g
fed
pellet
diet
supplement
fruit
two
day
prior
experi
anim
anesthet
cathet
implant
femor
arteri
measur
blood
pressur
later
tail
vein
inject
infus
test
substanc
thirti
min
experi
anim
receiv
intraven
inject
mgkg
furosemid
order
stimul
renin
releas
experi
marmoset
sedat
diazepam
mgkg
ip
kept
restrain
box
mean
blood
pressur
record
continu
heart
rate
measur
fix
interv
test
compound
standard
inject
variou
dose
intraven
infus
administ
oral
blood
pressur
record
min
intraven
infus
min
stop
infus
compar
chang
pretreat
valu
variou
dose
doserespons
curv
establish
fischli
et
al
monitor
arteri
pressur
consciou
chronic
instrument
monkey
use
telemetri
system
one
week
experi
anim
anesthet
high
fidel
pressur
tip
transduc
millar
instrument
inc
insert
abdomin
aorta
right
femor
arteri
cathet
tunnel
subcutan
back
monkey
interscapular
region
proxim
part
cathet
connect
transmitt
locat
jacket
worn
monkey
blood
pressur
transmit
continu
receiv
transform
signal
analogu
valu
blood
pressur
report
effect
renin
inhibitor
anesthet
rhesu
monkey
weigh
kg
anim
sodiumdeplet
administr
mgkgday
furosemidena
consecut
day
day
mgkg
furosemid
given
iv
min
start
experi
anesthesia
induc
mgkg
ketaminehydrochlorid
im
continu
mgkg
pentobarbitonena
slow
iv
drip
complet
surgic
procedur
insert
cathet
fluoroscop
control
follow
hemodynam
paramet
measur
puls
rate
systol
diastol
blood
pressur
regist
transduc
statham
id
one
femor
arteri
cathet
tip
manomet
millar
instrument
houston
texa
usa
introduc
left
ventricular
caviti
determin
left
ventricular
pressur
contractil
electron
deduc
left
ventricular
pressur
appropri
amplifi
hellig
gmbh
freiburg
germani
electrocardiogram
ecg
convent
lead
ii
taken
use
ecg
transduc
hellig
gmbh
heart
rate
measur
qrspeak
use
biotachomet
hellig
gmbh
cardiac
output
determin
use
thermodilut
method
thermodilut
integr
convert
cardiac
output
read
commerci
avail
equip
hmv
hoyer
bremen
determin
cardiac
output
ml
chill
isoton
glucos
solut
inject
rapidli
right
ventricl
cathet
via
right
jugular
vein
thermistor
place
aortic
arch
via
right
carotid
arteri
hemodynam
monitor
min
follow
iv
inject
variou
dose
potenti
renin
inhibitor
end
experi
ace
inhibitor
ramiprilat
given
iv
probe
addit
blood
pressur
lower
effect
blood
sampl
determin
ang
ii
concentr
renin
inhibit
plasma
drug
level
withdrawn
min
iv
inject
renin
inhibitor
volum
replac
iv
inject
isoton
glucos
solut
data
blood
sampl
obtain
anim
sacrif
overdos
pentobarbitonena
experi
intraduoden
administr
sodium
deplet
anesthesia
done
describ
small
side
branch
femor
radial
arteri
surgic
expos
cannul
blood
pressur
measur
use
pressur
transduc
id
heart
rate
determin
convent
ecg
lead
biotachomet
blood
sampl
withdrawn
via
cathet
place
saphen
vein
gastric
fiberscop
olympu
xp
introduc
duodenum
visual
control
renin
inhibitor
administ
intraduoden
servic
channel
fiberscop
volum
ml
blood
sampl
withdrawn
min
intraduoden
administr
wood
et
al
test
oral
effect
renin
inhibitor
aliskiren
marmoset
blood
pressur
heart
rate
measur
telemetri
consciou
anim
move
freeli
home
cage
pressur
transmitt
unit
model
scienc
usa
implant
periton
caviti
asept
condit
light
anesthesia
sensor
cathet
place
aorta
renal
arteri
point
upstream
due
high
speci
specif
renin
substrat
angiotensinogen
renin
inhibitor
treatment
hypertens
test
primat
model
marmoset
well
rhesu
monkey
proven
suitabl
model
wood
jm
schnell
cr
cumin
f
menard
j
webb
rl
aliskiren
novel
oral
effect
renin
inhibitor
lower
blood
pressur
marmoset
spontan
hypertens
rat
j
hyperten
discoveri
inhibitor
phosphodiesteras
effect
drug
patient
erectil
dysfunct
klotz
et
al
porst
et
al
stimul
use
appropri
vivo
anim
model
particular
rabbit
recommend
model
impot
research
bischoff
schneider
bischoff
saenz
de
tejada
et
al
confirm
earlier
work
area
thielen
et
al
kline
naganuma
et
al
lin
lin
adult
male
chinchilla
rabbit
weigh
kg
hous
individu
cage
least
week
arriv
room
temperatur
water
food
ad
libitum
studi
indwel
cathet
fill
salin
insert
margin
ear
vein
tape
posit
drug
inject
ear
vein
follow
small
volum
salin
time
note
appropri
time
anim
gentli
remov
cage
held
one
research
worker
rabbit
peni
visibl
erect
naganuma
et
al
howev
erect
occur
possibl
examin
pudend
area
measur
length
uncov
penil
mucosa
slide
calip
penil
erect
evalu
measur
length
nearest
millimet
uncov
penil
mucosa
slide
calip
min
administr
test
compound
continu
hourli
h
mean
valu
calcul
result
express
mean
sem
area
curv
calcul
integr
program
choi
et
al
compar
efficaci
verdenafil
sildenafil
facilit
penil
erect
anesthet
rabbit
penil
erect
elicit
submaxim
pelvic
nerv
stimul
everi
min
min
respons
assess
continu
record
intracavernos
pressur
system
arteri
pressur
min
et
al
test
augment
pelvicnervemedi
sexual
arous
anesthet
femal
rabbit
sildenafil
follow
paramet
measur
pelvic
nerv
stimul
hz
hemoglobin
concentr
oxygen
satur
femal
genit
vagin
labial
clitor
tissu
laser
oximetri
clitor
blood
flow
laser
doppler
flowmetri
vagin
lumin
pressur
balloon
cathet
pressur
transduc
vagin
lubric
tampon
carter
et
al
test
effect
select
phosphodiesteras
type
inhibitor
sildenafil
erectil
dysfunct
pentobarbitalanesthet
dog
increas
intracavernos
pressur
corpu
cavernosum
penil
blood
flow
induc
pelvic
nerv
stimul
frequenc
rang
hz
effect
increas
dose
sildenafil
electricstimul
intracavernos
pressur
penil
blood
flow
blood
pressur
heart
rate
evalu
sinc
classic
experi
goldblatt
et
al
clear
evid
ischemia
kidney
caus
elev
blood
pressur
activ
reninangiotensin
system
principl
use
acut
chronic
hypertens
rat
acut
renal
hypertens
induc
clamp
left
renal
arteri
h
reopen
vessel
accumul
renin
releas
circul
proteas
renin
catalyz
first
ratelimit
step
format
angiotensin
ii
lead
acut
hypertens
test
use
evalu
antihypertens
activ
drug
male
spraguedawley
rat
weigh
g
use
anim
anesthet
intraperiton
inject
mgkg
hexobarbit
sodium
pvccoat
dieffenbach
clip
place
onto
left
hilum
kidney
fix
back
muscl
renal
arteri
occlud
h
h
follow
surgeri
anim
anesthet
intraperiton
inject
mgkg
pentobarbit
sodium
trachea
cannul
facilit
spontan
respir
measur
systol
diastol
blood
pressur
cannula
carotid
arteri
connect
pressur
transduc
statham
p
db
administr
test
compound
jugular
vein
cannul
follow
stabl
blood
pressur
state
ganglion
blockad
perform
pentolinium
mgkg
iv
obtain
stabl
reduc
blood
pressur
valu
renal
arteri
clip
remov
lead
rise
blood
pressur
consequ
elev
plasma
renin
level
within
min
stabl
hypertens
achiev
control
test
substanc
administ
intraven
inject
dose
blood
pressur
monitor
continu
renew
increas
start
level
obtain
tentwelv
anim
use
per
compound
increas
blood
pressur
reopen
renal
arteri
reduct
blood
pressur
administra
sharp
transient
system
arteri
blood
pressur
associ
reflex
bradycardia
elicit
inject
cyanid
nicotin
lobelin
coronari
arteri
blood
stream
dog
berthold
et
al
phenomenon
name
cardiogen
hypertens
chemoreflex
prove
power
agent
initi
jame
et
al
basi
find
goldblatt
et
al
ischemia
kidney
induc
hypertens
variou
modif
techniqu
describ
sever
anim
speci
one
effect
modif
rat
call
method
male
spraguedawley
rat
weigh
g
anaesthet
mgkg
ip
pentobarbit
fur
back
shave
skin
disinfect
left
lumbar
area
flank
incis
made
parallel
long
axi
rat
renal
pedicel
expos
kidney
retract
abdomen
renal
arteri
dissect
clean
ushap
silver
clip
slip
around
near
aorta
use
special
forcep
schaffenburg
size
clip
adjust
intern
gap
rang
mm
right
kidney
remov
flank
incis
tie
renal
pedicl
skin
incis
close
wound
clip
week
clip
blood
pressur
measur
rat
valu
higher
mm
hg
select
experi
blood
pressur
read
taken
day
prior
drug
treatment
drug
administ
oral
volum
mlkg
rat
divid
anim
per
dose
anim
use
control
compound
administ
day
predrug
h
postdrug
blood
pressur
read
taken
chang
systol
blood
pressur
express
mm
hg
activ
determin
compar
treatment
blood
pressur
valu
control
blood
pressur
valu
day
predrug
blood
pressur
comparison
made
use
pair
ttest
evalu
statist
signific
duan
et
al
induc
renal
hypertens
male
hartley
guinea
pig
twostep
procedur
consist
ligat
left
caudal
renal
arteri
right
nephrectomi
arteri
blood
pressur
heart
rate
monitor
consciou
anim
aceinhibitor
reduc
blood
pressur
shamoper
renal
hypertens
guinea
pig
wherea
renin
inhibitor
effect
renal
hypertens
anim
boura
ala
product
hypertens
clamp
renal
arteri
first
describ
goldblatt
et
al
dog
later
method
modifi
e
g
wrap
techniqu
abram
sobin
dog
weigh
kg
anesthet
iv
inject
mgkg
thiopent
anesthesia
maintain
halothaneoxygen
mixtur
asept
condit
midlin
abdomin
incis
made
one
kidney
expos
wrap
cellophan
replac
contralater
kidney
expos
arteri
vein
uret
ligat
kidney
remov
abdomen
close
sutur
clip
day
surgeri
day
follow
dog
given
antibiot
bodi
temperatur
measur
twice
daili
day
follow
surgeri
six
week
follow
surgeri
blood
pressur
measur
use
tailcuff
method
record
tailcuff
attach
polygraph
anim
systol
blood
pressur
higher
mm
hg
consid
hypertens
particip
studi
evalu
potenti
antihypertens
compound
experi
blood
pressur
record
either
indirect
tailcuff
method
direct
measur
via
implant
arteri
cannula
day
read
made
everi
h
h
oral
treatment
potenti
antihypertens
compound
drug
administr
repeat
day
day
blood
pressur
read
taken
h
treatment
least
dog
use
per
dose
compound
start
valu
averag
read
applic
drug
follow
read
subtract
valu
record
fall
blood
pressur
variou
record
time
renal
hypertens
rat
achiev
mani
modif
method
stanton
techniqu
accord
grollman
kidney
expos
lumbar
incis
renal
capsul
remov
gentl
traction
ligatur
appli
tight
enough
deform
kidney
tight
enough
cut
tissu
renal
hypertens
may
induc
rat
encapsul
kidney
latex
rubber
capsul
abram
sobin
mould
form
plastic
use
rat
kidney
model
capsul
prepar
dip
mould
liquid
latex
allow
dri
air
three
applic
latex
appli
capsul
toughen
place
warm
run
tap
water
kidney
expos
lumbar
incis
renal
capsul
gentli
remov
capsul
appli
vasodil
depressor
reflex
origin
baroreceptor
area
carotid
sinu
aortic
arch
play
import
part
regul
blood
pressur
stimul
affer
buffer
fibr
exert
inhibitori
influenc
vasomotor
center
section
lead
persist
rise
blood
pressur
way
acut
neurogen
hypertens
induc
dog
adult
dog
either
sex
weigh
kg
anesthet
use
mgkg
sodium
thiopent
mgkg
sodium
barbit
mgkg
sodium
pentobarbit
iv
femor
vein
arteri
cannul
use
polyethylen
tube
administ
compound
iv
record
arteri
pressur
heart
rate
respect
left
ventricular
pressur
dpdt
record
via
left
common
carotid
arteri
postdeafferenti
use
millar
microtip
pressur
transduc
p
max
record
speed
chart
paper
cardiac
output
determin
introduc
swanganz
cathet
right
heart
pulmonari
arteri
via
jugular
vein
five
ml
cold
dextros
inject
right
atrium
edward
cardiac
output
comput
use
calcul
cardiac
output
temperatur
chang
pulmonari
arteri
record
made
polygraph
carotid
arteri
clear
bifurc
intern
extern
carotid
arteri
carotid
sinu
nerv
isol
ligat
section
bilater
vagotomi
perform
produc
neurogen
hypertens
mean
arteri
pressur
mm
hg
dog
allow
equilibr
approxim
min
bolu
test
compound
administ
intraven
inject
heart
rate
arteri
pressur
left
ventricular
pressur
pmax
dpdt
monitor
min
minimum
dog
use
compound
chang
cardiovascular
paramet
express
percentag
valu
administr
drug
neurogen
hypertens
baroreceptor
denerv
also
describ
rabbit
angelljam
rat
krieger
neurogen
hypertens
use
acut
experi
howev
less
use
chronic
experi
sinc
elev
blood
pressur
caus
buffer
nerv
section
labil
caus
renal
ischemia
mineralocorticoidinduc
hypertens
thought
due
sodium
retain
properti
steroid
caus
increas
plasma
extracellular
volum
hypertens
effect
increas
salt
load
unilater
nephrectomi
rat
male
spragu
dawley
rat
weigh
g
anesthet
ether
flank
incis
left
kidney
remov
rat
inject
twice
weekli
mgkg
sc
desoxycorticosteroneacet
oliv
oil
week
drink
water
replac
nacl
solut
blood
pressur
start
rise
one
week
reach
systol
valu
mm
hg
week
regimen
induc
docasalt
hypertens
modifi
mani
author
stanton
doca
pellet
peterfalvi
jequier
passmor
jimenez
implant
silast
devic
ormsbe
ryan
king
webb
use
instead
repeat
inject
docasalt
hypertens
also
achiev
without
nephrectomi
bockman
et
al
use
kininogendefici
brown
norway
katholiek
bnka
rat
majima
et
al
majima
et
al
show
suppress
rat
desoxycorticosteronesalt
hypertens
kallikreinkinin
system
examin
smallarteri
structur
wire
myograph
quantifi
messeng
rna
northern
blot
analysi
docasalt
hypertens
rat
administr
aceinhibitor
calcium
channel
antagonist
nitric
oxid
synthas
inhibitor
ullian
describ
wistarfurth
rat
model
mineralocorticoid
resist
rat
develop
twokidney
oneclip
hypertens
degre
wistar
rat
react
glucocorticoid
treatment
rapid
onset
hypertens
resist
develop
docanacl
hypertens
studi
docasalt
hypertens
mice
report
gross
et
al
gross
et
al
honeck
et
al
peng
et
al
wistarfurth
rat
model
mineralocorticoid
resist
kidney
internat
suppl
increas
dietari
carbohydr
intak
rais
blood
pressur
experiment
anim
increas
intak
either
sucros
glucos
shown
enhanc
develop
either
spontan
hypertens
salt
hypertens
rat
hall
hall
preuss
preuss
young
landsberg
hwang
et
al
first
report
hypertens
could
induc
normal
rat
feed
highfructos
diet
fructos
feed
also
found
caus
insulin
resist
hyperinsulinemia
hypertriglyceridemia
normal
rat
zavaroni
et
al
tobey
et
al
dai
mcneill
studi
concentrationand
durationdepend
fructoseinduc
hypertens
rat
group
male
wistar
rat
weigh
g
use
hous
two
per
cage
light
dark
cycl
allow
free
access
standard
laboratori
diet
purina
rat
chow
drink
fluid
drink
fluid
consist
either
tap
water
fructos
solut
bodi
weight
food
intak
fluid
intak
rat
measur
everi
week
treatment
use
tailcuff
method
systol
blood
pressur
puls
rate
measur
everi
week
treatment
blood
sampl
collect
everi
second
week
treatment
determin
plasma
glucos
insulin
triglycerid
sinc
maximum
effect
chosen
paramet
achiev
week
durat
treatment
limit
time
statist
analysi
perform
use
oneway
twoway
analysi
varianc
follow
newmankeul
test
reaven
et
al
reaven
et
al
found
attenu
fructoseinduc
hypertens
exercis
train
inhibit
somatostatin
treatment
brand
et
al
brand
et
al
found
increas
arteri
pressur
chronic
hyperinsulinemia
consciou
rat
hall
et
al
report
effect
week
highfat
diet
cardiovascular
renal
endocrin
function
chronic
instrument
consciou
dog
bodi
weight
increas
approxim
kg
wherea
map
cardiac
output
heart
rate
increas
respect
inherit
hypertens
rat
describ
smik
hall
phelan
smirk
laverti
smirk
phelan
genet
hypertens
gh
rat
simpson
phelan
okamoto
et
al
okamoto
et
al
report
develop
strain
spontan
hypertens
rat
mate
one
wistar
male
rat
spontan
occur
high
blood
pressur
femal
slightli
elev
blood
pressur
inbreed
sever
gener
high
incid
hypertens
blood
pressur
valu
mm
hg
achiev
strain
call
spontan
hypertens
rat
akamotoaoki
shr
wistarkyoto
rat
wki
hypertens
rat
clearli
hereditari
genet
determin
thu
compar
primari
hypertens
human
cardiac
hypertrophi
sen
et
al
cellular
ionic
transport
abnorm
observ
yamori
inbr
strain
salthypertensionsensitivey
salthypertensionresist
rd
develop
dahl
et
al
dahl
et
al
rapp
cicila
et
al
inoko
et
al
report
transit
compensatori
hypertrophi
dilat
fail
left
ventricl
dahl
saltsensit
rat
two
strain
rat
inbr
dissimilar
sensit
docasalt
hypertens
sabra
strain
separ
benishay
et
al
anoth
hypertens
strain
deriv
wistar
rat
produc
brothersist
mate
group
bianchi
et
al
bianchi
et
al
univers
milan
call
milan
hypertens
strain
mh
rat
show
cell
membran
defect
result
abnorm
kidney
function
salvati
et
al
studi
diuret
effect
bumetanid
isol
perfus
kidney
milan
hypertens
rat
furthermor
lyon
strain
hypertens
normotens
lowbloodpressur
rat
develop
dupont
et
al
vincent
et
al
dubay
et
al
rat
show
genet
determin
defect
central
nervou
function
spontan
hypertens
rat
develop
failur
month
select
bred
sever
substrain
spontan
hypertens
rat
separ
group
okamoto
et
al
includ
strokepron
strain
shr
shrsp
rat
increas
sympathet
tone
show
high
incid
hemorrhag
lesion
brain
motor
disturb
follow
death
yamori
feron
et
al
strain
obes
spontan
hypertens
rat
describ
koletski
ernsberg
et
al
new
techniqu
genet
engin
transgen
rat
hypertens
could
creat
increas
blood
pressur
spontan
hypertens
rat
determin
multipl
genet
loci
deng
rapp
dubay
et
al
new
technolog
loci
could
defin
also
new
model
hypertens
research
model
detect
antihypertens
drug
could
establish
bohlend
et
al
pinto
et
al
mullin
et
al
report
fulmin
hypertens
transgen
rat
harbor
mous
gene
rat
strain
tgr
monogenet
model
hypertens
research
describ
peter
et
al
lee
et
al
langheinrich
et
al
ohta
et
al
bohlend
et
al
reconstruct
human
reninangiotensin
system
transgen
rat
overexpress
human
angiotensin
gene
tgr
hogen
chronic
inject
human
recombin
renin
intraven
use
alzet
pump
zolk
et
al
describ
effect
quinapril
losartan
hydralazin
cardiac
hypertrophi
neuroeffector
mechan
transgen
tgr
rat
use
spontan
hypertens
rat
detect
potenti
antihypertens
compound
well
establish
basi
avail
data
prefer
given
particular
strain
abund
experi
gain
wistarkyoto
strain
transgen
rat
well
defin
genom
gain
import
pijl
et
al
describ
streptozotocininduc
diabet
mellitu
spontan
hypertens
rat
pathophysiolog
model
combin
effect
hypertens
diabet
rosenth
et
al
use
rat
cohenrosenth
diabet
hypertens
strain
examin
effect
aceinhibitor
atii
antagonist
calcium
antagonist
systol
pressur
spontan
blood
glucos
level
holycross
et
al
use
hypertens
shhf
mccfacp
rat
studi
plasma
renin
activ
develop
heart
failur
linz
et
al
compar
outcom
lifelong
treatment
ace
inhibitor
ramipril
young
prehypertens
strokepron
spontan
hypertens
rat
agematch
normotens
wistarkyoto
rat
lifelong
ace
inhibit
doubl
lifespan
hypertens
rat
match
normotens
rat
studi
genet
hypertens
mice
report
rosenberg
et
al
hamet
et
al
meneton
et
al
ohkubo
et
al
gener
transgen
mice
elev
blood
pressur
introduct
rat
renin
angiotensinogen
gene
gener
transgen
mice
elev
blood
pressur
introduct
rat
renin
angiotensinogen
gene
proc
natl
acad
sci
usa
ohta
k
kim
wanibuchi
h
ganten
iwao
k
contribut
local
reninangiotensin
system
cardiac
hypertrophi
phenotyp
modul
remodel
tgr
yang
et
al
found
increas
vascular
angiotensin
ii
receptor
express
chronic
inhibit
synthas
spontan
hypertens
rat
detriment
sequel
chronic
synthas
inhibit
rat
inhibit
treatment
ace
inhibitor
hropot
et
al
et
al
hsieh
et
al
report
inhibit
lname
acceler
hypertens
induc
perivascular
inflamm
rat
hropot
et
al
report
angiotensin
ii
subtyp
receptor
blockad
prevent
hypertens
renal
insuffici
induc
chronic
synthas
inhibit
rat
male
wistar
rat
age
week
weigh
g
place
random
metabol
cage
divid
four
six
group
six
eight
rat
group
control
free
access
tap
water
food
group
treat
lname
water
solut
week
daili
dose
mgkg
group
receiv
angiotensin
receptor
antagonist
fonsartan
mgkg
lorsatan
mgkg
week
daili
per
stomach
tube
group
receiv
fonsartan
lorasatan
alon
end
studi
urin
sampl
collect
retrobulbar
blood
sampl
taken
short
inhal
anesthesia
plasma
valu
creatin
pra
electrolyt
determin
clearanc
evalu
rat
anesthet
mgkg
thiopenton
ip
order
determin
glomerular
filtrat
rate
renal
plasma
flow
clearanc
inulin
paraaminohippur
perform
clearanc
experi
rat
sacrif
heart
kidney
remov
heart
perfus
isol
work
heart
prepar
via
aorta
modifi
krebshenseleit
buffer
contain
solvent
drug
preischem
period
min
acut
region
myocardi
ischemia
produc
clamp
left
coronari
arteri
close
origin
min
ischem
period
thereaft
clip
remov
chang
reperfus
monitor
reperfus
period
follow
cardiodynam
cardiometabol
paramet
measur
incid
durat
ventricular
fibril
left
ventricular
pressur
contractil
dpdt
max
heart
rate
coronari
flow
coronari
effluent
lactat
dehydrogenas
creatin
kinas
lactat
myocardi
tissu
lactat
glycogen
atp
creatin
phosphat
left
ventricular
pressur
measur
statham
pressur
transduc
p
db
differenti
yield
lv
dpdt
max
heart
rate
coronari
flow
determin
electromagnet
flow
probe
aortic
cannula
determin
lactat
releas
lactat
dehydrogenas
ldh
creatin
kinas
ck
activ
perfus
sampl
taken
coronari
effluent
analyz
spectrophotometr
result
present
arithmet
mean
sem
oneway
anova
calcul
systat
window
systat
evanston
ill
usa
follow
multipl
pairwis
comparison
accord
tukey
arnal
et
al
measur
cardiac
weight
rat
hypertens
induc
synthas
blockad
linz
et
al
review
interact
ace
kinin
sampaio
et
al
report
hypertens
plu
diabet
mimic
cardiomyopathi
induc
inhibit
rat
rossi
et
al
found
chronic
inhibit
synthas
induc
hypertens
cardiomyocyt
mitochondri
myocardi
remodel
absenc
hypertrophi
pyrrolizidin
alkaloid
monocrotalin
deriv
crotalaria
spectabili
hepatotox
pneumotox
rat
singl
inject
monocrotalin
lead
progress
pulmonari
hypertens
result
right
ventricular
hypertrophi
cardiac
failur
gillespi
et
al
todorovichhunt
et
al
patholog
chang
hemodynam
chang
associ
monocrotalin
administr
includ
bleb
lung
degener
fragment
endotheli
cell
perivascular
edema
extravas
red
blood
cell
muscular
pulmonari
arteri
arteriol
valdiva
et
al
lalich
et
al
huxtabl
et
al
hislop
reid
meyrick
reid
meyrick
et
al
ghodsi
hillik
et
al
sugita
et
al
hillik
roth
stenmark
et
al
altieri
et
al
molteni
et
al
lai
et
al
rat
given
monocrotalin
develop
sever
right
ventricular
hypertrophi
often
accompani
ascit
pleural
effus
ceconi
et
al
amelior
angiotensinconvert
enzym
inhibitor
penicillamin
demonstr
molteni
et
al
molteni
et
al
treatment
male
spragu
dawley
rat
weigh
g
test
drug
angiotensin
convert
enzym
inhibitor
vehicl
start
one
week
prior
singl
subcutan
inject
mgkg
monocrotalin
sacrific
day
later
pentobarbit
anesthesia
exsanguin
heart
lung
excis
thorac
caviti
remov
atria
heart
right
ventricl
separ
left
ventricl
plu
septum
blot
weigh
separ
left
lung
blot
weigh
minc
reweigh
dri
room
temperatur
day
three
pulmonari
arteri
segment
main
pulmonari
arteri
right
extrapulmonari
arteri
intrapulmonari
arteri
right
lower
lobe
isol
studi
vascular
respons
cylindr
segment
vessel
suspend
stainless
steel
hook
isol
tissu
bath
contain
modifi
krebshenseleit
buffer
aerat
co
end
experi
vessel
segment
blot
weigh
dimens
measur
crosssect
area
arteri
determin
tissu
weight
diamet
arteri
equilibr
h
g
passiv
appli
load
made
contract
kcl
washout
procedur
repeat
appli
load
increas
g
increment
respons
normal
maximum
activ
forc
develop
gener
arteri
experi
data
plot
function
appli
forc
chang
isometr
forc
monitor
forc
displac
transduc
grass
record
polygraph
respons
contractil
relax
agonist
assess
pulmonari
arteri
salineand
monocrotalinetr
rat
verumand
placebotr
group
cumul
concentrationrespons
curv
hyperton
kcl
angiotensin
ii
norepinephrin
gener
sequenti
vessel
rest
tone
arteri
contract
submaxim
norepinephrin
cumul
concentrationrespons
curv
vasorelax
isoproterenol
acetylcholin
determin
contract
express
activ
tension
develop
forc
gener
per
crosssect
area
relax
normal
precontract
tone
contractil
relax
respons
plot
function
neg
logarithm
agonist
concentr
differ
mean
respons
compar
ttest
group
data
molteni
et
al
treat
rat
continu
monocrotalin
drink
water
concentr
mgkgday
period
week
test
rat
receiv
aceinhibitor
time
drink
water
control
vehicl
end
experi
heart
lung
weigh
examin
light
electron
microscopi
madden
et
al
determin
largininerel
respons
pressur
vasoact
agent
monocrotalinetr
rat
pulmonari
arteri
ono
et
al
studi
effect
prostaglandin
e
pge
pulmonari
hypertens
lung
vascular
remodel
rat
monocrotalin
model
human
pulmonari
hypertens
yamauchi
et
al
studi
effect
oral
activ
endothelin
antagonist
monocrotalineinduc
pulmonari
hypertens
rat
gout
et
al
evalu
effect
adrenomedullin
isol
vascular
ring
rat
treat
monocrotalin
mgkg
sc
caus
pulmonari
hypertens
ventricular
hypertrophi
within
week
kanno
et
al
studi
effect
angiotensinconvert
enzym
inhibitor
pulmonari
arteri
hypertens
endotheli
nitric
oxid
synthas
express
monocrotalinetr
rat
evalu
right
ventricular
hypertrophi
result
pulmonari
arteri
hypertens
multislic
spinecho
mri
imag
acquir
time
point
cardiac
cycl
respiratori
ecg
gate
kanno
et
al
week
monocrotalin
treatment
kang
et
al
report
inhibitor
attenu
monocrotalineinduc
pulmonari
hypertens
rat
use
model
studi
role
nitric
oxid
rat
portal
hypertens
male
spraguedawley
rat
anesthet
mgkg
nembut
intraperiton
portal
vein
isol
stenosi
creat
singl
ligatur
silk
place
around
portal
vein
blunttip
needl
devascular
left
renal
vein
devascular
indispens
prevent
develop
excess
collater
vessel
inhibit
format
esophag
varic
portal
hypertens
state
needl
remov
ligatur
addit
silk
also
place
area
partial
ligat
loos
ligat
end
drawn
abdomin
wall
five
day
oper
end
silk
place
flank
simultan
pull
induc
complet
portal
vein
ligat
two
week
later
portal
hypertens
model
complet
portal
venou
pressur
blood
flow
volum
intraabdomin
viscera
plasma
plasma
measur
result
express
mean
standard
deviat
student
ttest
use
determin
signific
portal
hypertens
rat
shamoper
control
portal
hypertens
portal
vein
ligat
without
devascular
left
renal
vein
use
lee
et
al
braillon
et
al
oren
et
al
fernandez
et
al
moreno
et
al
isol
heartlung
dog
introduc
knowlton
starl
sinc
dog
model
use
mani
physiolog
pharmacolog
studi
krayer
krayer
mendez
somani
blum
takeda
et
al
ishikawa
et
al
ishikawa
et
al
ono
et
al
b
caffrey
et
al
hausknecht
et
al
fessler
et
al
seifen
et
al
seifen
et
al
naka
et
al
recent
rat
model
prefer
dietz
dietz
onwochei
et
al
onwochei
et
al
kashimoto
et
al
fukus
et
al
wistar
rat
weigh
g
anesthet
mgkg
pentobarbiton
ip
tracheotomi
perform
intermitt
posit
pressur
ventil
institut
air
chest
open
flood
icecold
salin
heart
arrest
cannula
insert
aorta
superior
measur
central
venou
pressur
inferior
vena
cava
heartlung
prepar
perfus
solut
contain
rat
blood
cell
anoth
rat
krebsring
bicarbon
buffer
hematocrit
ph
respect
concentr
buffer
constitu
mm
nacl
kcl
cacl
kh
po
mgso
nahco
glucos
heparin
perfus
pump
aorta
pass
pneumat
resist
collect
reservoir
maintain
return
inferior
vena
cava
model
organ
except
heart
lung
perfus
cardiac
output
determin
inflow
long
heart
fail
mean
arteri
pressur
regul
pneumat
resist
heart
rate
record
bioelectr
amplifi
cardiac
output
measur
electromagnet
blood
flow
meter
arteri
pressur
right
atrial
pressur
measur
transduc
amplifi
heart
perfus
initi
cardiac
output
mlmin
mean
arteri
pressur
mm
hg
test
drug
administ
perfus
min
start
experi
hemodynam
data
within
group
analyz
twoway
analysi
varianc
anova
repeat
measur
recoveri
time
measur
kruskalw
test
data
analyz
oneway
anova
follow
dunnett
test
multipl
comparison
use
starl
heartlung
prepar
dog
wollenberg
studi
energyrich
phosphat
suppli
fail
heart
shigei
hashimoto
studi
mechan
heart
failur
induc
pentobarbit
quinin
fluoroacet
dinitrophenol
dog
heartlung
prepar
effect
sympathomimet
amin
ouabain
imai
et
al
use
heartlung
prepar
dog
studi
cardiac
action
methoxamin
special
refer
antagonist
action
epinephrin
capri
oliverio
beaconsfield
et
al
use
heartlung
prepar
guinea
pig
robicsek
et
al
studi
metabol
function
autoperfus
heartlung
prepar
dog
dog
heartlung
prepar
use
seifen
et
al
studi
interact
calcium
channel
agonist
effect
digoxin
somani
blum
studi
blockad
epinephrineand
ouabaininduc
cardiac
arrhythmia
dog
riveron
et
al
investig
energi
expenditur
autoperfus
heartlung
prepar
namakura
et
al
studi
role
pulmonari
innerv
situ
lungperfus
prepar
new
model
neurogen
pulmonari
edema
hausknecht
et
al
investig
effect
lung
inflat
blood
flow
cardiopulmonari
resuscit
caffrey
et
al
evalu
effect
naloxon
myocardi
respons
isoproterenol
ono
et
al
estim
cardiodepress
potenc
variou
betablock
agent
ishikawa
et
al
graphic
analysi
drug
effect
dog
heartlung
prepar
particular
refer
pulmonari
circul
effect
norepinephrin
iizuka
studi
cardiac
effect
acetylcholin
congen
fessler
et
al
investig
mechan
reduc
lv
afterload
systol
diastol
posit
pleural
pressur
takeda
et
al
studi
cardiac
action
oxprenolol
beaconsfield
et
al
use
heartlung
prepar
guinea
pig
studi
cardiac
effect
rabbit
autoperfus
heartlung
prepar
use
muskett
et
al
muskett
et
al
isol
heartlung
prepar
cat
describ
beaufort
et
al
konto
et
al
konto
et
al
harvest
heartlung
block
calv
beaconsfield
p
oakley
c
carpi
rainsburi
r
del
basso
p
cardiac
effect
heartlung
prepar
intact
anim
eur
j
cardiol
beaconsfield
p
oakley
c
carpi
cardiac
effect
heartlung
prepar
intact
anim
eur
miller
rabkin
ms
preserv
rabbit
autoperfus
heartlung
prepar
potenti
role
indomethacin
surgic
forum
muskett
ad
burton
na
grossman
gay
wa
jr
rabbit
autoperfus
heartlung
prepar
j
surg
re
namakura
j
zhang
ishikawa
n
year
ago
langendorff
describ
studi
isol
surviv
mammalian
heart
use
mainli
cat
donor
sinc
method
improv
technic
site
nowaday
use
studi
guineapig
rabbit
rat
heart
principl
heart
perfus
retrograd
direct
aorta
either
constant
pressur
constant
flow
oxygen
salin
solut
retrograd
perfus
close
aortic
valv
situ
heart
diastol
perfus
displac
coronari
arteri
flow
coronari
sinu
open
right
atrium
origin
setup
ventricl
fill
perfus
therefor
perform
pressurevolum
work
paramet
usual
measur
contractil
forc
coronari
flow
cardiac
rhythm
guinea
pig
either
sex
weigh
g
sacrif
stun
studi
biochem
paramet
tissu
perfus
remov
heart
barbitur
anesthesia
artifici
respir
recommend
heart
remov
quickli
possibl
place
dish
contain
ringer
solut
associ
pericardi
lung
tissu
remov
aorta
locat
cut
point
divis
glass
plastic
cannula
introduc
aorta
tie
two
thread
perfus
start
oxygen
ringer
solut
krebshenseleit
buffer
heart
transfer
doubl
wall
plexiglass
perfus
apparatu
kept
water
thermostat
oxygen
ringer
solut
perfus
constant
pressur
mm
hg
temperatur
reservoir
small
steel
hook
string
attach
apex
heart
contractil
forc
measur
isometr
forc
transduc
preload
g
record
polygraph
coronari
flow
measur
drop
counter
altern
flow
measur
perform
use
mechanicelectron
flow
meter
consist
vertic
pipe
magnet
valv
hugo
sach
electron
kg
germani
heart
rate
measur
chronomet
coupl
polygraph
drug
inject
perfus
medium
aortic
cannula
reapprais
langendorff
heart
prepar
given
broadley
underlin
use
test
coronari
vasodil
drug
valu
langendorff
method
best
assess
demonstr
applic
physiolog
pharmacolog
direct
effect
measur
well
antagon
variou
physiolog
pharmacolog
agent
survey
variou
modif
langendorfftechniqu
isol
work
heart
prepar
given
ross
neeli
et
al
insert
second
cannula
pulmonari
vein
left
atrium
perfus
reservoir
flow
via
cannula
mitral
valv
left
ventricl
systol
heart
left
ventricl
repump
perfus
aorta
reservoir
perfus
flow
coronari
arteri
drip
outsid
heart
collect
vessel
heart
recircul
reservoir
roller
pump
flynn
et
al
underlin
differ
work
heart
prepar
origin
langendorff
method
report
effect
histamin
noradrenalin
peak
left
ventricular
systol
pressur
contractil
sinu
rate
coronari
flow
aortic
flow
total
cardiac
output
extern
pressurevolum
work
therefor
method
report
separ
ishiu
et
al
measur
simultan
ca
fluoresc
left
ventricular
pressur
beattobeat
basi
langendorff
guinea
pig
heart
investig
chang
ca
transient
left
ventricular
function
posit
inotrop
stimul
myocardi
ischemia
hukov
muschol
describ
prepar
isol
rabbit
heart
intact
sympath
nervou
suppli
right
stellat
ganglion
hendrikx
et
al
use
isol
perfus
rabbit
heart
test
effect
na
h
exchang
inhibitor
postischem
function
resynthesi
highenergi
phosphat
reduct
ca
overload
michio
et
al
modifi
langendorff
method
rabbit
work
heart
prepar
cannul
left
atrium
pressur
cm
h
left
atrium
heart
pump
solut
hydrostat
pressur
cm
h
aortic
flow
systol
aortic
pressur
coronari
flow
heart
rate
measur
influenc
aceinhibitor
heart
rate
lactat
coronari
effluat
gtplevel
myocardium
hypotherm
cardiac
arrest
studi
work
heart
prepar
rabbit
zegner
et
al
gottlieb
magnu
introduc
call
balloon
method
small
balloon
fix
tip
cathet
fill
water
insert
left
ventricl
via
one
pulmonari
vein
left
atrium
mitral
valv
balloon
size
fit
volum
left
ventricl
therefor
size
depend
anim
speci
bodi
weight
cathet
fix
tie
pulmonari
vein
stem
via
threeway
valv
balloon
extend
given
preload
beat
heart
exert
rhythmic
forc
balloon
thu
membran
pressur
transduc
advantag
method
forc
develop
preload
state
reproduc
pressur
unit
mm
hg
left
ventricular
contract
curv
use
calcul
continu
heart
rate
record
carri
without
problem
use
rate
meter
sakai
et
al
report
similar
method
adapt
mice
bardenheu
schrader
describ
method
wherebi
balloon
insert
left
ventricl
describ
howev
isovolumetr
pressur
left
ventricl
measur
instead
fluid
balloon
pump
cannula
close
extra
corpor
circul
fluid
forc
one
direct
recoil
valv
balloon
made
silicon
materi
use
teflon
form
linz
et
al
dimens
form
deriv
cast
left
ventricl
k
arrest
heart
inject
dental
cement
palavit
kulzer
co
gmbh
germani
heart
beat
fluid
volum
expel
balloon
correspond
stroke
volum
heart
record
mean
flow
meter
probe
integr
connect
seri
preload
afterload
adjust
independ
perfus
flow
retrograd
aorta
coronari
arteri
record
separ
follow
paramet
measur
isol
rat
heart
linz
et
al
linz
et
al
lvp
left
ventricular
pressur
statham
pressur
transduc
p
db
differenti
yield
lv
dpdt
max
hr
heart
rate
cardiac
output
coronari
flow
cf
determin
electromagnet
flow
probe
outflow
system
aortic
cannula
respect
coronari
venou
po
measur
cathet
place
pulmonari
arteri
type
e
electrod
connect
pmh
phblood
ga
monitor
radiomet
epicardi
electrocardiogram
record
obtain
via
two
silver
electrod
attach
heart
paramet
record
brush
record
myocardi
oxygen
consumpt
mwo
mlming
wet
weight
calcul
accord
equat
cf
coronari
flow
mlming
p
oxygen
partial
pressur
arteri
perfus
mm
hg
p
v
oxygen
partial
pressur
venou
effluent
perfus
mm
hg
c
ml
ml
perfus
repres
bunsen
solubl
coeffici
oxygen
dissolv
perfus
zander
euler
determin
lactat
dehydrogenas
ldh
creatin
kinas
ck
activ
perfus
sampl
taken
coronari
effluent
experi
heart
rapidli
frozen
liquid
nitrogen
store
left
ventricl
mg
taken
put
ml
icecold
hclo
disrupt
ultraturrax
junk
kunkel
ikawerk
type
tp
glycogen
hydrolyz
amyloglycosidas
ph
determin
glucos
furthermor
atp
creatin
phosphat
measur
avkiran
curti
construct
dual
lumen
aortic
cannula
permit
independ
perfus
left
right
coronari
bed
isol
rat
heart
without
necessit
cannul
individu
arteri
igic
describ
modif
isol
perfus
work
rat
heart
special
doubl
cannula
design
consist
outer
cannula
insert
aorta
inner
cannula
advanc
left
ventricl
perfus
fluid
flow
inner
cannula
left
ventricl
eject
aorta
outer
cannula
system
close
fluid
perfus
coronari
vessel
drip
outsid
heart
outer
cannula
open
certain
pressur
resist
appli
fraction
eject
fluid
perfus
coronari
vessel
rest
expel
inner
cannula
easili
retract
outer
cannula
place
aorta
prepar
provid
opportun
use
heart
work
nonwork
model
investig
function
heart
label
glucos
lactat
fatti
acid
perfus
h
c
barr
lopaschuk
directli
measur
energi
metabol
isol
rat
heart
krzeminski
et
al
describ
new
concept
isol
heart
prepar
onlin
computer
data
evalu
left
ventricular
pressur
record
mean
ballooncathet
special
suction
electrod
obtain
highamplitud
noisefre
electrogram
record
coronari
effluent
partial
pressur
oxygen
continu
monitor
enabl
calcul
myocardi
oxygen
consumpt
mvo
effluent
partial
pressur
carbon
dioxid
ph
valu
also
measur
simultan
computer
system
data
acquisit
calcul
storag
end
report
describ
dehnert
describ
continu
simultan
ultrason
record
two
cardiac
diamet
isol
perfus
guineapig
heart
measur
left
ventricular
transvers
diamet
ultrason
transmitt
posit
epicardium
largest
cardiac
diamet
correspond
ultrason
receiv
insert
right
atrium
right
ventricl
approxim
height
transmitt
right
ventricl
empti
isol
perfus
langendorffheart
automat
posit
opposit
transmitt
addit
transduc
place
heart
base
apex
assess
ventricular
longitudin
diamet
sever
author
use
isol
perfus
mous
heart
bittner
et
al
describ
workperform
heart
prepar
myocardi
perform
analysi
murin
heart
use
modifi
langendorff
apparatu
sumaray
yellon
b
construct
special
design
langendorff
apparatu
allow
perfus
isol
mous
heart
author
report
ischem
precondit
reduc
infarct
size
follow
global
ischemia
murin
myocardium
brook
apstein
measur
left
ventricular
systol
diastol
pressur
isovolum
contract
balloon
left
ventricl
mous
heart
sutherland
et
al
review
characterist
caution
use
isol
perfus
heart
mice
wang
et
al
studi
relationship
ischem
time
ischemiareperfus
injuri
isol
langendorffperfus
mous
heart
tejerotaldo
et
al
report
receptor
stimul
produc
late
precondit
induc
nitric
oxid
synthas
mous
heart
ross
et
al
found
adrenerg
receptor
decreas
inotrop
respons
mous
langendorff
heart
model
bratkovski
et
al
measur
coronari
flow
reserv
isol
heart
mice
plumier
et
al
gener
transgen
mice
express
human
heart
heat
shock
protein
upon
reperfus
heart
min
ischemia
langendorff
prepar
transgen
heart
versu
non
transgen
heart
show
significantli
improv
recoveri
contractil
forc
hannan
et
al
compar
eno
knockout
wildtyp
mous
heart
perfus
langendorff
apparatu
kreb
bicarbon
buffer
subject
min
global
normotherm
ischemia
follow
min
reperfus
myocardi
function
measur
use
ventricular
balloon
determin
time
onset
contract
left
ventricular
develop
pressur
lvdp
left
ventricular
enddiastol
pressur
lvedp
heart
ratepressur
product
rpp
sheikh
et
al
gener
transgen
mice
overexpress
fibroblast
growth
factor
fgf
protein
heart
isol
mous
heart
model
ischemiareperfus
injuri
use
assess
potenti
endogen
cardioprotect
neg
inotrop
substanc
test
heart
beat
normal
forc
evalu
posit
inotrop
compound
usual
requir
cardiac
forc
first
reduc
acut
experiment
heart
failur
induc
overdos
barbitur
sodium
thiopent
calcium
antagonist
kind
cardiac
failur
revers
drug
cardiac
glycosid
increas
ca
concentr
way
potenti
activ
new
drug
measur
use
isoproterenol
standard
thiopentalna
treatment
left
ventricular
pressur
lvp
dpdt
max
decreas
consider
wherea
coronari
flow
slightli
enhanc
drug
restor
lvp
dpdt
max
keep
coronari
blood
flow
elev
cardiac
glycosid
increas
lvp
dpdt
max
leav
coronari
flow
unchang
effect
drug
isoproterenol
dose
increas
contractil
forc
well
heart
frequenc
regist
inject
effect
isoproterenol
attenu
effect
potenti
agent
test
compar
isoproterenol
inhibit
versu
standard
propranolol
mg
langendorff
heart
extens
use
assess
coronari
dilat
activ
drug
broadley
rothaul
broadley
demonstr
releas
coronari
vasodil
mediat
guinea
pig
isol
heart
techniqu
employ
donor
recipi
heart
seri
order
demonstr
effect
calciumantagonist
mg
bacl
inject
induc
pronounc
spasm
coronari
arteri
therebi
reduc
coronari
flow
five
min
later
test
drug
inject
activ
compound
relax
effect
coronari
arteri
indic
increas
coronari
flow
effect
wean
bacl
inject
test
drug
standard
drug
e
g
nifedipin
test
increas
coronari
flow
express
percentag
flow
bacl
spasm
compar
effect
standard
use
variou
dose
doserespons
curv
establish
lindner
hajdu
describ
method
use
langendorff
heart
contractil
forc
coronari
flow
potassium
content
coronari
outflow
determin
flame
photometri
increas
potassium
outflow
correl
well
posit
inotrop
effect
lindner
measur
enzym
creatin
phosphokinas
cpk
lactat
dehydrogenas
ldh
dehydrogenas
glutamicoxalacet
transaminas
got
effluent
guinea
pig
heart
prepar
vari
degre
hypoxia
potassium
content
oxygen
tension
inflow
outflow
solut
determin
heart
rate
amplitud
contract
rate
coronari
vessel
perfus
record
addit
use
p
studi
metabol
nucleotid
phosphoryl
intermedi
carbohydr
isol
heart
perform
garlick
et
al
jacobu
et
al
holli
et
al
matthew
radda
langendorff
heart
prepar
also
use
test
influenc
compound
cardiac
rhythm
record
monophas
action
potenti
suction
electrod
appli
heart
ventricular
fibril
induc
simultan
inject
digitoxin
aconitin
perfus
fluid
lindner
cardiac
glycosid
shorten
refractori
period
decreas
conduct
veloc
increas
heterotop
stimulu
gener
aconitin
increas
markedli
heterotop
stimulu
gener
compound
togeth
induc
invari
ventricular
fibril
antiarrhythm
compound
test
way
fibril
inhibit
least
partial
prenylamin
quinidin
ajmalin
takeo
et
al
describ
protect
effect
antiarrhythm
agent
oxygendeficiencyinduc
contractil
dysfunct
isol
perfus
heart
hypoxia
isol
rabbit
heart
induc
perfus
heart
min
krebshenseleit
buffer
satur
ga
mixtur
n
co
contain
mm
mannitol
hypox
perfus
heart
reoxygen
min
oxygen
buffer
contain
glucos
dhein
et
al
studi
pathway
time
cours
epicardi
electr
activ
process
mean
computerassist
epicardi
potenti
map
use
matrix
unipolar
agcl
electrod
mm
spatial
ms
tempor
resolut
isol
rabbit
heart
perfus
accord
langendorff
techniqu
activ
time
surround
electrod
direct
veloc
activ
electrod
calcul
therebi
allow
construct
epicardi
vector
field
method
use
assess
arrhythmogen
antiarrhythm
drug
activ
ventricular
fibril
induc
langendorff
prepar
reduc
glucos
content
perfus
medium
ml
kcl
content
ml
burn
et
al
burn
et
al
lindner
perfus
period
min
epinephrin
inject
perfus
cannula
immedi
afterward
heart
stimul
current
hz
min
procedur
repeat
everi
min
standard
condit
achiev
fibril
continu
without
electr
stimul
heart
treat
way
serv
control
heart
stimul
way
treat
continu
infus
test
drug
standard
via
perfus
medium
differ
incid
fibril
calcul
use
test
balderston
et
al
modifi
langendorff
techniqu
rabbit
heart
order
perform
electrophysiolog
studi
bundl
electrogram
measur
plung
electrod
allow
atrioventricular
nodal
physiolog
evalu
directli
atrial
conduct
refractori
atrioventricular
node
conduct
refractori
hispurkinj
conduct
ventricular
conduct
refractori
could
accur
measur
effect
verapamil
flecainid
describ
lamontagn
et
al
isol
platelet
blood
healthi
human
donor
inject
platelet
bolus
perfus
line
langendorff
prepar
rabbit
heart
effluent
cyclic
gmp
determin
index
edrf
releas
gottlieb
r
magnu
r
nakano
chang
work
heart
prepar
rat
ischemia
induc
clamp
left
coronari
arteri
close
origin
remov
clip
chang
reperfus
period
observ
prevent
symptom
indic
efficaci
coronari
drug
prepar
use
modif
isol
work
heart
prepar
origin
use
guinea
pig
heart
bardenheu
schrader
wistar
rat
either
sex
weigh
g
sacrif
decapit
heart
remov
dissect
free
epicard
surround
connect
tissu
cannula
introduc
aorta
coronari
vessel
perfus
nonrecircul
perfus
medium
accord
langendorff
techniqu
left
ventricl
balloon
close
fit
ventricular
caviti
place
connect
artifici
system
circul
fluid
balloon
pump
cannula
close
extra
corpor
circul
forc
one
direct
recoil
valv
balloon
made
silicon
materi
use
teflon
form
linz
et
al
dimens
form
deriv
cast
left
ventricl
k
arrest
heart
inject
dental
cement
palavit
kulzer
co
gmbh
germani
heart
beat
fluid
volum
press
balloon
correspond
stroke
volum
heart
record
mean
flow
meter
probe
integr
connect
seri
preload
afterload
adjust
independ
perfus
flow
retrograd
aorta
coronari
arteri
record
separ
follow
paramet
measur
isol
rat
heart
linz
et
al
lvp
left
ventricular
pressur
statham
pressur
transduc
p
db
differenti
yield
lv
dpdt
max
hr
heart
rate
cardiac
output
coronari
flow
cf
determin
electromagnet
flow
probe
outflow
system
aortic
cannula
respect
coronari
venou
po
measur
cathet
place
pulmonari
arteri
type
e
electrod
connect
pmh
phblood
ga
monitor
radiomet
epicardi
electrocardiogram
record
obtain
via
two
silver
electrod
attach
heart
paramet
record
brush
record
myocardi
oxygen
consumpt
mwo
ml
ming
wet
weight
calcul
accord
equat
cf
coronari
flow
mlming
p
oxygen
partial
pressur
arteri
perfus
mm
hg
p
v
oxygen
partial
pressur
venou
effluent
perfus
mm
hg
c
ml
ml
perfus
repres
bunsen
solubl
coeffici
oxygen
dissolv
perfus
zander
euler
coronari
arteri
occlus
experi
scholz
et
al
scholz
et
al
isol
work
heart
perfus
period
min
preischem
period
modifi
krebshenseleit
buffer
constant
pressur
mm
hg
thereaft
acut
myocardi
ischemia
produc
clamp
left
coronari
arteri
close
origin
min
ischem
period
clip
reopen
chang
reperfus
monitor
min
reperfus
period
coronari
arteri
ligat
reperfus
heart
develop
ventricular
fibril
coronari
effluent
sampl
taken
lactat
lactat
dehydrogenas
ldh
creatin
kinas
ck
determin
experi
glycogen
lactat
atp
creatin
phosphat
myocardi
tissu
measur
test
drug
given
perfus
medium
either
occlus
min
reperfus
ex
vivo
studi
rat
treat
oral
test
drug
h
sacrific
prepar
isol
work
heart
incid
durat
ventricular
fibril
treatment
coronari
drug
compar
control
left
ventricular
pressur
lv
dpdt
max
coronari
flow
reduc
coronari
constrict
angiotensin
ii
wherea
enzym
activ
effluent
increas
myocardi
content
glycogen
atp
creatin
phosphat
decreas
cardiac
protect
drug
opposit
effect
valu
paramet
statist
compar
control
vogel
lucchesi
describ
isol
blood
perfus
felin
heart
prepar
evalu
pharmacolog
intervent
myocardi
ischemia
ventricular
function
measur
fluidfil
latex
balloon
within
left
ventricl
vleem
et
al
ligat
left
coronari
arteri
rat
thoracotomi
ether
anesthesia
fortyeight
hour
oper
heart
prepar
retrograd
constant
pressur
perfus
accord
langendorff
techniqu
igic
present
new
method
isol
work
rat
heart
special
doubl
cannula
design
consist
outer
cannula
insert
aorta
inner
cannula
advanc
left
ventricl
perfus
fluid
flow
inner
cannula
left
ventricl
eject
aorta
outer
cannula
system
close
fluid
perfus
coronari
vessel
drip
outsid
heart
outer
cannula
open
certain
pressur
resist
appli
fraction
eject
fluid
perfus
coronari
vessel
rest
expel
inner
cannula
easili
retract
outer
cannula
place
aorta
prepar
provid
opportun
use
heart
work
nonwork
model
investig
function
heart
pepe
mclennan
describ
maintain
afterload
model
ischemia
erythrocyteperfus
isol
work
heart
rat
character
pathophysiolog
reaction
isol
work
heart
perform
linz
et
al
extern
heart
power
ehp
mjming
calcul
use
formula
lvwwt
sv
indic
stroke
volum
map
mean
aortic
pressur
lap
mean
left
arteri
pressur
specif
weight
perfus
gcm
r
inner
radiu
aortic
cannula
e
eject
time
hr
heart
rate
lv
left
ventricl
lvwwt
left
ventricular
wet
weight
function
left
ventricl
alter
chang
aortic
pressur
afterload
constant
left
atrial
fill
load
preload
adjust
starl
resist
aortic
outflow
could
switch
min
fix
baselin
afterload
preset
higher
afterload
produc
stepwis
rise
mean
arteri
pressur
lee
et
al
studi
effect
acut
global
ischemia
cytosol
calcium
transient
perfus
isol
rabbit
heart
fluoresc
calcium
indic
indo
indo
heart
illumin
nm
fluoresc
record
simultan
nm
epicardi
surfac
left
ventricl
f
f
ratio
calcul
analog
circuit
allow
cancel
optic
motion
artifact
result
calcium
transient
regist
simultan
ventricular
pressur
demonstr
rapid
upstrok
slow
decay
similar
record
isol
ventricular
myocyt
global
ischemia
rapidli
suppress
contract
produc
concurr
increas
systol
diastol
level
calcium
transient
togeth
increas
durat
peak
effect
nicainoprol
reperfus
arrhythmia
isol
work
rat
heart
ischemia
reperfus
arrhythmia
myocardi
infarct
size
anesthet
rat
eur
j
pharmacol
pepe
mclennan
pl
maintain
afterload
model
ischemia
erythrocyteperfus
isol
work
heart
j
pharm
toxicol
meth
rajagopalan
r
ghate
av
subbarayan
p
linz
w
schoelken
ba
cardioton
activ
water
solubl
forskolin
deriv
piperidinoacetoxi
arzneim
forschdrug
re
ba
linz
w
lindpaintn
k
ganten
angiotensin
deterior
bradykinin
improv
cardiac
function
follow
ischaemia
isol
rat
heart
j
hyperten
suppl
model
chronic
heart
failur
spontan
hypertens
rat
describ
itter
et
al
see
use
group
studi
isol
work
heart
rat
chronic
infarct
itter
et
al
wkynhsd
shrnhsd
rat
age
month
random
two
group
sham
myocardi
infarct
mi
sham
procedur
consist
open
pericardium
place
superfici
sutur
epicardium
left
ventricl
lv
chronic
heart
failur
chf
induc
perman
week
occlus
left
coronari
arteri
mm
distal
origin
aorta
result
larg
infarct
free
left
ventricular
wall
eight
week
surgeri
paramet
indic
chf
measur
cardiac
hypertrophi
function
geometr
properti
determin
work
heart
mode
vivo
determin
mri
heart
weight
rat
anesthet
mixtur
ketaminexylazin
mgkg
ip
left
ventrolater
thorax
shave
prepar
creat
disinfect
surgic
access
area
stabl
anesthesia
achiev
anim
place
small
anim
oper
tabl
intub
ventil
room
air
use
small
anim
ventil
hugo
sach
elektronik
marchhugstedten
germani
level
anesthesia
deem
adequ
follow
loss
pedal
withdraw
reflex
absenc
palpebr
reflex
reflex
evalu
surgeri
oper
took
min
tidal
volum
adjust
ml
ventil
rate
breathsmin
left
thoracotomi
perform
via
third
intercost
space
heart
expos
pericardium
open
left
main
coronari
arteri
ligat
permahand
silk
usp
ethicon
nordersredt
germani
near
origin
aorta
mm
distal
edg
left
atrium
ligat
result
infarct
free
left
ventricular
wall
ligat
deem
success
anterior
wall
left
ventricl
turn
pale
point
lung
hyperinfl
increas
posit
endexpiratori
pressur
chest
close
rat
place
heat
pad
cover
layer
unbleach
tissu
paper
rat
extub
follow
return
reflex
continu
monitor
start
move
cage
avoid
ventricular
arrhythmia
lidocain
mgkg
im
given
surgeri
prevent
acut
lung
edema
rat
receiv
furosemid
lasix
mgkg
bodi
weight
twice
daili
day
via
drink
water
avoid
pain
distress
rat
receiv
metamizol
treatment
novalgin
mgkg
bodi
weight
im
directli
recoveri
period
kill
anim
week
mi
noninvas
sequenti
nuclear
magnet
reson
nmr
measur
heart
geometr
properti
done
thereaft
anim
anesthet
pentobarbiton
mgkg
ip
pentobarbit
subsequ
heparin
heparin
natrium
g
bodi
weight
ip
stabl
anesthesia
achiev
stage
iii
reflex
absent
anim
connect
artifici
respir
via
pe
polyethylen
tube
insert
trachea
ventil
room
air
transvers
laparotomi
right
anterolater
thoracotomi
perform
heart
rapidli
remov
evalu
function
work
heart
mode
heart
immers
physiolog
buffer
chill
aorta
dissect
free
mount
onto
cannula
intern
diamet
mm
attach
perfus
apparatu
heart
perfus
accord
method
langendorff
oxygen
co
noncircul
krebshenseleit
solut
follow
composit
mm
nacl
kcl
cacl
mgso
nahco
kh
po
glucos
na
pyruv
perfus
pressur
mmhg
connect
tissu
thymu
lung
care
remov
cathet
place
pulmonari
arteri
drain
coronari
effluent
perfus
collect
determin
coronari
flow
venou
po
measur
left
atrium
cannul
via
incis
left
auricl
pulmonari
vein
ligat
close
surfac
atria
tight
seal
leak
establish
equilibr
period
heart
switch
work
mode
use
fill
pressur
preload
mmhg
wkynhsd
mmhg
sh
rat
afterload
pressur
mmhg
wkynhsd
mmhg
sh
rat
valid
basi
paramet
afterload
pressur
enhanc
cumul
manner
addit
mmhg
mmhg
thereaft
isovolumetr
maxima
determin
enhanc
preload
pressur
step
mmhg
mmhg
flow
pressur
signal
comput
obtain
plugsysmeasur
system
hugo
sach
elektronik
marchhugstedten
germani
comput
data
perform
sampl
rate
hz
averag
everi
use
softwar
aquir
plu
ponemah
hugo
sach
elektronik
marchhugstedten
germani
evalu
extern
heart
work
total
heart
weight
left
right
ventricular
weight
determin
left
ventricl
section
transvers
four
slice
apex
base
eight
pictur
taken
rat
heart
two
slice
total
infarct
size
determin
planimetri
project
magnifi
slice
area
infarct
tissu
well
intact
myocardium
slice
ad
togeth
averag
infarct
fraction
left
ventricl
calcul
measur
express
percentag
left
ventricular
mass
left
ventricular
perimet
diamet
infarct
scar
length
well
wall
thick
infarct
wall
thin
determin
well
data
given
mean
sem
statist
perform
use
sa
system
statist
packag
sa
insititut
cari
nc
usa
sequenti
reject
ttest
accord
holm
holm
simpl
sequenti
reject
multipl
test
procedur
scand
j
stat
itter
g
jung
w
juretschk
p
ba
linz
w
model
chronic
heart
failur
spontan
hypertens
rat
shr
freshli
slaughter
beef
heart
immers
cold
oxygen
kreb
solut
immedi
transport
thermo
flask
laboratori
left
descend
coronari
arteri
sever
primari
branch
cut
spiral
strip
mm
long
mm
wide
specimen
store
h
arteri
strip
suspend
ml
organ
bath
initi
tension
g
immers
kreb
bicarbon
solut
gass
oxygen
contain
co
throughout
experi
kreb
solut
contain
mixtur
antagonist
inhibit
action
endogen
acetylcholin
histamin
catecholamin
hyoscin
hydrobromid
gml
methysergid
maleat
gml
mepyramin
maleat
gml
propranolol
hydrochlorid
gml
strip
superfus
solut
test
compound
concentr
rate
mlmin
oxygen
kreb
solut
contain
mixtur
antagonist
isometr
contract
record
grass
forcedisplac
transduc
type
ft
c
grass
polygraph
strip
superfus
kreb
solut
h
prior
experi
standard
compound
ngml
pge
induc
contract
ngml
pgi
induc
pronounc
relax
relax
induc
test
compound
express
percentag
maxim
respons
ngml
pgi
campel
paul
measur
effect
diltiazem
isometr
forc
gener
ca
energi
metabol
isol
porcin
coronari
arteri
determin
abil
analogu
human
generel
peptid
relax
isol
porcin
coronari
arteri
precontract
mm
kcl
cardiac
necrosi
produc
inject
natur
synthet
sympathomimet
high
dose
infarctlik
myocardi
lesion
rat
isoproterenol
describ
rona
et
al
lesion
total
partial
prevent
sever
drug
sympatholyt
calciumantagonist
group
male
wistar
rat
weigh
g
pretreat
test
drug
standard
either
sc
oral
week
receiv
mgkg
isoproterenol
sc
two
consecut
day
symptom
mortal
group
record
compar
rat
given
isoproterenol
alon
fortyeight
hour
first
isoproterenol
administr
rat
sacrif
autopsi
heart
remov
weigh
frontal
section
embed
histolog
examin
microscop
examin
allow
follow
grade
grade
chang
grade
focal
interstiti
respons
grade
focal
lesion
mani
section
consist
mottl
stain
fragment
muscl
fibr
grade
confluent
retrogress
lesion
hyalin
necrosi
fragment
muscl
fibr
sequestr
mucoid
edema
grade
massiv
infarct
occasion
acut
aneurysm
mural
thrombi
group
main
grade
calcul
standard
deviat
reveal
signific
differ
test
use
mani
author
evalu
coronari
activ
drug
calciumantagonist
cardioprotect
drug
like
nitroglycerin
molsidomin
et
al
classen
et
al
yang
et
al
report
protect
effect
human
adrenomedullin
ctermin
fragment
adrenomedullin
myocardi
injuri
produc
subcutan
inject
isoproterenol
rat
ligat
left
coronari
arteri
rat
describ
induc
acut
reduct
pump
function
dilat
left
ventricular
chamber
method
use
evalu
benefici
effect
drug
acut
chiariello
et
al
flaim
zeli
bernauer
chronic
inn
weisman
treatment
male
spragu
dawley
rat
weigh
g
anesthet
diethyleth
chest
open
left
thoracotomi
thread
insert
near
middl
later
margin
cutan
wound
carri
tunnel
left
pector
muscl
around
cranial
half
incis
heart
gentli
exterior
pressur
abdomen
ligatur
place
around
left
coronari
arteri
near
origin
tighten
within
second
heart
reposit
thorac
caviti
end
musculocutan
thread
tighten
close
chest
wall
enabl
anim
breath
spontan
speed
procedur
render
mechan
respir
unnecessari
evalu
drug
effect
rat
treat
min
h
occlus
subcutan
inject
standard
mgkg
propranolol
two
day
surgeri
rat
anesthet
mgkg
ip
pentobarbit
right
carotid
arteri
cannul
polyethylen
cathet
connect
pressur
transduc
fluidfil
cathet
advanc
left
ventricl
aortic
valv
measur
left
ventricular
systol
enddiastol
pressur
hemodynam
measur
heart
arrest
inject
ml
potassium
chlorid
chest
open
heart
isol
rins
mm
kcl
maintain
complet
diastol
doublelumen
cathet
advanc
left
ventricl
ascend
aorta
right
left
atria
tie
ligatur
right
ventricl
open
left
ventricular
chamber
fill
cryostat
freez
medium
smaller
two
cathet
lumen
connect
hydrostat
pressur
reservoir
maintain
level
correspond
enddiastol
pressur
measur
vivo
outlet
larger
lumen
rais
level
inlet
allow
fluid
two
lumen
equilibr
heart
rapidli
frozen
hexan
dryic
heart
serial
cut
cryostat
transvers
section
perpendicularli
longitudin
axi
apex
base
fix
distanc
eight
section
obtain
heart
collect
gelatinco
glass
slide
section
airdri
incub
min
nitroblu
tetrazolium
mm
succin
acid
phosphat
buffer
ph
rins
cold
distil
water
dehydr
ethyl
alcohol
clear
xylen
mount
synthet
resin
medium
viabl
tissu
appear
dark
blue
contrast
unstain
necrot
tissu
infarct
size
determin
planimetri
express
percentag
left
ventricular
area
thick
express
percentag
noninfarct
ventricular
wall
thick
chiariello
robert
et
al
automat
method
morphometr
analysi
imag
acquisit
comput
process
describ
porzio
et
al
myocardi
infarct
follow
coronari
arteri
ligat
spraguedawley
rat
wide
use
rat
model
heart
failur
left
coronari
arteri
complet
ligat
heart
failur
may
occur
consequ
chronic
myocardi
ischemia
john
olson
describ
coronari
arteri
pattern
mous
rat
hamster
guinea
pig
kaufman
et
al
fishbein
et
al
fishbein
et
al
use
variou
histochem
method
identif
quantif
border
zone
evolut
myocardi
infarct
sakai
et
al
describ
experiment
model
angina
pectori
intact
anesthet
rat
anesthet
rat
tip
special
carotid
cannula
place
close
right
left
coronari
ostium
singl
intraaort
inject
methacholin
acetylcholin
presenc
physostigmin
develop
reproduc
elev
st
segment
wave
electrocardiogram
coronari
drug
test
prevent
chang
ytrehu
et
al
analyz
effect
anesthesia
perfus
risk
zone
method
infarct
size
rat
rabbit
heart
infarct
et
al
place
loos
ligatur
atraumat
silk
around
left
anterior
descend
coronari
arteri
ether
anesthesia
rat
ten
day
later
acut
myocardi
infarct
produc
tighten
ligatur
kouchi
et
al
found
increas
g
protein
accompani
progress
postinfarct
remodel
hypertens
cardiomyopathi
rat
g
protein
subunit
studi
immunoblot
techniqu
et
al
polyclon
antiserum
rais
rabbit
carboxyltermin
decapeptid
retin
transduct
kenlkdcglf
coupl
keyhol
limpet
hemocyanin
recogn
g
g
g
g
et
al
membran
fraction
electrophores
sdspolyacrylamid
gel
transfer
nitrocellulos
filter
filter
incub
first
antibodi
g
g
second
antibodi
horseradish
peroxidaseconjug
goat
antirabbit
igg
amersham
immunoreact
signal
detect
mean
ecl
kit
amersham
liu
et
al
found
ligat
left
descend
coronari
arteri
lewi
inbr
rat
produc
uniformli
larg
infarct
low
mortal
model
may
superior
usual
model
spraguedawley
rat
mark
variabl
infarct
size
cardiac
dysfunct
coronari
arteri
ligat
induc
left
ventricular
remodel
cardiomyocyt
apoptosi
myocardi
fibrosi
indic
morpholog
studi
collagen
accumul
prevent
drug
treatment
belichard
et
al
nguyen
et
al
sia
et
al
et
al
natur
occur
peptid
nacetyserylaspartyllysylprolin
acsdkp
inhibitor
pluripot
hematopoiet
stem
cell
prolifer
normal
present
human
plasma
circul
mononuclear
cell
cleav
inact
form
nh
termin
catalyt
domain
ace
azizi
et
al
acut
angiotensin
convert
enzym
inhibit
increas
plasma
level
nacetylserylaspartyllysylprolin
azizi
et
al
morpholog
studi
collagen
determin
rasoul
et
al
found
antifibrot
effect
acsdkp
angiotensin
convert
enzym
inhibit
hypertens
rat
similarli
found
acsdkp
revers
inflamm
fibrosi
rat
heart
failur
myocardi
infarct
moreov
le
meur
et
al
discuss
whether
plasma
acsdkp
level
reliabl
marker
chronic
angiotensin
convert
enzym
inhibit
hypertens
patient
acsdkp
eia
kit
avail
cayman
ann
arbor
mich
usa
chen
et
al
found
inhibit
revers
myocardi
infarctioninduc
hypertrophi
heart
failur
inhibit
john
olson
describ
method
experiment
myocardi
infarct
coronari
occlus
small
anim
mous
hamster
rat
guinea
pig
scholz
et
al
describ
dosedepend
reduct
myocardi
infarct
size
rabbit
select
sodiumhydrogen
exchang
subtyp
inhibitor
gomol
lekich
test
ferret
myocardi
ischemiasalvag
model
vari
combin
durat
left
anterior
descend
coronari
occlus
reperfus
evalu
coronari
arteri
ligat
mice
michael
et
al
michael
et
al
gould
et
al
describ
surgic
procedur
induc
myocardi
ischemia
mice
ligat
left
anterior
descend
branch
left
coronari
arteri
male
mice
week
age
g
bodi
weight
use
anesthesia
produc
intraperiton
inject
pentobarbit
sodium
mgml
bodi
weight
mice
place
supin
posit
paw
tape
oper
tabl
direct
visual
trachea
endotrach
tube
insert
connect
harvard
rodent
volumecycl
ventil
cycl
min
volum
suffici
adequ
expand
lung
overexpand
inflow
valv
suppli
oxygen
studi
myocardi
respons
perman
occlus
ligat
anterior
descend
branch
left
coronari
arteri
achiev
tie
silk
sutur
around
arteri
sutur
pass
arteri
posit
mm
tip
normal
posit
left
auricl
studi
effect
reperfus
coronari
arteri
occlus
ligatur
tie
locat
coronari
arteri
use
perman
occlus
howev
allow
subsequ
reestablish
blood
flow
occlus
produc
place
length
polyethylen
pe
tube
od
mm
arteri
fix
place
ligatur
arteri
compress
tighten
ligatur
produc
myocardi
blanch
electrocardiograph
ecg
st
segment
elev
observ
perman
ligat
occlus
desir
time
blood
flow
restor
remov
ligatur
pe
tube
chest
wall
close
ticron
sutur
one
layer
chest
wall
muscl
second
layer
skin
subcutan
layer
surgic
close
chest
endotrach
tube
remov
warmth
provid
heat
lamp
oxygen
provid
via
nasal
cone
anim
given
mgkg
butorphanol
tartrat
analges
becam
sternal
recumb
within
h
surviv
experiment
infarct
mice
recov
allow
postop
physiolog
measur
shamoper
mice
underw
ident
procedur
placement
ligatur
undergo
coronari
arteri
occlus
guo
et
al
demonstr
effect
earli
late
phase
ischem
precondit
mice
result
demonstr
mous
robust
infarctspar
effect
occur
earli
late
phase
ischem
precondit
although
earli
phase
power
guo
et
al
found
late
precondit
induc
donor
adenosin
receptor
agonist
opioid
receptor
agonist
mediat
induc
synthas
lutgen
et
al
report
cardiac
structur
function
chang
chronic
myocardi
infarct
mous
scherrercrosbi
et
al
describ
echocardiograph
determin
risk
area
murin
model
myocardi
ischemia
myocardi
contrast
echocardiographi
perform
coronari
arteri
ligat
anesthet
mice
intraven
inject
contrast
microbubbl
transthorac
echo
imag
timevideo
intens
curv
obtain
anterior
later
septal
myocardi
wall
myocardi
ischemia
myocardi
contrast
echocardiographi
defect
compar
area
perfus
measur
evan
blue
stain
jone
lefer
describ
cardioprotect
action
acut
hmgcoa
reductas
inhibit
set
myocardi
infarct
janssen
et
al
report
cardiomyocytespecif
overexpress
synthas
improv
left
ventricular
lv
perform
reduc
compensatori
hypertrophi
myocardi
infarct
effect
cardiomyocyterestrict
overexpress
one
synthas
isoform
lv
remodel
myocardi
infarct
mice
test
lv
structur
function
perman
left
anterior
descend
lad
coronari
arteri
ligat
compar
transgen
mice
cardiomyocyterestrict
overexpress
wildtyp
litterm
wt
myocardi
infarct
system
hemodynam
measur
echocardiograph
assess
lv
fraction
shorten
fs
heart
weight
myocyt
width
assess
histolog
differ
wt
mice
inotrop
respons
grade
dose
isoproterenol
significantli
reduc
mice
one
week
lad
ligat
infarct
fraction
lv
differ
wt
mice
four
week
myocardi
infarct
howev
endsystol
lv
intern
diamet
lvid
greater
fs
maximum
minimum
rate
lv
pressur
develop
less
wt
mice
lv
weightbodi
weight
ratio
greater
wt
mice
lapoint
et
al
found
inhibit
improv
cardiac
function
myocardi
infarct
mous
myocardi
infarct
produc
ligat
lad
coronari
arteri
mice
two
day
later
mice
treat
select
inhibitor
vehicl
drink
water
week
treatment
period
mice
subject
twodimension
mmode
echocardiographi
determin
cardiac
function
heart
analyz
determin
infarct
size
interstiti
collagen
content
brain
natriuret
peptid
bnp
mrna
myocyt
crosssect
area
immunohistochem
stain
transform
growth
factor
tgf
shibuya
et
al
report
nacetylserylaspartyllysineprolin
prevent
renal
insuffici
matrix
expans
diabet
dbdb
mice
weinberg
et
al
found
coronari
ligat
experi
mice
rosuvastatin
reduc
experiment
left
ventricular
infarct
size
ischemiareperfus
injuri
total
coronari
occlus
yang
et
al
found
infarctspar
effect
adenosin
receptor
activ
due
primarili
action
lymphocyt
chimer
mice
creat
bone
marrow
transplant
arknockout
green
fluoresc
protein
gfp
donor
mice
irradi
congen
recipi
gfp
chimera
unabl
detect
gfpproduc
cell
vascular
endothelium
indic
bonemarrowderiv
cell
recruit
endothelium
appreci
level
bone
marrow
transplant
andor
acut
myocardi
infarct
inject
potent
select
agonist
adenosin
receptor
effect
hemodynam
paramet
reduc
infarct
size
mice
min
lad
arteri
occlus
follow
h
reperfus
kanno
et
al
found
determin
myocardi
infarct
size
follow
coronari
occlus
mice
regul
myocardi
connexin
hypertroph
remodel
review
teunissen
et
al
kuhlmann
et
al
report
granulocyt
coloni
stimul
factor
gcsf
alon
combin
stem
cell
factor
scf
improv
hemodynam
cardiac
function
myocardi
infarct
mice
reduc
induc
arrhythmia
infarct
heart
potenti
via
increas
express
arteriogenesi
size
infarct
studi
proxim
occlus
left
anterior
descend
coronari
arteri
openchest
dog
compound
potenti
reduc
infarcts
test
delin
postmortem
area
risk
coronari
arteriogram
made
inject
baso
gelatin
mass
left
coronari
ostium
infarct
area
visual
nitroblu
tetrazolium
chlorid
myocardi
section
dog
either
sex
weigh
approxim
kg
use
anim
anesthet
intraven
inject
pentobarbit
sodium
bolu
mgkg
follow
continu
infus
mgkgh
anim
place
right
later
posit
respir
maintain
tracheal
tube
use
posit
pressur
respir
arteri
blood
gase
check
ventil
rate
andor
oxygen
flow
rate
adjust
achiev
physiolog
blood
ga
valu
p
mm
hg
p
mm
hg
ph
peripher
vein
saphen
vein
cannul
administr
test
compound
ecg
record
continu
lead
ii
einthoven
record
peripher
systol
diastol
blood
pressur
cannula
femor
vein
connect
pressur
transduc
statham
p
db
determin
left
ventricular
pressur
lvp
millar
microtip
cathet
pc
insert
via
left
carotid
arteri
left
ventricular
enddiastol
pressur
lvedp
measur
highsensit
scale
pressur
curv
dpdt
max
differenti
heart
rate
count
heart
expos
left
thoracotomi
fourth
fifth
intercost
space
pericard
open
left
anterior
descend
coronari
arteri
lad
expos
reach
steadi
state
condit
hemodynam
paramet
approx
min
lad
ligat
first
diagon
branch
min
attempt
made
suppress
arrhythm
activ
ligat
test
substanc
vehicl
control
administ
intraven
bolu
inject
andor
continu
infus
schedul
administr
may
vari
hemodynam
paramet
regist
continu
whole
experi
end
experi
anim
sacrif
overdos
pentobarbit
sodium
heart
dissect
coronari
arteriogram
made
accord
schaper
et
al
delin
anatom
postmortem
area
risk
pursestr
sutur
place
around
left
coronari
ostium
sinu
valsalva
cannula
place
ostium
pursestr
sutur
tighten
micron
baso
suspend
gelatin
solut
inject
increas
pressur
min
mm
hg
min
mm
hg
min
mm
hg
heart
place
crush
ice
gel
inject
right
ventricl
remov
left
ventricl
plu
septum
cut
transvers
section
approx
cm
thick
apex
level
occlus
near
base
slice
angiogram
made
xray
tube
kv
assess
postmortem
area
risk
defect
opac
reduct
baso
fill
vessel
infarct
tissu
slice
incub
pnitroblu
tetrazolium
solut
gl
phosphat
buffer
ph
contain
mm
lmaleat
order
visual
infarct
tissu
bluevioletstain
healthi
tissu
unstain
necrot
tissu
slice
photograph
color
transpar
film
determin
infarct
area
left
ventricl
infarct
area
area
risk
measur
planimetri
project
slice
exclus
apex
slice
contain
ligatur
mortal
differ
hemodynam
paramet
determin
chang
paramet
drugtreat
anim
compar
vehicl
control
differ
characterist
evalu
separ
mean
valu
sem
infarct
area
area
risk
calcul
statist
analys
consist
regress
correl
analys
student
ttest
result
consid
signific
p
nachla
shnitka
describ
macroscop
identif
earli
myocardi
infarct
alter
dehydrogenas
activ
dog
stain
cardiac
tissu
nitrobt
biphenylen
ditetrazolium
chlorid
yield
dark
blue
formazan
viabl
muscl
necrot
muscl
fiber
chiariello
et
al
compar
effect
nitroprussid
nitroglycerin
ischem
injuri
acut
myocardi
infarct
dog
black
et
al
studi
cardioprotect
effect
heparin
nacetylheparin
vivo
dog
model
myocardi
ischem
reperfus
injuri
heart
remov
min
coronari
occlus
hreperfus
period
area
risk
determin
absenc
evan
blue
dye
perfus
aorta
retrograd
fashion
infarct
zone
absenc
formazan
pigment
within
area
risk
perfus
circumflex
coronari
arteri
triphenyltetrazolium
chlorid
reimer
et
al
test
effect
drug
protect
ischem
myocardium
unconsci
consciou
dog
consciou
model
dog
either
sex
weigh
kg
anesthet
thiamyal
sodium
mgkg
iv
underw
thoracotomi
intercost
space
heparinfil
polyvinyl
chlorid
cathet
posit
aortic
root
left
atrium
via
left
atrial
appendag
system
vein
mechan
adjust
snare
type
occlud
place
around
proxim
left
circumflex
coronari
arteri
first
margin
branch
temporari
occlus
result
cyanosi
least
inferior
wall
cathet
snare
either
exterior
posit
subcutan
pocket
back
neck
penicillin
unit
streptomycin
g
given
im
first
postop
day
least
day
allow
recoveri
surgeri
dog
fast
overnight
prior
studi
exterior
flush
cathet
min
allow
anim
adjust
laboratori
condit
morphin
sulfat
mgkg
im
given
min
occlus
addit
mgkg
iv
given
min
later
heart
rate
aortic
left
atrial
pressur
monitor
continu
perman
coronari
occlus
produc
sudden
onestag
tighten
snare
occlud
drug
administ
continu
iv
infus
h
hemodynam
measur
taken
min
occlus
min
occlus
raberg
et
al
describ
model
transient
myocardi
dysfunct
consciou
dog
mongrel
dog
train
run
treadmil
chronic
instrument
miniatur
pressur
transduc
left
ventricl
hydraul
occlud
place
around
circumflex
branch
left
coronari
arteri
two
pair
piecoelectr
crystal
sonomicrometri
implant
subendocardi
measur
region
myocardi
function
compar
episod
region
dysfunct
left
coronari
arteri
area
treadmil
run
found
partial
left
coronari
arteri
stenosi
induc
extern
fill
occlud
hartman
warltier
describ
model
multivessel
coronari
arteri
diseas
use
consciou
chronic
instrument
dog
hydraul
occlud
implant
around
left
anterior
descend
coronari
arteri
lad
ameroid
constrictor
around
left
circumflex
coronari
arteri
lcca
pair
piecoelectr
crystal
implant
within
subendocardium
lad
lcca
perfus
territori
measur
region
contractil
function
cathet
place
left
atrial
appendag
inject
radioact
microspher
measur
region
myocardi
perfus
bolu
inject
adenosin
administ
daili
via
left
atrium
evalu
lad
lcca
coronari
reserv
stenosi
ameroid
constrictor
radioact
microspher
administ
compar
region
perfus
within
normal
myocardium
flow
myocardium
suppli
occlud
stenot
coronari
arteri
holmborn
et
al
compar
triphenyltetrazolium
chlorid
stain
versu
detect
fibronectin
experiment
myocardi
infarct
pig
klein
et
al
use
intact
pig
found
myocardi
protect
na
h
exchang
inhibit
ischem
reperfus
heart
klein
et
al
measur
time
delay
cell
death
na
h
exchang
inhibit
region
ischem
reperfus
porcin
heart
garciadorado
et
al
determin
effect
na
h
exchang
blockad
ischem
rigor
contractur
reperfusioninduc
hypercontractur
pig
submit
min
coronari
occlus
h
reperfus
myocardi
segment
length
analysi
ultrason
microcrist
use
detect
ischem
rigor
reduct
passiv
segment
length
chang
hypercontractur
reduct
enddiastol
length
symon
et
al
test
attenu
region
dysfunct
respons
cycl
ischemia
min
reperfus
min
left
circumflex
coronari
arteri
consciou
swine
administr
na
h
exchang
inhibitor
anim
instrument
measur
arteri
blood
pressur
region
myocardi
blood
flow
color
microspher
systol
wall
thicken
normal
perfus
left
anterior
descend
left
circumflex
coronari
arteri
region
sonomicrometri
left
circumflex
coronari
arteri
blood
flow
veloc
doppler
revers
occlud
left
circumflex
coronari
arteri
hydraul
occlud
etoh
et
al
studi
myocardi
interstiti
matrix
metalloproteinas
activ
acut
myocardi
infarct
pig
sever
left
ventricular
failur
induc
repeat
inject
plastic
microspher
left
main
coronari
arteri
anesthet
dog
hemodynam
measur
perform
these
condit
test
drug
potenti
improv
cardiac
perform
test
use
evalu
influenc
drug
myocardi
perform
acut
ischem
left
ventricular
failur
dog
dog
either
sex
weigh
approxim
kg
anesthet
intraven
bolu
inject
mgkg
pentobarbit
sodium
continu
infus
mgkgh
anim
place
right
later
posit
respir
maintain
tracheal
tube
use
posit
pressur
respir
control
measur
endexpiratori
co
concentr
well
blood
gase
two
peripher
vein
cannul
administr
narcot
brachial
vein
test
compound
saphen
vein
ecg
record
continu
lead
ii
einthoven
record
peripher
systol
diastol
blood
pressur
cannula
right
femor
vein
connect
pressur
transduc
statham
p
db
determin
left
ventricular
pressur
lvp
millar
microtip
cathet
gould
pc
insert
via
left
carotid
arteri
left
ventricular
enddiastol
pressur
lvedp
measur
highsensit
scale
pressur
curv
dpdt
max
differenti
heart
rate
hr
count
measur
right
ventricular
pressur
millar
microtip
cathet
insert
via
right
femor
vein
systol
diastol
mean
pulmonari
arteri
pressur
pap
mean
pulmonari
capillari
pressur
cardiac
output
measur
thermodilut
techniqu
use
cardiac
index
comput
gould
sp
balloontip
tripl
lumen
cathet
gould
sp
thermistor
posit
pulmonari
arteri
via
jugular
vein
heart
expos
left
thoracotomi
fourth
fifth
intercost
space
pericard
open
left
circumflex
coronari
arteri
lcx
expos
measur
coronari
blood
flow
electromagnet
flow
probe
hellig
recom
place
proxim
part
lcx
polystyrol
microspher
compani
st
paul
minnesota
usa
diamet
dilut
dextran
mgml
salin
concentr
mg
microspheresml
mg
approx
bead
administr
microspher
angiogram
cathet
judkinsschmidt
femoraltorqu
william
cook
europ
ap
bp
insert
left
ostium
via
left
femor
arteri
microspher
inject
angiogram
cathet
left
ostium
initi
ml
later
ml
bolus
min
apart
microspher
inject
produc
stepwis
elev
lvedp
embol
termin
lvedp
increas
mm
hg
andor
papm
increas
mm
hg
andor
heart
rate
reach
beatsmin
embol
complet
min
inject
averag
dose
mgkg
microspher
hemodynam
variabl
allow
stabil
coronari
embol
least
min
test
substanc
vehicl
control
administ
intraven
bolu
inject
continu
infus
intraduoden
applic
record
obtain
chang
paramet
drugtreat
anim
compar
vehicl
control
statist
signific
differ
calcul
student
ttest
mean
embol
time
dose
microspher
number
microspher
applic
evalu
gorodetskaya
et
al
describ
simpl
method
produc
acut
heart
failur
coronari
vessel
embol
microspher
rat
damag
mammalian
heart
produc
prolong
ischemia
reperfus
reduc
precondit
myocardium
via
brief
cycl
ischemia
reperfus
prior
protract
ischem
event
ischem
precondit
shown
decreas
infarct
size
increas
recoveri
postischem
ventricular
function
murray
et
al
reduc
leakag
cellular
marker
protein
indic
cardiac
myocyt
death
volovsek
et
al
addit
preliminari
precondit
also
attenu
cardiac
arrhythmia
associ
subsequ
occlus
reperfus
vegh
et
al
mechanist
basi
phenomenon
discuss
parratt
parratt
vegh
adenosin
receptor
involv
myocardi
protect
ischem
precondit
rabbit
shown
baxter
et
al
adenosin
receptor
antagonist
demonstr
block
protect
produc
precondit
liu
et
al
short
term
administr
adenosin
shown
simul
protect
effect
ischem
precondit
toomb
et
al
observ
togeth
suggest
adenosin
gener
short
precondit
ischemia
recent
pharmacolog
studi
gross
auchampach
yao
gross
indic
involv
atpsensit
potassium
channel
recent
investig
indic
increas
product
ace
inhibitor
may
part
protect
mechan
linz
et
al
moreov
involv
prostanoid
bradykinin
precondit
process
discuss
wiemer
et
al
gho
et
al
found
limit
myocardi
infarct
size
rat
transient
renal
ischemia
support
hypothesi
mechan
lead
cardiac
protect
ischem
precondit
may
resid
heart
new
zealand
rabbit
either
sex
weigh
kg
initi
anesthet
intramuscular
inject
ketamin
mgml
xylazin
mgml
solut
dose
ml
per
kg
bodi
weight
tracheotomi
perform
facilit
artifici
respir
left
extern
jugular
vein
cannul
permit
constant
infus
mlmin
xylazin
mgml
heparin
salin
assist
maintain
anesthesia
fluid
volum
anesthesia
also
maintain
im
inject
ml
ketamin
mgml
xylazin
mgml
solut
xylazin
infus
start
anim
respir
room
air
tidal
volum
mlkg
frequenc
inflat
per
min
harvard
apparatu
usa
thereaft
ventil
adjust
inspiratori
room
air
supplement
co
maintain
arteri
blood
chemistri
within
follow
rang
ph
p
mm
hg
p
mm
hg
right
femor
arteri
vein
isol
catheter
measur
arteri
pressur
administr
drug
respect
thoracotomi
perform
fourth
intercost
space
lung
retract
expos
heart
pericardium
cut
expos
left
ventricl
solidst
pressur
transduc
cathet
e
g
microtip
millar
instrument
houston
usa
insert
apic
incis
secur
enabl
measur
pulsatil
left
ventricular
pressur
maxim
rate
increas
left
ventricular
pressur
lvdpdt
max
determin
electron
differenti
left
ventricular
pressur
wave
form
segment
prolen
sutur
loop
loos
around
margin
branch
left
main
coronari
arteri
facilit
coronari
occlus
experi
needl
electrod
insert
subcutan
lead
ii
configur
enabl
record
ecg
order
determin
heart
rate
help
confirm
occurr
ischemia
st
segment
elev
reperfus
myocardium
distal
coronari
occlus
continu
record
pulsatil
pressur
ecg
heart
rate
lvdpdt
simultan
display
polygraph
e
g
gould
chart
record
gould
inc
valley
view
usa
digit
real
time
person
comput
hemodynam
data
condens
summari
later
statist
analysi
ischem
precondit
induc
tighten
prolen
loop
around
coronari
arteri
min
loosen
reperfus
affect
myocardium
min
prior
subsequ
min
occlus
surgic
prepar
prior
min
occlus
rabbit
randomli
select
receiv
ischem
precondit
precondit
ischem
precondit
plu
treatment
test
drug
min
occlus
ligatur
releas
follow
min
reperfus
occlus
verifi
epicardi
cyanosi
distal
sutur
usual
accompani
alter
hemodynam
ecg
reperfus
valid
return
origin
color
system
hemodynam
summar
experiment
period
experi
termin
min
reperfus
heart
excis
determin
infarct
size
area
risk
immedi
anim
sacrif
margin
branch
left
coronari
arteri
reocclud
india
ink
rapidli
inject
syring
needl
left
ventricular
chamber
demarc
blacken
normal
myocardium
unstain
area
risk
rabbit
sacrif
heart
remov
section
breadloaf
fashion
apex
base
perpendicular
long
axi
right
ventricl
remov
slice
leav
left
ventricl
septum
slice
weigh
portion
wash
incub
phosphat
buffer
salin
solut
triphenyl
tetrazolium
chlorid
gml
sigma
min
salvag
myocardium
area
risk
stain
brick
red
wherea
infarct
tissu
remain
unalt
color
slice
place
sheet
plexigla
area
normal
risk
infarct
slice
trace
sheet
clear
acet
trace
digit
analyz
use
computer
planimetri
compar
rel
composit
slice
respect
normal
tissu
area
risk
infarct
myocardium
planimetri
perform
computer
analysi
system
e
g
quantimet
imag
analysi
system
leica
deerfield
usa
surfac
area
normal
tissu
area
risk
infarct
myocardium
side
slide
averag
individu
slide
contribut
slide
total
infarct
area
risk
area
risk
percentag
total
left
ventricular
mass
entir
left
ventricl
prorat
weight
slice
garciadorado
et
al
ad
adjust
contribut
slice
infarct
tissu
area
risk
left
ventricular
mass
threedimension
mathemat
represent
total
myocardi
infarct
size
risk
zone
calcul
rabbit
mean
tabul
treatment
group
statist
comparison
data
present
mean
sd
system
hemodynam
data
analyz
anova
use
statisticaw
softwar
mean
consid
significantli
differ
p
li
et
al
found
dog
experi
precondit
one
brief
ischem
interv
effect
precondit
multipl
ischem
period
contrast
vegh
et
al
found
dog
experi
two
brief
precondit
period
coronari
occlus
adequ
period
reperfus
reduc
sever
arrhythmia
yang
et
al
found
second
window
protect
ischem
precondit
consciou
rabbit
minim
infarct
arrhythmia
late
precondit
myocardi
stun
consciou
pig
togeth
increas
heat
stress
protein
hsp
describ
sun
et
al
szilvassi
et
al
describ
antiischem
effect
induc
ventricular
overdr
pace
consciou
rabbit
model
precondit
rabbit
equip
right
ventricular
electrod
cathet
pace
intracavit
record
polyethylen
cannula
left
ventricl
right
carotid
arteri
measur
intraventricular
pressur
blood
pressur
one
week
surgeri
consciou
anim
ventricular
overdr
pace
beatsmin
min
result
intracavit
st
segment
elev
shorten
ventricular
effect
refractori
period
decreas
maximum
rate
pressur
develop
blood
pressur
increas
left
ventricular
enddiastol
pressur
proport
durat
stimulu
precondit
ventricular
overdr
pace
appli
min
ventricular
overdr
pace
markedli
attenu
ischem
chang
wherea
ventricular
overdr
pace
effect
ventricular
overdr
pace
induc
precondit
effect
lost
atherosclerot
rabbit
szilvassi
et
al
howev
delay
cardiac
protect
could
induc
anim
szeker
et
al
park
sw
qiu
bolli
r
late
precondit
myocardi
stun
endogen
protect
mechan
confer
resist
postischem
dysfunct
h
brief
ischemia
consciou
pig
volovsek
subramanian
r
reboussin
effect
durat
ischaemia
precondit
mechan
function
enzym
releas
energi
product
isol
work
rat
heart
j
mol
cell
cardiol
wiemer
g
ba
becker
rha
buss
r
ramiprilat
enhanc
endotheli
autacoid
format
inhibit
breakdown
endotheliumderiv
bradykinin
magnet
reson
imag
mri
prefer
techniqu
visual
lesion
brain
spinal
cord
patient
ms
visual
reson
signal
tissu
proton
place
timevari
strong
magnet
field
frequent
use
paramet
measur
ms
spinlattic
relax
time
spinspin
relax
time
mri
routin
use
tomograph
imag
techniqu
anatom
pictur
creat
tissu
section
contrast
differ
brain
structur
mri
techniqu
determin
differ
densiti
diffus
proton
well
differ
relax
time
imag
sensit
water
patholog
alter
ms
brain
associ
alter
distribut
tissu
water
edema
techniqu
highli
use
visual
spatial
distribut
lesion
contrast
imag
determin
mainli
differ
lattic
densiti
dens
structur
compact
white
matter
low
valu
wherea
rel
loos
structur
grey
matter
lesion
higher
valu
distinguish
inflammatori
activ
inact
lesion
paramagnet
dye
gadoliniumdtpa
intraven
inject
mmol
kg
area
increas
bloodbrain
barrier
permeabl
leak
brain
parenchyma
caus
local
enhanc
weight
signal
intens
third
import
mri
techniqu
ms
magnet
transfer
ratio
mtr
imag
mtr
given
tissu
defin
ratio
free
proton
versu
proton
bound
tissu
macromolecul
mri
emerg
highli
accur
quantit
tool
evalu
cardiac
function
peshock
et
al
alshafei
et
al
perform
mri
analysi
cardiac
cycl
event
diabet
rat
test
effect
angiotensinconvert
enzym
inhibit
diabet
induc
wistar
rat
age
week
rat
anesthet
use
halothan
oxygen
blood
glucos
level
check
given
singl
intraperiton
inject
streptozotocin
mgkg
bodi
weight
control
rat
receiv
sham
inject
citrat
buffer
week
old
one
diabet
group
treat
gl
captopril
drink
water
mr
imag
rat
anesthet
use
halothan
oxygen
weigh
systol
blood
pressur
measur
noninvas
use
rat
tail
blood
pressur
monitor
imag
session
confirm
physiolog
stabil
electrocardiograph
ecg
monitor
use
shield
subcutan
electrod
tektronix
oscilloscop
cine
imag
protocol
perform
anesthet
anim
place
special
design
homebuilt
halfsinespac
birdcag
radiofrequ
rf
probe
unit
contain
within
cylindr
plastic
holder
fit
within
gradient
set
intern
diamet
cm
rf
probe
unit
made
halfsin
space
birdcag
rf
probe
intern
diamet
cm
open
end
rf
shield
consist
cylind
copper
gauz
surround
slide
birdcag
tune
capacitor
coaxial
cabl
carri
rf
ballon
et
al
assembl
includ
ecg
lead
attach
plug
ecg
lead
unit
anchor
anesthet
deliveri
tube
near
nose
anim
experi
use
oxford
instrument
uk
superconduct
magnet
horizont
intern
bore
cm
gate
cine
protocol
synchron
line
acquisit
set
time
follow
altern
electrocardiograph
r
wave
acquisit
repeat
slice
posit
equal
increment
time
cardiac
cycl
sequenc
turn
repeat
line
gener
imag
acquir
twice
signal
averag
preced
procedur
turn
repeat
time
obtain
signalaverag
imag
everi
one
contigu
transvers
slice
examin
imag
session
therefor
requir
time
cardiac
cycl
durat
effect
repeat
time
tr
approxim
ms
short
echo
time
te
ms
reduc
motion
artifact
ensur
good
contrast
blood
myocardium
imag
data
transfer
mri
consol
use
inhous
hardwar
softwar
remot
unix
workstat
quantit
analysi
use
inhous
softwar
base
camr
librari
camr
dr
n
j
herrod
herchel
smith
laboratori
medicin
chemistri
univers
cambridg
use
noninvas
mri
techniqu
model
chronic
heart
failur
spontan
hypertens
rat
bryant
et
al
franco
et
al
describ
mri
invas
evalu
develop
heart
failur
transgen
mice
myocardi
express
tumor
necrosi
wiesmann
et
al
report
analysi
right
ventricular
function
healthi
mice
murin
model
heart
failur
byin
vivo
mri
kraitchman
et
al
describ
quantit
ischemia
detect
cardiac
magnet
reson
stress
test
use
fast
harmon
phase
mti
fastharp
dog
reddi
et
al
discuss
feasibl
porcin
model
heal
myocardi
infarct
integr
cardiac
mri
threedimension
electroanatom
map
guid
left
ventricular
cathet
manipul
pelzer
et
al
report
estrogen
agonist
inhibit
cardiac
hypertrophi
improv
hemodynam
function
estrogendefici
spontan
hypertens
rat
improv
left
ventricular
function
upon
treatment
also
observ
cardiac
mri
studi
mal
hous
individu
provid
food
water
ad
libitum
inbr
brown
norway
bn
n
da
rat
obtain
harlan
spragu
dawley
indianapoli
ind
anesthesia
inject
mgkg
bodi
weight
sodium
pentobarbit
ip
ukg
bodi
weight
heparin
inject
syngen
group
en
bloc
donor
heart
lung
taken
bn
rat
transplant
anoth
bn
rat
allogen
group
graft
da
rat
transplant
bn
rat
group
divid
two
group
one
group
treat
mgkg
per
day
ciclosporin
csa
group
given
csa
graft
surviv
monitor
everi
day
palpat
contract
transplant
heart
oper
procedur
describ
kanno
et
al
brief
chest
wall
donor
rat
open
left
lung
ligat
excis
azygo
vein
left
superior
right
superior
vena
cava
ligat
divid
descend
thorac
aorta
transect
ml
cold
univers
wisconsin
solut
uw
solut
dupont
pharma
infus
inferior
vena
cava
fluid
drain
aorta
clear
follow
ligat
divis
inferior
vena
cava
ascend
aorta
dissect
transect
portion
left
common
carotid
arteri
left
subclavian
arteri
follow
ligat
divis
right
brachiocephal
arteri
left
common
carotid
arteri
remov
heart
lung
donor
right
lung
wash
time
bronchu
uw
solut
contain
penicillin
g
graft
place
cold
uw
solut
min
transplant
next
left
inguin
portion
recipi
rat
open
dissect
make
enough
space
transplant
organ
left
lower
part
abdomin
wall
open
transvers
fashion
left
femor
vessel
midlin
abdomin
organ
retract
right
aorta
inferior
vena
cava
beyond
bifurc
dissect
vessel
clamp
appropri
open
aorta
made
receiv
aorta
graft
endtosid
fashion
rhythmic
heartbeat
commenc
spontan
heart
lung
regain
circul
remov
clamp
hemostasi
surgic
field
abdomin
wall
sutur
care
taken
kink
obstruct
aorta
graft
mri
measur
carri
bruker
avanc
drx
mr
instrument
equip
shield
gradient
vivo
mr
imag
transplant
heartlung
obtain
period
h
infus
dextranco
ultrasmal
superparamagnet
iron
oxid
uspio
particl
imag
sequenc
consist
gradient
echo
sequenc
trigger
ecg
ventil
strokesmin
mlkg
trte
ms
flip
angl
equal
ernst
angl
slice
thick
mm
field
view
cm
data
matrix
size
zerofil
scan
time
min
ecg
lead
place
hind
limb
rat
transplant
pick
heartbeat
transplant
heart
effect
chang
mri
signal
intens
measur
whole
ventricular
wall
transplant
heart
mr
signal
intens
heart
normal
leg
muscl
uspio
particl
readili
taken
muscular
tissu
accord
gellissen
et
al
dextranco
uspio
particl
synthes
accord
method
palmacci
josephson
slight
modif
dodd
et
al
mr
relax
r
spinlattic
relax
rate
constant
per
mol
fe
uspio
r
spinspin
relax
rate
constant
per
mol
fe
uspio
measur
moll
respect
vivo
studi
dextranco
uspio
particl
dialyz
pb
solut
dilut
concentr
feml
ml
suspens
e
mg
fekg
bodi
weight
inject
intraven
studi
day
transplant
dextranco
uspio
particl
inject
intraven
mention
anim
subject
mri
h
later
anim
place
insid
magnet
scan
region
interest
defin
manual
bruker
softwar
mr
signal
intens
entir
ventricular
wall
plane
measur
inject
uspio
particl
postop
day
pod
anim
allotranspl
given
csa
pod
pod
day
reinject
uspio
particl
pod
mr
experi
complet
transplant
heart
extirp
fix
formaldehyd
embed
paraffin
section
hematoxylineosin
stain
perl
prussian
blue
stain
perform
transplant
patholog
laboratori
univers
pittsburgh
medic
center
histolog
analysi
patholog
grade
heart
reject
base
criteria
establish
intern
societi
heart
lung
transplant
also
perform
laboratori
blind
manner
monoclon
antirat
macrophag
antibodi
serotec
use
primari
antibodi
macrophag
immunohistochemistri
carri
abc
stain
system
santa
cruz
biotechnolog
accord
manufactur
protocol
result
present
mean
sd
result
analyz
anova
statview
softwar
sa
institut
valu
p
consid
statist
signific
dodd
sj
william
suhan
jp
et
al
prolong
administr
coronari
drug
shown
increas
number
size
interarteri
collater
dog
pig
coronari
occlus
vineberg
et
al
meesmann
bachmann
increas
rate
develop
collater
arteri
observ
physic
exercis
dog
schaper
et
al
well
chronic
administr
coronari
dilat
drug
lumb
hardi
even
effect
stimulu
collater
develop
acut
gradual
occlus
one
sever
major
coronari
branch
fill
arteri
coronari
bed
plastic
provid
possibl
make
collater
visibl
quantifi
schmidt
schmier
kadatz
dog
weigh
kg
anesthet
pentobarbit
sodium
mgkg
iv
respir
artifici
thorax
open
open
pericard
ameroid
cuff
place
around
major
coronari
branch
gradual
swell
plastic
materi
occlud
lumen
within
week
dog
treat
daili
test
drug
placebo
week
recoveri
period
submit
exercis
treadmil
ergomet
week
treatment
anim
sacrif
heart
remov
coronari
bed
flush
salin
liquid
plastic
araldit
use
fill
whole
coronari
tree
bulbu
aorta
aortic
valv
glu
togeth
order
prevent
fill
left
ventricl
red
color
araldit
use
fill
arteri
tree
venou
part
coronari
vasculatur
fill
blue
color
araldit
venou
sinu
uniform
fill
pressur
fill
time
viscos
materi
import
polymer
complet
sever
hour
tissu
digest
potassium
hydroxid
method
give
stabl
prepar
preserv
long
time
plastic
cast
drug
treat
anim
compar
cast
dog
submit
procedur
without
drug
treatment
procedur
allow
impress
demonstr
format
arteri
collater
result
post
mortem
araldit
implet
agre
function
result
experiment
coronari
occlus
boor
reynold
cellular
calcium
flux
regul
receptoroper
voltagedepend
channel
sensit
inhibit
calcium
entri
blocker
term
calcium
antagonist
introduc
fleckenstein
fleckenstein
two
drug
prenylamin
verapamil
origin
found
coronari
dilat
langendorffexperi
shown
mimic
cardiac
effect
simpl
ca
withdraw
diminish
ca
high
energi
phosphat
util
contractil
forc
oxygen
requir
beat
heart
without
impair
na
depend
action
potenti
paramet
effect
clearli
distinguish
blockad
could
promptli
neutral
elev
ca
catecholamin
cardiac
glycosid
measur
restor
ca
suppli
contractil
system
follow
year
mani
ca
antagonist
introduc
therapi
specif
ca
antagonist
interfer
uptak
ca
myocardium
prevent
myocardi
necrot
aris
deleteri
intracellular
ca
overload
act
basic
specif
inhibitor
slow
transsarcolemn
ca
influx
slightli
affect
fast
na
current
initi
normal
myocardi
excit
calcium
channel
site
action
drug
modifi
channel
function
classifi
bean
porzig
tsien
tsien
sped
paoletti
nomenclatur
structurefunct
relationship
voltageg
calcium
channel
review
catteral
et
al
kochegarow
review
therapeut
applic
modul
voltageg
calcium
channel
four
main
type
voltag
depend
calcium
channel
describ
l
type
long
last
type
transient
n
type
neuron
p
type
purkinj
cell
differ
function
dolphin
local
tissu
cell
also
sensit
pharmacolog
agent
ferrant
triggl
dascal
kitamura
et
al
specif
radioligand
wide
distribut
ltype
channel
exist
isoform
consist
sever
subunit
known
sensit
dihydropyridin
phenylalkylamin
benzothiazepin
insensit
segment
requir
antagonist
bind
analyz
peterson
et
al
schuster
et
al
mitterdorf
et
al
hockerman
et
al
striessnig
et
al
catteral
berjukow
et
al
discuss
molecular
mechan
calcium
channel
block
israpidin
striessnig
et
al
describ
role
ltype
ca
channel
ca
channelopathi
ttype
channel
locat
mainli
cardiac
sinoatri
node
differ
electrophysiolog
characterist
ltype
channel
massi
perezrey
et
al
review
molecular
physiolog
lowvoltageactiv
ttype
calcium
channel
given
perezrey
nand
ptype
calcium
channel
blocker
occur
neuron
cell
involv
neurotransmitt
releas
olivera
et
al
bertolino
mintz
et
al
woppmann
et
al
et
al
miljanich
ramachandran
fisher
bourqu
ikeda
ertel
et
al
sinnegg
et
al
radiolabel
dihydropyridin
calcium
channel
antagonist
hnitrendipin
salter
grover
campiani
et
al
select
ligand
drug
receptor
site
associ
voltagedepend
calcium
channel
constant
concentr
radioligand
hnitrendipin
nm
incub
increas
concentr
nonlabel
test
drug
mm
presenc
plasma
membran
bovin
cerebr
cortic
test
drug
exhibit
affin
calcium
channel
abl
compet
radioligand
channel
bind
site
thu
lower
concentr
rang
test
drug
competit
reaction
occur
potent
test
drug
two
freshli
slaughter
bovin
brain
obtain
slaughterhous
place
icecold
prepar
buffer
laboratori
approx
g
wet
weight
two
frontal
cerebr
cortic
separ
brain
tissu
homogen
glass
teflon
potter
icecold
prepar
buffer
correspond
g
cerebr
wet
ml
buffer
centrifug
g
min
result
pellet
resuspend
approx
ml
prepar
buffer
homogen
centrifug
final
pellet
dissolv
prepar
buffer
correspond
g
cerebr
cortex
wet
ml
buffer
membran
suspens
immedi
store
aliquot
ml
protein
content
membran
suspens
determin
accord
method
lowri
et
al
bovin
serum
albumin
standard
day
experi
requir
volum
membran
suspens
slowli
thaw
centrifug
g
min
result
pellet
resuspend
volum
icecold
incub
buffer
yield
membran
suspens
protein
content
mgml
homogen
glass
teflon
potter
membran
suspens
stir
cool
min
start
experi
tend
bind
plastic
materi
dilut
step
done
glass
tube
concentr
sampl
prepar
triplic
total
volum
incub
sampl
microtit
plate
bind
reaction
start
ad
membran
suspens
per
incub
sampl
mg
proteinml
sampl
incub
min
bath
shaker
reaction
stop
subject
total
incub
volum
rapid
vacuum
filtrat
glass
fibr
filter
therebi
membranebound
separ
free
radioact
filter
wash
immedi
approx
ml
icecold
rins
buffer
per
sampl
retain
membranebound
radioact
filter
measur
addit
ml
liquid
scintil
cocktail
per
sampl
packard
liquid
scintil
counter
follow
paramet
calcul
total
bind
nonspecif
bind
specif
bind
total
bind
nonspecif
bind
dissoci
constant
k
test
drug
determin
competit
experi
hnitrendipin
versu
nonlabel
drug
computersupport
analysi
bind
data
k
valu
test
drug
concentr
receptor
occupi
test
drug
affin
constant
k
moll
record
serv
paramet
assess
efficaci
test
drug
standard
data
nifedipin
k
moll
h
israpidin
use
mani
author
label
ligand
bind
experi
grassegg
et
al
nokin
et
al
striessnig
et
al
yaney
et
al
miwa
et
al
ichida
et
al
kalasz
et
al
ikeda
et
al
rutledg
triggl
shimasu
et
al
et
al
natal
et
al
matth
et
al
peri
et
al
yaney
et
al
perform
bind
experi
h
membran
cell
pancreat
grown
plastic
cultur
flask
medium
rpmi
supplement
fetal
bovin
serum
streptomycin
uml
penicillin
cell
kept
humidifi
incub
co
air
mainten
flask
subcultur
everi
day
confluenc
bind
experi
h
membran
cell
remov
flask
incub
min
mm
mop
nmorpholino
propanesulfon
acid
mm
egta
ph
osmot
ruptur
cell
homogen
brinkmann
polytron
follow
centrifug
g
min
pellet
resuspend
wash
twice
final
pellet
resuspend
mm
cacl
mm
mop
ph
protein
concentr
mgml
membran
incub
room
temperatur
h
final
volum
weiland
oswald
bound
free
radioligand
separ
vacuum
filtrat
glass
fiber
filter
schleicher
follow
three
wash
filter
ml
incub
buffer
nonspecif
bind
determin
presenc
nitrendipin
radioact
retain
filter
determin
liquid
scintil
count
concentr
free
radioligand
calcul
scintil
count
aliquot
incub
mixtur
nonspecif
condit
centrifug
sever
calcium
entri
blocker
nimodipin
diltiazem
verapamil
desmethoxyverapamil
label
use
bind
studi
order
elucid
calcium
channel
recognit
site
may
use
classif
calcium
antagonist
ferri
glossmann
glossmann
et
al
goll
et
al
lee
et
al
glossmann
et
al
schoemak
langer
ruth
et
al
reynold
et
al
vaghi
et
al
identifi
phenylalkylaminebind
polypeptid
calcium
channel
prepar
naito
et
al
describ
photoaffin
label
purifi
skelet
muscl
calcium
antagonist
receptor
h
azidobutyryl
diltiazem
watanab
et
al
report
azidobutyryl
clentiazem
label
benzothiazepin
bind
site
subunit
skelet
muscl
calcium
channel
tissu
heterogen
calcium
channel
antagonist
bind
site
demonstr
gould
et
al
photoaffin
label
cardiac
calcium
channel
azidopin
describ
knau
et
al
describ
uniqu
fluoresc
phenylalkylamin
probe
ltype
ca
channel
bind
site
appear
primarili
associ
ntype
voltagedepend
calcium
channel
feigenbaum
et
al
wagner
et
al
cohen
et
al
recommend
peptid
iiia
valuabl
pharmacolog
tool
known
ligand
block
ltype
calcium
channel
high
affin
voltag
caus
unlik
block
ttype
calcium
channel
intracellular
action
potenti
guinea
pig
papillari
muscl
record
partial
depolar
achiev
potassium
enrich
ringer
solut
addit
isoproterenol
rest
potenti
increas
mv
result
inactiv
fast
sodium
channel
condit
upstrok
veloc
indic
calcium
flux
membran
decreas
calcium
blocker
guinea
pig
either
sex
pirbright
white
strain
weigh
g
sacrif
stun
carotid
arteri
sever
thorac
cage
open
immedi
heart
remov
place
contain
prewarm
preoxygen
ringer
solut
pericardium
atria
trim
away
left
ventricl
open
two
strongest
papillari
muscl
remov
fix
suction
electrod
electr
stimul
forc
transduc
registr
contract
initi
normal
ringer
solut
oxygen
carbogen
co
temperatur
use
standard
micro
electrod
techniqu
appli
measur
action
potenti
via
glass
micro
electrod
contain
kcl
solut
insert
intracellularli
papillari
muscl
stimul
rectangular
puls
v
ms
durat
interv
ms
interv
two
stimuli
variabl
order
determin
refractori
period
intens
electr
current
stimul
threshold
intracellular
action
potenti
amplifi
differenti
registr
upstrok
veloc
hugo
sach
micro
electrod
amplifi
togeth
contract
forc
display
oscilloscop
gould
digit
storag
oscilloscop
os
record
gould
record
incub
period
min
ringer
solut
chang
follow
composit
contain
time
potassium
less
sodium
nacl
gl
kcl
gl
cacl
gl
nahco
gl
glucos
gl
depolar
isoproterenol
mg
per
ml
ad
measur
rest
potenti
increas
mv
result
inactiv
fast
inward
sodium
channel
result
slow
rise
action
potenti
sensit
calcium
antagonist
drug
kohlhardt
fleckenstein
test
compound
ad
concentr
effect
compound
test
lower
concentr
compar
standard
nifedipin
concentr
decreas
upstrok
veloc
test
variou
concentr
test
compound
compar
standard
kstrophanthin
cardiac
glycosid
inhibit
membranebound
na
k
activ
atpas
lead
increas
intracellular
ca
ca
ion
activ
contractil
apparatu
caus
distinct
enhanc
contract
procedur
use
evalu
compound
calcium
channel
block
activ
measur
abil
decreas
atrial
contract
induc
kstrophanthin
hsestimul
hugo
sach
elektronik
marchhugstetten
germani
stimul
data
frequenc
hz
durat
ms
voltag
v
guinea
pig
either
sex
weigh
g
sacrif
blow
nape
neck
exsanguin
left
atrium
remov
place
organ
bath
attach
isoton
strain
gaug
base
wire
electrod
stimul
ringersolut
aerat
carbogen
kept
atrium
continu
stimul
via
stimul
voltag
slowli
increas
threshold
level
contract
record
polygraph
prior
drug
administr
two
prevalu
obtain
ad
cymarin
organ
bath
measur
increas
contractil
forc
follow
min
washout
recoveri
period
test
drug
ad
bath
follow
administr
min
later
chang
contractil
forc
alway
measur
min
addit
standard
compound
verapamil
hydrochlorid
nifedipin
percent
inhibit
induc
contract
determin
calcium
antagonist
also
evalu
langendorff
heart
prepar
leboeuf
et
al
report
protect
effect
bepridil
flunarizin
veratrineinduc
contractur
rat
atria
conclud
result
model
agent
may
effect
ltype
calcium
ionchannel
blocker
protect
calcium
overload
ischaemia
reperfus
injuri
contract
aorta
ring
induc
ad
potassium
chlorid
norepinephrin
organ
bath
contain
slightli
modifi
kreb
bicarbon
buffer
test
drug
calcium
channel
block
activ
relax
effect
rabbit
either
sex
weigh
kg
sacrif
overdos
pentobarbit
sodium
chest
caviti
open
descend
thorac
aorta
level
aortic
arch
level
diaphragm
rapidli
remov
place
beaker
oxygen
kreb
bicarbon
buffer
content
magnesium
calcium
slightli
diminish
kreb
bicarbon
buffer
result
follow
composit
tissu
transfer
dish
contain
fresh
oxygen
warm
kreb
solut
fat
loos
connect
tissu
care
remov
keep
tissu
moist
solut
eight
ring
mm
width
obtain
mount
ml
tissu
bath
contain
oxygen
warm
kreb
solut
initi
tension
set
g
tissu
allow
incub
period
h
time
kreb
solut
chang
everi
min
also
time
tension
maintain
g
prior
end
h
equilibr
period
kreb
solut
chang
tissu
allow
stabil
g
tension
sustain
contract
gener
addit
either
mm
kcl
mm
norepinephrin
twenti
min
addit
agonist
test
drug
ad
final
concentr
bath
percent
relax
read
taken
min
addit
test
drug
least
relax
occur
accumul
concentrationrelax
curv
establish
min
period
time
addit
concentr
test
compound
activ
tension
calcul
tissu
time
point
prior
addit
test
compound
also
point
min
addit
concentr
test
compound
activ
tension
defin
differ
gener
tension
baselin
tension
percent
relax
predrug
precontract
level
calcul
concentr
test
compound
number
experi
constitut
dose
rang
id
calcul
linear
regress
analysi
hof
vuorela
compar
three
method
assess
calcium
antagon
rabbit
aorta
smooth
muscl
matsuo
et
al
report
simpl
specif
screen
method
caentri
blocker
presenc
variou
cachannel
blocker
ca
caus
relax
rat
uterin
smooth
muscl
tonic
contract
oxytocin
calciumfre
medium
prolong
preincub
mm
egta
mich
et
al
use
spiral
cut
prepar
rat
aorta
ring
rabbit
ear
arteri
test
calcium
entri
blocker
activ
et
al
describ
smooth
muscl
cell
line
origin
fetal
rat
aorta
suitabl
studi
voltag
sensit
calcium
channel
calcium
channel
antagonist
inhibit
basal
potassium
chlorid
stimul
ca
uptak
hof
rp
vuorela
hj
guinea
pig
pirbright
white
strain
either
sex
weigh
g
sacrif
stun
pulmonari
arteri
remov
cut
spiral
angl
result
strip
cut
length
cm
one
piec
suspend
oxygen
normal
tyrod
solut
organ
bath
preload
g
contract
regist
isoton
strain
transduc
record
polygraph
h
equilibrium
time
normal
solut
exchang
potassium
enrich
tyrod
solut
arteri
strip
react
contract
achiev
min
maximum
addit
min
exchang
normal
tyrod
solut
perform
ten
min
later
contract
induc
potassium
enrich
solut
height
contract
reach
constant
level
test
substanc
ad
potassium
induc
contract
record
height
contract
express
percent
initi
potassium
induc
contract
lavag
procedur
repeat
higher
dose
standard
calcul
regress
line
decreas
contract
versu
control
variou
dose
measur
mm
percentag
inhibit
variou
dose
taken
calcul
ed
use
cardioacceler
respons
pith
rat
calcium
entri
blocker
distinguish
agent
mode
action
involv
direct
blockad
calcium
entri
clapham
male
spraguedawley
rat
g
anaesthet
methohexiton
sodium
mgkg
ip
follow
cannul
trachea
rat
pith
one
orbit
stainless
steel
rod
immedi
artifici
respir
room
air
strokesmin
g
bodi
weight
via
palmer
small
anim
respir
pump
jugular
vein
cannul
administr
drug
arteri
blood
pressur
record
carotid
arteri
use
pressur
transduc
heart
rate
deriv
phasic
arteri
pressur
signal
phase
lock
loop
ratemet
brl
instrument
servic
paramet
display
record
anim
kept
warm
incandesc
lamp
posit
cm
pith
rod
withdrawn
tip
lay
thorac
portion
spinal
cord
rat
receiv
tubocurarin
mgkg
iv
bilater
vagotom
cardioacceler
respons
obtain
continu
electr
stimul
thorac
spinal
cord
squar
wave
puls
ms
durat
supramaxim
voltag
frequenc
hz
use
pith
rod
stimul
electrod
indiffer
electrod
insert
subcutan
femor
region
rat
result
tachycardia
beatsmin
includ
experi
cardioacceler
respons
stabil
min
cumul
intraven
dose
drug
correspond
vehicl
administ
succeed
dose
given
respons
previou
dose
stabil
calcium
antagonist
inhibit
dosedepend
tachycardia
elicit
electr
stimul
spinal
cord
wherea
lignocain
nicorandil
effect
dose
calciumantagonist
reduc
tachycardia
test
three
min
administr
drug
calcium
glucon
mgmin
water
mlmin
infus
use
harvard
apparatu
compact
infus
pump
effect
calcium
entri
blocker
blocker
antagon
level
tachycardia
immedi
prior
drug
administr
taken
respons
drug
express
percentag
predos
tachycardia
inhibitori
effect
seen
id
confid
limit
interpol
linear
regress
analysi
signific
differ
group
receiv
calcium
glucon
parallel
vehicl
control
calcul
student
ttest
differenti
effect
calciumantagonist
achiev
rel
simpl
vivo
model
guidelin
studi
arrhythmia
man
anim
regard
experiment
design
well
classif
quantif
analysi
given
lambeth
convent
walker
et
al
antiarrhythm
drug
classifi
variou
group
subgroup
borchard
et
al
frumin
et
al
colatski
follmer
podrid
coromila
nattel
rosen
schwartz
scholz
woosley
raven
sanguinetti
grant
nattel
scholz
classif
base
electrophysiolog
effect
e
g
action
potenti
interact
membran
receptor
ion
channel
heterogen
classif
criteria
result
vivid
discuss
sicilian
gambit
vaughan
william
particular
clinic
studi
cast
investig
challeng
therapeut
valu
antiarrhythm
drug
weirich
antoni
antoni
propos
subdivis
drug
accord
satur
behavior
frequencydepend
block
onsetkinet
class
antiarrhythm
drug
directli
alter
membran
conduct
cation
particularli
na
k
reduc
upstrok
veloc
v
max
cardiac
action
potenti
blockad
fast
na
channel
lead
depress
conduct
veloc
prolong
voltageand
timedepend
refractori
period
increas
threshold
excit
cardiac
muscl
class
antiarrhythm
drug
subclassifi
accord
effect
action
potenti
durat
class
antiarrhythm
drug
quinidinelik
substanc
e
g
disopyramid
procainamid
ajmalin
lengthen
action
potenti
durat
reflect
ecg
lengthen
qtinterv
effect
ad
fast
sodium
channel
result
delay
recoveri
inactiv
lidoacainelik
drug
e
g
mexiletin
phenytoin
tocainid
contrast
shorten
action
potenti
durat
class
c
antiarrhythm
drug
e
g
encainid
flecainid
propafenon
indecainid
produc
quinidineand
lidocainelik
effect
exert
differenti
action
durat
action
potenti
purkinj
fibr
shorten
ventricular
muscl
class
ii
antiarrhythm
drug
antagonist
exert
antiarrhythm
effect
antagon
electrophysiolog
effect
catecholamin
mainli
mediat
increas
slow
calcium
inward
current
class
iii
antiarrhythm
drug
e
g
amiodaron
bretylium
sotalol
prolong
action
potenti
lead
correspond
increas
effect
refractori
period
action
mainli
due
block
outward
repolar
current
howev
activ
sodium
calcium
inward
current
prolong
plateau
action
potenti
may
also
involv
class
iv
antiarrhythm
drug
e
g
verapamil
diltiazem
slow
calcium
channel
blocker
suppress
slow
calcium
inward
current
calciumdepend
slow
action
potenti
winslow
review
method
detect
assess
antiarrhythm
activ
szeker
suggest
ration
screen
program
select
effect
antiarrhythm
drug
arrhythmia
model
rat
review
cheung
et
al
arrhythmogen
stimuli
divid
three
group
chemic
electr
mechan
szeker
papp
wilson
larg
number
chemic
agent
alon
combin
capabl
induc
arrhythmia
administr
anesthet
like
chloroform
ether
halothan
sensit
agent
follow
precipit
stimulu
intraven
adrenalin
cardiac
glycosid
usual
ouabain
aconitin
veratrum
alkaloid
caus
arrhythmia
sensit
arrhythmogen
substanc
differ
among
variou
speci
possibl
produc
arrhythmia
electr
stimul
heart
difficulti
evalu
antiarrhythm
drug
approach
discuss
szeker
serial
electr
stimul
result
flutter
fibril
possibl
reproduc
main
type
arrhythmia
clinic
import
flutter
threshold
ventricular
multipl
respons
threshold
may
determin
anesthet
dog
administr
test
drug
arrhythmia
induc
directli
ischemia
reperfus
ischemia
either
infarct
coronari
ligat
sever
phase
arrhythmia
found
two
stage
coronari
arteri
ligat
techniqu
describ
harri
focus
late
arrhythmia
curti
walker
examin
seven
score
attempt
valid
use
arrhythmia
score
vivo
model
consciou
rat
influenc
reperfus
arrhythmia
test
variou
speci
e
g
rat
pig
dog
cat
bergey
et
al
winslow
curti
et
al
record
electrocardiogram
essenti
tool
evalu
antiarrhythm
drug
johnston
et
al
curti
walker
adaikan
et
al
similar
heart
rate
electrocardiogram
differ
variou
speci
bazett
kisch
heis
kimbel
beinfield
lehr
budden
et
al
driscol
osborn
hay
et
al
mani
author
use
bipolar
lead
ii
right
foreleg
left
hindleg
line
neutral
place
heart
addit
lead
right
left
foreleg
state
lie
axi
horizont
heart
lead
iii
left
foreleg
left
hindleg
line
vertic
heart
may
use
well
unipolar
lead
usual
design
v
v
unipolar
lead
design
avl
avr
avf
sever
speci
use
procedur
rat
penz
et
al
hay
et
al
describ
male
spragu
dawley
rat
weigh
g
anesthet
intraperiton
inject
mgkg
pentobarbiton
right
jugular
vein
cannul
inject
left
coronari
arteri
cannul
record
blood
pressur
polygraph
ecg
record
use
lead
type
ii
configur
along
anatom
axi
heart
determin
palpat
ecg
record
standard
chart
speed
mm
polygraph
simultan
storag
oscilloscop
measur
interv
made
chart
record
memori
trace
monitor
sinc
rat
difficult
detect
twave
correspond
exactli
twave
seen
speci
beinfeld
lehr
driscol
surawicz
twave
calcul
made
basi
repolar
wave
follow
qr
complex
follow
variabl
measur
time
depolar
wave
cross
atria
pr
interv
qr
interv
qt
interv
rsh
height
peak
r
wave
rsh
magnitud
taken
measur
extent
swave
depress
exert
class
sodium
channel
block
antiarrhythm
statist
analys
base
anova
follow
duncan
test
differ
mean
order
demonstr
relationship
drug
effect
standard
cumul
doserespons
curv
construct
osborn
osborn
describ
restrain
devic
facilit
electrocardiogram
record
consciou
rat
curti
walker
johnston
et
al
studi
respons
ligat
coronari
arteri
action
antiarrhythm
consciou
rat
hay
et
al
studi
ecg
guinea
pig
rabbit
primat
stark
et
al
describ
epicard
surfac
stimul
techniqu
sstecg
langendorff
perfus
guinea
pig
heart
epicardi
bundl
record
guinea
pig
vivo
describ
todt
raberg
chronic
record
bundl
awak
nonsed
dog
report
karpawich
et
al
atle
et
al
van
de
water
et
al
report
formula
correct
qt
interv
electrocardiogram
dog
chang
heart
rate
describ
dual
electrophysiolog
test
atrial
antireentri
ventricular
antifibrillatori
studi
anesthet
dog
reentri
portion
model
creat
surgic
yshape
crush
around
tissu
superior
inferior
vena
cava
tissu
parallel
av
groov
pace
induc
tachycardia
result
circu
movement
around
tricuspid
ring
persist
durat
regular
cycl
length
antifibrillatori
activ
assess
determin
ventricular
fibril
threshold
use
trainstimuli
method
weissenburg
et
al
develop
experiment
model
long
qt
syndrom
consciou
dog
screen
bradycardiadepend
proarrhythm
effect
drug
studi
electrophysiolog
torsad
de
point
bauer
et
al
describ
proand
antiarrhythm
effect
fast
cardiac
pace
canin
model
acquir
long
qt
syndrom
holter
monitor
consciou
dog
describ
krumpl
et
al
b
coker
recommend
anesthet
rabbit
model
ischemiaand
reperfusioninduc
arrhythmia
baboon
monkey
macaca
sp
use
adaikan
et
al
plant
alkaloid
aconitin
persist
activ
sodium
channel
infus
aconitin
anesthet
rat
caus
ventricular
arrhythmia
drug
consid
antiarrhythm
properti
test
aconitineintox
rat
male
ivanova
rat
weigh
g
use
anim
anesthet
intraperiton
inject
gkg
urethan
five
aconitin
dissolv
n
hno
administ
continu
infus
saphen
vein
mlmin
ecg
lead
ii
record
everi
second
test
compound
inject
oral
intraven
screen
dose
mgkg
min
start
aconitin
infus
eightten
anim
use
per
compound
antiarrhythm
effect
test
compound
measur
amount
g
anim
durat
infus
induc
ventricular
extrasystol
ventricular
tachycardia
ventricular
fibril
death
higher
dose
aconitin
treat
group
compar
untreat
control
group
indic
antiarrhythm
activ
statist
signific
group
assess
student
ttest
score
allot
intens
durat
effect
rel
efficaci
standard
compound
standard
data
procainamid
mgkg
iv
lidocain
mgkg
iv
lead
increas
ld
correspond
ld
approxim
g
aconitin
antagon
vivo
proven
valuabl
screen
method
antiarrhythm
activ
scherf
studi
auricular
tachycardia
caus
aconitin
administr
dog
scherf
et
al
provok
atrial
flutter
fibril
anesthet
dog
applic
crystal
aconitin
delphinin
surfac
right
atrium
appendix
area
near
head
sinu
node
mc
leod
reynold
induc
arrhythmia
aconitin
isol
rabbit
atrium
nwangwu
et
al
use
aconitin
arrhythmogen
agent
screen
antiarrhythm
agent
mice
yamamoto
et
al
use
urethaneanesthet
rat
artifici
respir
tubocurarin
pretreat
thoracotomi
incis
pericardium
piec
filter
paper
soak
aconitin
solut
appli
right
atrium
test
drug
appli
continu
iv
infus
addit
ecg
lead
ii
intraatri
ecg
monitor
aconitineantagon
consciou
mice
screen
procedur
recommend
dadkar
bhattacharya
anesthet
mice
winslow
nakayama
et
al
describ
topic
applic
aconitin
small
cup
place
right
atrium
dog
induc
supraventricular
arrhythmia
method
use
cat
develop
winslow
addit
aconitin
model
vaill
et
al
demonstr
select
cacl
continu
infus
screen
method
rat
evalu
antiarrhythm
calcium
antagonist
mous
chloroform
model
recommend
lawson
vargaftig
et
al
induc
ventricular
fibril
mice
inhal
chloroform
papp
et
al
propos
experiment
bacl
arrhythmia
quantit
assay
antiarrhythm
drug
use
calcium
chlorideinduc
arrhythmia
antiarrhythm
activ
evalu
anesthet
male
rat
cardiac
arrhythmia
induc
singl
intraven
inject
cacl
mgkg
induc
arrhythmia
analyz
magnitud
initi
bradycardia
onset
incid
durat
induc
fibril
induct
arrhythmia
anim
allow
recov
complet
min
test
compound
inject
differ
dose
intraven
effect
test
compound
basal
heart
rate
examin
percentag
chang
heart
rate
calcul
seven
min
later
arrhythmogen
dose
cacl
readminist
effect
treatment
induc
arrhythmia
paramet
evalu
percentag
chang
measur
paramet
protect
nonprotect
induc
fibril
tripathi
thoma
describ
method
product
ventricular
tachycardia
rat
guinea
pig
expos
anim
benzen
vapor
min
follow
intraven
adrenalin
inject
arrhythmia
could
induc
chang
medium
cultur
rat
heart
muscl
cell
wenzel
kloeppel
isol
rat
heart
ventricular
fibril
induc
isoprenalin
catecholomethyl
transferas
inhibitor
high
perfus
temperatur
sono
et
al
takei
describ
experiment
arrhythmia
guinea
pig
induc
grayanotoxini
biolog
activ
diterpenoid
plant
famili
ericacea
overdos
cardiac
glycosid
digoxin
induc
ventricular
extrasystol
ventricular
fibril
final
death
occurr
symptom
delay
antiarrhythm
drug
male
guinea
pig
marioth
strain
weigh
g
anesthet
mgkg
pentobarbit
sodium
intraperiton
trachea
one
jugular
vein
one
carotid
arteri
catheter
posit
pressur
ventil
appli
respiratori
pump
rhema
gmbh
germani
breathsmin
carotid
arteri
use
monitor
system
blood
pressur
via
pressur
transduc
digoxin
infus
jugular
vein
perfus
pump
asid
bonz
pp
rate
mlmin
cardiac
arrest
electrocardiogram
lead
iii
record
subcutan
steelneedl
electrod
hellig
treat
group
n
anim
receiv
test
drug
either
oral
h
intraven
min
prior
infus
control
group
n
least
anim
receiv
digoxin
infus
period
onset
ventricular
extrasystol
ventricular
fibril
cardiac
arrest
record
total
amount
infus
digoxin
induc
ventricular
fibril
calcul
standard
drug
lidocain
mgkg
iv
ramipril
mgkg
po
use
student
ttest
dose
digoxin
need
induc
ventricular
extrasystol
ventricular
fibril
cardiac
arrest
respect
treatment
antiarrhythm
drug
compar
statist
control
receiv
digoxin
tebrachii
intraduoden
administr
test
drug
duodenum
cannul
electrocardiogram
regist
needl
electrod
lead
ii
heart
frequenc
deriv
rpeak
ecg
twothre
anim
use
one
compound
strophanthin
k
administ
continu
ivinfus
rate
thirtyfourti
min
later
sign
cardiac
glycosid
intox
appear
lead
ventricular
tachycardia
multifoc
ventricular
arrhythmia
state
achiev
strophanthin
infus
termin
arrhythmia
stabl
min
test
substanc
administ
intraven
dose
mgkg
intraduoden
dose
mgkg
ecg
ii
record
obtain
time
min
follow
administr
test
drug
iv
administr
test
compound
consid
antiarrhythm
effect
extrasystol
immedi
disappear
test
compound
show
posit
effect
increas
dose
administ
mininterv
test
substanc
revers
arrhythmia
next
dose
administ
reappear
stabl
arrhythmia
id
administr
test
compound
consid
definit
antiarrhythm
effect
extrasystol
disappear
within
min
test
drug
consid
effect
improv
strophanthin
intox
within
min
follow
drug
administr
evalu
therapeut
effect
drug
difficult
somewhat
arbitrari
sinc
clearcut
correl
effect
test
compound
durat
effect
e
return
normal
ecg
standard
drug
ajmalin
quinidin
lidocain
reestablish
normal
sinu
rhythm
dose
mgkg
iv
mgkg
id
arrhythmia
elimin
min
iv
min
id
follow
drug
administr
etting
et
al
use
arrhythmia
dog
induc
ouabain
studi
effect
phentolamin
arrhythmia
garrett
et
al
studi
antiarrhythm
activ
n
ndiisopropylndiethylaminoethylurea
hydrochlorid
anesthet
dog
arrhythmia
induc
ouabain
aconitin
acetylcholin
furthermor
ultralow
frequenc
ballistocardiogram
ecg
registr
perform
dog
raper
wale
studi
effect
ouabainand
adrenalineinduc
arrhythmia
cat
kerr
et
al
studi
effect
vasodil
drug
ouabaininduc
arrhythmia
anesthet
dog
modifi
method
product
cardiac
arrhythmia
ouabain
anesthet
cat
publish
rao
et
al
infus
ouabain
intraven
guinea
pig
determin
onset
ventricular
extrasystol
fibril
thoma
tripathi
studi
effect
agonist
antagonist
differ
affin
receptor
ouabaininduc
arrhythmia
cardiac
arrest
guinea
pig
krzeminski
wascher
et
al
use
ouabaininduc
arrhythmia
guinea
pig
evalu
potenti
antidysrhythm
agent
use
ouabaininduc
arrhythmia
anesthet
wistar
rat
evalu
cyclopenteno
b
thiophen
deriv
antiarrhythm
agent
use
antiarrhythm
drug
treatment
ventricular
arrhythmia
aim
prevent
develop
ventricular
fibril
sever
electr
stimul
techniqu
use
measur
ventricular
fibril
threshold
singl
puls
stimul
train
puls
stimul
continu
stimul
sequenti
puls
stimul
adult
dog
weigh
kg
anesthet
sodium
pentobarbit
mgkg
ventil
air
use
harvard
respiratori
pump
systol
arteri
pressur
monitor
bodi
temperatur
maintain
thermal
blanket
chest
open
midlin
sternotomi
heart
suspend
pericardi
cradl
sinu
node
crush
mm
diamet
agagcl
stimul
electrod
embed
teflon
disc
sutur
anterior
surfac
left
ventricl
heart
driven
squar
anod
constant
current
puls
ms
basic
cycl
prematur
stimul
one
test
stimulu
drive
electrod
electr
stimul
program
digit
stimul
record
electrod
place
surfac
ventricl
silver
plate
implant
skin
right
femor
region
indiffer
electrod
lead
ii
bodi
surfac
electrocardiogram
monitor
determin
ventricular
fibril
threshold
vft
train
puls
deliv
ms
everi
eighteenth
basic
drive
stimulu
current
intens
increas
diastol
threshold
increment
ventricular
fibril
occur
minim
current
intens
puls
train
requir
induc
sustain
ventricular
fibril
defin
vft
ventricular
fibril
occur
heart
immedi
defibril
allow
recov
control
condit
min
antiarrhythm
drug
administ
femor
vein
ventricular
fibril
threshold
vft
determin
administr
test
drug
given
time
interv
mean
valu
experi
compar
use
student
ttest
marshal
et
al
winslow
suggest
determin
vft
pentobarbiton
anesthet
rat
wu
et
al
recommend
consciou
dog
model
reentrant
atrial
tachycardia
describ
dual
electrophysiolog
test
atrial
antireentri
ventricular
antifibrillatori
studi
dog
reentri
portion
model
creat
surgic
yshape
crush
around
tissu
superior
inferior
vena
cava
tissu
parallel
av
groov
antifibrillatori
activ
assess
determin
ventricular
fibril
threshold
use
trainstimuli
method
chronic
prepar
rat
model
electr
induc
arrhythmia
describ
walker
beatch
coronari
arteri
ligat
anesthet
rat
result
arrhythmia
myocardi
infarct
follow
occlus
left
main
coronari
arteri
mark
ventricular
dysrhythmia
occur
electrocardiogram
record
ligat
subsequ
reperfus
amount
infarct
tissu
measur
mean
pnitroblu
tetrazolium
chloridestain
myocardi
section
model
use
test
drug
potenti
antiarrhythm
activ
group
male
spraguedawley
rat
weigh
g
use
anim
anesthet
intraperiton
inject
mgkg
pentobarbit
sodium
trachea
intub
allow
artifici
ventil
starl
pump
cathet
place
extern
jugular
vein
administr
test
compound
peripher
blood
pressur
record
common
carotid
arteri
use
pressur
transduc
polygraph
chest
open
left
thoracotomi
forth
intercost
space
open
pericard
heart
exterior
gentl
pressur
chest
wall
thin
silk
thread
ethicon
metric
attach
atraumat
needl
place
around
left
coronari
arteri
mm
distal
origin
left
coronari
arteri
later
ligat
point
anim
ventil
room
air
use
stroke
volum
g
bodi
weight
rate
strokesmin
heart
place
back
chest
caviti
anim
procedur
produc
dysrhythmia
sustain
fall
mean
arteri
blood
pressur
less
mm
hg
discard
studi
equilibr
time
approx
min
test
substanc
vehicl
control
administ
intraven
inject
five
min
later
ligatur
left
coronari
arteri
close
either
min
case
infarcts
assess
subsequ
reperfus
min
oral
applic
test
compound
dissolv
suspend
vehicl
min
occlus
peripher
blood
pressur
ecg
lead
ii
record
continu
whole
experi
rectal
temperatur
maintain
number
ventricular
prematur
beat
vpb
ventricular
tachycardia
vt
ventricular
fibril
vf
count
occlus
reperfus
period
evalu
accord
guidelin
lambeth
convent
end
reperfus
period
anim
sacrif
overdos
pentobarbit
sodium
heart
dissect
cut
transvers
section
approx
mm
thick
apex
base
slice
stain
pnitroblu
tetrazolium
chlorid
solut
gl
pnitroblu
tetrazolium
chlorid
phosphat
buffer
contain
mm
lmaleat
order
visual
infarct
tissu
bluevioletstain
healthi
tissu
unstain
necrot
tissu
slice
photograph
color
transpar
film
determin
infarct
area
left
ventricl
infarct
area
measur
planimetri
project
slice
exclus
apex
slice
contain
ligatur
follow
paramet
evalu
differ
characterist
evalu
separ
compar
posit
control
mgkg
nicainoprol
iv
chang
paramet
drugtreat
anim
compar
vehicl
control
valu
statist
signific
assess
student
ttest
linz
et
al
report
isol
rat
heart
ischemiareperfus
injuri
perfus
bradykinin
reduc
durat
incid
ventricular
fibril
improv
cardiodynam
reduc
releas
cytosol
enzym
end
preserv
energyrich
phosphat
glycogen
store
mulder
et
al
studi
effect
chronic
treatment
calcium
antagonist
rat
chronic
heart
failur
induc
coronari
arteri
ligat
effect
antihypertens
agent
cardiac
vascular
remodel
discuss
mallion
et
al
armstrong
jm
vitro
method
evalu
antiarrhythm
antiischem
agent
use
program
electr
stimul
rabbit
heart
j
pharmacol
toxicol
meth
bernier
hears
dj
man
reperfusioninduc
arrhythmia
oxygenderiv
free
radic
studi
antifre
radic
intervent
free
radicalgener
system
isol
perfus
rat
heart
circ
re
black
sc
rodger
iw
linz
w
h
petri
p
ba
effect
nicainoprol
reperfus
arrhythmia
isol
work
heart
ischemia
reperfus
arrhythmia
myocardi
infarct
size
anesthet
rat
eur
j
pharmacol
mulder
p
richard
v
thuillez
c
coronari
arteri
occlus
anesthet
dog
accompani
increas
heart
rate
heart
contractil
left
ventricular
enddiastol
pressur
blood
pressur
well
ventricular
arrhythmia
subsequ
reperfus
period
high
percentag
control
anim
die
ventricular
fibril
drug
potenti
protect
effect
test
reduc
hemodynam
electr
chang
dog
either
sex
weigh
kg
use
anesthesia
induc
intraven
inject
mgkg
thiobutobarbit
sodium
maintain
iv
administr
mgkg
chloralos
mgkg
urethan
follow
subcutan
administr
mgkg
morphin
anim
place
right
later
posit
respir
maintain
tracheal
tube
use
posit
pressur
respir
bird
mark
peripher
vein
saphen
vein
cannul
administr
test
compound
ecg
record
continu
lead
ii
einthoven
record
peripher
systol
diastol
blood
pressur
cannula
femor
arteri
connect
pressur
transduc
statham
p
db
determin
left
ventricular
pressur
lvp
millar
microtip
cathet
pc
insert
via
left
carotid
arteri
left
ventricular
enddiastol
pressur
lvedp
measur
highsensit
scale
heart
rate
hr
determin
lvp
wave
form
myocardi
contractil
measur
rate
rise
lvp
dpdt
max
sum
stsegment
elev
calcul
five
valu
peripher
limb
ecg
lead
ii
pressurer
index
pri
bp
hr
serv
measur
oxygen
consumpt
heart
expos
left
thoracotomi
fourth
fifth
intercost
space
pericard
open
left
anterior
descend
coronari
arteri
lad
prepar
silk
sutur
place
around
lad
first
diagon
branch
equilibr
period
approx
min
test
substanc
vehicl
control
administ
intraven
bolu
twenti
min
later
ligatur
coronari
arteri
close
min
occlus
period
test
compound
vehicl
control
given
continu
infus
releas
coronari
obstruct
anim
monitor
min
reperfus
period
paramet
record
whole
experi
end
test
surviv
anim
sacrif
overdos
pentobarbit
sodium
follow
paramet
evalu
mortal
hemodynam
arrhythmia
ventricular
extrasystol
prematur
ventricular
contract
pvc
percent
anim
pvc
number
min
ventricular
tachycardia
vt
vt
defin
sequenc
seven
consecut
ventricular
extrasystol
durat
min
ventricular
fibril
vf
percent
anim
vf
differ
characterist
evalu
separ
chang
paramet
drugtreat
anim
compar
vehicl
control
statist
signific
differ
calcul
mean
student
ttest
standard
data
mortal
repres
experi
control
anim
die
ventricular
fibril
min
reperfus
period
one
molsidominetr
anim
die
death
also
ventricular
fibril
reperfus
phase
molsidomin
given
continu
infus
mgkgmlmin
occlus
period
control
receiv
salin
varma
melvil
describ
ventricular
fibril
induc
coronari
occlus
hypothermia
dog
wilkerson
downey
describ
techniqu
produc
ventricular
arrhythmia
dog
coronari
occlus
embolu
glass
bead
introduc
coronari
circul
via
rigid
cannula
insert
carotid
arteri
weissenburg
et
al
describ
model
dog
suitabl
screen
bradycardiadepend
proarrhythm
effect
drug
studi
electrophysiolog
torsad
de
point
coker
recommend
anesthet
rabbit
model
ischemiaand
reperfusioninduc
arrhythmia
thiemermann
et
al
describ
rabbit
model
experiment
myocardi
ischemia
reperfus
drug
administ
intraven
infus
min
occlus
left
anteriorlater
coronari
arteri
continu
min
occlus
subsequ
h
reperfus
period
hendrikx
et
al
report
na
h
exchang
inhibitor
hoe
improv
postischem
function
highenergi
phosphat
resynthesi
reduc
ca
overload
isol
perfus
rabbit
heart
barrett
et
al
describ
method
record
epicardi
monophas
action
potenti
ischemiainduc
arrhythmia
follow
coronari
arteri
ligat
intact
rabbit
naslund
et
al
describ
close
chest
model
pig
occlus
induc
pentobarbiton
anesthet
mechan
ventil
pig
inject
mm
ball
preselect
coronari
arteri
reperfus
achiev
retract
ball
via
attach
filament
dalonzo
et
al
evalu
effect
potassium
channel
open
pacingand
ischemiainduc
ventricular
fibril
anesthet
pig
sack
et
al
describ
effect
na
h
antiport
inhibitor
postischem
reperfus
pig
heart
premaratn
et
al
use
baboon
open
chest
model
myocardi
ischemia
reperfus
baboon
underw
occlus
left
anterior
descend
coronari
arteri
h
fifteen
min
occlus
treat
group
receiv
hyaluronidas
iv
period
ischem
period
follow
h
reperfus
end
reperfus
period
heart
excis
perfus
bed
risk
infarct
determin
infus
microvascular
dye
todt
h
schundertatzb
raberg
g
program
electr
stimul
myocardi
infarct
reperfus
consciou
dog
j
pharmacol
meth
linz
w
ba
role
bradykinin
cardiac
effect
angiotensinconvert
enzym
inhibitor
j
cardiovasc
pharmacol
suppl
linz
w
wiemer
g
gohlk
p
unger
ba
contribut
bradykinin
cardiovascular
action
ace
inhibitor
lindpaintn
k
ganten
harri
found
mortal
dog
coronari
occlus
ligat
procedur
lower
ligat
left
descend
coronari
arteri
partial
occlud
min
time
total
ligat
perform
condit
arrhythmia
develop
within
h
reach
peak
h
abat
within
day
dog
either
sex
anesthet
intraven
inject
methohexiton
sodium
mgkg
endotrach
tube
insert
anesthesia
maintain
halothan
heart
expos
incis
fourth
fifth
intercost
space
anterior
descend
branch
left
coronari
arteri
dissect
free
second
branch
ligat
two
stage
two
ligatur
place
around
arteri
gaug
needl
first
ligatur
tie
round
arteri
needl
remov
thirti
min
later
second
ligatur
tie
tightli
round
arteri
chest
close
layer
min
second
ligatur
tie
dog
allow
recov
observ
made
dog
consciou
e
g
h
ligat
coronari
arteri
dog
posit
lie
side
remain
posit
throughout
experi
mean
blood
pressur
record
cathet
place
femor
arteri
lead
ii
av
l
electrocardiogram
blood
pressur
continu
record
control
period
min
drug
administr
drug
administ
either
inject
continu
infus
via
hind
leg
vein
number
sinu
ectop
beat
count
success
period
beat
distinct
p
wave
preced
mean
frontal
qr
vector
normal
durat
count
sinu
origin
other
denot
ectop
model
resembl
late
arrhythmia
occur
postinfarct
patient
use
modif
mani
author
e
g
kerr
et
al
reynold
brown
gomol
garthwait
et
al
krumpl
et
al
b
trolesemongh
et
al
spinelli
et
al
method
produc
experiment
complet
atrioventricular
block
dog
describ
review
dubray
et
al
boucher
duchenemarullaz
gomol
aw
group
lucchesi
describ
experiment
dog
model
test
protect
sudden
coronari
death
patterson
et
al
uprichard
et
al
b
chi
et
al
chi
et
al
b
kitzen
et
al
black
et
al
black
et
al
purposebr
male
mongrel
dog
weigh
kg
anesthet
mgkg
pentobarbit
iv
dog
ventil
room
air
cuf
endotrach
tube
harvard
respir
cannula
insert
left
extern
jugular
vein
left
thoracotomi
perform
fourth
fifth
rib
heart
expos
suspend
pericardi
cradl
left
anterior
descend
coronari
arteri
lad
isol
tip
left
atrial
appendag
left
circumflex
coronari
arteri
lcx
isol
cm
origin
hypoderm
needl
place
lad
ligatur
tie
around
arteri
needl
needl
remov
result
critic
stenosi
vessel
lad
perfus
min
presenc
critic
stenosi
ischem
injuri
anterior
ventricular
myocardium
achiev
occlus
lad
silicon
rubber
snare
vessel
reperfus
h
presenc
critic
stenosi
period
lad
reperfus
epicardi
bipolar
electrod
silver
post
interelectrod
separ
sutur
left
atrial
appendag
subsequ
atrial
pace
bipolar
plung
electrod
stainless
steel
mm
long
mm
separ
sutur
interventricular
septum
adjac
occlus
site
overli
right
ventricular
outflow
tract
rvot
two
similar
stainless
steel
bipolar
plung
electrod
sutur
left
ventricular
lv
wall
one
distribut
lad
distal
occlus
infarct
zone
iz
second
distribut
lcx
noninfarct
zone
nz
silverco
copper
wire
electrod
pass
wall
lumen
lcx
sutur
adjac
surfac
heart
silver
disc
electrod
implant
subcutan
ecg
monitor
surgic
incis
close
anim
allow
recov
anim
treat
recoveri
period
day
program
electr
stimul
either
test
drug
solvent
direct
anod
current
nickelcadmium
batteri
pass
ohm
resistor
appli
electrod
lumen
left
circumflex
coronari
arteri
cathod
batteri
connect
sc
implant
disc
electrod
lead
ii
ecg
record
everi
min
cardiocassett
record
h
constant
anod
current
develop
ventricular
fibril
anim
sacrif
heart
excis
thrombu
mass
lcx
remov
weigh
heart
section
transvers
incub
min
solut
tetrazolium
triphenyl
chlorid
identif
infarct
area
time
onset
ventricular
ectopi
lethal
arrhythmia
provid
record
cardiocassett
nonsustain
sustain
tachyarrhythmia
evalu
sudden
coronari
death
one
lead
caus
death
develop
countri
fact
warrant
use
complic
model
higher
anim
search
activ
drug
describ
experiment
prepar
sudden
cardiac
death
dog
anim
chronic
instrument
studi
month
anterior
myocardi
infarct
balloon
cathet
around
circumflex
coronari
arteri
inflat
produc
acut
myocardi
ischemia
occlus
maintain
min
sever
day
later
anim
subject
submaxim
stress
motordriven
treadmil
min
last
minut
exercis
left
coronari
arteri
occlud
treadmil
stop
occlus
maintain
second
minut
schwartz
et
al
analyz
baroreceptor
reflex
consciou
dog
without
myocardi
infarct
get
insight
mechan
sudden
death
cahn
cervoni
review
use
anim
model
sudden
cardiac
death
drug
develop
pak
et
al
found
canin
tachycardiainduc
cardiomyopathi
use
model
studi
mechan
therapi
sudden
cardiac
death
heart
failur
adamson
et
al
perform
longitudin
studi
dog
high
low
risk
sudden
death
found
unexpect
interact
blockad
heart
rate
variabl
myocardi
infarct
basso
et
al
recommend
arrhythmogen
right
ventriculopathi
caus
sudden
death
boxer
dog
anim
model
human
diseas
schwartz
billman
group
develop
method
evalu
antiarrhythm
drug
activ
cardiovascular
paramet
exerciseplusischemia
test
mongrel
dog
weigh
kg
anesthet
instrument
measur
left
circumflex
cbf
left
ventricular
pressur
ventricular
electrogram
billman
hamlin
billman
et
al
billman
et
al
anim
given
innovar
vet
mgkg
fentanyl
citrat
mgkg
hydroperidol
iv
preanesthet
wherea
surgic
plane
anesthesia
induc
sodium
pentobarbit
mgkg
iv
left
thoracotomi
made
fourth
intercost
space
heart
expos
support
pericardi
cradl
puls
doppler
flow
transduc
hydraul
occlud
place
around
left
circumflex
arteri
pair
insul
silverco
wire
sutur
epicardi
surfac
left
right
ventricl
electrod
use
ventricular
pace
record
ventricular
electrogram
hr
determin
use
gould
biotachomet
gould
instrument
cleveland
oh
precalibr
solidst
pressur
transduc
konigsberg
instrument
pasadena
ca
insert
left
ventricl
via
stab
wound
apic
dimpl
final
twostag
occlus
left
anterior
descend
coronari
arteri
perform
approxim
one
third
distanc
origin
induc
anterior
wall
myocardi
infarct
vessel
partial
occlud
min
tie
lead
cardiovascular
instrument
tunnel
skin
exit
back
anim
neck
transderm
fentanyl
patch
deliv
h
place
back
neck
secur
adhes
tape
decreas
postop
discomfort
addit
bupivacain
hcl
longact
local
anesthet
inject
block
intercost
nerv
e
pain
fiber
area
incis
anim
place
prophylact
antibiot
therapi
amoxicillin
mg
po
three
time
daili
day
anim
place
intens
care
set
first
h
place
antiarrhythm
therapi
billman
hamlin
billman
et
al
billman
et
al
studi
begin
week
product
myocardi
infarct
anim
walk
motordriven
treadmil
train
lie
quietli
without
restraint
laboratori
tabl
recoveri
period
suscept
vf
test
anim
run
motordriven
treadmil
workload
increas
everi
min
total
min
protocol
begin
warmup
period
anim
run
kmh
grade
speed
increas
kmh
grade
increas
everi
min
follow
last
minut
exercis
left
circumflex
coronari
arteri
occlud
treadmil
stop
occlus
maintain
addit
min
total
occlus
time
min
larg
metal
plate
diamet
cm
place
across
anim
chest
electr
defibril
achiev
minim
delay
anim
unconsci
vf
begin
occlus
immedi
releas
vf
occur
anim
receiv
one
follow
treatment
exerciseplusischemia
test
repeat
pretreat
standard
drug
glibenclamid
mgkg
iv
drug
inject
cephal
vein
min
exercis
begin
exerciseplusischemia
test
repeat
pretreat
test
drug
final
second
control
salin
exercis
plu
ischemia
test
perform
week
last
drug
test
least
day
intermit
drug
treatment
drug
given
random
order
subsequ
day
effect
refractori
period
determin
use
medtron
model
programm
stimul
rest
myocardi
ischemia
heart
pace
beat
intrastimulu
interv
ms
puls
durat
ms
twicediastol
threshold
intrastimulu
interv
progress
shorten
last
pace
beat
singl
extrastimulu
refractori
period
repres
shortest
interv
capabl
gener
cardiac
respons
measur
use
either
left
right
ventricular
electrod
procedur
complet
within
control
valu
determin
refractori
period
measur
repeat
standard
drug
glibenclamid
mgkg
iv
test
drug
complet
studi
refractori
period
determin
myocardi
ischemia
occlus
left
circumflex
coronari
arteri
onset
coronari
occlus
k
atp
implic
vascular
regul
particularli
cbf
aversano
et
al
belloni
hintz
daut
et
al
therefor
effect
standard
test
drug
respons
brief
interrupt
cbf
also
evalu
anim
place
laboratori
data
averag
past
exercis
level
coronari
occlus
data
averag
last
line
point
vf
onset
occlus
onset
total
area
peak
cbf
return
base
line
measur
occlus
percent
repay
calcul
reactiv
hyperemia
respons
occlus
averag
obtain
one
valu
anim
data
analyz
use
analysi
varianc
repeat
measur
f
ratio
found
exceed
critic
valu
p
scheff
test
use
compar
mean
valu
effect
drug
intervent
arrhythmia
format
determin
use
test
yate
correct
continu
data
report
mean
sem
cardiac
arrhythmia
pr
interv
qt
interv
evalu
paper
speed
mm
qt
interv
correct
hr
use
bazett
method
test
combin
coronari
constrict
physic
exercis
may
resembl
close
situat
coronari
patient
morillo
et
al
publish
model
sustain
atrial
fibril
chronic
rapid
atrial
pace
dog
halothaneanesthet
mongrel
dog
underw
insert
transven
lead
right
atrial
appendag
continu
pace
beatsmin
week
twodimension
echocardiographi
perform
assess
effect
rapid
atrial
pace
atrial
size
atrial
vulner
defin
abil
induc
sustain
repetit
atrial
respons
program
electr
stimul
effect
refractori
period
erp
measur
two
endocardi
site
right
atrium
sustain
atrial
fibril
av
defin
af
min
anim
sustain
af
quadripolar
epicardi
electrod
surgic
attach
left
right
atria
local
atrial
fibrillatori
cycl
length
afcl
measur
window
mark
biatrial
enlarg
document
week
continu
rapid
atrial
pace
increas
atrial
area
least
necessari
induc
sustain
af
studi
use
method
perform
gaspo
et
al
gaspo
et
al
yue
et
al
sun
et
al
nattel
li
shiroshitatakeshita
et
al
studi
effect
drug
atrial
fibril
promot
atrialtachycardia
remodel
dog
mongrel
dog
anesthet
ketamin
mgkg
iv
diazepam
mgkg
iv
halothan
unipolar
lead
insert
jugular
vein
right
ventricular
apex
right
atrial
appendag
connect
pacemak
medtron
subcutan
pocket
neck
bipolar
electrod
insert
right
atrium
stimul
record
serial
electrophysiolog
studi
av
block
creat
radiofrequ
ablat
control
ventricular
respons
atrial
tachypac
right
ventricular
pacemak
program
beatsmin
h
recoveri
baselin
closedchest
serial
electrophysiolog
studi
perform
ketaminediazepamisofluran
anesthesia
atrial
tachypac
beatsmin
initi
closedchest
electrophysiolog
studi
repeat
day
atrial
tachypac
final
openchest
electrophysiolog
studi
perform
day
morphinechloralos
anesthesia
result
atrial
tachypac
drugtreat
dog
compar
result
dog
without
treatment
control
dog
anesthet
ventil
mechan
atrial
pacemak
deactiv
right
atrium
appendag
effect
refractori
period
measur
basic
length
ms
basic
stimuli
follow
prematur
extrastimulu
decrement
longest
fail
captur
defin
effect
refractori
period
af
induc
atrial
burst
pace
hz
time
threshold
current
estim
mean
af
durat
dog
af
induc
time
af
durat
min
time
af
last
min
averag
af
last
longer
min
consid
sustain
termin
dc
cardiovers
rest
period
allow
continu
measur
openchest
electrophysiolog
studi
dog
anesthet
ventil
mechan
femor
arteri
femor
vein
cannul
pressur
monitor
drug
administr
median
sternotomi
perform
bipolar
electrod
hook
right
atrial
left
atrial
appendag
record
stimul
programm
stimul
digit
cardiovascular
instrument
use
deliv
twicethreshold
current
five
silicon
sheet
contain
bipolar
electrod
sutur
onto
atrial
surfac
fareh
et
al
atrial
effect
refractori
period
measur
multipl
basic
cycl
length
right
left
atrial
appendag
basic
cycl
length
ms
six
addit
site
right
left
atrium
posterior
wall
right
left
atrium
inferior
wall
right
left
atrium
bachmann
bundl
atrial
fibril
vulner
determin
percentag
atrial
site
af
could
induc
singl
extrastimuli
data
present
mean
sem
multiplegroup
comparison
obtain
anova
af
durat
data
analyz
logarithm
transform
bonferronicorrect
test
use
evalu
individualmean
differ
atrial
fibril
common
tachyarrhythmia
human
caus
palpit
decreas
cardiac
output
heart
failur
system
thromboembol
associ
signific
mortal
wijffel
et
al
demonstr
chronic
instrument
consciou
goat
model
episod
atrial
fibril
may
selfperpetu
atrial
fibril
beget
atrial
fibril
suggest
may
pure
electrophysiolog
explan
term
atrial
electr
remodel
increas
atrial
fibril
time
model
extens
use
studi
pathophysiolog
mechan
influenc
drug
wijffel
et
al
wijffel
et
al
wijffel
et
al
allessi
et
al
tieleman
et
al
duytschaev
et
al
duytschaev
et
al
garratt
fynn
van
der
velden
veloso
brendel
peukert
et
al
blaauw
et
al
blaauw
et
al
studi
efficaci
atrial
select
blocker
earli
ultrarapid
compon
delay
rectifi
kur
remodel
atria
goat
femal
goat
weigh
kg
use
accord
method
duytschaev
et
al
teflonfelt
plaqu
multipl
electrod
sutur
onto
free
wall
atrium
bachmann
bundl
left
ventricl
lead
tunnel
subcutan
neck
exterior
four
connector
experi
start
week
surgeri
atrial
fibril
induc
fibril
pacemak
wijffel
et
al
atria
pace
biphas
stimuli
ms
durat
threshold
atrial
effect
refractori
period
measur
free
wall
right
left
atria
regular
pace
interv
ms
singl
interpol
stimuli
appli
eight
basic
stimuli
start
within
refractori
period
longest
interv
fail
captur
atria
increment
taken
atrial
effect
refractori
period
atrial
conduct
veloc
measur
along
bachmann
bundl
right
atrial
pace
distanc
conduct
veloc
measur
rang
cm
length
fibril
wave
determin
right
atrial
free
wall
measur
refractori
period
conduct
veloc
af
refractori
period
measur
slow
fixedr
pace
hz
result
seri
singl
randomli
coupl
prematur
stimuli
local
captur
af
evidenc
radial
spread
activ
pace
site
short
delay
stimulu
respons
coupl
interv
percentag
captur
determin
shortest
interv
captur
atrium
taken
refractori
period
conduct
veloc
determin
map
electrod
contain
electrod
interelectrod
distanc
mm
local
conduct
vector
within
area
electrod
least
af
cycl
use
determin
conduct
veloc
induc
af
measur
right
left
atria
singl
prematur
stimuli
appli
regular
pace
ms
case
prematur
beat
induc
rapid
irregular
rhythm
last
af
consid
induc
af
cycl
length
measur
automat
algorithm
detect
neg
intrins
deflect
fibril
electrogram
median
valu
consecut
interv
calcul
qt
durat
measur
atrial
pace
persist
af
either
epicardi
electrogram
precordi
ecg
bazett
formula
appli
af
anoth
approach
use
correct
qt
durat
goat
relationship
rr
interv
qt
durat
determin
af
rrqt
relationship
drug
administr
compar
normal
rrqt
relat
electrophysiolog
effect
test
drug
convent
class
iii
drug
measur
h
day
af
drug
infus
intraven
h
time
af
cycl
length
monitor
min
infus
refractori
period
conduct
veloc
median
rr
interv
qt
durat
measur
success
cardiovers
defin
termin
af
within
h
drug
administr
differ
group
evalu
pair
student
ttest
twoway
repeat
anova
post
hoc
bonferroni
ttest
mcnemar
test
use
compar
af
induc
chang
correct
qt
durat
calcul
onesampl
ttest
differ
consid
signific
p
result
present
mean
sem
blockad
cardiac
potassium
channel
result
prolong
repolar
refractori
mode
action
class
iii
antiarrhythm
drug
human
heart
ultrarapid
delay
rectifi
potassium
current
kur
identifi
atrial
ventricular
tissu
appear
contribut
action
potenti
repolar
atrium
ventricl
molecular
correl
human
cardiac
ultrarapid
delay
rectifi
potassium
current
seem
protein
fedida
et
al
wang
et
al
feng
et
al
feng
et
al
sinc
prolong
ventricular
repolar
seem
invari
associ
proarrhythmia
earli
afterdepolar
lead
torsad
de
point
arrhythmia
shown
avail
potassium
channel
blocker
class
iii
drug
highli
select
potent
kr
channel
blocker
dofetilid
torppedersen
et
al
blockad
cardiac
current
exclus
present
atria
highli
desir
expect
devoid
ventricular
proarrhythm
effect
therefor
atrial
channel
highli
attract
target
search
new
safer
atrial
antiarrhythm
drug
nattel
singh
seri
studi
wirth
knobloch
knobloch
et
al
knobloch
et
al
wirth
et
al
investig
electrophysiolog
antiarrhythm
effect
kur
channel
blocker
left
versu
right
pig
atrium
vivo
comparison
kr
blocker
pig
castrat
male
pig
kg
german
landrac
premed
ml
rompun
im
xylacin
hcl
mgml
mgkg
im
ml
hostaket
ketamin
hcl
mgml
mgkg
im
anesthet
iv
bolu
ml
narcoren
pentobarbit
mgml
mgkg
iv
follow
continu
intraven
infus
mgkg
per
h
pentobarbit
anim
ventil
room
air
oxygen
respir
abvintensiv
stephan
gackenbach
germani
left
thoracotomi
lung
retract
pericardium
incis
heart
suspend
pericardi
cradl
bipolar
bodi
surfac
ecg
record
use
subcutan
needl
electrod
classic
lead
ii
lead
iii
arrang
atrial
effect
refractori
period
erp
measur
differ
basic
cycl
length
bcl
ms
perform
wirth
knobloch
atrial
respons
pace
procedur
visual
via
monophas
action
potenti
map
left
right
atrium
describ
condit
train
ten
basic
stimuli
twicediastol
pace
threshold
follow
diastol
extrastimulu
puls
durat
ms
start
ms
expect
erp
decrement
uh
univers
heart
stimul
biotronik
berlin
germani
longest
coupl
interv
unabl
elicit
propag
atrial
respons
taken
atrial
erp
left
atrial
erp
measur
via
map
pace
cathet
ep
technolog
model
boston
scientif
la
garennecolomb
franc
fix
pig
middl
left
atrial
free
wall
approxim
perpendicular
posit
hold
devic
yuan
et
al
tip
map
pace
cathet
cover
spong
program
stimul
perform
map
pace
cathet
right
atrial
map
erp
measur
taken
endocardium
right
atrium
also
via
steerabl
map
pace
cathet
cathet
insert
via
v
femorali
use
atrial
stimul
posit
right
atrium
check
palpit
typic
atrial
map
morpholog
durat
addit
short
rapid
atrial
pace
bcl
ms
ventricl
abl
follow
indic
frequent
pwave
dissoci
qr
complex
signific
differ
endocardi
epicardi
erp
measur
free
wall
either
atrium
baselin
drug
erp
measur
procedur
mere
follow
ten
condit
stimuli
erpmeasur
procedur
frequent
trigger
run
atrial
tachycardia
left
right
atrium
occurr
tachycardia
primarili
unintend
exploit
paramet
judgement
antiarrhythm
efficaci
compound
refer
left
atrial
vulner
whether
run
atrial
tachyarrhythmia
occur
erpmeasur
procedur
given
bcl
note
occurr
trigger
tachyarrhythmia
sum
three
bcl
test
three
time
point
period
drug
thu
maxim
occurr
control
drug
period
individu
anim
nine
drug
dissolv
polyethyleneglycol
peg
riedeld
haen
seelz
germani
administ
iv
min
volum
ml
vehicl
inject
least
min
drug
drug
separ
group
pig
use
data
present
mean
sem
twoway
anova
repeat
measur
follow
student
ttest
use
calcul
statist
signific
differ
left
right
atrial
erp
prolong
three
basic
cycl
length
inhibit
left
atrial
vulner
valu
p
accept
signific
longest
erp
pace
rate
drug
administr
taken
express
absolut
percent
increas
vehicl
control
interatri
differ
refractori
calcul
differ
left
right
atrial
erp
accord
antiarrhythm
drug
divid
differ
class
depend
mode
action
class
antiarrhythm
agent
decreas
upstrok
veloc
action
potenti
blockad
na
channel
class
ii
drug
block
class
iii
antiarrhythm
agent
prolong
action
potenti
durat
presum
blockad
k
channel
class
iv
antiarrhythm
agent
inhibit
slow
calcium
influx
plateau
action
potenti
ca
channel
blockad
electrophysiolog
action
also
function
manifest
e
g
na
channel
blockad
decreas
excit
k
channel
blockad
lengthen
refractori
period
ca
channel
blockad
decreas
tension
cardiac
muscl
simpl
accur
nonmicroelectrod
method
necessari
identifi
classifi
potenti
antiarrhythm
drug
class
iii
iv
right
ventricular
guinea
pig
papillari
muscl
develop
tension
dt
excit
ex
effect
refractori
period
erp
measur
guinea
pig
either
sex
weigh
g
stun
carotid
arteri
sever
thorac
cage
open
immedi
heart
remov
place
contain
prewarm
preoxygen
physiolog
solut
pericardium
atria
tissu
remov
heart
pin
dissect
dish
right
ventricl
open
tendin
end
papillari
muscl
ligat
silk
thread
chorda
tendina
freed
ventricl
opposit
end
papillari
muscl
cut
free
close
ventricular
wall
nonlig
end
papillari
muscl
clamp
tissu
holder
end
leucit
block
contain
platinum
wire
field
electrod
prepar
transfer
tissu
bath
contain
ml
physiolog
salt
solut
gass
continu
co
maintain
temperatur
ph
silk
thread
use
connect
muscl
grass
forc
transduc
initi
rest
tension
g
establish
muscl
field
stimul
contract
isometr
stimulu
durat
ms
frequenc
hz
voltag
twice
threshold
puls
deliv
use
grass
constant
voltag
stimul
develop
tension
record
use
polygraph
record
prepar
equilibr
manner
min
bath
solut
chang
everi
min
control
measur
forcefrequ
curv
stimulu
strengthdur
curv
effect
refractori
period
made
follow
min
bath
exchang
e
last
min
equilibr
forcefrequ
curv
obtain
measur
develop
tension
rang
stimul
frequenc
hz
tissu
contract
frequenc
brief
period
stimul
hz
insert
increment
purpos
hz
insert
keep
pace
histori
constant
well
minim
progress
nonspecif
depress
lower
frequenc
stimul
seri
preand
postdrug
develop
tension
frequenc
express
percentag
predrug
develop
tension
hz
percent
chang
post
treatment
versu
pretreat
develop
tension
hz
use
quantit
agent
inotrop
effect
stimulu
strengthdur
curv
determin
vari
stimulu
durat
ms
find
threshold
voltag
produc
correspond
stimulu
respons
durat
degre
shift
strengthdur
curv
measur
comput
area
preand
posttreat
curv
boundari
area
determin
first
xaxi
parallel
last
xaxi
perpendicular
durat
line
origin
second
fourth
durat
effect
refractori
period
erp
measur
hz
use
twin
puls
stimuli
everi
puls
second
delay
stimulu
ident
basic
drive
puls
introduc
procedur
repeat
shorten
delay
ms
increment
valu
erp
taken
longest
delay
singl
respons
twin
puls
chang
erp
comput
differ
ms
preand
posttreat
erp
valu
conclus
min
predrug
equilibr
period
aliquot
test
drug
design
achiev
desir
final
concentr
ad
bath
tissu
must
equilibr
h
drug
solut
postdrug
measur
forcefrequ
curv
stimulu
strengthdur
curv
effect
refractori
period
obtain
chang
effect
refractori
period
erp
post
treatment
minu
pretreat
degre
shift
strengthdur
curv
geometr
area
preand
posttreat
curv
percent
chang
post
treatment
develop
tension
hz
calcul
result
calcul
use
classifi
compound
class
iii
iv
antiarrhythm
agent
basi
effect
develop
tension
excit
effect
refractori
period
upward
right
shift
strengthdur
curv
decreas
excit
characterist
class
antiarrhythm
agent
disopyramid
select
prolong
effect
refractori
period
characterist
class
iii
antiarrhythm
agent
sotalol
depress
develop
tension
andor
flatten
revers
forcefrequ
curv
characterist
class
iv
antiarrhythm
agent
verapamil
model
electr
stimul
isol
guinea
pig
papillari
muscl
simpl
method
classifi
antiarrhythm
agent
drug
multipl
action
therefor
belong
one
class
character
analysi
action
potenti
necessari
odonoghu
platia
recommend
use
monophas
action
potenti
record
evalu
antiarrhythm
drug
shibuya
et
al
studi
effect
local
anesthet
bupivacain
contract
membran
potenti
isol
canin
right
ventricular
papillari
muscl
analysi
action
potenti
conclud
low
concentr
contract
depress
mainli
due
na
channel
block
wherea
high
concentr
also
ca
channel
may
block
kodama
et
al
maryuama
et
al
studi
effect
potenti
antiarrhythm
maximum
upstrok
veloc
durat
action
potenti
isol
right
papillari
muscl
guinea
pig
well
influenc
agent
singl
ventricular
myocyt
borchard
et
al
describ
method
induc
arrhythmia
asystolia
applic
hz
altern
current
ac
electr
driven
isol
left
atria
right
papillari
muscl
guinea
pig
increas
drive
frequenc
hz
effect
signific
reduct
threshold
acarrhythmia
guinea
pig
papillari
muscl
chang
atria
decreas
temperatur
increas
ca
mmoll
elev
threshold
acarrhythmia
asystolia
fast
sodium
channel
inhibitor
increas
threshold
acarrhythmia
left
atria
papillari
muscl
wherea
slow
channel
inhibitor
verapamil
ineffect
concentr
intracellular
action
potenti
left
ventricular
guinea
pig
papillari
muscl
record
electr
stimul
stimul
frequenc
vari
order
determin
refractori
period
rest
potenti
upstrok
veloc
durat
action
potenti
threshold
refractori
period
contractil
forc
measur
vitro
compound
affect
durat
effect
refractori
period
may
antiarrhythm
proarrhythm
effect
addit
inotrop
effect
posit
neg
test
compound
determin
guinea
pig
either
sex
marioth
strain
weigh
g
sacrif
stun
carotid
arteri
sever
thorac
cage
open
immedi
heart
remov
place
contain
prewarm
preoxygen
ringer
solut
pericardium
atria
trim
away
left
ventricl
open
two
strongest
papillari
muscl
remov
fix
suction
electrod
electr
stimul
forc
transduc
registr
contract
ringer
solut
oxygen
carbogen
co
temperatur
use
standard
micro
electrod
techniqu
appli
measur
action
potenti
via
glass
micro
electrod
contain
kcl
solut
insert
intracellularli
papillari
muscl
stimul
rectangular
puls
v
ms
durat
interv
ms
interv
two
stimuli
variabl
order
determin
refractori
period
intens
electr
current
stimul
threshold
intracellular
action
potenti
amplifi
differenti
registr
upstrok
veloc
dvdt
hugo
sach
micro
electrod
amplifi
togeth
contract
forc
display
oscilloscop
gould
digit
storag
oscilloscop
os
record
gould
record
effect
fast
sodium
channel
well
calcium
channel
studi
former
requir
measur
normal
action
potenti
latter
slow
action
potenti
obtain
mm
k
estim
rel
refractori
period
second
stimuli
set
decrement
interv
contract
ceas
rel
refractori
period
defin
minimum
time
interv
two
stimuli
stimuli
answer
contract
stimul
threshold
also
measur
equilibrium
time
min
test
compound
ad
min
follow
paramet
compar
predrug
valu
rest
potenti
mv
upstrok
veloc
vs
durat
action
potenti
ms
stimul
threshold
v
refractori
period
ms
contract
forc
mg
organ
bath
flush
thoroughli
two
consecut
applic
increas
test
drug
dose
contractil
forc
mm
rel
refractori
period
ms
determin
drug
administr
ed
ms
ed
ms
valu
determin
ed
ed
defin
concentr
test
drug
organ
bath
rel
refractori
period
reduc
prolong
ms
ms
sinc
mani
antiarrhythm
agent
possess
addit
neg
inotrop
effect
chang
forc
contract
also
determin
ed
valu
calcul
logprobit
analys
score
allot
rel
efficaci
standard
compound
lidocain
propranolol
quinidin
follow
chang
indic
antiarrhythm
activ
increas
stimul
threshold
decreas
upstrok
veloc
prolong
action
potenti
increas
refractori
period
upstrok
veloc
durat
action
potenti
use
classif
purpos
tand
et
al
studi
electromechan
effect
class
iii
antiarrhythm
drug
guinea
pig
rat
papillari
muscl
atria
use
convent
microelectrod
techniqu
shirayama
et
al
studi
similar
techniqu
electrophysiolog
effect
sodium
channel
blocker
isol
guinea
pig
left
atria
daw
describ
method
examin
substanc
act
refractori
period
cardiac
muscl
use
isol
rabbit
auricl
method
recommend
first
step
screen
program
quinidinelik
activ
schallek
wellen
et
al
studi
decreas
maximum
drive
frequenc
isol
guinea
pig
auricl
antiarrhythm
drug
betablock
salako
et
al
record
electropotenti
along
conduct
system
stimul
proxim
part
bundl
rabbit
brown
wu
et
al
gwilt
et
al
b
blood
flow
restrict
aorta
rat
induc
hypertens
also
cardiac
hypertrophi
within
sever
week
angiotensin
convert
enzym
inhibitor
even
subantihypertens
dose
antihypertens
drug
inhibit
cardiac
hypertrophi
et
al
gohlk
et
al
linz
bruckschlegel
et
al
ogawa
et
al
male
spragu
dawley
rat
weigh
g
fast
h
surgeri
anesthesia
induc
ip
inject
mgkg
hexobarbit
abdomen
shave
moisten
disinfect
open
cut
parallel
linea
alba
intestin
moisten
salin
place
plastic
cover
prevent
desicc
aorta
prepar
free
connect
tissu
left
renal
arteri
underlaid
silk
thread
cannula
mm
place
longitudin
aorta
aorta
cannula
tie
cannula
remov
leav
aortic
lumen
determin
diamet
cannula
intestin
place
back
abdomin
caviti
applic
mg
rolitetracyclin
reverin
shamoper
control
band
perform
skin
close
clip
anim
treat
daili
period
week
dose
aceinhibitor
antihypertens
drug
found
previous
effect
lower
blood
pressur
rat
end
experi
blood
pressur
measur
hexobarbit
anesthesia
mgkg
ip
via
indwel
cathet
left
carotid
arteri
blood
pressur
measur
consciou
rat
conventi
tailcuff
method
possibl
due
larg
pressur
differ
across
ligatur
therefor
one
measur
end
studi
possibl
heart
remov
rins
salin
free
blood
gentli
blot
dryness
total
cardiac
mass
determin
weigh
electron
balanc
nearest
mg
atria
adjac
tissu
trim
weight
left
ventricl
includ
septum
well
remain
cardiac
tissu
repres
right
ventricl
determin
separ
weight
calcul
per
g
bodi
weight
total
cardiac
mass
weight
left
right
ventricl
treat
rat
compar
oper
control
shamoper
control
uetmasu
et
al
describ
simpl
method
produc
grade
aortic
insuffici
rat
subsequ
develop
cardiac
hypertrophi
select
perfor
right
cup
aortic
valv
combin
left
valv
cup
perform
use
plastic
rod
insert
right
common
carotid
arteri
hypertrophi
heart
hypertens
cardiac
insuffici
observ
similar
method
use
yamazaki
et
al
studi
alter
cardiac
adrenoceptor
calcium
channel
subsequ
aortic
insuffici
umemura
et
al
studi
baroreflex
function
ishiy
et
al
studi
effect
angiotensin
ii
antagonist
develop
cardiac
hypertrophi
due
volum
overload
hyperplast
growth
respons
vascular
smooth
muscl
cell
thorac
aorta
found
follow
induct
acut
hypertens
rat
aortic
coarctat
owen
reidi
chang
cardiac
gene
express
compens
hypertrophi
transit
cardiac
decompens
rat
aortic
band
studi
feldman
et
al
muder
et
al
produc
aortic
stenosi
rat
place
silver
clip
inner
diamet
mm
ascend
aorta
schunkert
et
al
studi
alter
growth
respons
establish
cardiac
pressur
overload
hypertrophi
rat
aortic
band
prevent
cardiac
hypertrophi
aortic
band
ace
inhibitor
probabl
mediat
bradykinin
could
shown
linz
et
al
linz
et
al
linz
et
al
b
linz
et
al
weinberg
et
al
weinberg
et
al
studi
effect
angiotensin
receptor
inhibit
hypertroph
remodel
ace
express
rat
pressureoverload
hypertrophi
due
ascend
aortic
stenosi
rat
model
heart
failur
review
chronic
heart
failur
induc
rat
occlus
coronari
arteri
one
first
report
recent
report
pfeffer
et
al
hodsman
et
al
van
veldhuisen
et
al
et
al
liu
et
al
liu
et
al
jadavo
et
al
describ
model
chronic
heart
failur
chf
spontan
hypertens
rat
adult
male
shrnhsd
wkynhsd
rat
harlan
spragu
dawley
winkelmann
germani
weigh
g
use
cardiovascular
failur
induc
perman
week
occlus
left
coronari
arteri
mm
distal
origin
aorta
result
larg
infarct
free
left
ventricular
wall
eight
week
surgeri
paramet
indic
chf
measur
cardiac
hypertrophi
function
geometr
properti
determin
work
heart
mode
vivo
determin
mri
heart
weight
hydroxyprolineprolin
ratio
measur
indic
heart
fibrosi
rat
anesthet
mixtur
ketaminexylazin
mgkg
ip
left
ventrolater
thorax
shave
prepar
creat
disinfect
surgic
access
area
stabl
anesthesia
achiev
anim
place
small
anim
oper
tabl
intub
ventil
room
air
use
small
anim
ventil
hugo
sach
elektronik
marchhugstedten
germani
level
anesthesia
deem
adequ
follow
loss
pedal
withdraw
reflex
absenc
palpebr
reflex
tidal
volum
adjust
ml
ventil
rate
breathsmin
left
thoracotomi
perform
via
third
intercost
space
heart
expos
pericardium
open
left
main
coronari
arteri
ligat
permahand
silk
usp
ethicon
norderstedt
germani
near
origin
aorta
mm
distal
edg
left
atrium
ligat
result
infarct
free
left
ventricular
wall
ligat
deem
success
anterior
wall
left
ventricl
turn
pale
point
lung
hyperinfl
increas
posit
endexpiratori
pressur
chest
close
rat
place
heat
pad
continu
monitor
start
move
cage
avoid
ventricular
arrhythmia
lidocain
im
given
surgeri
sham
procedur
consist
open
pericardium
place
superfici
sutur
epicardium
lv
prevent
acut
lung
edema
rat
receiv
furosemid
mgkg
twice
daili
day
via
drink
water
kill
anim
week
mi
noninvas
sequenti
nuclear
magnet
reson
nmr
measur
heart
geometr
properti
done
thereaft
anim
anesthet
pentobarbiton
mgkg
ip
subsequ
heparin
heparin
sodium
g
bodi
weight
ip
stabl
anesthesia
achiev
stage
iii
reflex
absent
anim
connect
artifici
respir
via
pe
tube
insert
trachea
ventil
room
air
right
carotid
arteri
cannul
polyethylen
cathet
monitor
mean
blood
pressur
systol
blood
pressur
diastol
blood
pressur
heart
rate
stabl
time
cours
min
transvers
laparotomi
right
anterolater
thoracotomi
perform
heart
rapidli
remov
evalu
function
work
heart
mode
thereaft
heart
weight
left
right
ventricular
weight
determin
infarct
size
determin
left
ventricl
section
transvers
four
slice
apex
base
infarct
size
determin
planimetri
express
percentag
lv
mass
lung
weight
lung
histolog
section
evalu
hydroxyprolineprolin
ratio
determin
paraffinembed
slice
left
ventricl
anim
monitor
mri
day
day
postmi
rat
anesthet
mixtur
halothan
n
ooxygen
special
manufactur
rat
mask
fulli
anesthet
rat
phase
iii
place
cradl
made
plexigla
supin
posit
respir
ecg
monitor
continu
mri
experi
perform
accord
rudin
et
al
imag
acquir
spinecho
sequenc
se
field
view
mm
imag
resolut
pixel
dimens
mm
four
adjac
transvers
slice
record
slice
thick
mm
acquisit
data
coronari
pilot
scan
measur
adequ
posit
transvers
slice
mri
data
acquisit
gate
cardiac
cycl
physiograd
sm
mr
monitor
system
bruker
karlsruh
germani
two
set
transvers
imag
acquir
one
endsystol
anoth
enddiastol
enddiastol
defin
imag
obtain
ms
onset
r
wave
ecg
correspond
largest
caviti
area
endsystol
defin
imag
smallest
lv
caviti
area
imag
analysi
done
use
bruker
softwar
karlsruh
germani
paramet
left
ventricular
enddiastol
volum
lvedv
left
ventricular
endsystol
volum
lvesv
septum
size
infarct
size
eject
fraction
ef
left
ventricular
chamber
diamet
r
circumfer
measur
ef
estim
percentag
term
subtract
lvedvlvesv
procedur
rat
ventil
oxygen
mask
replac
brought
back
cage
monitor
start
move
cage
anim
anesthet
pentobarbiton
mgkg
ip
subsequ
heparin
heparin
sodium
g
bodi
weight
ip
stabl
anesthesia
achiev
anim
connect
artifici
respir
via
pe
tube
insert
trachea
ventil
room
air
right
carotid
arteri
cannul
polyethylen
cathet
cathet
connect
plugsi
measur
system
hugo
sach
elektronik
marchhugstedten
germani
monitor
mean
blood
pressur
systol
blood
pressur
diastol
blood
pressur
heart
rate
stabl
time
cours
min
final
investig
heart
anesthet
rat
rapidli
remov
immers
physiolog
buffer
chill
aorta
dissect
free
mount
onto
cannula
intern
diamet
mm
attach
perfus
apparatu
heart
perfus
accord
method
langendorff
oxygen
co
noncircul
krebshenseleit
solut
follow
composit
mm
nacl
kcl
cacl
mgso
nahco
kh
po
glucos
napyruv
perfus
pressur
mmhg
connect
tissu
thymu
lung
care
remov
cathet
place
pulmonari
arteri
drain
coronari
effluent
perfus
collect
determin
coronari
flow
venou
po
measur
left
atrium
cannul
via
incis
left
auricl
pulmonari
vein
ligat
close
surfac
atria
tight
seal
leak
establish
equilibr
period
heart
switch
work
mode
use
fill
pressur
preload
mmhg
wkynhsd
mmhg
sh
rat
afterload
pressur
mmhg
wkynhsd
mmhg
sh
rat
valid
basi
paramet
afterload
pressur
enhanc
cumul
manner
addit
mmhg
mmhg
thereaft
isovolumetr
maxima
determin
enhanc
preload
pressur
step
mmhg
mmhg
flow
pressur
signal
comput
obtain
plugsysmeasur
system
comput
data
perform
sampl
rate
hz
averag
everi
use
softwar
aquir
plu
ponemah
hugo
sach
elektronik
marchhugstedten
germani
evalu
extern
heart
work
total
heart
weight
left
right
ventricular
weight
determin
left
ventricl
section
transvers
four
slice
apex
base
eight
pictur
taken
rat
heart
two
slice
total
infarct
size
determin
planimetri
project
magnifi
slice
area
infarct
tissu
well
intact
myocardium
slice
ad
togeth
averag
infarct
fraction
left
ventricl
calcul
measur
express
percentag
lv
mass
left
ventricular
perimet
diamet
infarct
scar
length
well
wall
thick
infarct
wall
thin
determin
well
accord
rat
infarct
size
exclud
studi
lung
weight
determin
organ
immers
formalin
ph
lung
cut
small
piec
dehydr
embed
paraffin
hematoxylin
eosin
section
evalu
light
microscopi
embed
rest
fix
left
ventricular
tissu
freezedri
prolin
hydroxyprolin
analyz
accord
method
de
rojkind
ratio
calcul
data
given
mean
sem
statist
perform
use
sa
system
statist
packag
sa
institut
cari
nc
usa
sequenti
reject
ttest
jain
et
al
studi
effect
angiotensin
ii
receptor
blockad
coronari
ligat
exercis
train
treadmil
rat
medvedev
gorodetskaya
induc
heart
failur
rat
microembol
coronari
vessel
plastic
microspher
katona
et
al
found
select
sensori
denerv
capsaicin
aggrav
adriamycininduc
cardiomyopathi
rat
simpl
rapid
method
develop
high
output
heart
failur
cardiac
hypertrophi
rat
produc
aortacav
shunt
describ
garcia
diebold
rat
weigh
g
anesthet
mgkg
ip
pentobarbiton
vena
cava
abdomin
aorta
expos
open
abdomin
caviti
via
midlin
incis
aorta
punctur
union
segment
twothird
caudal
renal
arteri
onethird
cephal
aortic
bifurc
dispos
needl
needl
advanc
aorta
perfor
adjac
wall
penetr
vena
cava
bulldog
vascular
clamp
place
across
aorta
caudal
left
renal
arteri
aorta
clamp
needl
fulli
withdrawn
drop
cyanoacryl
glue
use
seal
aortapunctur
point
clamp
remov
later
patenc
shunt
verifi
visual
swell
vena
cava
mix
arteri
venou
blood
periton
caviti
close
silk
thread
stitch
skin
metal
clip
rat
aortacav
shunt
develop
cardiac
hypertrophi
significantli
higher
absolut
rel
heart
weight
studi
aortocav
shunt
rat
publish
flaim
et
al
liu
et
al
isoyama
et
al
studi
myocardi
hypertrophi
creat
aortic
insuffici
rat
terlink
et
al
studi
ventricular
dysfunct
rat
diffus
isoproterenolinduc
myocardi
necrosi
describ
model
chronic
heart
failur
produc
multipl
sequenti
coronari
microembol
dog
rockman
et
al
rockman
et
al
develop
model
ventricular
hypertrophi
intact
mous
use
microsurg
techniqu
eightweekold
adult
mice
weigh
g
anesthet
intraperiton
inject
mixtur
mgkg
ketamin
mgkg
xylazin
mgkg
morphin
anim
place
dissect
microscop
supin
posit
midlin
cervic
incis
made
expos
trachea
carotid
arteri
endotrach
intub
cannula
connect
volum
cycl
rodent
ventil
supplement
oxygen
tidal
volum
ml
respiratori
rate
per
min
left
right
carotid
arteri
cannul
flame
stretch
tube
cathet
connect
modifi
statham
transduc
chest
caviti
enter
second
intercost
space
left
upper
sternal
border
small
incis
thymu
gentli
deflect
field
view
expos
aortic
arch
transvers
aorta
isol
carotid
arteri
constrict
nylon
sutur
ligatur
needl
latter
promptli
remov
yield
constrict
mm
diamet
provid
reproduc
transvers
aortic
constrict
hemodynam
effect
acut
chronic
constrict
follow
monitor
pressur
gradient
two
carotid
arteri
anesthet
anim
systol
mean
arteri
pressur
baselin
total
occlus
ligatur
tie
earli
min
late
day
transvers
aortic
constrict
record
increas
systol
pressur
provid
adequ
mechan
stimulu
develop
cardial
hypertrophi
confirm
myocardi
hypertrophi
shamoper
aorticconstrict
heart
examin
day
oper
heart
examin
cell
size
perfus
glutaraldehyd
apex
immers
osmium
tetroxid
dehydr
grade
alcohol
embed
araldit
tissu
block
section
thick
mount
slide
stain
toluidin
blue
cell
area
measur
manual
trace
cell
outlin
imag
system
connect
comput
end
experi
mice
sacrif
anesthesia
heart
excis
weigh
atria
ventricl
separ
frozen
liquid
nitrogen
northern
blot
analysi
total
rna
extract
singl
step
extract
guanidinium
thiocyan
rna
size
fraction
agaros
gel
electrophoresi
transfer
nylon
membran
vacuum
blot
hybrid
appropri
complementari
dna
probe
label
p
random
prime
specif
activ
cpmng
variabl
measur
express
mean
sd
statist
signific
differ
shamoper
thorac
aorticconstrict
anim
assess
student
ttest
dom
et
al
studi
myosin
heavi
chain
regul
myocyt
contractil
depress
lv
hypertrophi
aorticband
mice
okada
et
al
subject
mice
transvers
aortic
constrict
echocardiograph
analysi
demonstr
cardiac
hypertrophi
failur
week
surgeri
cardiac
express
endoplasmat
reticulum
chaperon
significantli
increas
indic
pressur
overload
transvers
aortic
constrict
induc
prolong
endoplasmat
reticulum
stress
sever
author
report
develop
murin
model
cardiac
failur
kaplan
et
al
rockman
et
al
balasubramaniam
et
al
suzuki
et
al
walther
et
al
wang
et
al
liao
et
al
xu
et
al
studi
cardioprotect
mice
heart
failur
dual
inhibit
angiotensin
convert
enzym
ace
neutral
endopeptidas
nep
mice
target
delet
b
kinin
receptor
gene
mice
age
week
anesthet
mgkg
sodium
pentobarbit
ip
intub
ventil
room
air
use
positivepressur
respir
left
thoracotomi
perform
via
fourth
intercost
space
lung
retract
expos
heart
pericardium
open
left
anterior
descend
coronari
arteri
ligat
nylon
sutur
near
origin
pulmonari
outflow
tract
edg
left
atrium
acut
myocardi
ischemia
consid
success
anterior
wall
left
ventricl
turn
pale
obviou
st
segment
elev
observ
lung
inflat
increas
posit
endexpiratori
pressur
thoracotomi
site
close
shamoper
mice
subject
procedur
except
sutur
around
left
anterior
coronari
arteri
tie
systol
blood
pressur
measur
consciou
mice
use
noninvas
computer
tailcuff
system
cardiac
geometri
function
evalu
doppler
echocardiograph
system
lv
diastol
dimens
measur
eject
fraction
calcul
lvad
lva
lvad
lvad
lv
diastol
area
lva
lv
systol
area
four
week
surgeri
strain
separ
one
group
treat
ace
inhibitor
one
group
treat
nep
inhibitor
one
group
treat
inhibitor
one
control
group
drug
administ
drink
water
week
end
studi
mice
anesthet
pentobarbit
heart
stop
diastol
intraventricular
inject
kcl
heart
lung
liver
weigh
assess
hypertrophi
congest
infarct
size
determin
gomori
trichrom
stain
express
ration
infarct
portion
total
lv
circumfer
section
slice
doublestain
fluoresceinlabel
peanut
agglutinin
delin
myocyt
crosssect
area
interstiti
space
rhodaminelabel
griffonia
simplicifolia
lectin
show
capillari
calcul
interstiti
collagen
fraction
total
surfac
area
microscop
field
interstiti
space
collagen
plu
capillari
area
occupi
capillari
alon
measur
computerassist
videodensometri
week
treatment
plasma
renin
measur
data
express
mean
se
mortal
rate
compar
use
test
echo
blood
pressur
heart
weight
lung
weight
infarct
size
plasma
renin
concentr
histolog
data
pair
twosampl
test
use
nonparametr
method
use
perform
comparison
interest
congest
heart
failur
man
character
cardiac
hypertrophi
peripher
edema
lung
liver
congest
dyspnea
hydrothorax
ascit
effect
treatment
achiev
cardiac
glycosid
base
techniqu
report
method
develop
induc
congest
heart
failur
guinea
pig
symptom
close
human
patholog
vogel
marx
vogel
et
al
male
guinea
pig
weigh
g
use
fur
ventral
thorax
shave
skin
disinfect
anim
anesthet
ether
skin
cut
scissor
left
side
length
cm
left
musculu
pectorali
cut
costal
insert
elev
forth
intercost
space
open
two
blunt
forcep
heart
press
open
left
hand
pericardium
open
fine
forcep
pull
back
basi
heart
beat
heart
extrud
thorax
wound
pressur
left
hand
right
thorax
wall
ringshap
clamp
cover
thin
rubber
tube
place
around
basi
heart
keep
heart
outsid
thorax
without
close
blood
circul
thread
soak
dilut
disinfect
solut
place
loop
around
apex
heart
tighten
apic
third
ventricl
tie
degre
tighten
loop
essenti
complet
interrupt
blood
suppli
apic
third
result
necrosi
avoid
well
loop
slip
technic
skill
necessari
place
loop
around
beat
heart
correct
posit
remov
clamp
heart
place
back
incis
forth
fifth
costal
rib
close
musculu
pectorali
place
wound
intrathorac
air
form
pneumothorax
remov
pressur
side
thorax
applic
antibiot
emuls
skin
wound
close
surgic
procedur
finish
within
short
period
time
anim
develop
symptom
sever
congest
heart
failur
death
rate
within
day
lung
weight
rel
heart
weight
significantli
increas
exud
thorax
caviti
ascit
amount
ml
extrem
valu
ml
lung
edema
liver
congest
found
histolog
peripher
edema
pretermin
dyspnea
tachypnea
observ
treat
variou
dose
cardiac
glycosid
sc
im
period
day
symptom
cardiac
insuffici
e
g
volum
transud
well
death
rate
dosedepend
diminish
surviv
rate
ed
valu
cardiac
glycosid
calcul
dosag
rang
therapeut
dose
man
experiment
model
guinea
pig
reflect
close
symptom
cardiac
insuffici
man
e
g
lung
congest
hydrothorax
liver
congest
ascit
peripher
edema
cardiac
hypertrophi
therapeut
potenc
cardiac
glycosid
evalu
method
addit
factor
known
enhanc
symptom
congest
heart
failur
man
like
salt
load
diphtheria
toxin
increas
mortal
hydrop
symptom
method
use
special
purpos
howev
need
consider
train
technic
skill
cardiomyopathi
syrian
hamster
describ
bajusz
et
al
bajusz
lossnitz
bajusz
bajusz
et
al
b
homburg
bajusz
gertz
diseas
origin
autosom
recess
transmiss
disord
lead
degen
lesion
striat
muscl
particular
myocardium
histopatholog
chang
consist
myocytolyt
necrosi
follow
fibrosi
calcif
evolut
cardiomyopath
diseas
character
five
distinct
phase
prenecrot
stage
patholog
evid
time
activ
myocytolysi
cellular
necrosi
phase
fibrosi
calcium
deposit
overlap
period
reactiv
hypertrophi
remain
viabl
myocyt
final
stage
depress
myocardi
perform
failur
model
cardiomyopathi
syrian
hamster
use
sever
author
one
note
sever
strain
cardiomyopath
hamster
use
strain
bio
capasso
et
al
capasso
et
al
chemla
et
al
chemla
et
al
strain
bio
tapp
et
al
sen
et
al
strain
chf
cm
van
meel
et
al
haleen
et
al
strain
ver
donck
et
al
strain
kato
et
al
strain
chf
desjardin
et
al
hanton
et
al
variou
experiment
protocol
describ
author
use
surviv
rate
heart
weight
end
point
e
g
van
meel
et
al
ver
donck
et
al
hanton
et
al
gener
experi
start
anim
age
day
capasso
et
al
capasso
et
al
studi
mechan
electr
properti
cardiomyopath
heart
syrian
hamster
use
isol
left
ventricular
posterior
papillari
muscl
tapp
et
al
test
stressinduc
mortal
cardiomyopath
hamster
five
consecut
daili
period
supin
immobil
sen
et
al
test
inotrop
calcium
kinet
effect
calcium
channel
agonist
antagonist
primari
cultur
isol
cardiac
myocyt
haleen
et
al
test
effect
angiotensin
convert
enzym
inhibitor
surviv
also
left
ventricular
failur
isol
langendorff
heart
measur
left
ventricular
enddiastol
pressur
dpdt
max
mean
coronari
flow
dixon
et
al
test
effect
receptor
antagonist
cardiac
collagen
remodel
cardiomyopath
syrian
hamster
addit
effect
left
ventricular
papillari
muscl
strip
chemla
et
al
test
effect
diaphragm
contractil
cardiomyopath
syrian
hamster
whitmer
et
al
kuo
et
al
test
sarcolemm
sarcoplasmat
reticulum
calcium
transport
cardiomyopath
syrian
hamster
nigro
et
al
identifi
syrian
hamster
cardiomyopathi
gene
tanguay
et
al
test
coronari
cardiac
sensit
vasoselect
benzothiazepinelik
calcium
antagonist
isol
perfus
fail
heart
syrian
hamster
bilat
et
al
recommend
syrian
hamster
model
dilat
cardiomyopathi
chaga
diseas
femal
hamster
infect
via
intraperiton
rout
trypanosoma
cruzi
strain
blood
trypomastigot
surviv
monitor
echocardiographi
perform
month
histopatholog
examin
carri
end
studi
period
posit
effect
variou
drug
found
cardiomyopath
hamster
cardiac
glycosid
inotrop
compound
betablock
calcium
antagonist
aceinhibitor
specif
effect
challeng
tightskin
tsk
mous
genet
model
pulmonari
emphysema
connect
right
ventricular
hypertrophi
gardi
et
al
right
ventricl
pressur
guidanc
transven
screwin
pacemak
lead
medtron
advanc
cathet
ventricular
apex
implant
endocardi
pacemak
implant
subcutan
right
abdomin
wall
pacemak
lead
connect
subcutan
pacemak
rapid
ventricular
pacinginduc
heart
failur
could
induc
transven
implant
pacemak
system
rabbit
allow
recov
least
day
surgeri
pacemak
start
induct
heart
failur
proper
pacemak
function
check
intraop
time
program
subsequ
day
rabbit
chf
group
underw
pace
stepwis
increas
stimul
frequenc
day
first
day
anim
pace
beatsmin
bpm
protocol
result
elvd
defin
signific
lv
systol
dysfunct
cardiac
enlarg
decreas
perfus
pressur
clinic
sign
failur
pace
rate
increas
bpm
day
bpm
anoth
day
elvd
evolv
chf
cardiac
enlarg
decreas
perfus
pressur
togeth
clinic
sign
fluid
retent
ascit
baselin
control
pace
bpm
day
elvd
end
protocol
chf
consciou
arteri
pressur
measur
invas
via
medial
ear
arteri
guid
mmode
echocardiogram
obtain
end
pace
protocol
rabbit
kill
iv
euthanasia
tissu
rapidli
harvest
heart
trim
ice
snap
frozen
liquid
nitrogen
store
c
process
echocardiographi
long
shortaxi
echocardiogram
hp
sono
mhz
probe
perform
light
sedat
mg
midazolam
im
supin
posit
left
parastern
window
lv
enddiastol
lvedd
endsystol
lvesd
dimens
diastol
systol
thick
left
ventricular
anterior
wall
aedth
aesth
posterior
wall
pedth
pesth
well
left
atrial
diamet
lad
determin
three
repeat
guid
mmode
trace
use
ase
convent
measur
fraction
shorten
fs
calcul
fs
lveddlvesd
lvedd
analyt
method
analysi
cardiac
natriuret
peptid
express
mrna
extract
atrial
left
ventricular
sampl
util
commerci
kit
fasttrack
invitrogen
probe
brain
natriuret
peptid
bnp
dna
restrict
fragment
contain
gene
rabbit
bnp
use
result
quantit
studi
express
mean
sem
comparison
control
elvd
chf
group
perform
analysi
varianc
anova
follow
fisher
least
signific
differ
test
comparison
atrial
lv
tissu
well
atrial
natriuret
peptid
anp
bnp
perform
pair
student
ttest
statist
signific
defin
p
arnolda
et
al
studi
adriamycin
cardiomyopathi
rabbit
klimtova
et
al
perform
compar
studi
chronic
toxic
effect
daunorubicin
doxorubicin
rabbit
alexand
et
al
studi
electrograph
chang
follow
coronavirusinduc
myocard
dilat
cardiomyopathi
rabbit
describ
transgen
model
human
troponin
ibas
hypertroph
cardiomyopathi
rabbit
excret
clinic
sign
heart
failur
pace
rate
increas
weekli
bpm
earli
left
ventricular
dysfunct
evolv
overt
congest
heart
failur
avid
sodium
retent
clinic
sign
congest
baselin
control
dog
pace
bpm
day
end
protocol
overt
chf
urin
collect
measur
sodium
excret
consciou
mean
arteri
pressur
measur
via
port
cathet
guid
mmode
echogram
obtain
arteri
blood
drawn
cardiac
fill
pressur
cardiac
output
measur
thermodilut
method
baselin
end
protocol
arteri
blood
collect
edta
tube
measur
anp
bnp
cgmp
pra
aldosteron
ang
ii
euthanasia
heart
rapidli
trim
left
ventricl
weight
calcul
index
lv
weight
bodi
weight
result
express
mean
se
comparison
control
earli
lv
dysfunct
overt
chf
perform
anova
follow
fisher
least
signific
differ
test
kleaveland
et
al
nagatsu
et
al
use
techniqu
experiment
mitral
regurgit
dog
induc
left
ventricular
dysfunct
sheath
introduc
across
aortic
valv
carotid
arteri
urolog
calculu
retriev
forcep
advanc
sheath
mitral
valv
apparatu
use
sever
chorda
tendinea
pulmonari
capillari
wedg
pressur
rose
mmhg
forward
stroke
volum
reduc
baselin
ventriculogram
perform
confirm
angiograph
sever
mitral
regurgit
creat
dell
italia
et
al
su
et
al
induc
mitral
regurgit
percutan
chordal
ruptur
dog
kinney
et
al
publish
method
induc
acut
revers
tricuspid
insuffici
anesthet
dog
wire
spiral
advanc
atrioventricular
canal
right
atrium
spiral
caus
regurgit
prevent
complet
apposit
valv
leaflet
permit
retrograd
flow
occur
spiral
lumen
degre
regurgit
control
use
spiral
differ
size
creation
tricuspid
insuffici
demonstr
onset
right
atrial
pressur
v
wave
balloon
right
atrium
ventricular
systol
palpat
atrial
thrill
color
doppler
echocardiographi
model
revers
allow
repeat
trial
variou
grade
regurgit
carlyl
cohn
describ
nonchirurg
model
chronic
left
ventricular
dysfunct
method
accomplish
repetit
dc
shock
guidewir
introduc
percutan
posit
left
ventricl
along
intraventricular
septum
extern
paddl
left
ventricular
apex
produc
local
left
ventricular
necrosi
without
obstruct
coronari
blood
flow
dog
transmyocardi
directcurr
shock
sabbah
et
al
sabbah
et
al
gengo
et
al
produc
chronic
heart
failur
dog
multipl
sequenti
intracoronari
embol
microspher
dog
underw
three
nine
intracoronari
embol
polystyren
latex
microspher
diamet
perform
week
apart
embol
discontinu
left
ventricular
eject
fraction
less
use
multipl
coronari
microembol
dog
wherebi
three
nine
embol
perform
week
apart
first
three
embol
consist
ml
microspher
suspens
inject
subselect
either
left
anterior
descend
left
circumflex
coronari
arteri
altern
fashion
subsequ
embol
consist
ml
microspher
divid
equal
left
anterior
descend
left
circumflex
coronari
arteri
lv
eject
fraction
magovern
et
al
describ
canin
model
left
ventricular
dysfunct
caus
five
weekli
intracoronari
infus
adriamycin
koid
describ
premorbid
determin
left
ventricular
dysfunct
model
gradual
induc
pressur
overload
dog
mongrel
dog
studi
week
gradual
impos
ascend
aortic
constrict
use
novel
band
techniqu
band
initi
gradient
mmhg
creat
band
week
band
hemodynam
left
ventricular
mechan
examin
cardiac
catheter
pressur
overload
increas
tighten
band
valentin
et
al
devaux
et
al
describ
xlink
muscular
dystrophi
dog
cardiac
insuffici
similar
duchenn
muscular
dystrophi
men
recommend
anim
model
cardiac
insuffici
cardiac
failur
studi
pig
use
sever
experiment
procedur
chow
et
al
recommend
rapid
ventricular
pace
pig
experiment
model
congest
heart
failur
farrar
et
al
studi
pacinginduc
dilat
cardiomyopathi
pig
congest
heart
failur
produc
rapid
ventricular
pace
bpm
week
spinal
et
al
spinal
et
al
spinal
et
al
spinal
et
al
examin
consequ
chronic
supraventricular
tachycardia
variou
paramet
ventricular
dysfunct
subendocardi
chang
pig
carrol
et
al
investig
gene
express
swine
model
ventricular
hypertrophi
pressur
overload
multani
et
al
studi
longterm
angiotensin
convert
enzym
angiotensin
ireceptor
inhibit
pacinginduc
heart
failur
pig
heart
failur
induc
rapid
atrial
pace
bpm
week
kassab
et
al
kassab
et
al
investig
remodel
right
ventricular
branch
hypertrophi
pig
krombach
et
al
studi
effect
amlodipin
congest
heart
failur
pig
rest
treadmil
exercis
left
thoracotomi
perform
yorkshir
pig
anesthesia
cathet
connect
vascular
access
port
place
thorac
aorta
pulmonari
arteri
left
atrium
access
port
place
subcutan
pocket
flow
probe
place
around
pulmonari
arteri
immedi
distal
pulmonari
cathet
electr
connect
exterior
thoracolumbar
fascia
shield
stimul
electrod
sutur
onto
left
atrium
connect
programm
pacemak
buri
subcutan
pocket
thoracotomi
close
layer
pleural
space
evacu
air
recoveri
measur
perform
normal
rest
condit
exercis
pacemak
activ
bpm
period
day
last
day
one
group
treat
drug
serv
control
day
studi
electrocardiogram
perform
pacemak
deactiv
stabil
period
mmode
echocardiograph
studi
use
imag
left
ventricl
parastern
approach
left
ventricular
fraction
shorten
calcul
enddiastol
dimens
endsystol
dimens
diastol
dimens
express
percentag
access
port
enter
pressur
obtain
use
extern
calibr
transduc
flow
probe
connect
digit
flowmet
digit
flow
signal
stroke
volum
comput
beattobeat
basi
averag
minimum
eject
pulmonari
system
vascular
resist
comput
mean
pressur
divid
cardiac
output
multipli
constant
convert
resist
unit
sampl
drawn
pulmonari
arteri
atrial
cathet
measur
oxygen
satur
hemoglobin
content
plasma
sampl
assay
renin
activ
endothelin
concentr
catecholamin
level
result
present
mean
sem
pairwis
test
individu
group
mean
compar
use
bonferroni
probabl
zhang
et
al
studi
function
bioenerget
consequ
postinfarct
left
remodel
porcin
model
proxim
left
coronari
arteri
occlus
use
gener
myocardi
infarct
young
pig
anim
follow
sever
month
remodel
left
ventricl
develop
left
ventricular
wall
thick
eject
fraction
wall
stress
measur
mri
myocardi
atp
creatin
phosphat
inorgan
phosphat
level
measur
spatial
local
pnmr
spectroscopi
region
myocardi
blood
flow
measur
radioact
microspher
mri
studi
perform
standard
siemen
medic
system
vision
oper
anim
anesthet
sodium
pentobarbit
cathet
place
femor
arteri
advanc
lv
chamber
lv
pressur
record
anim
place
left
side
helmholtz
coil
diamet
cm
use
improv
signal
nois
comput
lv
wall
stress
imag
acquisit
trigger
lv
pressur
fluidfil
lv
cathet
imag
sequenc
synchron
lv
pressur
trace
electron
lv
pressur
signal
record
fed
compar
set
threshold
level
upslop
lv
pressur
curv
begin
systol
signal
compar
sent
puls
former
fed
ecg
port
magnet
reson
system
treat
like
standard
electrograph
input
run
puls
sequenc
scout
imag
taken
axial
plane
singleshot
ultrafast
gradient
echo
sequenc
wilk
et
al
geiger
et
al
axial
imag
horizont
vertic
longaxi
imag
obtain
altern
back
forth
sever
time
true
vertic
long
axi
left
ventricl
obtain
longaxi
scout
imag
shortaxi
segment
cine
turboflash
slice
prescrib
cover
myocardium
apex
base
doubleobliqu
shortaxi
turboflash
imag
cover
heart
apex
base
slice
thick
mm
interslic
gap
paramet
segment
cine
sequenc
trteflip
angl
degre
fov
cm
matrix
pixel
size
mm
mm
slice
thick
mm
atkinson
et
al
sequenc
use
segment
kspace
acquisit
three
phaseencod
line
gather
per
cardiac
phase
per
heartbeat
total
imag
acquisit
requir
approxim
heartbeat
slice
locat
tempor
imag
resolut
data
acquisit
window
sequenc
ms
per
cardiac
imag
myocardi
level
took
min
acquir
sinc
two
acquisit
use
averag
heart
rate
anim
bpm
averag
number
shortaxi
slice
need
imag
entir
myocardium
apex
base
six
eight
protocol
provid
high
signaltonois
cine
sequenc
cover
entir
heart
obtain
highresolut
anatom
heart
imag
multislic
singlephas
spinecho
imag
trig
systol
phase
acquir
cover
entir
heart
imag
permit
precis
delin
extent
scar
region
heart
imag
taken
slice
thick
mm
fov
cm
result
true
spatial
resolut
mm
mm
pixel
size
tr
sequenc
equal
rr
interv
ms
echo
time
te
set
ms
total
measur
time
averag
slice
min
imag
data
archiv
optic
disk
copi
sun
sparc
workstat
evalu
use
automat
segment
program
imageview
siemen
cooper
research
program
base
robust
deform
model
endocardi
epicardi
border
segment
ventricular
boundari
cardiac
magnet
reson
imag
segment
techniqu
combin
user
interfac
allow
one
load
sort
visual
analyz
cardiac
studi
min
segment
algorithm
base
steepest
descent
well
dynam
program
strategi
integr
via
multiscal
analysi
minim
energi
function
result
contour
ventricular
boundari
use
construct
threedimension
model
visual
comput
hemodynam
paramet
automat
segment
endocardi
epicardi
boundari
perform
calcul
ventricular
volum
ef
lv
diastol
systol
volum
absolut
myocardi
mass
multislic
multiphas
magnet
reson
cine
imag
start
userspecifi
approxim
boundari
interior
point
ventricl
one
start
imag
one
slice
algorithm
gener
automat
contour
correspond
epicardium
endocardium
automat
propag
slice
cardiac
phase
spatial
propag
phase
given
slice
locat
tempor
propag
cardiac
studi
observ
could
make
manual
correct
six
seven
pair
contour
first
column
temporalspati
matrix
manual
modif
gener
made
apex
base
level
mean
lv
wall
thick
shortaxi
ring
averag
three
measur
remot
zone
anterior
wall
septum
wall
thick
scar
averag
three
measur
scar
area
lvsa
measur
slice
comput
subtract
total
area
enclos
endocardium
enclos
subepicardium
result
area
multipli
slice
thick
obtain
volum
slice
total
lv
mass
volum
calcul
ad
volum
shortaxi
slice
total
lvsa
obtain
divid
total
lv
wall
mass
volum
mean
lv
wall
thick
slice
similarli
lvssa
obtain
divid
total
scar
volum
sum
scar
volum
short
axi
mean
scar
thick
short
axi
lv
mass
comput
total
lv
wall
mass
volum
multipli
specif
graviti
myocardium
calcul
lv
mass
lv
enddiastol
volum
v
endsystol
volum
v
slice
repres
area
enclos
endocardium
total
lv
volum
comput
ad
volum
slice
lvef
calcul
vv
v
interobserv
intraobserv
error
calcul
lv
mass
lv
volum
shown
mg
ml
respect
mcdonald
et
al
meridion
wall
stress
comput
lv
pressur
simultan
obtain
shortaxi
view
lv
mri
lv
caviti
diamet
averag
thick
remot
lv
wall
describ
grossman
et
al
measur
perform
magnet
interfac
sisco
spectroscopi
imag
system
corpor
consol
lv
pressur
signal
use
gate
nmr
data
acquisit
cardiac
cycl
respiratori
gate
achiev
trigger
ventil
cardiac
cycl
data
acquisit
robitail
et
al
pand
hnmr
frequenc
mhz
respect
spectra
record
late
diastol
puls
repetit
time
repetit
time
allow
full
relax
atp
p
reson
relax
cp
reson
zhang
mcdonald
cp
reson
intens
correct
minor
satur
correct
factor
determin
heart
two
spectra
record
consecut
without
transmur
differenti
one
repetit
time
allow
full
relax
repetit
time
use
measur
radiofrequ
transmiss
signal
detect
perform
surfac
coil
coil
cement
sheet
silicon
rubber
mm
thick
larger
diamet
coil
capillari
contain
phosphonoacet
acid
place
coil
center
serv
refer
proton
signal
water
detect
surfac
coil
use
homogen
magnet
field
adjust
posit
anim
magnet
coil
near
magnet
gradient
isocent
accomplish
spinecho
experi
readout
gradient
inform
gather
step
also
use
determin
spatial
coordin
spectroscop
local
chemic
shift
measur
rel
cp
assign
chemic
shift
ppm
rel
phosphor
acid
ppm
spatial
local
across
lv
wall
perform
rappisisfsw
method
hendrich
et
al
signal
origin
restrict
use
b
gradient
adiabat
invers
puls
column
coaxial
surfac
coil
perpendicular
lv
wall
column
dimens
mm
within
column
signal
local
use
b
gradient
five
voxel
center
rotat
increment
fsw
local
use
nineterm
fourier
seri
expans
fourier
coeffici
number
free
induct
decay
acquir
term
fourier
expans
multipl
factor
use
construct
voxel
report
previous
posit
voxel
rel
coil
set
use
b
magnitud
coil
center
experiment
determin
case
measur
length
phosphonoacet
acid
refer
locat
coil
center
set
spatial
local
transmur
spectra
acquir
min
total
scan
accumul
within
block
reson
intens
quantifi
use
integr
routin
provid
sisco
softwar
reson
use
atp
determin
sinc
data
acquir
transmitt
frequenc
posit
cp
reson
offreson
effect
peak
neglig
numer
valu
cp
atp
voxel
express
ratio
cpatp
p
level
measur
chang
baselin
valu
p
use
integr
obtain
region
cover
p
reson
variou
method
use
induc
cardiac
failur
sheep
pressur
overload
aortic
band
aoyagi
et
al
charl
et
al
volum
load
myocardi
infarct
charl
et
al
rapid
ventricular
pace
rademak
rademak
rademak
byrn
et
al
moreno
et
al
coronari
microembol
monreal
et
al
rademak
et
al
studi
combin
angiotensin
convert
enzym
inhibit
adrenomedullin
ovin
model
heart
failur
induc
rapid
ventricular
pace
coopworth
ewe
kg
instrument
via
left
later
thoracotomi
gener
anesthesia
induc
mgkg
thiopenton
maintain
halothanenitr
oxid
two
polyvinyl
chlorid
cathet
insert
left
atrium
blood
sampl
left
atrial
pressur
lap
determin
konigsberg
pressuretip
transduc
insert
aorta
record
mean
arteri
pressur
map
electromagnet
flow
probe
place
around
ascend
aorta
measur
cardiac
output
co
french
swanganz
cathet
insert
pulmonari
arteri
infus
french
hisbundl
electrod
stitch
subepicardi
wall
left
ventricl
left
ventricular
pace
lead
extern
incis
back
bladder
cathet
insert
per
urethra
urin
collect
anim
allow
recov
day
commenc
studi
protocol
experi
anim
held
metabol
cage
free
access
water
ate
diet
chaff
sheep
pellet
contain
mmolday
sodium
mmolday
potassium
mmol
sodium
administ
oral
daili
nacl
tablet
use
applic
heart
failur
induc
day
rapid
left
ventricular
pace
bpm
maintain
continu
pace
durat
studi
four
separ
day
rest
day
sheep
receiv
random
order
vehicl
control
haemaccel
human
adrenomedullin
alon
ngmin
per
kg
infus
h
ace
inhibitor
alon
captopril
mg
bolu
mgh
infus
h
agent
combin
infus
administ
total
volum
ml
via
pulmonari
arteri
cathet
commenc
hour
mean
arteri
pressur
left
atrial
pressur
cardiac
output
calcul
total
peripher
resist
ctpr
mean
arteri
pressurecardiac
output
record
interv
prior
infus
baselin
min
infus
postinfus
period
hemodynam
measur
determin
onlin
computerassist
analysi
blood
sampl
drawn
left
atrium
min
immedi
preinfus
baselin
min
infus
postinfus
period
sampl
taken
tube
ice
centrifug
g
min
store
either
assay
immunoreact
ir
adrenomedullin
camp
plasma
renin
activ
angiotensin
ii
aldosteron
atrial
natriuret
peptid
brain
natriuret
peptid
catecholamin
cortisol
sampl
individu
anim
measur
assay
avoid
interassay
variabl
plasma
electrolyt
hematocrit
measur
everi
sampl
taken
urin
volum
sampl
measur
urin
camp
sodium
potassium
creatinin
excret
collect
everi
h
creatinin
clearanc
calcul
urin
creatinineplasma
creatinin
result
express
mean
sem
baselin
hemodynam
hormon
valu
repres
mean
four
two
measur
respect
made
h
immedi
preinfus
statist
analysi
perform
repeatedmeasur
anova
baselin
data
treatment
compar
treatmentand
timerel
differ
four
studi
limb
determin
use
twoway
anova
treatmenttim
interact
quot
text
statist
signific
assum
p
hemodynam
stabil
ensur
baselin
data
record
intraven
dobutamin
infus
interv
upwardli
titrat
rate
examin
effect
adrenerg
stimul
dose
rang
catecholamin
studi
chosen
alter
inotrop
lusitrop
state
without
caus
untoward
increas
heart
rate
steadyst
hemodynam
measur
made
minut
infus
period
level
pacemak
briefli
turn
determin
effect
dobutamin
heart
rate
four
anim
group
studi
increment
pace
blockad
esmolol
ivv
pace
protocol
result
larger
group
anim
studi
blockad
detail
previou
report
briefli
atrial
pace
institut
rate
intrins
heart
rate
avoid
compet
rhythm
increas
increment
critic
heart
rate
achiev
critic
heart
rate
defin
rate
dpdt
max
reach
maximum
minimum
respect
progress
increas
heart
rate
show
previous
hyperthyroid
significantli
increas
critic
heart
rate
dpdt
max
ec
dobutamin
lv
dpdt
max
determin
fit
log
dose
transform
data
sigmoid
relat
softwar
graph
pad
addit
anim
chronic
instrument
could
examin
effect
adrenerg
stimul
one
anim
die
suddenli
receiv
thyroid
hormon
day
remain
three
anim
adrenerg
agonist
terbutalin
infus
product
hyperthyroid
state
increment
dose
terbutalin
mindos
infus
dose
rang
thyroid
function
test
perform
baselin
experi
euthyroid
state
termin
experi
within
h
last
dose
hyperthyroid
state
radioimmunoassay
free
level
measur
state
pair
mean
data
compar
student
ttest
effect
thyroid
statu
catecholamin
dose
hemodynam
dimens
variabl
examin
repeatedmeasur
anova
superanova
abacu
concept
signific
differ
found
group
mean
compar
contrast
valu
p
consid
signific
unless
specifi
data
express
mean
sd
variou
speci
use
studi
experiment
cardiac
failur
breisch
et
al
studi
effect
pressureoverload
hypertrophi
left
myocardium
young
adult
cat
hypertrophi
induc
constrict
ascend
aorta
genao
et
al
recommend
dilat
cardiomyopathi
turkey
anim
model
studi
human
heart
failur
et
al
studi
energi
metabol
normal
hypertrophi
right
ventricl
ferret
heart
wang
et
al
studi
ca
handl
myofibrillar
ca
sensit
ferret
cardiac
myocyt
pressureoverload
hypertrophi
bovin
hereditari
cardiomyopathi
recommend
anim
model
human
dilat
cardiomyopathi
eschenhagen
et
al
kojima
et
al
komuro
et
al
komuro
et
al
komuro
et
al
yamazaki
et
al
yamazaki
et
al
yamazaki
et
al
describ
method
induc
hypertrophi
cardiomyocyt
mechan
stress
vitro
primari
cultur
cardiomyocyt
prepar
ventricl
neonat
wistar
kyoto
rat
accord
method
simpson
savion
cultur
treat
day
mm
bromodeoxyuridin
suppress
prolifer
nonmyocardi
cell
elast
cultur
dish
cm
made
vulcan
liquid
silicon
rubber
consist
methylvinyl
polysiloxan
dimethyl
hydrogen
silicon
resin
use
platinum
catalyst
bottom
disc
thick
highli
transpar
inorgan
filler
either
compon
cell
plate
field
densiti
cellscm
cultur
medium
consist
dulbecco
modifi
eagl
medium
fetal
bovin
serum
mechan
stress
cardiac
cell
appli
gentli
pull
hang
dish
peg
chang
length
dish
result
almost
ident
chang
length
cell
along
singl
axi
kimuro
et
al
cardiocyt
stretch
drug
e
g
angiotensinii
receptor
antagonist
ad
min
stretch
protein
analysi
silicon
dish
stretch
h
day
serum
starvat
h
phenylalanin
ad
min
end
stress
cell
rapidli
rins
four
time
icecold
phosphatebuff
salin
incub
min
ice
ml
trichloroacet
acid
total
trichloroacet
acidinsolubl
radioact
dish
determin
liquid
scintil
count
determin
mitogenactiv
protein
kinas
cardiomyocyt
lyse
ice
centrifug
aliquot
supernat
myocyt
extract
incub
kinas
buffer
mml
trishcl
ph
mml
mgcl
mml
dithiothreitol
apt
p
atp
protein
kinas
inhibitor
peptid
mml
egta
substrat
myelin
basic
protein
reaction
stop
ad
stop
solut
contain
hcl
mml
atp
bovin
serum
albumin
aliquot
supernat
spot
paper
whatman
wash
phosphor
acid
dri
count
determin
ofcfo
mrna
northern
blot
analysi
perform
valu
express
mean
sem
comparison
group
made
oneway
anova
follow
dunnett
modifi
ttest
interest
approach
induc
hypertrophi
cardiac
cell
vitro
use
predominantli
one
research
group
confirm
research
group
includ
modif
mechan
procedur
seem
necessari
komuro
biolog
standard
cardiac
glycosid
necessari
long
drug
use
therapi
plant
extract
mixtur
variou
glycosid
standard
unit
intern
standard
pharmacolog
method
use
purpos
adopt
mani
pharmacopoeia
nowaday
histor
interest
hold
true
frog
method
pigeon
method
burn
et
al
particularli
frog
method
use
standard
method
adopt
us
pharmacopoeia
x
h
test
healthi
frog
rana
pipien
weigh
g
select
cold
storag
room
one
hour
assay
weight
record
place
wire
cage
water
depth
cm
dose
digitali
calcul
approxim
mlg
bodi
weight
inject
made
ventral
lymph
sac
one
hour
later
anim
pith
heart
remov
examin
systol
arrest
ventricl
wide
dilat
atrium
indic
typic
result
calcul
activ
term
intern
unit
made
percentag
dead
anim
test
group
versu
group
receiv
intern
standard
pigeon
method
introduc
hanzlik
adopt
usp
xvii
depend
observ
intraven
inject
cardiac
glycosid
emet
action
pigeon
origin
test
adult
pigeon
weigh
g
inject
solut
cardiac
glycosid
suitabl
wing
vein
axillari
region
vomit
occur
within
min
regard
posit
result
two
dose
test
solut
standard
inject
percentag
vomit
pigeon
regist
point
assay
allow
calcul
ed
valu
potenc
ratio
compar
standard
modif
method
cat
method
introduc
describ
detail
lind
van
wijngarden
guinea
pig
method
describ
isol
cat
papillari
muscl
method
introduc
catel
gold
still
use
evalu
synthet
cardioglycosid
posit
inotrop
compound
referenc
detail
survey
evalu
cardiac
glycosid
given
bahrmann
greef
use
isol
papillari
muscl
isol
heart
prepar
moreov
influenc
na
k
atpas
vitro
model
specif
cardiac
glycosid
gundertremi
weber
describ
mechan
action
review
scholz
grupp
analog
antiarrhythm
agent
feldmann
propos
classif
system
categor
inotrop
agent
accord
suppos
mode
action
class
inotrop
agent
increas
intracellular
cyloamp
includ
agonist
phosphodiesteras
inhibitor
class
ii
inotrop
agent
affect
sarcolemm
ion
pump
channel
particular
cardiac
glycosid
inhibit
na
k
atpas
class
iii
agent
modul
intracellular
calcium
mechan
therapeut
inotrop
agent
kind
yet
avail
class
iv
inotrop
agent
multipl
mechan
action
bound
enzym
coupl
atp
hydrolysi
transloc
na
k
ion
across
plasma
membran
seri
conform
transit
e
e
state
enzym
enzym
heterodim
consist
catalyt
subunit
kda
associ
glycosyl
subunit
kda
three
alpha
subunit
identifi
cdna
clone
heart
enzym
na
k
atpas
target
posit
inotrop
glycosid
therefor
interest
character
posit
inotrop
compound
test
base
determin
phosphat
gener
atp
special
condit
inhibit
bovin
cerebr
na
k
atpas
prepar
accord
schoner
et
al
measur
addit
variou
concentr
test
compound
compar
standard
ml
mm
imidazol
ph
ml
mm
mgcl
ml
dpnh
mgml
ml
mm
nh
cl
ml
mm
atp
ml
mm
phosphoenolpyruv
ml
pyruvatekinas
mgml
uml
ml
lactatedehydrogenas
mgml
uml
ml
nacl
ml
bovin
cerebr
atpas
depend
activ
enzym
ml
distil
water
enzym
activ
start
addit
atp
solut
min
inhibitor
variou
concentr
cardiac
glycosid
ad
na
k
atpas
activ
measur
coupl
optic
assay
reaction
continu
record
correct
mg
activ
atpas
inhibit
na
k
atpas
ouabain
inhibit
atpas
measur
addit
variou
concentr
test
compound
doserespons
curv
establish
compar
standard
kstrophanthin
potenc
ratio
calcul
brooker
jelliff
marcu
et
al
describ
vitro
assay
base
displac
radiolabel
ouabain
bound
atpas
variou
glycosid
anoth
method
base
inhibit
rubidium
uptak
erythrocyt
lowenstein
belz
prepar
na
k
atpasecontain
cardiac
cell
membran
rat
heart
maixent
et
al
describ
two
na
katpas
isoenzym
canin
cardiac
myocyt
molecular
basi
inotrop
toxic
effect
digitali
effect
ouabain
na
k
atpas
activ
cell
human
rhabdomyosarcoma
cell
line
studi
miller
et
al
special
equip
microphysiomet
mcconnel
et
al
vitro
method
use
determin
plasma
level
glycosid
maixent
et
al
larg
substitut
radioimmunoassay
specif
individu
glycosid
nevertheless
inhibit
na
k
atpas
use
indic
activ
new
semisynthet
cardiac
glycosid
isol
cardiac
tissu
chosen
studi
decreas
perform
prolong
electr
stimul
restor
forc
influenc
cardiac
glycosid
describ
method
use
cat
papillari
muscl
cat
either
sex
weigh
kg
use
anim
anesthet
ether
thorax
open
rapidli
heart
remov
papillari
muscl
right
ventricl
isol
fix
organ
bath
contain
oxygen
ringer
solut
one
end
muscl
tie
tissu
holder
one
strain
gaug
muscl
stimul
electr
v
ms
durat
rate
contract
record
polygraph
h
muscl
begin
fail
forc
contract
diminish
fraction
control
point
cardiac
glycosid
ad
bath
restor
contractil
forc
level
approach
control
standard
dose
ngml
ouabain
potenc
natur
semisynthet
glycosid
determin
method
catecholamin
like
adrenalin
ngml
isoprenalin
ngml
activ
well
increas
contractil
forc
calcul
percentag
predos
level
doserespons
curv
establish
use
variou
dose
use
isol
papillari
muscl
strip
recommend
evalu
inotrop
compound
variou
chemic
class
instead
cat
papillari
muscl
isol
left
atrium
guinea
pig
use
see
sect
test
cardiac
glycosid
calcium
content
ringer
solut
reduc
andersom
compar
respons
guinea
pig
pace
left
atria
variou
posit
inotrop
agent
two
differ
calcium
concentr
mm
consist
good
result
obtain
lower
calcium
concentr
isoproterenol
ouabain
amrinon
et
al
studi
posit
inotrop
substanc
like
isoprenalin
milrinon
isol
cardiac
prepar
differ
sourc
use
isol
papillari
muscl
wistarkyoto
rat
spontan
hypertens
rat
also
human
papillari
muscl
strip
patient
moder
heart
failur
nyha
iiiii
compar
effect
papillari
muscl
strip
patient
sever
heart
failur
nyha
iv
recommend
new
posit
inotrop
agent
screen
human
myocardi
tissu
patient
heart
failur
labow
et
al
recommend
human
atrial
trabecular
prepar
evalu
inotrop
substanc
et
al
test
posit
inotrop
agent
isol
cardiac
prepar
differ
sourc
e
g
human
papillari
muscl
strip
patient
sever
heart
failur
nyha
iv
human
papillari
muscl
strip
patient
moder
heart
failur
nyha
iiiii
human
atrial
trabecula
isol
papillari
muscl
wistarkyoto
rat
isol
papillari
muscl
spontan
hypertens
rat
suggest
posit
inotrop
effect
screen
isol
myocardium
patient
heart
failur
special
strain
syrian
hamster
develop
cardiomyopathi
anim
use
evalu
cardioton
drug
see
sect
hamster
cardiomyopathi
bio
age
week
use
control
normal
syrian
hamster
fib
hybrid
age
anim
pretreat
heparin
mgkg
ip
min
later
heart
prepar
accord
method
langendorff
perfus
heart
ringer
solut
mm
h
hydrostat
pressur
prepar
allow
equilibr
isol
state
min
diastol
preload
g
forc
contract
record
isometr
strain
gaug
transduc
polygraph
e
g
heliscriptor
record
hellig
gmbh
freiburg
germani
signal
heart
rate
measur
chronomet
coronari
flow
measur
electromagnet
flowmet
compound
inject
via
aortic
cannula
inflow
heartring
solut
contractil
forc
coronari
flow
heart
diseas
normal
anim
regist
applic
test
drug
mean
valu
standard
deviat
calcul
drug
applic
statist
compar
use
student
ttest
jasmin
et
al
show
prolong
vivo
administr
benefici
effect
varieti
cardiovascular
drug
includ
verapamil
prenylamin
dibenamin
propranolol
chronic
administr
week
subcutan
weishaar
et
al
found
benefici
effect
calcium
channel
blocker
diltiazem
administr
digitali
contrast
experi
ottenwel
et
al
hamster
treat
oral
digoxin
surviv
show
signific
amelior
patholog
syndrom
heart
failur
ottenwel
je
tapp
wn
natelson
bh
effect
chronic
digitali
therapi
cours
heart
failur
endocrin
function
cardiomyopath
hamster
re
commun
chem
pathol
pharmacol
rajagopalan
r
ghate
av
subbarayan
p
linz
w
schoelken
ba
cardioton
activ
water
solubl
forskolin
deriv
piperidinoacetoxi
arzneim
forschdrug
re
weishaar
burrow
sd
kim
sn
kobylarzsing
dc
andrew
lk
quad
mm
overhis
r
kaplan
hr
protect
fail
heart
compar
effect
chronic
administr
digitali
diltiazem
myocardi
metabol
cardiomyopath
hamster
j
appl
cardiol
cardiac
glycosid
induc
net
loss
potassium
cardiac
tissu
due
inhibit
na
k
atpas
therefor
potassium
increas
effluent
isol
guinea
pig
heart
phenomenon
use
paramet
activ
digitalislik
compound
lindner
hajdu
isol
heart
guinea
pig
accord
langendorff
prepar
describ
sect
coronari
outflow
measur
count
drop
effluent
photocel
effluent
collect
funnel
thin
upward
shape
outlet
allow
withdraw
small
fluid
sampl
analysi
flame
photomet
pump
attach
valv
chang
sampl
flame
photomet
everi
follow
sequenc
effluent
tyrodesolut
heart
distil
water
tyrodesolut
use
perfus
distil
water
potassium
content
affluent
effluent
tyrodesolut
compar
regist
varianrecord
differ
attribut
potassium
outflow
heart
doserespons
curv
flat
therapeut
rang
much
steeper
toxic
rang
follow
paramet
record
calcul
coronari
flow
mlmin
contractil
forc
potassium
loss
mvalmin
good
correl
found
measur
potassium
loss
posit
inotrop
effect
cardiac
glycosid
method
suitabl
quick
determin
efficaci
digitalislik
substanc
facilit
discrimin
posit
inotrop
compound
like
adrenalin
purpos
method
origin
introduc
describ
detail
lind
van
wijingaarden
establish
cat
unit
cardiac
glycosid
prepar
hatcher
brodi
defin
cat
unit
amount
crystallin
ouabain
fatal
within
nineti
minut
kilogram
cat
drug
inject
slowli
almost
continu
femor
vein
time
cardiac
arrest
intraven
infus
solut
defin
concentr
standard
use
refer
unknown
solut
test
prepar
compar
standard
method
use
test
natur
semisynthet
glycosid
cat
either
sex
weigh
kg
temporarili
anesthet
ether
anesthesia
maintain
mgkg
chloralos
given
intraven
anim
fix
leg
heat
oper
tabl
tracheostomi
perform
tracheal
cannula
insert
ecg
record
lead
ii
intraven
infus
test
solut
start
endpoint
cardiac
arrest
reach
within
min
proper
adjust
concentr
infus
solut
hatcher
origin
method
modifi
mani
author
method
use
guinea
pig
introduc
knaffl
essenti
similar
cat
method
guinea
pig
weigh
g
anesthet
urethan
gkg
im
anim
secur
oper
tabl
trachea
cannul
jugular
vein
cannul
infus
test
prepar
cardiac
arrest
record
ecg
lead
ii
dog
guinea
pig
use
mongolian
gerbil
merion
unguiculatu
extrem
suscept
carotid
occlus
peculiar
anatom
occurr
incomplet
circl
willi
without
posterior
commun
arteri
frequent
rudimentari
anterior
commun
arteri
clamp
carotid
arteri
induc
bilater
temporari
brain
ischemia
levin
sohn
bosma
et
al
et
al
hossmann
et
al
chandler
et
al
patholog
anim
model
allow
simul
circulatori
disturb
human
brain
hippocampu
one
vulner
region
brain
ischemia
anoxia
gerbil
known
develop
select
neuron
damag
sector
hippocampu
follow
brief
period
forebrain
ischemia
damag
differ
convent
describ
ischem
neuron
injuri
slow
develop
ito
et
al
kirino
hossmann
et
al
occlus
time
vari
allow
determin
variou
paramet
e
g
ischemia
induc
amnesia
see
sect
male
mongolian
gerbil
strain
hoe
gerk
jird
weigh
g
randomli
divid
group
anim
test
control
group
prior
test
anim
hous
climatecontrol
environ
food
water
avail
ad
libitum
fifteen
minut
surgeri
gerbil
receiv
test
compound
oral
intraperiton
administr
control
group
treat
vehicl
alon
exposur
common
carotid
arteri
perform
anesthesia
sodium
pentobarbit
mgkg
ip
chloralhydr
mgkg
ip
atropin
sulfat
mgkg
ip
carotid
arteri
isol
surround
tissu
loop
unwax
dental
floss
place
around
arteri
cm
length
doubl
lumen
cathet
pass
level
carotid
arteri
muscl
layer
dorsal
surfac
neck
end
dental
floss
thread
separ
lumen
leav
loos
loop
around
arteri
two
day
later
occlus
arteri
produc
gentli
pull
dental
floss
arteri
complet
occlud
floss
center
wall
cathet
heifitz
clip
place
floss
exterior
end
tube
maintain
occlus
variou
interv
min
clip
remov
circul
restor
complet
bilater
occlus
arteri
confirm
behavior
symptom
e
depress
spontan
motor
activ
shallow
rapid
respir
ptosi
care
taken
avoid
drop
bodi
temperatur
stage
experi
experiment
manipul
anim
place
heat
pad
complet
recoveri
motor
activ
subject
place
individu
observ
glass
kept
temperatur
observ
neurolog
symptom
circl
behavior
jump
roll
seizur
opisthotonu
tonic
convuls
etc
min
variou
interv
gerbil
sacrif
brain
remov
follow
paramet
measur
two
hour
occlus
degre
brain
edema
water
content
differ
weight
wet
dri
brain
content
sodium
potassium
hemispher
separ
put
preweight
watch
glass
determin
wet
weight
hemispher
dri
open
petri
dish
day
temperatur
cool
dri
weight
note
sodium
potassium
concentr
dri
brain
hemispher
determin
flame
photometri
na
k
ratio
calcul
histolog
examin
anim
sacrif
day
ischemia
ether
anesthesia
decapit
brain
remov
frozen
co
hippocampi
section
coron
cryostat
section
thick
nissl
glial
fibrillari
acid
protein
gfap
stain
histochem
local
calcium
nissl
stain
quantit
evalu
section
mount
thaw
glass
slide
nissl
stain
cover
slip
permount
order
standard
histolog
procedur
rule
possibl
differ
stain
intens
due
technic
inconsist
slide
control
experiment
group
process
togeth
stain
min
differenti
seri
alcohol
min
extent
hippocamp
nerv
cell
damag
reflect
cell
loss
decreas
stainabl
assess
measur
amount
nisslstain
materi
predetermin
repres
region
area
aid
guid
densitomet
leitz
textur
analysi
system
measur
field
fit
width
soma
layer
calcium
local
modif
techniqu
describ
kashiwa
atkinson
use
cytochem
local
ionic
calcium
principl
techniqu
calcium
complex
chelat
agent
produc
insolubl
chromophor
stock
solut
two
solut
use
glyoxalbi
gbha
ml
absolut
ethanol
ml
gbha
b
naoh
ml
distil
water
ml
naoh
stain
procedur
first
cryostat
section
place
immedi
cold
absolut
aceton
rapid
fixat
min
next
float
section
transfer
alcohol
min
transfer
stain
solut
min
section
place
alcohol
mount
glass
slide
quench
necessari
view
photograph
immedi
gfap
glial
fibrillari
acid
proteingli
fibrillari
acid
protein
fluorescencemicroscopi
follow
slide
mount
cryostat
section
fix
min
formaldehyd
solut
phosphatebuff
salin
pb
section
incub
mous
primari
antibodi
gfap
boehring
mannheim
frg
min
dilut
pb
antibodi
show
cross
reaction
also
gfap
pig
rat
indic
low
speci
select
graber
kreutzberg
section
rins
pb
incub
tetramethylrhodamin
isothiocyan
tritc
specif
mous
immunoglobulin
g
sigma
dilut
pb
control
section
incub
pb
instead
primari
antibodi
measur
express
extinct
unit
per
measur
field
taken
three
slide
anim
averag
statist
analysi
done
student
ttest
sensit
gerbil
select
accord
method
delbarr
et
al
method
pupil
dilat
obtain
atropin
sulfat
min
anesthesia
ocular
fundu
examin
direct
ophthalmoscop
hein
ligat
min
later
anim
absenc
retin
blood
flow
ligat
consid
posit
use
p
nuclear
magnet
reson
spectroscopi
sasaki
et
al
studi
energi
metabol
ischem
brain
gerbil
vivo
unanesthetizedgerbil
model
cerebr
ischemia
describ
chandler
et
al
use
microdialysi
adenosin
metabolit
measur
directli
brain
male
gerbil
dux
et
al
two
microdialysi
probe
carnegi
medicin
sweden
implant
stereotact
brain
anim
one
left
dorsal
hippocampu
one
right
striatum
fibr
fix
cranium
use
dental
wax
dialys
collect
min
interv
concentr
adenosin
hypoxanthin
inosin
determin
hplc
et
al
fredholm
et
al
kindi
et
al
measur
glial
fibrillari
acid
protein
vimentin
mrna
level
northern
blot
analysi
protein
content
immunoblot
analysi
gerbil
neocortex
striatum
hippocampu
transient
ischemia
mcrae
et
al
studi
effect
drug
treatment
activ
microgli
antigen
hippocamp
section
ischemia
gerbil
cerebr
fluid
patient
alzheim
diseas
amyloid
precursor
protein
nurs
corbett
found
neuroprotect
gerbil
global
cerebr
ischemia
sever
day
mild
druginduc
hypothermia
protect
ampaantagonist
nbqx
may
due
decreas
bodi
temperatur
protract
period
subnorm
temperatur
postischem
period
obscur
interpret
preclin
studi
smith
et
al
describ
model
forebrain
ischemia
rat
induc
transient
occlus
carotid
arteri
exsanguin
blood
pressur
mm
hg
method
use
extens
nuglisch
et
al
oberpichl
et
al
rischk
krieglstein
krieglstein
peruch
nuglisch
et
al
prehn
et
al
rischk
krieglstein
seif
el
nasr
et
al
peruch
et
al
male
wistar
rat
weigh
g
anesthet
halothan
connect
starl
type
respir
deliv
halothan
n
jugular
vein
tail
arteri
catheter
withdraw
blood
monitor
blood
pressur
anticoagul
achiev
intraven
heparin
iukg
applic
blood
gase
blood
ph
blood
pressur
blood
glucos
measur
min
prior
ischemia
min
ischemia
halothan
n
discontinu
rat
allow
recov
min
period
muscl
paralysi
maintain
mgkg
suxamethonium
chlorid
repeat
everi
min
inject
trimethaphan
camphor
sulfon
mgkg
forebrain
ischemia
induc
clamp
carotid
arteri
exsanguin
blood
pressur
mm
hg
prevent
decay
intraischem
brain
temperatur
environment
temperatur
adjust
mean
infrar
heat
lamp
min
ischemia
carotid
clamp
remov
blood
pressur
restor
reinfus
shed
blood
minim
system
acidosi
rat
receiv
intraven
mgkg
nahco
anim
remov
respir
regain
spontan
respir
variou
paramet
use
evalu
consequ
transient
forebrain
ischemia
effect
drug
treatment
local
cerebr
blood
flow
determin
c
iodoantipyrin
method
histolog
assess
ischem
cell
damag
hippocampu
day
ischemia
seif
el
nasr
et
al
nuglisch
et
al
local
cerebr
glucos
util
use
c
deoxyglucos
method
describ
quantit
analysi
electrocorticogram
peruch
et
al
kochhar
et
al
use
two
focal
cerebr
ischemia
model
rabbit
multipl
cerebr
embol
model
inject
microspher
intern
carotid
circul
spinal
chord
ischemia
model
occlud
aorta
predetermin
period
gilbo
et
al
describ
isol
mechan
mainten
dog
brain
andju
et
al
krieglstein
et
al
describ
prepar
isol
perfus
rat
brain
studi
effect
cerebr
metabol
cerebr
ischemia
model
consciou
mice
describ
himori
et
al
electr
activ
brain
depend
continu
energi
suppli
hypoxia
induc
test
anim
inhal
nitrogen
mark
hypoxia
depress
cerebr
metabol
result
electr
failur
brain
procedur
use
investig
abil
test
compound
antagon
hypoxiainduc
electr
failur
brain
measur
hypoxiatoler
eeg
recoveri
male
spragu
dawley
rat
strokepron
rat
weigh
g
use
anesthet
hexobarbit
sodium
mgkg
ip
surgic
implant
epidur
eegelectrod
refer
electrod
pariet
frontal
cortex
minimum
one
week
recoveri
period
test
start
rat
receiv
test
compound
intraven
intraperiton
administr
control
group
treat
vehicl
alon
thirti
min
ip
administr
immedi
iv
administr
anim
anaesthet
hexobarbit
sodium
mgkg
ip
stage
surgic
anesthesia
reach
anim
place
hypoxia
chamber
eeg
ecg
record
use
hellig
record
hypoxia
induc
inhal
nitrogen
lh
reach
isoelectr
eeg
nitrogen
inhal
termin
anim
allow
breath
room
air
record
continu
eeg
potenti
regist
follow
paramet
measur
test
control
group
hypoxia
toler
ht
time
start
nitrogen
inhal
onset
isoelectr
eeg
latenc
eeg
recoveri
time
end
nitrogen
inhal
onset
eeg
potenti
valu
test
control
group
compar
percent
chang
calcul
statist
student
ttest
unpair
comparison
perman
middl
cerebr
arteri
mca
occlus
techniqu
rat
wide
employ
evalu
variou
kind
neuroprotect
agent
cerebr
ischemia
ginsberg
busto
focal
cerebr
infarct
achiev
use
modif
mca
occlus
model
describ
tamura
et
al
pak
et
al
adult
male
spraguedawley
rat
weigh
g
use
experi
anim
anesthet
nitrou
oxideoxygen
mixtur
contain
halothan
mask
put
nose
selfrespir
maintain
surgeri
take
around
min
right
femor
arteri
vein
catheter
monitor
blood
pressur
blood
sampl
administr
drug
left
mca
occlus
perform
via
subtempor
approach
without
remov
zygomat
arch
tempor
muscl
high
magnif
surgic
microscop
left
mca
coagul
microbipolar
coagul
olfactori
tract
proxim
portion
mca
cranial
window
mm
diamet
cut
afterward
anesthesia
stop
mca
occlus
arteri
cathet
remov
soon
mca
occlus
venou
cathet
maintain
constant
infus
drug
swivel
system
harvard
apparatu
uk
anim
maintain
normotherm
homeotherm
system
homeotherm
blanket
system
harvard
apparatu
uk
surgeri
mean
arteri
blood
pressur
mabp
record
continu
model
polygraph
grass
usa
arteri
gase
ph
phblood
ga
analyz
corn
usa
well
hematocrit
blood
glucos
measur
twice
min
mca
occlus
follow
mca
occlus
bilater
tempor
muscl
temperatur
therm
ahlborn
messund
regelungstechnik
germani
monitor
surgeri
sever
minut
sacrific
two
six
twelv
twentyfour
hour
discontinu
anesthesia
rat
level
conscious
motor
activ
evalu
use
grade
scale
normal
activ
spontan
activ
arous
tactil
stimul
arous
pain
stimul
spontan
activ
immedi
sacrific
neurolog
statu
examin
use
grade
scale
observ
deficit
forelimb
flexion
decreas
resist
later
push
without
circl
statu
grade
circl
four
group
rat
studi
vehicletr
control
drugtreat
anim
differ
dose
rat
reanesthet
h
mca
occlus
sacrif
intraven
inject
kcl
immedi
sacrific
brain
remov
frozen
min
forebrain
cut
eight
coron
slice
rat
brain
slicer
process
tetrazolium
chlorid
ttc
emuls
techniqu
area
brain
stain
ttc
drawn
diagram
preselect
coron
level
forebrain
without
knowledg
experiment
treatment
area
ischem
damag
cerebr
hemispher
cerebr
cortex
caudat
nucleu
drawn
diagram
measur
planimet
koizumi
japan
integr
determin
volum
salom
et
al
subject
femal
goat
min
global
cerebr
ischemia
halothanen
anesthesia
episod
transient
global
ischemia
achiev
occlus
two
extern
carotid
arteri
simultan
extern
compress
jugular
vein
neck
tourniquet
reperfus
period
start
occlus
releas
monitor
h
de
ley
et
al
studi
experiment
thromboembol
stroke
induc
inject
singl
autolog
blood
clot
intern
cerebr
arteri
dog
bypositron
emiss
tomographi
focal
cerebr
ischemia
rat
induc
irradi
intens
green
light
via
fibr
optic
skull
inject
dye
rose
bengal
result
cerebr
infarct
studi
variou
paramet
infarct
volum
water
content
local
cerebr
blood
flow
glucos
util
male
spraguedawley
rat
g
use
anesthesia
induc
halothan
oxygen
maintain
halothan
oxygen
appli
via
face
mask
small
incis
made
skin
right
femor
vein
thin
cathet
insert
one
ml
dye
rose
bengal
concentr
mgml
salin
inject
midlin
head
incis
made
right
side
skull
expos
intens
green
light
produc
xenon
lamp
zeiss
frg
pass
filter
wavelength
nm
schott
mainz
frg
heat
filter
schott
mainz
frg
direct
skull
level
bregma
min
mm
diamet
illumin
circl
determin
pass
light
fibr
optic
schott
mainz
frg
close
contact
skull
temperatur
skull
underneath
fibr
optic
chang
time
illumin
end
induct
period
temporari
cathet
remov
femor
vein
remain
patent
follow
closur
catheter
site
liquid
sutur
histoacryl
braun
melsungen
frg
incis
leg
head
likewis
sutur
liber
applic
local
anesthet
anesthet
ga
mixtur
discontinu
rat
allow
recov
conscious
warm
environ
time
appropri
experi
perform
due
noninvas
natur
techniqu
possibl
measur
blood
pressur
blood
gase
ischem
period
howev
rectal
temperatur
plasma
glucos
concentr
control
osmot
control
minipump
model
alzet
usa
place
peritoneum
two
group
six
male
spragu
dawley
rat
bodi
weight
g
minipump
fit
via
thin
polyethylen
cathet
femor
vein
rat
pump
contain
either
ml
physiolog
salin
ml
solut
drug
studi
anim
given
ischem
insult
describ
previou
section
seventytwo
hour
induct
ischemia
rat
sacrif
decapit
brain
remov
frozen
coron
section
cut
cryotom
fix
haidenhain
susa
stain
cresyl
violet
ischem
area
section
measur
volum
ischem
chang
calcul
use
linear
trapezoid
extrapol
area
measur
three
group
six
rat
use
one
group
receiv
ischem
lesion
illumin
green
light
omit
experiment
protocol
two
group
lesion
describ
one
lesion
group
receiv
test
drug
oral
min
min
h
induct
ischemia
sham
oper
group
treat
salin
timepoint
twentyfour
hour
later
rat
sacrif
decapit
brain
rapidli
remov
place
cut
block
mm
gradat
two
cut
made
mm
less
anterior
posterior
lesion
thick
section
produc
divid
left
nonles
right
lesion
halv
place
preweigh
vial
wet
weight
tissu
sampl
care
measur
tissu
frozen
liquid
nitrogen
left
vacuum
less
torr
h
remov
vial
seal
prevent
rehydr
reweigh
obtain
dri
weight
tissu
water
content
express
percentag
wet
weight
tissu
calcul
data
present
mean
sd
mean
left
contralater
lesion
right
ipsilater
lesion
comparison
ttest
pair
comparison
use
p
statist
differ
group
calcul
use
unpair
ttest
boquillon
et
al
produc
cerebr
infarct
mice
intraven
inject
mgkg
rose
bengal
focal
illumin
intact
skull
surfac
min
laser
sourc
oper
nm
power
level
mw
matsuno
et
al
use
similar
model
induc
cerebr
ischemia
rat
base
middl
cerebr
arteri
occlus
photochem
reaction
rose
bengal
irradi
high
intens
green
light
stieg
et
al
studi
neuroprotect
nmda
receptorassoci
openchannel
blocker
memantin
photothrombot
model
cerebr
focal
ischemia
neonat
rat
excel
correl
infarct
size
determin
magnet
reson
imag
mri
histopatholog
analysi
anim
found
matsuno
h
uematsu
umemura
k
tagiguchi
asai
murakana
nakashima
simpl
reproduc
cerebr
thrombosi
model
rat
induc
photochem
reaction
effect
plasminplasminogen
activ
chimera
model
j
pharm
toxicol
meth
stieg
pe
sathi
warach
le
da
lipton
sa
neuroprotect
nmda
receptorassoci
openchannel
blocker
memantin
photothrombot
model
cerebr
focal
ischemia
neonat
rat
eur
j
pharmacol
transient
global
ischemia
induc
rat
electrocauter
vertebr
arteri
follow
clamp
carotid
arteri
male
wistar
rat
weigh
g
use
rat
anesthet
methohexit
sodium
mgkg
iv
vertebr
arteri
electrocauter
pulsinelli
brierley
rat
fast
overnight
reanesthet
follow
day
halothan
intub
femor
arteri
vein
cannul
allow
blood
sampl
blood
withdraw
record
mean
arteri
pressur
map
sampl
blood
taken
regular
time
interv
blood
gasacid
base
statu
analyz
instrument
laboratori
rectal
temperatur
measur
thermistor
control
mean
heat
lamp
fourvessel
occlus
ischemia
induc
min
bilater
carotid
clamp
follow
period
reflow
head
rat
fix
stereotact
frame
skin
incis
head
pull
apart
mm
hole
drill
cranium
microdialysi
probe
sandberg
et
al
implant
region
hippocampu
mm
later
mm
dorsal
bregma
window
dialysi
membran
mm
cortic
surfac
electroencephalogram
eeg
measur
continu
tungsten
electrod
attach
dialysi
probe
probe
perfus
rate
modifi
ringer
solut
dialys
sampl
everi
min
analyz
purin
hagberg
et
al
amino
acid
lindroth
et
al
one
group
receiv
test
drug
ip
min
prior
ischemia
wherea
control
group
obtain
salin
anim
follow
min
ischemia
h
reflow
hplc
analys
carri
use
reversephas
c
column
water
isocrat
elut
flow
rate
mlmin
ambient
temperatur
adenosin
inosin
hypoxanthin
mobil
phase
mm
nh
h
po
ph
methanol
ischem
insult
min
reflow
temperatur
temporali
muscl
control
immedi
follow
ischemia
rat
divid
two
group
one
group
treat
test
drug
salin
bolu
inject
administ
ip
min
ischemia
miniosmot
pump
implant
abdomin
caviti
deliv
test
drug
day
control
anim
receiv
bolu
salin
miniosmot
pump
fill
salin
seven
day
later
rat
anesthet
pentobarbit
perfusionfix
formol
salin
histolog
evalu
done
blind
hippocamp
damag
semiquantifi
accord
follow
score
system
damag
scanti
damag
moder
damag
sever
damag
complet
loss
pyramid
cell
hippocampu
purin
amino
acid
data
express
mean
sem
differ
evalu
nonparametr
mannwhitney
test
neuroprotect
efficaci
test
drug
evalu
twotail
student
ttest
addit
assess
neuron
damag
block
et
al
test
spatial
learn
treat
rat
one
week
occlus
morri
water
maze
vitro
releas
adenosin
inosin
hypoxanthin
rat
hippocamp
slice
determin
without
drug
male
spraguedawley
rat
weigh
g
decapit
hippocampi
isol
cut
thick
slice
place
krb
contain
mm
nacl
kcl
mgso
kh
po
nahco
glucos
cacl
equilibr
co
incub
medium
brought
room
temperatur
period
min
krb
replac
fresh
medium
slice
incub
min
room
temperatur
follow
min
fresh
krb
follow
initi
incub
slice
label
min
hadenin
two
label
slice
transfer
plastic
cylind
nylon
net
base
togeth
slice
place
glass
superfus
chamber
slice
superfus
flow
rate
mlmin
krb
min
wash
collect
min
fraction
begin
continu
throughout
remaind
experi
ml
aliquot
fraction
taken
determin
radioact
use
scintil
spectrometri
scintil
fluid
picofluor
remain
ml
taken
hplc
analysi
purin
amino
acid
hypoxiahypoglycemia
induc
superfus
krb
contain
glucos
n
co
min
follow
recoveri
procedur
describ
test
drug
ad
perfus
fluid
appropri
concentr
ml
aliquot
taken
hplc
analysi
pool
two
aliquot
total
ml
lyophil
concentr
fold
analysi
sampl
analyz
adenosin
inosin
hypoxanthin
hplc
radioact
associ
fraction
also
determin
collect
eluent
column
appropri
time
hplc
analys
carri
use
reversephas
c
column
water
isocrat
elut
flow
rate
mlmin
ambient
temperatur
adenosin
inosin
hypoxanthin
mobil
phase
mm
nh
h
po
ph
methanol
valu
adenosin
inosin
hypoxanthin
express
two
way
releas
rate
per
slice
pmolmin
slice
percentag
total
amount
releas
radioact
total
hlabel
releas
purin
data
express
mean
sem
differ
evalu
nonparametr
mannwhitney
test
dunwiddi
tv
use
vitro
brain
slice
neuropharmacolog
electrophysiolog
techniqu
pharmacolog
alan
r
liss
inc
pp
hagberg
h
p
fredholm
b
rudolphi
k
effect
adenosin
uptak
inhibitor
propentofyllin
extracellular
adenosin
glutam
evalu
neuroprotect
efficaci
ischemia
neonat
adult
rat
krieglstein
j
oberpichl
ed
pharmacolog
cerebr
ischemia
wissenschaftlich
verlagsgesellschaft
mbh
stuttgart
pp
cerebr
glucos
util
determin
use
c
accord
local
cerebr
blood
flow
use
c
iodoantipyrin
measur
describ
roger
et
al
synthes
flabel
vesamicol
deriv
evalu
small
anim
positron
emiss
tomographi
hume
et
al
measur
vivo
satur
kinet
two
dopamin
transport
probe
use
small
anim
positron
emiss
tomographi
scanner
cerebr
blood
flow
cerebrovascular
resist
measur
inject
inert
radioact
ga
xenon
evalu
xe
clearanc
curv
anesthet
baboon
experi
perform
baboon
papio
cynocephalu
weigh
kg
initi
sedat
phencyclidin
mg
im
follow
intraven
inject
sodium
thiopent
mgkg
anim
intub
posit
pressur
ventil
deliv
nitrou
oxid
oxygen
open
circuit
continu
intraven
infus
phencyclidin
mgkgmin
given
throughout
cours
experi
suxamethonium
mg
im
administ
everi
min
order
assist
control
ventil
respiratori
pump
experi
end
tidal
concentr
co
continu
measur
ventil
pump
adjust
maintain
arteri
co
tension
paco
mm
hg
control
measur
arteri
blood
sampl
taken
everi
measur
cerebr
blood
flow
cbf
measur
paco
pao
ph
direct
read
electrod
corn
bodi
temperatur
maintain
around
mean
electr
heat
blanket
infrar
heat
lamp
cathet
insert
aorta
via
femor
arteri
continu
measur
arteri
blood
pressur
withdraw
arteri
blood
sampl
femor
vein
cannul
one
continu
infus
phencyclidin
infus
test
drug
cathet
insert
right
lingual
arteri
tip
lay
distal
carotid
bifurc
cathet
flush
regular
interv
heparin
salin
prevent
platelet
aggreg
tip
studi
requir
intraven
administr
test
drug
branch
extern
carotid
arteri
ligat
requir
intracarotid
administr
test
drug
anoth
cathet
retrograd
advanc
extern
carotid
arteri
tip
lay
next
tip
lingual
cathet
cathet
attach
constantr
infus
pump
sage
instrument
heparin
salin
infus
rate
mlmin
act
control
drug
infus
burr
hole
made
midlin
fissur
cathet
insert
sagitt
sinu
withdraw
cerebr
venou
blood
sampl
hole
seal
plaster
pari
scalp
temporali
muscl
remov
diathermi
level
zygomat
arch
collim
scintil
crystal
place
tempor
region
expos
skull
right
side
angl
way
view
brain
overli
skull
approxim
xenon
dissolv
ml
steril
heparin
salin
iu
inject
cathet
lingual
branch
carotid
arteri
gammaray
emiss
xe
detect
scintil
counter
attach
photomultipli
puls
amplifi
subject
puls
height
analysi
peak
kev
kev
reduc
compton
scatter
fed
rate
meter
scaler
output
rate
meter
display
chart
record
cerebr
blood
flow
calcul
heightarea
equat
et
al
formula
use
f
cbf
ml
blood
per
g
brain
tissu
per
min
brain
tissueblood
partit
coeffici
xe
figur
use
veall
mallett
h
maximum
initi
height
xe
clearanc
curv
count
per
min
taken
chart
record
h
height
clearanc
curv
min
peak
height
count
per
total
integr
count
min
clearanc
taken
scaler
correct
background
activ
period
cerebr
oxygen
consumpt
measur
product
dbf
differ
oxygen
content
arteri
blood
cerebr
venou
blood
sampl
sagitt
sinu
blood
oxygen
measur
charcoalfuel
cell
system
lexo
con
estim
cerebrovascular
resist
obtain
subtract
mean
sagitt
sinu
pressur
mean
arteri
pressur
divid
pressur
differ
cbf
electroencephalograph
read
record
bilater
throughout
experi
seri
hole
drill
calvarium
mm
apart
two
row
row
mm
later
sagitt
sutur
hole
thread
receiv
nylon
screw
silversilv
chlorid
ball
electrod
fix
loos
electrod
posit
epidur
free
end
solder
multichannel
socket
mount
calvarium
plaster
pari
follow
complet
surgeri
anim
left
undisturb
h
least
three
control
estim
cbf
paramet
made
steadi
condit
flow
arteri
blood
pressur
blood
ga
tension
obtain
intraven
administr
stabl
control
valu
establish
infus
start
cbf
measur
min
start
min
infus
stop
min
flow
period
give
total
infus
time
min
flow
measur
made
min
stop
infus
intracarotid
administr
establish
control
valu
intracarotid
infus
test
drug
begun
cbf
measur
min
infus
stop
min
commenc
post
infus
measur
made
min
data
present
mean
valu
sem
evalu
statist
signific
perform
mean
student
ttest
bonferroni
correct
kozniewska
et
al
wang
et
al
measur
cerebr
blood
flow
rat
intracarotid
inject
xe
solomon
et
al
clozel
watanab
induc
cerebr
vasoconstrict
inject
autolog
blood
cisterna
magna
rat
cerebr
blood
flow
measur
radioact
microspher
techniqu
lin
et
al
describ
model
subarachnoid
hemorrhageinduc
cerebr
vasospasm
mice
adult
mice
receiv
inject
autolog
blood
cisterna
magna
diamet
larg
intracrani
vessel
measur
h
day
subarachnoid
hemorrhag
diffus
blood
clot
evid
anterior
posterior
circul
vascular
wall
thicken
lumen
narrow
corrug
intern
elast
lamina
observ
acut
h
delay
day
phase
vasoconstrict
occur
subarachnoid
hemorrhag
overal
mortal
model
recommend
screen
therapeut
candid
delay
cerebr
vasospasm
induc
anesthet
dog
remov
ml
cerebrospin
fluid
inject
volum
fresh
autolog
arteri
nonheparin
blood
cisterna
magna
varso
et
al
model
subarachnoid
hemorrhag
procedur
repeat
third
day
angiogram
taken
vertebralbasilar
vessel
reduct
diamet
basilar
arteri
taken
endpoint
imaizumi
et
al
produc
experiment
subarachnoid
hemorrhag
intracistern
inject
arteri
blood
rabbit
degre
vasospasm
effect
calcitonin
generel
peptid
evalu
angiograph
measur
basilar
arteri
diamet
inou
et
al
produc
experiment
subarachnoid
hemorrhag
cynomolgu
monkey
place
clot
around
intern
carotid
arteri
seri
angiograph
analys
perform
subarachnoid
hemorrhag
day
treatment
calcitonin
generel
peptid
examin
chang
diamet
ipsilater
intern
carotid
arteri
middl
cerebr
arteri
anterior
cerebr
arteri
hugh
et
al
adapt
xenon
clearanc
techniqu
simultan
measur
cutan
blood
flow
rabbit
larg
number
skin
site
within
anim
cerebr
blood
flow
anaesthet
cat
measur
fluvographi
heat
transfer
coeffici
brain
measur
probe
repres
indirect
blood
flow
valu
method
measur
devic
consist
thermo
probe
attach
tissu
order
record
continu
heat
transport
hensel
devic
depend
electr
heat
part
unheat
refer
point
differ
temperatur
heat
part
devic
unheat
refer
point
function
local
blood
flow
increas
flow
tend
lower
local
temperatur
carri
away
heat
gain
vice
versa
cat
either
sex
weigh
kg
anaesthet
intraperiton
administr
pentobarbit
sodium
mgkg
intub
tracheal
tube
left
femor
vein
right
femor
arteri
cannul
iv
drug
administr
determin
arteri
blood
pressur
respect
arteri
cannula
connect
statham
transduc
p
db
intraduoden
drug
administr
duodenum
cannul
follow
laparotomi
actual
start
experi
arteri
blood
ga
concentr
determin
anim
use
test
show
normal
blood
ga
concentr
cours
experi
blood
flow
blood
pressur
blood
ga
concentr
regularli
monitor
head
anim
fix
stereotact
devic
skull
cap
dura
open
probe
place
surfac
cortex
region
margin
frontal
gyru
expos
brain
cover
moist
swab
fluvograph
hartmannbraun
frankfurt
use
appropri
thermo
probe
test
correct
posit
thermocoupl
respons
anim
inhal
carbon
dioxid
air
inject
epinephrin
adrenalin
use
lead
distinct
increas
cerebr
blood
flow
follow
stabil
paramet
mention
standard
compound
administ
chang
blood
flow
record
five
min
obtain
origin
valu
test
compound
administ
standard
compound
pentoxifyllin
mgkg
iv
administr
mgkg
id
administr
percent
chang
heat
transfer
coeffici
use
indirect
measur
chang
cerebr
blood
flow
statist
student
ttest
perform
unpair
comparison
principl
laser
doppler
effect
base
fact
laser
light
beam
direct
tissu
scatter
static
structur
well
move
cell
light
beam
scatter
move
red
cell
undergo
frequenc
shift
accord
doppler
effect
beam
scatter
static
tissu
alon
remain
unshift
frequenc
number
doppler
shift
per
time
record
measur
erythrocyt
flow
given
volum
mean
direct
flow
determin
rel
chang
micro
circulatori
blood
flow
record
procedur
use
detect
test
compound
improv
blood
suppli
brain
flow
red
blood
cell
ischem
skelet
muscl
male
spraguedawley
rat
weigh
g
anaesthet
pentobarbit
sodium
mgkg
ip
trachea
expos
intub
short
tracheal
tube
allow
ventil
follow
vessel
cannul
femor
vein
cannul
test
drug
administr
femor
arteri
cannul
blood
pressur
record
blood
ga
analysi
actual
start
experi
arteri
blood
ga
concentr
determin
anim
use
test
show
normal
blood
ga
concentr
pa
co
mm
hg
pa
mm
hg
mean
arteri
blood
pressur
drop
mm
hg
cours
experi
blood
flow
blood
pressur
blood
ga
concentr
regularli
monitor
head
anim
fix
stereotact
devic
trepan
skull
open
mm
diamet
laser
doppler
probe
place
mm
surfac
brain
valu
measur
laser
doppler
apparatu
periflux
perim
kb
stockholm
follow
stabil
paramet
mention
standard
compound
administ
chang
blood
flow
record
five
min
obtain
origin
valu
test
compound
infus
follow
two
administr
test
compound
standard
compound
administ
durat
effect
measur
half
life
second
small
area
femor
arteri
right
hind
limb
expos
laser
doppler
probe
place
mm
muscl
surfac
actual
start
experi
arteri
blood
ga
concentr
determin
anim
use
proceed
show
normal
blood
ga
concentr
cours
experi
blood
pressur
record
rbc
flux
record
continu
stabil
output
signal
femor
arteri
occlud
lead
underperfus
muscl
right
pelvic
limb
stage
test
compound
administ
intraven
infus
min
mlmin
standard
compound
cerebr
blood
flow
propentofyllin
mgkg
iv
percent
increas
blood
flow
produc
propentofyllin
rang
percent
increas
blood
flow
test
drug
administr
determin
compar
valu
drug
administr
statist
student
ttest
unpair
comparison
test
substanc
versu
standard
iadecola
prado
et
al
raszkiewicz
et
al
measur
influenc
nitric
oxid
cortic
cerebr
blood
flow
anesthet
rat
laserdoppl
flowmetri
benessiano
et
al
measur
aortic
blood
flow
rangeg
doppler
flowmet
anesthet
rat
partridg
measur
nerv
blood
flow
sciatic
nerv
anesthet
rat
laser
doppler
flowmet
applic
local
anesthet
epinephrin
result
sustain
sensorymotor
cognit
defect
tang
et
al
report
impair
learn
memori
experiment
model
concuss
brain
injuri
mice
bemana
nago
induc
acut
intercrani
hypertens
cat
continu
inflat
extradur
balloon
physiolog
salin
constant
rate
mlh
h
point
inflat
discontinu
balloon
remain
expand
addit
hour
deflat
model
traumat
injuri
spinal
cord
use
springer
et
al
femal
long
evan
rat
weigh
g
anesthet
pentobarbit
dorsal
laminectomi
perform
expos
spinal
cord
thorac
level
vertebr
column
stabil
clamp
column
vertebra
new
york
univers
nyu
impactor
devic
use
produc
accur
reproduc
damag
rat
spinal
cord
gruner
basso
et
al
devic
weight
drop
apparatu
use
optic
potentiomet
record
movement
impact
rod
vertebr
column
follow
impact
connect
pc
monitor
rod
vertebr
movement
impact
smm
adc
map
calcul
pixelwis
use
monoexponenti
model
le
bihan
et
al
perfusionweight
imag
perform
ultrafast
version
arteri
spin
tag
techniqu
kersken
et
al
frank
et
al
four
rat
per
group
independ
experi
three
coron
slice
record
thu
cover
central
part
ischem
lesion
measur
paramet
te
ms
tr
ms
matrix
averag
experi
consist
two
imag
acquisit
separ
recoveri
period
first
acquisit
blood
flow
neck
adiabat
invert
prepar
time
zgradient
mtm
field
mg
offreson
frequenc
hz
mean
prepar
distanc
cm
upstream
imag
plane
second
acquisit
inflow
spin
left
undisturb
phase
separ
recoveri
period
perfus
experi
two
imag
suffer
signal
loss
due
magnet
transfer
effect
differ
magnet
inflow
blood
perfusionweight
imag
obtain
subtract
acquisit
without
prior
adiabat
spin
invers
second
acquisit
inflow
spin
left
undisturb
perfusionweight
imag
obtain
subtract
acquisit
without
prior
adiabat
spin
invers
data
transfer
pc
imag
analysi
carri
use
imag
process
softwar
scion
imag
window
scion
corpor
frederick
md
usa
lesion
volum
calcul
use
adc
map
ischem
lesion
area
estim
sum
pixel
rel
adc
compar
healthi
contralater
hemispher
hoehnberlag
et
al
perfus
signal
intens
refer
homolog
contralater
region
given
ratio
ipsilater
contralater
valu
ms
wi
dwi
ms
pdwi
dwi
diffusionsensit
gradient
bvalu
smm
appli
along
inferior
superior
axi
brain
two
averag
acquir
per
phase
encod
step
imag
collect
inplan
resolut
mm
contigu
slice
total
acquisit
time
min
perfus
hindquart
rat
constant
flow
rate
allow
evalu
effect
drug
peripher
vascular
bed
sinc
constant
blood
flow
maintain
chang
vascular
resist
perfus
bed
directli
proport
chang
perfus
pressur
variou
method
exist
measur
peripher
blood
flow
rat
microspher
techniqu
electromagnet
flowmetri
doppler
ultrason
flowmetri
radioact
microspher
use
calcul
distribut
blood
heart
variou
organ
tissu
administr
test
compound
method
microspher
inject
left
cardiac
ventricl
postul
first
contract
cardiac
muscl
expel
sphere
circul
consequ
microspher
trap
differ
organ
accord
organ
perfus
rate
primari
screen
method
use
test
distinguish
compound
blood
flow
alter
activ
microspher
use
diamet
mark
isotop
test
four
differ
radioact
element
use
cr
sr
sc
ce
allow
determin
blood
flow
dose
administr
differ
compound
differ
dose
compound
male
wistar
rat
weigh
g
anaesthet
pentobarbit
trachea
expos
intub
short
endotrach
tube
allow
ventil
prior
test
jugular
vein
cannul
administr
test
drug
carotid
arteri
cannul
later
cathet
pass
retrograd
ventricl
ventricular
pressur
record
assur
correct
emplac
cathet
tip
ventricl
cathet
connect
anoth
cathet
allow
inject
microspher
left
ventricl
later
right
arteria
brachiali
cannul
connect
hellig
blood
pressur
record
cours
test
blood
pressur
measur
continu
left
femor
arteri
cannul
connect
infus
pump
experi
blood
withdrawn
arteri
prepar
rat
allow
min
recov
actual
start
experi
arteri
blood
ga
concentr
anim
measur
anim
use
experi
show
normal
blood
ga
concentr
follow
procedur
blood
pressur
ventricular
pressur
heart
rate
continu
record
determin
baselin
blood
flow
anim
receiv
ml
vehiclemin
min
period
minut
rat
receiv
first
inject
microspher
cr
simultan
mlmin
blood
withdrawn
femor
arteri
cathet
one
minut
pump
thu
use
refer
organ
anim
allow
min
recov
administr
drug
test
compound
infus
jugular
vein
rate
mlmin
min
follow
inject
second
microspher
sr
procedur
repeat
use
two
microspher
sc
ce
follow
administr
second
third
test
compound
end
experi
blood
ga
concentr
measur
anim
kill
organ
remov
usual
blood
flow
determin
follow
organ
determin
effect
test
compound
blood
flow
underperfus
skelet
muscl
experi
perform
right
femor
arteri
clamp
way
effect
test
drug
ischem
normal
skelet
muscl
left
thorac
limb
compar
anim
rate
blood
flowtissu
certain
time
determin
measur
radioact
differ
tissu
compar
result
blood
sampl
blood
flow
variou
peripher
organ
e
g
renal
blood
flow
measur
electromagnet
flowmet
e
g
transflow
skalar
medic
holland
doppler
ultrason
flowmetri
shaffer
medvedev
lapp
et
al
studi
region
vascular
resist
consciou
spontan
hypertens
rat
chronic
instrument
puls
doppler
flow
probe
allow
measur
renal
mesenter
hind
quarter
blood
flow
hartman
et
al
valid
transittim
ultrason
volum
flow
meter
simultan
measur
electromagnet
flow
meter
method
lepor
et
al
use
electron
paramagnet
reson
investig
time
cours
nitric
oxid
gener
suscept
nitric
oxid
synthas
ischemiareperfus
injuri
rat
skelet
muscl
vivo
total
hind
limb
ischemia
appli
h
use
rubber
band
tourniquet
method
end
ischemia
tourniquet
remov
limb
allow
reperfus
variou
time
interv
beatti
et
al
measur
carotid
arteri
vascular
resist
anesthet
rabbit
carotid
blood
flow
measur
doppler
flow
probe
place
around
right
common
carotid
arteri
doserespons
curv
reduct
carotid
arteri
vascular
resist
construct
inject
variou
dose
substanc
pmethyl
ester
via
right
lingual
arteri
intraven
inject
variou
dose
select
tachykinin
nk
receptor
antagonist
inhibit
effect
dosedepend
effect
blood
pressur
analyz
whether
mediat
central
cardial
peripher
action
inject
small
dose
test
compound
directli
vascular
bed
thu
avoid
chang
central
hemodynam
peripher
vasodil
activ
compound
test
test
use
evalu
direct
vasodil
constrict
activ
drug
vivomeasur
blood
flow
male
femal
beagl
labradorharri
dog
weigh
kg
use
dog
premed
intraven
heparin
bolu
iukg
success
inject
iukg
everi
min
anesthet
intraven
inject
thiobarbit
sodium
mgkg
iv
chloralos
mgkg
iv
urethan
mgkg
iv
respir
maintain
room
air
tracheal
tube
use
posit
pressur
respir
blood
ga
analysi
perform
regular
time
interv
oxygen
suppli
via
respir
need
measur
peripher
blood
flow
administ
test
substanc
bypass
insert
femor
arteri
incorpor
electromagnet
flow
probe
port
inject
femor
arteri
also
equip
bypass
use
administr
refer
compound
second
test
drug
record
peripher
blood
pressur
heart
rate
one
bypass
connect
pressur
transduc
statham
p
bd
paramet
record
continu
whole
experi
stabl
hemodynam
condit
achiev
least
min
vehicl
administ
control
min
later
test
compound
immedi
administr
port
flush
physiolog
salin
success
dose
administ
recoveri
baselin
valu
read
taken
time
min
necessari
addit
mininterv
follow
drug
administr
standard
compound
carbocromen
mgkg
characterist
blood
pressur
systol
bp
diastol
bpd
heart
rate
hr
peripher
blood
flow
pf
chang
blood
pressur
heart
rate
peripher
blood
flow
differ
time
drug
administr
compar
vehicl
control
valu
obtain
min
predrug
period
n
result
present
mean
sem
statist
signific
assess
mean
pair
ttest
score
compar
efficaci
standard
compound
intens
durat
effect
region
blood
flow
determin
use
microspher
rudolph
heyman
method
base
principl
biolog
inert
microspher
trap
due
diamet
microvasculatur
hale
cliff
use
radioact
microspher
disadvantag
buckberg
et
al
use
fluoresc
label
microspher
measur
region
organ
perfus
recommend
glenni
et
al
prinzen
glenni
van
oosterhout
et
al
raab
et
al
thein
et
al
describ
autom
use
fluoresc
microspher
use
special
sampl
process
unit
zymaterobot
system
zymark
idstein
germani
modifi
handl
special
filtrat
devic
measur
renal
blood
flow
dog
intraren
arteri
infus
adrenomedullin
local
oxygen
pressur
directli
relat
oxygen
suppli
peripher
organ
e
g
muscl
luebber
local
oxygen
pressur
po
record
directli
muscl
surfac
follow
procedur
effect
test
compound
local
oxygen
pressur
po
normal
ischem
skelet
muscl
determin
male
beagl
dog
weigh
kg
use
dog
anesthet
intraperiton
administr
pentobarbit
sodium
nembut
prior
test
follow
vessel
cannul
v
femorali
left
pelvic
limb
cannul
administr
test
compound
femorali
left
pelvic
limb
cannul
blood
pressur
record
v
femorali
right
pelvic
limb
cannul
cours
test
blood
withdrawn
vein
monitor
lactat
concentr
small
area
muscl
right
pelvic
limb
right
thorac
limb
expos
muscl
relax
induc
intraven
inject
mgkg
alcuronium
chlorid
alloferin
maintain
ip
administr
mgkg
alloferin
min
interv
trachea
expos
intub
assist
dog
respir
po
electrod
place
expos
muscl
area
right
hind
limb
stabil
po
curv
femor
arteri
right
hind
limb
occlud
put
clip
around
vessel
muscl
po
drop
rapidli
follow
stabil
test
compound
given
intraven
infus
min
intraduoden
administr
stage
po
non
ischem
muscl
record
simultan
via
second
electrod
right
thorac
extrem
clip
remov
maxim
one
hour
procedur
repeat
four
time
one
anim
blood
ga
concentr
ph
determin
begin
end
experi
standard
compound
pentoxifyllin
follow
paramet
determin
maxim
increas
po
mm
hg
administr
test
drug
durat
effect
determin
half
life
blood
flow
mesenter
vascular
bed
situ
eikenburg
randal
et
al
jackson
inagami
studi
rat
way
similar
perfus
hindquart
wistar
rat
either
sex
weigh
g
anesthet
combin
urethan
mgkg
iv
sodium
pentobarbiton
mg
kg
abdomen
open
midlin
incis
segment
superior
mesenter
arteri
expos
care
dissect
surround
tissu
care
taken
avoid
damag
accompani
nerv
termin
one
cannula
insert
carotid
arteri
superior
mesenter
arteri
blood
carotid
arteri
forc
peristalt
pump
desaga
superior
mesenter
arteri
use
glass
coil
kept
blood
requir
fill
tube
initi
obtain
donor
rat
heparin
administ
intraven
anim
prior
cannul
mesenter
arteri
blood
pressur
perfus
pressur
measur
statham
p
db
pressur
transduc
record
hellig
record
pump
speed
initi
adjust
perfus
pressur
equal
system
blood
pressur
intraarteri
inject
mesenter
vascular
bed
made
punctur
tube
go
toward
peripheri
intraven
inject
made
cannula
insert
extern
jugular
vein
chang
vascular
resist
measur
compar
perfus
pressur
drug
administr
constant
blood
flow
maintain
chang
vascular
resist
perfus
bed
directli
proport
chang
perfus
pressur
control
pulmonari
blood
flow
lobar
arteri
pressur
measur
anesthet
cat
lippton
et
al
hyman
et
al
mcmahon
kadowitz
dewitt
et
al
adult
cat
either
sex
weigh
kg
sedat
ketamin
hydrochlorid
mgkg
im
anesthet
pentobarbit
sodium
mg
kg
iv
anim
fix
supin
posit
supplement
dose
anesthet
administ
maintain
uniform
level
anesthesia
trachea
intub
anim
breath
room
air
enrich
co
system
arteri
pressur
measur
cathet
insert
aorta
femor
arteri
intraven
inject
made
cathet
posit
inferior
vena
cava
femor
vein
perfus
left
lower
lung
lobe
special
design
triplelumen
balloon
perfus
cathet
arrow
intern
read
pa
pass
fluoroscop
guidanc
left
extern
jugular
vein
arteri
left
lower
lobe
anim
heparin
iukg
iv
lobar
arteri
isol
distens
balloon
cuff
perfus
cathet
lobe
perfus
way
cathet
lumen
beyond
balloon
cuff
blood
withdrawn
femor
arteri
perfus
pump
lobar
arteri
pressur
measur
second
port
mm
cuff
perfus
cathet
perfus
rate
adjust
lobar
arteri
perfus
pressur
approxim
mean
pressur
main
pulmonari
arteri
left
atrial
pressur
measur
doublelumen
cathet
pass
transsept
vein
drain
left
lower
lobe
cathet
tip
posit
left
atrial
pressur
port
distal
lumen
cm
lobar
vein
second
cathet
port
near
venoatri
junction
lobar
arteri
pressur
elev
high
steadi
state
level
administr
n
nitrolarginin
follow
intralobar
infus
stabl
prostaglandinendoperoxid
analogu
doserespons
curv
administr
grade
dose
drug
e
g
decreas
lobar
arteri
pressur
skelet
muscl
stimul
reach
maxim
forc
contract
mean
muscl
forc
function
level
near
exhaust
use
maxim
substrat
suppli
circul
femor
arteri
occlud
lead
underperfus
subsequ
lack
substrat
consequ
muscl
forc
contract
decreas
rapidli
measur
chang
contractil
forc
caus
drug
administr
reveal
drug
abil
restor
ischem
muscl
function
follow
procedur
drug
test
effect
forc
contract
ischem
skelet
muscl
male
wistar
rat
weigh
g
anaesthet
intraperiton
administr
pentobarbit
nembut
mgkg
tracheal
tube
place
assist
rat
ventil
left
carotid
arteri
cannul
blood
pressur
record
left
jugular
vein
cannul
iv
administr
test
drug
incis
made
skin
right
pelvic
limb
distal
groin
skelet
muscl
expos
ankl
skin
care
trim
away
muscl
assur
contract
impair
retract
skin
major
nerv
suppli
sever
small
length
descend
branch
femor
arteri
prepar
free
freeli
hang
muscl
attach
forc
transduc
rang
g
z
rhema
germani
rest
tension
g
place
muscl
prevent
dehydr
skin
left
attach
muscl
muscl
kept
moist
continu
drip
naclsolut
prepar
rat
allow
recov
least
min
two
needl
electrod
insert
muscl
squar
impuls
ms
gener
stimul
hugo
sach
elektronik
freiburg
germani
muscl
stimul
frequenc
contract
per
minut
amplitud
increas
gradual
muscl
maxim
contractil
forc
usual
follow
stabil
femor
arteri
occlud
clip
min
subsequ
reopen
least
min
test
drug
administ
intraven
infus
mlmin
min
five
minut
start
drug
infus
arteri
clamp
min
drug
infus
still
go
forc
contract
continu
record
declamp
arteri
rat
allow
recov
least
min
whole
procedur
repeat
anoth
test
drug
way
differ
compound
test
anim
standard
compound
pentoxifyllin
follow
paramet
measur
percent
inhibit
contractil
forc
drug
administr
arteri
clamp
percent
inhibit
contractil
forc
drug
administr
arteri
clamp
percent
increas
contractil
forc
drug
administr
calcul
attempt
made
measur
effect
drug
vasculatur
tonu
also
muscl
metabol
weselcouch
demusz
studi
drug
effect
ischem
hindlimb
ferret
hindlimb
stimul
contract
isometr
via
supramaxim
electr
stimul
sciatic
nerv
ischemia
induc
partial
occlus
abdomin
aorta
pentoxifyllin
attenu
loss
function
doserel
manner
okyayuzbaklouti
et
al
studi
function
histomorpholog
biochem
chang
atrophi
skelet
muscl
use
novel
immobil
model
rat
le
tallec
et
al
report
effect
dimethylformamid
vivo
fatigu
metabol
rat
skelet
muscl
measur
nuclear
magnet
reson
spectroscopi
compound
isol
rabbit
ear
use
determin
effect
test
compound
perfus
rate
administr
norfenephrin
induc
vasoconstrict
lead
decreas
perfus
rate
compound
vasodilatori
properti
inhibit
norfenephrin
induc
fall
perfus
rate
wherea
vasoconstrictor
potenti
effect
miyahara
et
al
use
arteri
ring
rabbit
ear
arteri
vitro
contract
perivascular
nerv
stimul
noradrenalin
high
potassium
mm
solut
high
dose
dexamethason
decreas
amplitud
contract
furthermor
author
perform
vivo
experi
albino
rabbit
wherebi
fur
remov
distal
part
ear
appli
depilatori
cream
least
h
experi
apic
region
ear
strip
adhes
tape
time
remov
keratin
epiderm
layer
rabbit
anesthet
experiment
part
ear
place
high
resolut
magnifi
camera
immobil
use
bilay
adhes
tape
vascular
reaction
induc
topic
applic
corticosteroid
record
chronic
use
videotap
aoki
chiba
describ
method
separ
intralumin
extralumin
perfus
basilar
arteri
dog
polyethylen
roof
design
cover
canin
basilari
arteri
extralumin
superfus
stream
could
pass
arteri
simultan
receiv
intralumin
perfus
vein
classifi
two
group
respond
respond
epinephrin
acetylcholin
sympathet
nerv
stimul
studi
dog
shown
rice
et
al
reactiv
vein
consider
amount
smooth
muscl
wherea
nonreact
one
lack
appreci
amount
smooth
muscl
fibr
tunica
media
special
prepar
allow
registr
local
venou
vasoconstrict
dog
weigh
kg
anesthet
mgkg
pentobarbit
sodium
iv
trachea
cannul
dog
ventil
respir
pump
femor
vein
cannul
system
inject
administr
mgkg
heparin
sodium
iv
saphen
vein
femor
arteri
cannul
venou
cannula
place
approxim
cm
distal
junction
anoth
vein
nonperfus
branch
junction
ligat
constant
blood
flow
maintain
femor
arteri
use
sigmamotor
pump
flow
adjust
normal
physiolog
pressur
vein
maintain
perfus
pressur
measur
pump
vein
chang
pressur
reflect
chang
venou
resist
peak
chang
perfus
pressur
use
measur
pressur
chang
record
data
blood
flow
maintain
constant
level
therefor
chang
pressur
must
reflect
chang
resist
pressur
record
polygraph
use
statham
pressur
transduc
addit
record
perfus
pressur
venou
pressur
measur
two
addit
point
along
vein
order
record
venou
pressur
central
site
perfus
shaft
needl
place
end
cm
piec
thin
silast
tube
end
gaug
needl
insert
attach
statham
pressur
transduc
pressur
record
polygraph
one
needl
insert
vein
proxim
junction
two
vein
second
needl
place
vein
distanc
tip
perfus
cannula
first
needl
distanc
two
needl
way
pressur
decreas
across
junction
adjac
segment
measur
simultan
inject
test
compound
made
cannula
pump
saphen
vein
chang
pressur
measur
three
transduc
record
standard
dose
norepinephrin
inject
respons
test
drug
measur
mm
hg
calcul
percentag
respons
norepinephrin
clinic
standard
diagnos
abdomin
aortic
aneurysm
proliferatoractiv
receptor
ligand
potent
inhibitor
angiogenesi
vitro
vivo
j
biol
chem
chick
chorioallanto
membran
assay
origin
describ
auerbach
et
al
use
modif
sever
author
test
angiogenesi
inhibit
angiogenesi
e
g
taylor
folkman
vu
et
al
mcnatt
et
al
gagliardi
collin
ribatti
et
al
oikawa
shimamura
reilli
et
al
iurlaro
et
al
fertil
white
leghorn
chicken
egg
incub
constant
humid
incub
day
squar
window
open
shell
ml
albumen
remov
allow
detach
develop
chorioallanto
membran
cam
window
seal
glass
egg
return
incub
day
mm
gelatin
spong
load
phosphatebuff
salin
alon
neg
control
contain
mgml
angiogen
recombin
basic
fibroblast
growth
factor
alon
posit
control
togeth
variou
dose
test
compound
implant
top
cam
spong
trap
sampl
allow
slow
releas
product
cam
examin
daili
day
angiogen
respons
peak
day
blood
vessel
enter
spong
within
focal
plane
cam
recogn
microscop
count
two
observ
doubleblind
fashion
zeiss
sr
stereomicroscop
photograph
ovo
camera
system
zeiss
oberkochen
germani
better
highlight
vessel
cam
inject
larg
allanto
vein
india
ink
solut
fix
serra
fluid
dehydr
grade
ethanol
render
transpar
methylbenzo
day
microscop
count
embryo
membran
fix
ovo
bouin
fluid
spong
underli
immedi
adjac
cam
portion
remov
embed
paraffin
section
along
plane
parallel
cam
surfac
stain
aqueou
solut
toluidin
blue
angiogenesi
measur
planimetr
point
count
method
four
six
magnif
field
cover
almost
whole
everi
third
section
within
serial
slide
spong
per
sampl
analyz
within
superimpos
intersect
point
squar
reticulum
mm
transvers
section
microvessel
ie
capillari
venul
without
lumen
occupi
intersect
point
count
calcul
mean
sd
per
section
per
cam
group
cam
statist
signific
differ
calcul
compar
data
experi
control
use
student
ttest
oh
et
al
studi
lymphat
differenti
avian
chorioallanto
membran
use
microinject
mercox
resin
semiand
ultrathin
section
immunohistochem
detect
fibronectin
muscl
actin
situ
hybrid
vascular
endotheli
growth
factor
probe
use
chick
chorioallanto
membran
assay
giannopoul
et
al
show
amifostin
inorgan
thiophosphatecytoprotect
agent
inhibit
angiogenesi
vivo
lichtenberg
et
al
lichtenberg
et
al
recommend
subcutan
air
sac
model
rat
simpl
method
vivo
screen
antiangiogenesi
subcutan
inject
air
rat
result
format
air
pouch
air
pouch
kept
inflat
repeat
inject
air
develop
structur
synovi
line
edward
et
al
subcutan
air
pouch
appear
like
bursal
caviti
synovi
joint
kowanko
et
al
day
cell
air
sac
appear
transpar
membran
format
new
vessel
studi
anesthesia
ml
air
introduc
dorsal
femal
spragu
dawley
rat
weigh
g
subcutan
inject
use
gaug
needl
produc
air
sac
locat
approxim
cm
behind
head
anim
air
sac
reinflat
everi
forth
day
wall
air
sac
becom
progress
thicker
time
approxim
day
suffici
line
cell
establish
spong
implant
anim
anesthet
cm
incis
made
clip
skin
cover
air
sac
blunt
dissect
use
open
cm
deep
caviti
toward
cranial
base
air
sac
care
separ
skin
membran
cellulos
implant
spontex
spong
diamet
mm
care
press
caviti
membran
away
incis
site
incis
close
sutur
anim
treat
day
variou
dose
test
compound
volum
mlkg
vehicl
subcutan
inject
made
light
co
anesthesia
hind
leg
cm
away
air
sac
inject
site
chosen
elimin
risk
induc
irrit
sideeffect
membran
day
treatment
anim
sacrif
receiv
min
inject
ilabel
immunoglobulin
via
tail
vein
overli
skin
air
sac
remov
expos
transpar
membran
extent
vascular
prolifer
score
situ
slight
background
vascular
new
vessel
reach
spong
mani
new
vessel
reach
penetr
implant
intens
format
new
vessel
reach
penetr
implant
follow
situ
score
implant
membran
anim
place
plastic
vial
contain
formalin
radioact
measur
counter
implant
examin
microscop
stain
haematoxylin
eosin
extent
vascular
prolifer
score
situ
compar
vehicl
treat
anim
wilcoxon
test
angiogen
respons
measur
iactiv
cpm
subject
analysi
varianc
follow
dunnett
ttest
compar
dose
vehicl
cpm
logtransform
obtain
varianc
homogen
correl
situ
score
cpm
estim
spearman
rank
correl
coeffici
rank
cpm
valu
studi
lichtenberg
et
al
inocul
vascular
endotheli
growth
factor
produc
tumor
cell
subcutan
directli
membran
format
vessel
measur
day
later
furthermor
slowreleas
pellet
contain
angiogen
factor
basic
fibroblast
growth
factor
vascular
endotheli
growth
factor
implant
subcutan
membran
nakamura
et
al
studi
suppress
angiogenesi
induc
mous
tumor
cell
dorsal
air
sac
assay
mice
funahashi
et
al
develop
mous
dorsal
air
sac
model
quantifi
vivo
tumorinduc
angiogenesi
determin
measur
blood
volum
area
skin
held
contact
tumor
cellcontain
chamber
use
crlabel
red
blood
cell
schreiber
et
al
describ
hamster
cheek
pouch
assay
test
angiogenicantiangiogen
activ
new
simpl
method
vivo
screen
antiangiogenesi
pharmacol
toxicol
lichtenberg
j
hjarnaa
p
jv
kristjansen
peg
hansen
binderup
l
rat
subcutan
air
sac
model
quantit
assay
antiangiogenesi
induc
vessel
pharmacol
toxicol
nakamura
katsuki
shibutani
oikawa
dienogest
synthet
steroid
suppress
embryon
tumorcellinduc
angiogenesi
eur
j
pharmacol
schreiber
ab
winkler
derynk
r
transform
growth
potent
angiogen
factor
epiderm
growth
factor
scienc
norrbi
et
al
norrbi
et
al
norrbi
et
al
describ
mesenter
window
assay
rat
quantit
measur
induct
inhibit
angiogenesi
tissu
use
membran
windowlik
part
mesenteri
normal
vascular
appear
lack
signific
physiolog
angiogenesi
sinc
mesenter
window
nativ
measur
thick
vasculatur
virtual
twodimension
due
structur
metabol
simplic
test
tissu
mesenter
window
microvasculatur
regard
ideal
test
system
establish
function
influenc
defin
factor
zweifach
angiogenesi
induc
ip
inject
mastcel
secretagogu
compound
twice
daili
day
male
spragu
dawley
rat
weigh
g
test
compound
salin
inject
sc
h
inject
compound
angiogenesi
quantifi
microscop
count
number
vessel
profil
per
unit
length
mesenter
window
microtom
section
per
specimen
cut
perpendicularli
surfac
central
part
window
reflect
degre
branch
degre
tortuos
degre
spatial
expans
vasculatur
four
specimen
per
anim
analyz
four
mesenter
window
specimen
spread
fix
object
slide
stain
toluidin
blue
measur
rel
vascular
area
three
randomli
select
vascular
view
field
per
mesentericwindow
spread
analyz
microvascular
length
per
unit
area
vascular
tissu
total
microvascular
length
comput
vascular
area
anim
multipli
mean
microvascular
length
correspond
treatment
group
nonparametr
twotail
mannwhitney
u
rank
sum
test
unpair
observ
use
statist
analysi
c
express
secret
use
polyclon
antivegfc
antiserum
cell
grown
confluenc
tissu
cultur
flask
nunc
roskild
denmark
condit
media
collect
lowserum
growth
condit
tumor
tissu
snapfrozen
liquid
nitrogen
homogen
ripa
buffer
sd
igep
nadeoxychol
proteaseinhibitor
cocktail
phosphatebuff
salin
vegfc
antibodi
isol
serum
use
hitrap
proteina
sepharos
column
deplet
antihi
antibodi
fraction
done
antigenaffin
purif
use
mg
immobil
txntb
protein
tryparedoxin
txn
trypanosoma
brucei
tb
antigenaffin
purif
antibodi
perform
immobil
mg
rat
vegfc
nhsactiv
hitrap
column
amersham
bioscienc
freiburg
develop
highli
sensit
specif
sandwich
elisa
vegfc
done
use
standard
method
rabbit
igg
use
coat
antigenaffin
purifi
biotinyl
antibodi
use
detector
antibodi
biotinyl
antibodi
done
mg
igg
mm
carbon
buffer
ph
mgml
use
biotinamidohexano
acid
nh
sigma
st
loui
mo
usa
molecular
ratio
biotin
protein
standard
human
rat
dndcvegfc
use
concentr
rang
ngml
visual
detector
streptavidinenzym
conjug
use
endogen
woburn
mass
usa
follow
addit
tmb
tetramethylbenzidin
roch
mannheim
germani
stop
reaction
h
absorb
measur
nm
elisa
plate
reader
labsystem
finland
gener
sampl
analyz
differ
dilut
measur
dilut
duplic
sampl
dilut
least
sampl
diluent
bendermedsystem
vienna
rissanen
et
al
found
vegfd
strongest
angiogenesi
lymphangiogenet
factor
among
vegf
deliv
skelet
muscl
via
adenovirus
overnight
embed
oct
cryostat
section
view
fluoresc
microscopi
